Implantable Electrodes for Upper Limb Prosthetic Control by Lancashire, HT
Implantable Electrodes for Upper Limb
Prosthetic Control
Henry Thomas Lancashire
A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Engineering
of the
University College London.
Department of Chemistry
University College London
10th September 2015
I think you’ll find it’s a bit more complicated
than that ...
Dr. Ben Goldacre (badscience.net)
2
I, Henry Thomas Lancashire, confirm that the work presented in this thesis is my own. Where
information has been derived from other sources, I confirm that this has been indicated in the thesis.
Name
Date
3
Abstract
This thesis describes a study investigating implantable interfaces with muscles and peripheral nerves.
Current prostheses for upper limb amputees do not provide intuitive control over hand, wrist and elbow
motion. By implanting electrodes for recording and stimulating onto muscles and into nerves in the
amputation stump a greater number of control signals may be made available, signals which will be used
to control dextrous hand movements.
An implantable epimysial interface was developed using a bone-anchored device to hard-wire sig-
nals across the skin barrier. In a single ovine model pilot study the bone-anchor was implanted trans-
tibially and the epimysial electrode was place superficially to m. peroneus teritus. Physiological signals
were obtained over 12 weeks during treadmill walking. The external connector on the bone-anchor failed
at 12 weeks, correlating with a drop in signal quality in an otherwise robust interface integrated with bone
and skin tissue. The ovine bone-anchor model was repeated in 6 sheep for 19 weeks, with epimysial
recordings made regularly. Increasing signal quality was seen during the study and was significantly
greater from implanted electrodes compared with skin surface electrodes at 19 weeks (p = 0.016). Some
complications with skin-implant integration were observed in proximally located implants. Crosstalk
between muscles was assessed using pre-terminal nerve stimulation, and was found to be dependent
upon muscle location and innervation. The ovine m. peroneus teritus model was used to assess recovery
following targeted muscle reinnervation. Muscle signal recovery was observed approximately one month
after surgery correlating with the start of functional recovery (assessed by force plate analysis). These
studies indicate that a suitably modified bone-anchored device may be suitable for signal transmission in
human patients, providing a stable, long-term solution to both prosthesis attachment and control.
The potential of nerve interfaces for prosthetic control was investigated. The microchannel neural
interface (MNI) was chosen because it overcomes limitations with other neural microarray designs:
signal strength; cross-talk, and the locations of Nodes of Ranvier. MNIs confine regenerating nerves to
small, ∼ 100 µm diameter, insulating tubes, this increases the length within which nerve signals can be
recorded and amplifies the recorded signals. However, in vivo MNIs can become occluded by fibrosis
that reduces or prevents axon regeneration. Two in vitro studies of neurocompatibility were carried out
to investigate strategies for improving axon regeneration within microchannels.
The first in vitro study compared the effect of different adsorbed endoneurial basement membrane
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proteins on PC-12 cell neurite extension on silicone substrates. The optimal protein coating concentra-
tions for poly-D-lysine, collagen-IV and laminin-2,(-4) were determined. The optimal concentrations
were compared with mixtures of basement membrane proteins, the effect of mixture coating order and
constitution were investigated. It was found that endoneurial BM proteins significantly enhance neurite
outgrowth compared with controls. Two coatings were suggested as most suited for improving neural re-
generation within microchannels: a single layer coating of 10 µg/cm2 collagen-IV; and a mixed coating
of 10 µg/cm2 collagen-IV, 1 µg/cm2 laminin-2,(-4), and 0.175 µg/cm2 nidogen-1.
The second in vitro study investigated the effect of grooved, roughened and multi-scale silicone
surfaces on on PC-12 cell neurite extension. Deeper, narrower grooves were shown to increase the
extent of neurite alignment, while resulting in fewer, longer, neurites. Roughening surfaces was shown
to increase the amount of protein (collagen-IV) which adsorbed from solution and increase the number of
neurites each cell extended. Surfaces with multiscale topographies synergistically increased the number
and length of neurites and guided neurite growth along the groove direction.
MNIs were manufactured for in vivo testing. These MNIs were used to determine the effect of
adsorbed endoneurial basement membrane proteins on nerve regeneration in vivo, but the multiscale
topographies were not applied during manufacturing. Four alternative manufacturing methods were in-
vestigated and iterative improvements were made to create a stacked interface with multiple microchan-
nel layers. Microchannel layers were created by laser patterning silicone and metal foil components,
followed by plasma bonding to create a 3-dimensional structure with 150 µm deep, 200 µm wide mi-
crochannels. Electrode impedances of 27.2 ± 19.8 kΩ at 1kHz were achieved by DC etching. The
method overcomes some current limitations on electrode connectivity and microchannel sealing, and
may improve recording capabilities over single layer designs by increasing the ratio of electrodes to
microchannels.
Manufactured MNIs were tested in a rat sciatic nerve transection model. Following implantation
nerves were allowed to regenerate for one and two months. First, suture and fibrin glue were compared
as MNI fixation methods for one month, the nerve regenerated within the fibrin glue, outside the inter-
face lumen, therefore sutures were chosen as a long term fixation method. The influence of endoneurial
basement membrane protein coatings, identified previously, on nerve regeneration with MNIs was in-
vestigated. Nerves regenerated through the MNIs over two months and began to reinnervate the distal
limb. Improvements in the sciatic function index were observed over two months, with no significant
differences between protein coated and control interfaces. Some weak histological evidence for the
use of protein coatings was found, with axon diameters increased distal to protein coated MNIs. Elec-
tromyographic and electroneurographic recordings demonstrated similar signal amplitudes to previous
studies.
In order to bring the research described in this thesis to clinical practice further engineering im-
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provements to the design and manufacture of electrodes, which utilise materials or coatings to enhance
neurocompatibility, is required. Avenues for further research are discussed and additional experiments
and investigations are described. By combining developments in implantable muscle and nerve interfaces
with surgical techniques and improvements in neurocompatibility the promise of upper limb prosthetic
control may be realised.
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Chapter 1
Introduction
1.1 Aims and Overview
This thesis investigates the control of upper limb prostheses using implanted devices for amputees. The
research covers in vitro and in vivo studies of neural interfaces and in vivo studies of muscle interfaces.
The overall aim of the thesis is to improve implanted devices for reliable and long lasting prosthetic
control.
This thesis comprises 7 individual chapters:
Chapter 1 presents an introduction to the challenges experienced by upper limb amputees. Current
systems for upper limb control are presented and the need for improvement is demonstrated. This chapter
briefly describes the electrophysiology of muscle and nerve and how this relates to prosthesis control.
An overview of implantable muscle and nerve interfaces is given and key points are noted including
biocompatibility and the need for communication across the skin barrier.
Chapter 2 investigates the use of a bone-anchored device for electromyography (EMG) from im-
planted electrodes. Signal quality and cross-talk from implanted electrodes are considered in long term
in vivo tests. In addition, a model of targeted muscle reinnervation is presented. The aim of this chapter is
to record muscle signals from implanted electrodes in cognisant, moving animals and transfer these sig-
nals using a bone-anchored device. It is hypothesised that: signal quality will be better with implanted
epimysial electrodes compared with skin surface EMG electrodes; and that cross-talk from adjacent
muscles will be minimal compared with the target muscle when using epimysial electrodes. It is also
hypothesised that neural regeneration and muscle activity will be observed following targeted muscle
reinnervation in a sheep hind limb model.
Chapter 3 is an in vitro study of biological augmentation to improve neurocompatibility of neural
interface surfaces. Experiments assess the use of single-protein and multi-protein coatings to improve
neurite outgrowth. Coatings are optimised and compared against commercial standard coatings. The
aim of this chapter is to develop and test a coating that could be applied within a microchannel neural
interface (MNI) to improve peripheral nerve regeneration within microchannels. It is hypothesised that:
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endoneurial basement membrane protein coatings increase neurite outgrowth on silicone surfaces com-
pared with control coatings; and that a mix of basement membrane proteins improves neurite outgrowth
to the same extent as a commercial ECM gel coating.
Chapter 4 presents an in vitro study of topographical augmentation to improve neurocompatibility
of neural interface surfaces. Experiments assess the use of surface roughening and grooving to improve
neurite outgrowth. Combined roughened and grooved surfaces are investigated, and use of multiscale
surface topographies is discussed. The aim of this chapter is to develop and test a surface topography
that could be applied within a microchannel to improve neural regeneration. It is hypothesised that:
a combination of grooves and nanoscale roughening will increase neurite outgrowth compared with
grooved samples and increase neurite alignment compared with roughened samples; and that PC-12 cells
will exhibit contact guidance and alignment on multiscale surface topographies. It is also hypothesised
that combining multiscale topography and mixed endoneurial basement membrane protein coatings will
increase neurite outgrowth compared with multiscale topography and single-protein coatings.
Chapter 5 discusses manufacturing techniques for neural implants with a particular focus on mi-
crochannel neural interfaces. The chapter describes materials selection and fabrication methods. Four
designs are covered and the advantages and disadvantages of each discussed. The chosen design was
fabricated and this is described in detail with improvements to electrode performance using DC etching
presented. The aim of this chapter is to investigate manufacturing processes for microchannel neural
interfaces and to assess the resulting interface designs. It is hypothesised that direct current etching will
significantly reduce electrode impedance.
Chapter 6 is an in vivo study of microchannel neural interfaces. Building upon chapters 3 and 5
biological augmentation of the microchannel surface using multi-protein coatings is investigated through
function, electrophysiology and histology. The aim of this chapter is to test multi-protein coatings in
vivo as a modification for MNIs. It is hypothesised that: multi-protein coatings improve functional,
histological and electrophysiological outcomes following MNI implantation in a rat sciatic nerve model.
Chapter 7 presents the general conclusions and proposes key future work.
1.2 Upper-Limb Amputation
In the UK 215 people underwent an upper limb amputation in 2006/07. Over 85% of these new referrals
were aged under 65 years, reflecting the etiology of the condition (primarily trauma, 58%) [3]. Approx-
imately 0.11 major upper limb amputations per 100,000 person-years take place in Maryland (USA) and
Sweden [4]. In the USA over 70% of trauma related amputees are aged under 65 years, and over 90%
of upper limb amputations are trauma related (over 70% of trauma related amputations are upper limb);
there are approximately 541,000 people living with an upper limb amputation in the USA, of whom
41,000 have major limb loss (2005 estimates) [5]. Younger, more active, individuals are most likely to
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suffer traumatic amputation and will be most affected by the loss of an upper limb and the resulting loss
of function [4].
Central to improving quality of life for upper limb amputees is restoring full, intuitive hand, wrist
and elbow motion.
1.2.1 Restoring Function without Prostheses
Surgical procedures have aimed to prevent the need for amputation. Microsurgery allows the repair of
fine structures within the limb, recreating the vasculature and neural pathways needed for correct limb
function, although success can be limited. These techniques can now save limbs which would previously
have been amputated [6].
Where a limb is completely severed, but the extent of soft tissue injury is minimal, microsurgical
techniques have made re-implantation and transplantation possible [6]. Survival rates in modern proced-
ures are approximately 90%, however, functional outcome is typically poor, with patients regaining only
weak hand function and some sensory perception [7–9]. In addition, transplantation requires a suitable
donor and immunosuppression of the patient to prevent rejection [7].
Where surgical repair is contraindicated, for example in cases of severe injury, crush injury or
otherwise untreatable osteosarcoma, amputation may be required. For amputees wishing to regain some
upper limb and hand function artificial limbs or prostheses are the most common solution.
1.3 Requirements for Upper-Limb Prostheses
Patients’ requirements for upper limb prostheses are diverse. Users often try a number of designs before
settling on one or more which are suitable for daily use [10,11]. Amputees value the comfort and function
of their prostheses highly, however, regular activities such as housework, exercising, cooking and driving
are regularly described as challenging [10, 12]. Patients almost universally want better prostheses and
some are dissatisfied with the current options (see fig. 1.1). Dudkiewicz et. al. found that at least 50%
of powered prosthesis users swap to cosmetic prostheses; complaints included limited hand movement
and difficultly using the prosthesis [11]. Commercially available powered prostheses are reliable, but
typically have limited degrees-of-freedom (DoF), range of motion and intuitiveness and cannot achieve
the capabilities of the natural human hand [13] .
“...in the 30+ years since my amputation I haven’t seen great improvements in arms...”
Respondent 509.
“I would like it to be connected to my brain, where it moves when I think about it moving.”
Respondent 112.
Figure 1.1: Prosthesis users’ comments to Biddiss et. al., 2007 [10].
Advancements in prosthesis design and control systems have been made recently, however few of
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these are in widespread clinical use. Farina et. al. [14] state that:
None of the systems so far proposed in the literature fulfills [sic] all the important criteria
needed for widespread acceptance by the patients, i.e. intuitive, closed-loop, adaptive, and
robust real-time ... control, minimal number of recording electrodes with low sensitivity to
repositioning, minimal training, limited complexity and low [power] consumption.
In a human hand there are 22 degress of freedom (DoF) controlled by 38 muscles [15]. To fully
mirror hand motion upper limb prostheses require 38 actuators, each with a separate activating signal
from the user 1. A key limitation of current solutions is the number of control channels. Therefore in
order to improve hand control, an increase in the number of control channels is required.
This thesis will focus on solutions to improve prosthetic control. In particular implantable devices
and surgical approaches will be considered.
Other factors are key to prosthetic control, including signal acquisition, control algorithms and
external prosthesis design. These will be considered and discussed briefly in this introduction, however,
these are beyond the main scope of this thesis.
1.4 Upper-Limb Prosthesis Designs
Prosthesis designs have different advantages and disadvantages which lead users to choose a particular
design. Broad prosthesis types are discussed below, however other designs are available, for example
specialist sports prostheses [4, 12, 17].
1.4.1 Cosmetic Prostheses
Cosmetic prostheses aim to reproduce lifelike appearance at the expense of any active movement. Also
referred to as aesthetic prostheses, they are typically lighter, placing less stress on the amputation stump
than other prosthetic designs.
1.4.2 Body-Powered Prostheses
Body-powered prostheses use a cable system to transmit a body movement into the movement of the
prosthesis [18]. Body-powered prostheses are typically low cost and light, also providing some direct
haptic feedback to the user via the cable. However, they are often designed with function rather than
appearance in mind and are not life-like.
Cable systems often require complex strap systems which are difficult to apply. For amputees with
high level trans-humeral amputation or shoulder-disarticulation this can involve a vest, a common source
of users’ complaints.
1Underactuated prostheses can achieve more degrees of freedom than they have actuators, allowing for life-like motion with
lighter prostheses [16].
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1.4.3 Myoelectric Prostheses
Many current prostheses are controlled using muscle signals captured using skin-surface electrodes,
typically two, placed on antagonist muscles. These signals can be used: to drive a single degree of
freedom (DoF) following rectification and, often, continuous time-averaging; or to control a finite-state
map, where modes (grasp patterns or individual DoFs) are selected by a rarely used signal, commonly
co-contraction or double-contraction [13, 19].
Myoelectric hands do not appear life-life, however many manufacturers make cosmetic socks or
sleeves to mimic normal appearance (see fig. 1.2). Some users decide they prefer the “cyborg” look of
the normal prosthesis and choose not to use a cosmetic covering [personal correspondence with manu-
facturers].
The inherent disadvantage of this system is that it is unintuitive, and because the prosthesis is
controlled in a non-physiological way, actions can only be performed in series, interposed by mode
switching to change the DoF. Unintuitive control strategies are associated with a steep learning curve for
patients, requiring many visits to an outpatient centre or prosthetist.
Figure 1.2: Commercially available myoelectric prostheses. (a) Ottobock DMC Plus. (b) Touchbionics
iLimb. (c) Ottobock Michaelangelo hand. (d) RSL Steeper Bebionic. (a) Is a typical hand widely used
in clinical practice providing proportional control over a single degree of freedom (wrist rotation can be
added separately). (b–d) Are the most advanced hand prostheses clinically available to date (Jan 2014)
allowing patients to control a range of grasp patterns. Reproduced from [13] permission received, with
kind permission from Springer Science and Business Media. REDACT IN ONLINE COPY.
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1.4.4 Neuroelectric Prostheses
Neuroelectric prostheses are typically modified myoelectric prosthesis, and function in the same manner.
The key difference is that control signals are obtained from patients’ nerves. Interfaces with nerves also
enable sensory feedback to be provided to the patient, therefore neuroelectric protheses can be fitted with
pressure sensitive finger-pads or other sensors.
1.4.5 Hybrid Prostheses
Hybrid prostheses combine two alternative control strategies into one design. Commonly a myoelec-
tric hand is coupled to a body powered elbow introducing more DoF without vastly complicating the
prosthesis design [18].
1.5 Biology and Electrophysiology for Recordings
1.5.1 Peripheral Nerve Physiology
The peripheral nervous system (PNS) is defined by John Hubbard as:
“the cranial nerves, spinal nerves and peripheral ganglia which lie outside the brain and
spinal cord.” [20]
It is these nerves that will be considered for implantation of neural interfaces.
Peripheral nerves (figs. 1.3 and 1.4, page 30) are formed of bundled axons (nerve fibres or neurons)
surrounded by connective tissue, the epineurium [21]. The epineurium mainly consists of collagen and
adipose tissue. It also contains blood and lymphatic vessels. Collagens (predominantly Type I) and
elastic fibres (eg. elastin) of the epineurium are longitudinally aligned. Slight undulations in alignment
give nerves flex and stretch [22]. The epineurim also has small populations of macrophages, fibroblasts
and mast cells.
Each fascicle (nerve bundle) is surrounded by inner epineurium, in turn surrounded by outer epi-
neurium. Between the epineurium and the nerve bundles is the perineurium, a sheath, which controls the
substances transported into the fascicle, forming a blood-nerve barrier [23]. The perineurium is formed
of cell layers and type IV collagen fibrils with a basement membrane of collagen, fibronectin, laminin
and glycosaminoglycans [22]. Basement membranes (BMs) are thin extracellular matrix layers which
are present basolateral to cell monolayers, the composition of BM is tissue specific [24]. Perineurial
cells are hypothesised to originate from a fibroblast lineage in vivo [25]. Fascicles are arranged spa-
tially within the nerve according to their target organ, discrete fascicles branch from the nerve trunk to
innervate a distal target organ or group [26].
Axons within the perineurium are surrounded by endoneurium, formed primarily from connective
tissue, but also containing fibroblasts, macrophages, blood vessels and mast cells. Type I and III collagen
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are present in the endoneurium. The endoneurium also helps maintain the blood-nerve barrier, creating
an environment appropriate for nerve fibres.
Peripheral nerve axons are subdivided into two types: myelinated and unmyelinated. Myelinated
axons are surrounded by an insulating myelin sheath, formed by Schwann cells. At regularly spaced
intervals Nodes of Ranvier are present, separating individual Schwann cells. The nodes of Ranvier
dramatically increase the conduction velocity of myelinated axons (up to 80 m/s). The axons themselves
are typically large, α axons are 5 - 12 µm in diameter, with smaller β, γ and δ axons typically larger
than 1 µm diameter. Human myelinated axon density is between 7,000 - 15,000 mm−2 [22]. Not all
axons are myelinated; up to 20 unmyelinated axons can be associated with a single Schawann cell in an
arrangement called a Remak bundle. These small axons (0.4 - 1.2 µm diameter) have lower conduction
velocities (0.5 - 2 m/s) than unmyelinated axons. Human unmyelinated axon density is approximately
30,000 mm−2 [22]. Schwann cells are surrounded by their own basement membranes composed mainly
of type IV collagen and laminin. The structure within this basement membrane is described by Zochodne
as the axon-SC-BM complex [22].
Figure 1.3: Structure of a typical peripheral nerve trunk. The structure of particular nerves can vary
greatly from the structure shown in terms of the number of fascicles and the organisation of inner and
outer epineurium. PNS nerves can be >1mm thick [23, 27], reproduced from [23] with kind permission
from John Wiley and Sons. ©2000 Anatomical Society of Great Britain and Ireland.
1.5.1.1 Neurons
In the nervous system signals are carried by neurons. A typical neuron has 3 parts: a cell body, many
dendrites and one axon. For peripheral nervous system neurons cell nuclei are located within the spinal
cord or within ganglia. The cell body contains the nucleus and most of the cells’ organelles. Dendrites
and axons are processes, which transfer neural signals. The dendrites interface with other neurons or
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Figure 1.4: Anatomy of a typical peripheral nerve trunk. The structure of particular nerves can vary
greatly from the structure shown in terms of the number of fascicles and the organisation of inner and
outer epineurium.
with sensory cells, receiving signals. The signals are then transferred to the axon, which conducts the
signal to another neuron or an end organ. Axons can divide, having multiple terminals each forming a
synapse, where communication with the next cell or dendrite takes place [28].
1.5.1.2 In Vitro Neural Models
The nervous system and neural cells may be modelled in vitro using ex vivo cell cultures, as primary
cultures or tissue slice cultures, and cell lines [29, 30]. The most widely used cell line is the PC-12
pheochromocytoma [31]. This line, derived from rat adrenomedullary tumour, is sensitive to nerve
growth factor (NGF); exhibiting a change in phenotype to neuron-like [22, 32].
1.5.2 Muscle Physiology
Muscles are the body’s motors. There are three types of muscle in the human body: cardiac, smooth,
and skeletal muscle [28, 33]. This thesis will consider skeletal muscle (see fig. 1.5).
Skeletal muscle is controlled voluntarily and is responsible for movement and posture. Skeletal
muscles are composed of bundles of muscle fibres, myocytes, which form from multiple fused cells (see
fig. 1.6). Muscle fibres are elongated structures with a sarcolemma, or plasma membrane, surround-
ing a cell with multiple nuclei, organelles, channels (transverse tubules and sarcoplasmic reticulum)
and myofibrils. Myofibrils, within muscle fibres generate muscle contractions by the sliding-filament
mechanism.
Individual muscle fibres are surrounded by a basement membrane and a sheath of connective tissue
called the endomysium. The endomysium and other connective tissues are mainly composed of colla-
gen which transmits force from the muscle to the bone through tendons. Bundles of tens to hundreds
31
of muscle fibres (fasciculi or fascicles) are surrounded by a connective layer called perimysium. The
fascicles are arranged into an entire muscle, which is covered in the epimysium.
Where a motor neuron axon meets a muscle fibre a neuromuscular junction (NMJ) forms. The
NMJ is a synapse between the nerve and muscle, this allows the transmission of a nerve action potential
to the muscle by the neurotransmitter acetylcholine. A muscle fibre is innervated by only one motor
neuron, however a single motor neuron can innervate multiple muscle fibres. The group of muscle fibres
stimulated by a single motor neuron is a motor unit.
Figure 1.5: Structure of a skeletal muscle. The muscle is surrounded by epimysium. With the muscle,
fibre bundles, called fasciculi are surrounded by perimysium. Each fibre is surrounded by endomysium.
The structure of particular muscles can vary from the generic structure shown. Reproduced from [33,34]
permission received. REDACT IN ONLINE COPY.
1.5.3 Bioelectricity
Nerves and muscles are electrically active tissues. The importance of electricity in the control of
movement has been known since 1781 when Galvani first experimented on the muscles of dissected
frogs [35, 36]. In a series of experiments up to his death in 1798 Galvani showed that electrical stimula-
tion from both lightning and a static generator elicited responses when applied to the sciatic nerve trunk
of a frog, and that nerves were the conductors of this “animal electricity” [37, 38]. 2
2Others credited with discovering the link between electricity and movement include: Dutch scientists in the South Americas;
Benjamin Franklin; and Peter Abildgaard, a Danish veterinarian [39, 40]. There is evidence that electrical stimulation has been
used medically since 2500BCE, when the Ancient Egyptians used Nile catfish to deliver 400V shocks for the relief of haemorrhoid
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Figure 1.6: Structure of a skeletal muscle fibre. The muscle fibre is has a plasma membrane, or sar-
colemma. Within the membrane are special organelles called myofibrils. Myofibrils are arranged in
sarcomeres, a banded, longitudinal structure of actin and myosin between z-lines. Organelles including
mitochondria and the sarcoplasmic reticulum support myofibril function by providing ATP and calcium
ions respectively. Reproduced from [33, 34] permission received. REDACT IN ONLINE COPY.
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Later, in the 19th Century, Emil Heinrich Du Bois-Reymond showed that nerve impulses are ac-
companied by a change in voltage, the action potential [44]. It is this action potential, or the summation
of action potentials from a number of neurons, which can be measured by neural electrodes.
1.5.3.1 Nerve Electrophysiology
Neurons at rest actively maintain a negative membrane potential, with a positive charge externally and
a negative charge internally (varying between –40 mV and –75 mV depending upon neuron type and
behaviour). The resting potential is achieved by actively maintaining concentration gradients of Na+,
K+, Ca2+ and Cl− across the cell membrane. This resting potential is generated both actively and
passively. Active potential generation is by ionic pumps, such as the Na+-K+ pump (Na+, K+-ATPase).
In the presence of intracellular Na+ the Na+-K+ pump hydrolyses ATP and extrudes 3Na+ in exchange
for 2K+, generating a membrane potential. Additional ionic pumps: extrude Ca2+ and Cl−; and regulate
the intracellular pH.
Passive maintenance of the resting potential is by ionic diffusion along concentration gradients. As
K+ is concentrated within the cell it will tend to diffuse across the membrane. Diffusion of K+ across
the membrane creates a voltage difference, attracting K+ to diffuse into the cell. At the equilibrium
potential (Eion) these two factors are balanced. Typical mammalian neuron equilibrium potentials are
shown in table 1.1.
Ion Equilibrium Potential (mV)
K+ –102
Na+ +56
Ca2+ +125
Cl− -76
Table 1.1: Typical equilibrium potentials for mammalian neurons.
Action potentials are mediated by the opening of selective ion channels in the cell membrane.
Opening these ion channels rapidly increases the membrane permeability to their specific ions. The
action potential begins with ligand gated ion channels, which open upon neurotransmitter binding, al-
lowing ions such as Na+ and Ca2+ to diffuse into the cell, this depolarises the membrane. Depolarisation
to the action potential threshold (typically –55 mV) opens voltage gated Na+ channels, further depol-
arising the membrane, and opening more voltage gated Na+ channels in a positive feedback loop. The
membrane potential further depolarises reaching a positive potential (typically +40 mV, a change of
about +100 mV). K+ channels are activated during depolarisation which act to repolarise the cell, after
which the channels deactivate (close) and the resting potential is generated by ion pumps. The action
pain [41,42]. A concise discussion of the scientific discovery of the nervous system is available from “In Our Time - The Nervous
System” (BBC Radio 4, 10th February 2011) [43].
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potential travels along the axon due to these local membrane depolarisations, lasting for approximately
1 ms [45–48].
1.5.3.2 Muscle Electrophysiology
Muscle fibres exhibit “action potentials” similarly to neurons. At the neuro-muscular junction the re-
lease of acetycholine neurotransmitter from the motor axon causes the activation of ligand gated ion
channels permeable to Ca2+. This in turn leads to the opening of calcium-induced Ca2+ channels in
the sarcoplasmic reticulum throughout the muscle fibres in a positive feedback loop. Intracellular Ca2+
causes the activation of ATP-ase activity, changing the binding of myosin and actin in the myofibrils,
and contracting the sarcomere in a process known as the sliding filament mechanism. In the muscle the
action potential propagation occurs within one motor unit and can last between 2 ms and 5 ms [48, 49].
1.5.4 Extracellular Electrophysiology
The magnitude of the action potential can only truly be captured by intracellular recordings: by compar-
ing the potential across the cell membrane [50]. Intracellular action potentials in myofibrils and neurons
are approximately 100 mV. Intracellular recordings damage cells, and are unsuitable for recording across
many neurons or a whole muscle.
To record from many cells extracellular recordings are used, this is known as electroneurography
(ENG) and electromyography (EMG). Extracellularly the action potentials can be observed in the local
changes in charge distribution. These charge distributions are the result of ion flow across the membrane
during depolarisation and repolarisation varying extracellular ionic concentration. This creates an elec-
tric potential or voltage, which can be measured using electrodes. These voltages are typically small, in
the range of: 1 mV for muscle potentials and <100 µV for neural potentials [51].
In addition to signal amplitude, frequency is a consideration for electrophysiology. The maximum
frequency of an active cell is dependent upon the time taken for re-polarisation of the membrane, the
kilohertz range is typical, with many action potentials every second. The signals from individual neurons
or myofibrils can be recorded with small electrodes (<4000 µm2) placed close to the cell of interest [52].
Typically even a very small electrode will record signals from multiple neurons or myofibrils [53]. In
muscles large electrodes can be used to record the EMG signal across an entire muscle. When multiple
myofibrils fire at once (in a muscle contraction) the separate extracellular action potentials sum forming
a motor unit action potential (MUAP). Individual MUAPs can be identified from a complex signal by
sorting based upon the MUAP amplitude and shape [54]. The recorded EMG can be used to determine
whether a muscle is active, an estimate of contraction force, and the extent of muscle fatigue [55].
For nerves similar action potentials (spikes) form from the sum of multiple extracellular action po-
tentials. Neurons, which fire separately or simultaneously, create recordable spikes that sum to form the
recorded ENG signal. As with MUAPs spikes can be identified by sorting, allowing small, functionally
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similar, groups of neurons to be identified [54]. By mapping the ENG activity to particular actions or
stimuli, spikes responsible for particular motor or sensory signals can be determined.
1.5.4.1 Signal-to-Noise Ratios in Electrophysiology
To record small signals, in the µV scale of ENG, the signal must be distinguishable above the noise level.
The signal-to-noise ratio (SNR), the ratio of the signal amplitude to the noise amplitude, describes the
signal quality [56]. In order to distinguish the signals, the SNR should be at least 5:1 [52, 57].
Noise is defined as the components of the recording which are not part of the signal of interest.
This can include: biological noise from adjacent electrically active tissues; electrical noise from outside
sources (e.g. 50 Hz power lines); movement artefacts; and thermal noise [52, 56, 58].
Thermal noise (Johnson-Nyquist noise) can be reduced by keeping electrode impedance low. Im-
pedance is a measure of resistance to alternating current flow. The relationship between thermal noise
(root mean squared voltage, vn) and impedance is described by eq. (1.1), a function of temperature (T ,
Kelvin), impedance (Z, Ohms) and bandwidth (∆f , Hz), where kB is Boltzmann’s Constant (joules per
Kelvin). For a typical electrode impedance of 1 MΩ at body temperature with a recording bandwidth of
10kHz the thermal noise is around 13.1 µV rms, or 40 µV peak-peak. This is in the order of a typical
recorded AP (action potential) [59].
EMG electrodes are larger, with lower impedances (<10 kΩ) and the bandwidth of interest is smal-
ler (∼1kHz). Coupled with a greater signal amplitude (1 mV) this means that thermal noise is less likely
to cause problems when recording muscle signals.
vn =
√
4kBTZ∆f (1.1)
The electrode/tissue interface plays a key role in the SNR. The signal amplitude is dependent upon
the electrode/source distance, which is determined by the electrode/tissue interface. To minimise this
distance a neural interface design that supports intimate electrode/tissue contact over long implantation
periods (years to decades) should be chosen [26, 53, 60–62]. Alternatively, or additionally, interface
designs can aim to ‘bring the nerves to the electrode’ [26]. Neural biocompatibility will determine
whether an interfaces supports intimate electrode/tissue contact. ‘Surface [neural] biocompatibility’ is
discussed below, and is a major theme of this thesis [63].
Signal amplitude decreases rapidly with distance from the axon membrane and from the Nodes
of Ranvier (voltage is approximately inversely proportional to distance from the current source, see
eq. (1.2)3). Nodes of Ranvier are small, 1µm long, unmyleinated sections 100’s of micrometers apart.
Small, penetrating electrodes are unlikely to be positioned in proximity to the nodes of most adjacent
axons. FitzGerald et. al. showed that increasing the length of nerve from which signals are collected
3The potential (voltage, φ) at distance (r) from a point source in a homogenous volume conductor Where: I0 is the total applied
current at source; and σ is the conductivity of the volume conductor [63].
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will increase the signal amplitude irrespective of Node position and reduce problems such as cross-talk
and electrode — nerve distance [59].
φ =
I0
4piσr
(1.2)
1.5.5 Peripheral Nerve Injury and Regeneration
The implantation of any nerve electrode will cause a degree of nerve injury. Sunderland defined five
degrees of nerve injury, from least to most severe these are listed in fig. 1.7 [64, 65]. Routine electrode
procedures, such as nerve conduction studies, may cause nerve damage, although to 2003 no reported
cases are known [66]. Temorary parethesia, a tingling sensation, is occasionally encountered during or
following needle electrode procedures, indicating low severity nerve injury [personal correspondence].
Other needle procedures have been reported to cause severe nerve injuries of type 3 and above, causing
functional impairment [67, 68]. Implantation of microchannel neural interfaces (MNIs) requires com-
plete nerve transection, a type 5 nerve injury. To acquire signals using a MNI, regeneration must take
place. MNI design is discussed further below.
First Degree Injury A temporary block to conduction in the axon.
Second Degree Injury Axonal damage, causing degeneration below the lesion to
axon(s) only. Endoneurial tube remains intact.
Third Degree Injury Endoneurial damage, where the fascicles remain in continuity.
Structures within the fascicles become damaged.
Fourth Degree Injury Fascicular damage, where only the outer epineurium remains
in continuity. All the structures within the nerve trunk are damaged.
Fifth Degree Injury Part or full transection of the nerve, where no structures are left
in continuity and surgical repair is required.
Figure 1.7: The five degrees of nerve injury described by Sunderland. From least severe (First Degree)
to most severe (Fifth Degree) [64, 65]. Sixth Degree, or mixed nerve injury, has also been described.
The processes following nerve injury were first described in 1850 by Waller [69]. Wallerian degen-
eration is the breakdown of axons following a transecting peripheral nerve injury. Distal to the injury site
axons degenerate completely, although the distal axons remain intact and electrically active for several
days following injury [70]. Proximal axons also sometimes degenerate, as far as the closest proximal
Node of Ranvier. Proximal neurons can exhibit cell body atrophy, and, in severe cases, complete neurite
degeneration [71].
Following injury Schwann cells down-regulate myelin synthesis, proliferate, and, along with mac-
rophages, phagocytose the myelin sheath [71]. 3 to 4 weeks following injury most of the myelin has been
removed, leaving nerve stump endoneurial tubes filled with Schwann cells [70, 72]. If a gap is present
in the severed nerve Schwann cells proliferate and form bands of Bunger (cords of nucleated cells) to
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bridge the gap [71]. Where a microchannel interface or a nerve guidance conduit is interposed in the
nerve gap, bands of Bunger can be expected to form within the lumen(s) of the device. The lumen is the
opening along the guidance conduit through which the nerve can regenerate.
Neural regeneration begins with axons sprouting from the intact proximal nerve, 1 to 3 days after
the nerve injury [71]. In the absence of structural cues from a distal nerve sheath or an end organ
(common in amputation) a neuroma forms, and may persist. Neuromas are deposits of connective scar
tissue around the regenerating axon sprouts [73]. Successful regeneration occurs if axon sprouts enter
the proximal end of the distal nerve section. Axon regeneration is then guided by Schwann cells and
endoneurial sheaths, regenerating at approximately 1 mm/day in humans [74]. Following reinnervation
of an end organ Schwann cells begin the process of myelination, forming nodes of Ranvier; however,
full functionality does not return immediately following myelination [71]. Nerve structure matures over
time following reinnervation. ‘Mini-fascicles’ can form in advance of consolidation into classical nerve
fascicle structure [22]. Changes in axon organisation, cross sectional area, and fascicular arrangement,
following regeneration cause the pattern of innervation to be altered.
If the nerve is not severed, for example in crush injuries, regenerating axons demonstrate substrate
mediated responses, where Wallarian degeneration occurs but the myelin sheath remains in continuity
(2◦ Sunderland Injury, [65]). In this case regeneration is directed within the original endoneurial tube
and the pattern of innervation is similar to before injury [64].
4◦ and 5◦ injury typically require surgical intervention [64]. Nerve repair by end-to-end coaptation
is limited to cases where the nerve gap is smaller than 5 mm [75,76]. For repair of gaps longer than 5 mm
(the scale of a MNI) the current clinical gold standard is autograft [71, 76, 77]. Nerve guidance conduits
aim to replace autograft in clinical practice; however, functional recovery is often poor compared with
the gold standard [78].
1.6 Recording Interface Designs
This thesis aims to improve upon implanted devices for prosthetic control. Interfaces designed for EMG
and ENG recording will be considered separately, because, although there is some cross-over in designs,
the approaches are usually different.
Interfaces can be grouped by their level of invasiveness [55,79] (see fig. 1.8). Increasingly invasive
designs are typically more selective, able to record from a smaller volume of tissue, and therefore from
fewer nerve or muscle fibres. However, more invasive surgical procedures are more likely to cause severe
tissue reactions [80]. Designs will be considered from the least to most invasive (see table 1.2).
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Figure 1.8: A comparison of different peripheral nerve electrode (and muscle electrode) designs. In
practice these factors are also influenced by patient anatomy, implantation method and the foreign body
response. Adapted from [55], with kind permission from John Wiley and Sons. ©2005 Peripheral Nerve
Society.
1.6.1 Muscle Interfaces
1.6.1.1 Surface Myoelectrodes
The majority of EMG recording is not accomplished with implantable electrodes, but with electrodes
placed on the skin surface or with acute invasive needle procedures.
Surface electrodes are typically large, with conductive gel pads for acute recordings or metal pads
for long-term surface electromyography (sEMG) [58]. These record global data from the tissues under-
lying the electrode. Surface electrodes are limited by a number of reliability issues: difficulty placing
the electrodes in repeatable locations; electrode lift-off; impedance variations due to atmospheric mois-
ture and perspiration; changes in muscle location relative to the skin; crosstalk from deep or adjacent
muscles [15, 81]. Recording from deep residual muscles using sEMG is a particular challenge, low pass
filtering by connective tissue and signals from superficial muscles can mask the signal [15, 82].
Crosstalk is a key consideration for sEMG. When several muscles are active at the same time,
electrodes, which record from a large area will observe interference from local muscles. When using
one muscle to control one action this reduces the number of independent control channels available [13].
To avoid this problem alternative control strategies such as pattern recognition and regression analysis
have been used. Alternatively selectivity could be increased by directly placing the recording site closer
to the muscle: within the body [83].
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1.6.1.2 Needle Myoelectrodes
Needle myoelectrodes, or fine wire electrodes, are used for short term clinical tests of muscle and nervous
function. Although they have been used in laboratory conditions to test control strategies and experi-
mental hypotheses [15, 84], they are not suitable for long-term use by patients [79].
1.6.1.3 Implantable Myoelectrodes
Placement of the electrodes directly on or in the muscles of interest is one solution for the problems
associated with skin surface electrodes. This allows individual muscles (both superficial and deep) re-
sponsible for specific actions to be targeted, increasing selectivity and reducing cross-talk [4, 81, 84].
Electrodes implanted on muscles are epimysial electrodes, while electrodes implanted within
muscles are intramuscular electrodes (see fig. 1.8). Epimysial electrodes are mounted in a backing,
which is sutured onto the epimysium. Following implantation a fibrous capsule forms around these
electrodes, holding them in place [85].
Epimysial electrodes have been used for functional electrical stimulation (FES) for over 20 years
[86–88]. FES uses electrical currents to activate the motor nerves of otherwise paralysed muscles in
patients following spinal cord injury, stroke, and other conditions. These interfaces often use large
single (monopolar) electrodes, these can be used for recording, however small bipolar or tripolar designs
are more common [89]. The electrodes are mounted in a backing which is sutured onto the epimysium.
Following implantation a fibrous capsule forms around these electrodes, holding them in place [85].
Intramuscular electrodes can be used percutaneously, as needle electrodes, or implanted perman-
ently. Helically wound wire with an uninsulated tip is commonly used, inserted into the belly of the
muscle, with a barbed anchor to hold the electrode in place. However, this design can damage muscle
fibres. Intramuscular electrodes have been used for functional electrical stimulation (FES), although in
fewer cases than epimysial electrodes [86].
Wireless intramuscular electrodes have been developed. The Implantable Myoelectric Sensor
(IMES) enables signal capture from up to 32 bipolar electrode implants, although first in human trials
have used only four implants [81, 90–92]. Other wireless systems have been designed, with connections
for up to four bipolar electrodes [93, 94].
Alternative myoelectrode designs have been developed. These aim to provide more recording sites,
for increased selectivity or recording over a larger area. [83, 95, 96]. Intramuscular wires with multiple
sites along the interface have been used in acute experiments and multi-electrode epimysial sheets have
been used for months in animal models.
Fibrosis surrounding implanted myoelectrodes may be advantageous. A fibrous capsule will hold
the electrode in place, maintain a constant environment, and counter-intuitively increase signal strength
[81,97]. Signal strength is partially dependent upon tissue resistivity according to Ohm’s law: restricting
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Figure 1.9: A comparison of different peripheral nerve interface designs. Extraneural (epineural)
electrodes are cuffs or flat interface nerve electrodes (FINE) [104]. Intraneural electrodes can pen-
etrate the nerve Utah slant electrode array (USEA) [105, 106], longitudinal intra-fascicular electrodes
(LIFEs) [107, 108], and transverse intra-fascicular multichannel electrodes (TIMEs) [109, 110]. Regen-
erative electrodes can have electrodes enclosed in holes (sieve) [111, 112], microchannels (microchan-
nel roll electrode, MCRE) [51, 113], or open on a flat surface (regenerative multielectrode interface,
REMI) [114, 115]. Reproduced from [103], with kind permission from Cambridge University Press.
current flow, at the interface of the low resistivity muscle and the high resistivity fibrous capsule [98,99],
proportionally increases potential difference.
1.6.2 Nerve Interfaces
Interfacing directly with the peripheral nervous system could enable upper limb amputees to control
multichannel prosthetic limbs intuitively [100]. However, developing neural interfaces for chronic im-
plantation remains a challenge [101]. Microchannel peripheral nerve interfaces, which are a focus of
this thesis, overcome some of the difficulties encountered with extracellular neural recordings from peri-
pheral nerves [59].
Neural interfaces have been widely reviewed in the literature [4, 26, 52, 53, 55, 58, 79, 83, 102, 103],
and the main designs and their advantages and limitations will be discussed (see fig. 1.9, table 1.2). Im-
plantation within or onto a nerve is a delicate, invasive process, which can damage nerves. Regeneration
of the nerve and the biocompatibility of the neural interface is critical for stable chronic applications [80].
The trade-off between invasivity and selectivity is a major challenge in neural recordings (see fig. 1.8).
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1.6.2.1 Epineural Interfaces
Epineural interfaces follow the same design principles as epimysial electrodes. An insulating backing
holds two or more electrodes, which is then sutured onto the epineurium [55]. Damage to the nerve
trunk is avoided, however the selectivity is low, because signals from the entire nerve are recorded. Epi-
neural electrodes have been used for functional electrical stimulation, enabling selectivity over muscle
activation not achieved using surface electrodes [87].
1.6.2.2 Cuff Neural Interfaces
Cuff interfaces are commonly used for implanted functional electrical stimulation [88], however the same
design can monitor neural activity within the whole nerve. Cuffs encircle the nerve with an insulating
backing containing electrodes designed as complete rings or single points. Both cuff and epineurial
designs are less invasive, and less selective than intrafasciular designs [55], and are easily replaced in
the event of failure [79]. By insulating the nerve from its surroundings, cuff electrodes can shield the
electrodes from local EMG signals [26]. To increase the selectivity of cuff designs flat interface nerve
electrodes (FINEs) have been developed which flatten nerves, increasing separation between fascicles.
FINEs have been shown to damage nerves flattened to high degree [104, 116]; however, FINEs are now
in use in patient trials [117].
1.6.2.3 Interfascicular Interfaces
Interface designs which introduce electrodes between fascicles are interfascicular interfaces. The slowly
penetrating interfascicular nerve electrode (SPINE) separates fascicles using blunt silicone tabs with ex-
posed electrodes [118]. Over 24 hours the tabs rearrange fascicles allowing greater functional selectivity
than epineural designs, however longer term testing is required to test their stability [55, 118].
1.6.2.4 Intrafascicular Interfaces
Intrafascicular interfaces are inserted within the peripheral nerve. The simplest intrafascicular electrode
is a microwire, such as the stainless steel wires used by Strumwasser for cortical recording in the 1950’s
[102, 119]. Gold, platinum alloys, tungsten and other metals are also used to form <100 µm diameter
wires which penetrate the nerve [42, 57]. By stacking microwires, in 2D and 3D, arrays of exposed tips
can be formed to record from throughout a nerve [120–122].
Modern microwire designs such as the multi-electrode longitudinally implanted intra-fascicular
electrodes (LIFEs) have improved the selectivity and stability recordings [107,108]. LIFEs are not metal
wires, but are polymeric thin films with patterned metal electrodes and tracks [108], they can be arrayed
to access many fascicles within a single nerve [123]. LIFEs and their further development transverse
intra-fascicular multichannel electrodes (TIMEs) have achieved multi-electrode capacity with diameters
of<100 µm and insertable lengths of up to 5 mm [109,110]. Recently TIME implants have been used to
control a prosthesis and provide sensory feedback in real-time over 30 days for an upper-limb amputee
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[124], in vivo experiments indicate that longer implantation will be possible in the near future (ethical
approval permitting) [125]. Thin-film processes have been used to create soft, compliant microelectrode
arrays which are promising for in vivo spinal cord stimulation and recording [126]. Microwires formed
from carbon fibres <10 µm diameter have been promising for cortical applications, and may be suitable
for peripheral nerve recordings in future [127, 128].
1.6.2.5 Microelectrode Arrays
Arrays of electrodes known as “Microelectrode Arrays” (MEAs) are a common approach to selective
interfaces with the central and peripheral nervous systems. They are typically designed to penetrate the
neural tissue, acting as intrafascicular interfaces.
The ‘Utah Array’, an array of 100 silicon needle electrodes, is the “workhorse for [most] cortical
interfaces” [129], and has been applied to the PNS [102,105]. The electrodes often have platinum coated
tips and are isolated from neighbouring spikes with a silicon nitride coating. Design variations include
slanted arrays for the measurement and stimulation of fibres at different depths within a nerve, and high
density arrays for interfacing with small structures [130]. This MEA has been successfully tested in
the PNS of a human subject (Dr. K. Warwick). However, 80% of the electrodes failed over 96 days,
due to fatigue of percutaneous wires, and signal quality had declined [131, 132]. Cortically, the Utah
Array has been used to provide control over prosthetic hands for tetraplegic patients, with usable control
signal after 1000 days implantation [133, 134]. The Utah Array has been used chronically for 1 year in
cat and 2 months in rat peripheral nerves [135–137]. The interface causes persistent inflammation and
fibrosis, with some nerve regeneration and reduced fibre diameter observed. In both these cases axons
were present within the expected recording volumes. The Utah array has been commercially marketed
by Braingate™Co. as the Bionic Array [62,138]. Prior to the start of the research described in this thesis
Utah array designs were considered for investigation, however they are currently prohibitively expensive
for research [personal communication].
Other MEA designs include the “Michigan Electrode”, after designs by Wise et. al. in the 1970’s,
which is a thin-film MEA with penetrating silicon needles. The design allows a high density of electrode
sites with minimal tissue displacement by patterning several electrodes onto each shank of an electrode
[42, 102, 139]. This design enables a true 3-dimensional array of electrodes to be introduced into the
tissue.
The profusion of MEA designs presents researchers and clinicians a problem when trying to choose
an implant. A comparison of 5 MEAs, including the Utah and Michigan interfaces, has shown that design
does affect the implant suitability [140]. Following cortical implantation in rats immune response was
observed surrounding all the tested designs, and impedance and mean SNR were highly variable, both
within and between electrode designs. Although MEA design does impact upon implantation response,
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the authors suggested that implant application should be the most significant factor in interface choice
[140].
1.6.2.6 Regenerative Interfaces
Regenerative interfaces, or sieves, are the most invasive group of peripheral nerve interfaces. Their
design requires complete nerve transection (type 5 nerve injury) and regeneration of axons though holes
or slits in the interfaces. Electrodes are sited at the holes are used to record from the axon or axons which
have regenerated [53].
For regenerative interfaces to work axons must regenerate through the holes in the device and remain
functional for the lifetime of the patient [55]. The theoretical selectivity limit for regenerative interfaces
is to have one axon per hole. This would require holes of 2 µm to 10 µm diameter, which has not been
feasible in practice. Axons do not regenerate through small diameter holes, or become damaged by
any small movement of the implant [55, 141]. Early interfaces were manufactured using stiff silicon or
ceramic substrates, however soft polyimide sieve designs have been used more recently, demonstrating
improvements in regeneration in the short term with a functional decline during chronic implantation
[55, 111, 112].
Regenerative interfaces have been introduced into nerve guidance channels. The “regenerative scaf-
fold electrode” is a flat epoxy sheet with longitudinal electrodes inserted within the lumen of a guidance
channel, which is then sutured within a transected nerve [114, 142]. Axons regenerate well in the open
channel structures, however the flat interface limits the selectivity of this design.
To date regenerative interfaces have not been tested in human subjects. Limits on implantation time
for first-in-human trials mean that there is often insufficient time for axons to regenerate and recover
from the nerve transection at surgery. A key issue for the use of regenerative electrodes with long-
term amputees is whether the nerve will regenerate following transection. Delayed nerve repair causes
a dramatic reduction in the number of axons which regenerate (up to 67% in animal models) [143].
This applies in the case of amputees, where the nerves have been left without an end organ since the
amputation.
Flat sieve designs are typically only 10 µm thick, therefore it is unlikely that nodes of Ranvier will
be close to an electrode. Neural signal strength is greatest closest to the nodes of Ranvier [63]; however,
the nodes can be 100’s of µm apart, and are approximately 1 µm in length, therefore the likelihood of
positioning a small recording electrode in proximity to a node is low. This limits the selectivity of basic
regenerative interfaces.
1.6.2.7 Microchannel Neural Interfaces
The neural interface type considered in this work are the microchannel neural interfaces, a subset of
regenerative electrodes. Microchannel neural interface manufacture is discussed in detail in chapter 5
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and in vivo testing is discussed in chapter 6. This thesis will mainly consider the previous work by a
collaboration between the University of Cambridge, University of Birmingham and EPFL, Switzerland,
although alternative, similar designs have been proposed.
Microchannel interfaces are designed to overcome key issues with many neural electrode designs,
signal strength and the role of nodes of Ranvier. The microchannel encloses a group of regenerated axons
within a long insulating tube approximately 100 µm diameter and up to 5 mm in length [51, 59, 113].
Confining the nerve and electrodes within a small diameter electrically insulating channel increases the
length of axon from which signals can be recorded. In addition, microchannels increase signal amplitude
and reduce cross-talk, a phenomenon first described in the 1960’s, which has since been demonstrated
both in vitro and in vivo [59, 144]. Microchannel interfaces can record meaningful signals even if the
electrode (metal) surface is not immediately proximal to a node of Ranvier, because the signal is confined
within the insulating tube. The most impressive results to date have recorded in vitro signals as large as
4.5 mV from cortical neural tissue using 10 µm diameter, 400 µm long, channels. This is a gain over
recordings in open culture of approximately 20 times and an SNR up to 450 [145].
A range of microchannel interface designs have been developed. Removable formers have been
used to create circular cross-section microchannels in silicone [113,146–148]. Thin-film processes have
been used to create ridged structures with metal electrodes at the base of U-shaped troughs, by rolling
the structures or capping the trough with a second thin film enclosed microchannels can be formed
[146,149–154]. Other microchannel devices also propose to use thin-film manufacturing techniques: the
Georgia Tech Regenerative Electrode (GT-RE) [114, 115, 155, 156]; and the regenerative microchannel
based electrode interface (ReME) [157, 158].
The greatest signal gain is achieved by using long, narrow microchannels [146]. However, nerve
regeneration through microchannels is impeded, with myelinated axon regeneration greatest in shorter,
larger microchannels [113]. In vivo small diameter channels of 50 µm become blocked with fibrous,
connective tissue [51, 113]. In addition, the trauma of implantation and resulting foreign body reaction
cause fibrosis, which can either completely occlude microchannels, or reduce the space for axonal re-
generation [51,113]. Microchannel neural interfaces should be designed such that neural regeneration is
encouraged and fibrosis is discouraged.
Table 1.2: An overview of muscle and nerve interfaces suitable for use in upper-limb prosthetic control.
References to key examples are cited in the table, additional detail is provided in the main text of this
thesis and the following reviews [4, 26, 52, 53, 55, 58, 79, 83, 102, 103].
Interface Design Advantages Disadvantages
Muscle Interfaces
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Interface Design Advantages Disadvantages
Surface Myo-
electrodes
Large pads placed
on the skin surface
Simple to use, non-
invasive
Non-intuitive, low num-
ber of control channels,
variable signals
Needle Myo-
electrodes
Stiff needles or
microwires which
are implanted
transcutaneously
High selectivity at motor
unit level
Only suitable for acute
laboratory experiments
Epimysial
Electrodes
Insulating back-
ing placed on
epimysium with
one of more point
electrodes
Increased number of con-
trol channels compared
with surface myoelec-
trodes, reduced cross-talk
Non-intuitive, invasive
Intramuscular
Electrodes
Helically wound
wire with an ex-
posed tip implanted
into the muscle belly
High selectivity over in-
dividual muscles, reduced
cross-talk
Cause muscle damage,
can migrate following
fibrosis and muscle
movement
IMES [81, 91,
92]
Hermetically sealed
capsule(s) with bi-
opolar electrodes
Increased number of con-
trol channels compared
with surface myoelec-
trodes, reduced cross-talk
Cause muscle damage,
limited by wireless link
Epimysial Ar-
rays [95, 96]
Non-targeted array
of electrodes placed
on the epimysium of
one or more muscles
Detailed information suit-
able for pattern recogni-
tion
Large implants required
Nerve Interfaces
Epineural
Interface
Insulating back-
ing placed on
epineurium with
one of more point
electrodes
Minimise nerve damage,
easily removed if dam-
aged
Low selectivity
Cuff Interface Insulating backing
surrounds nerve
with circumferential
or point electrodes
Minimise nerve damage,
easily removed if dam-
aged, shield nerve from
local EMG
Low selectivity, can cause
nerve damage if compres-
sion or micro-movement
occur
Flat Inter-
face Nerve
Electrode
(FINE) [104]
Cuffs designed to
flatten nerves and
separate fascicles
Increased selectivity over
cuff interfaces
Cause nerve damage if the
compression is too great
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Interface Design Advantages Disadvantages
Microwires Fine metal wires
with exposed re-
cording tip
Easily manufactured,
high selectivity in acute
experiments
Commonly used percu-
taneously, not designed
for chronic implantation
Longitudinally
Implanted
Intra-
Fascicular
Electrodes
(LIFEs)
[107, 108]
Microwires or thin-
films with multiple
electrodes implanted
parallel along a
single nerve or
fascicle
Fascicle and subfascicle
selectivity, high flexibility
reduces nerve damage
Implanted within fas-
cicles causing moderate,
fibre level, nerve dam-
age, requires multiple
implants to interface with
a large volume within a
single nerve
Transverse
Intra-
Fascicular
Multichannel
Electrodes
(TIMEs)
[109, 110]
Microwires or thin-
films with multiple
electrodes implanted
across a nerve
through multiple
fascicles
Fascicle and subfascicle
selectivity, high flexibility
reduces nerve damage
Implanted within fas-
cicles causing moderate,
fibre level, nerve damage
Utah Slant
Electrode Ar-
ray (USEA)
[105, 106]
Array of silicon
spikes with elec-
trodes at the tips
High density electrode
sites in 3 dimensions,
high selectivity
Stiff silicon causes per-
sistent tissue response
Sieve (regener-
ative) Interface
[111, 112]
An array of holes
through a planar
substrate with elec-
trode sited at the
holes
High selectivity Require complete nerve
transection, regeneration
through small holes is
poor, micromotion can
cause nerve damage in
chronic implantation
Regenerative
Multielec-
trode Inter-
face (ReMI)
[114, 115]
Flat sheet of elec-
trodes mounted in
a nerve guidance
channel
Create intimate contact
between nerves and the
interface surface
Require complete nerve
transection, limited se-
lectivity over a small sub-
set of neurons
Microchannel
Neural Inter-
face (MNI)
[51, 113, 148]
An array of insulat-
ing tubes containing
point electrodes for
nerve regeneration
Increased signal amp-
litude, signals recorded
irrespective of Node of
Ranvier position, shield
nerve from local EMG,
high selectivity
Require complete nerve
transection or nerve root
surgery, regeneration
through long and small
microchannels is poor
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1.6.3 Other Considerations for Electrophysiology
1.6.3.1 Amplification of EMG and ENG signals
ENG and EMG signals must be amplified prior to data analysis, recording or decoding. This is usually
achieved using differential amplification, which amplifies the difference between two inputs (typically
two electrodes placed along the length of the muscle or nerve) while rejecting signals common to the
two inputs [56]. The common signal includes noise from distant muscles (increasing selectivity) and 50
Hz power lines, this quality is described as “common mode rejection”.
Amplification can reduce the role of thermal noise. Cables have inherent impedance, increasing
approximately proportionally with length. Amplifying the signal close to the electrodes reduces the role
of cable impedance before amplification. This pre-amplification will lift the signal over the thermal noise
level for the remaining cable length.
Increased EMG and ENG selectivity can be achieved by using different recording electrode arrange-
ments. Monopolar electrodes record differences with respect to a remote reference electrode, gathering
information around the electrode with signals inversely proportional to distance from the electrode. Bi-
opolar electrodes, ’single differentials‘, also record from a volume of tissue around the electrodes. The
’double-differential‘ electrode design, or the mathematically equivalent branched electrode (a.k.a. quasi-
tripole), reduces crosstalk and the tissue volume within which signals are recorded (see fig. 1.10, pg.
49) [159–162]. Further modifications, such as the revised quasi-tripole configuration, can improve the
signal quality yet further [163]. Quasi-tripolar electrode arrangements have been chosen for MNIs in
order to reduce noise and to allow directional stimulation for feedback applications [51, 59, 113].
1.6.3.2 Active Implantable Interfaces
In order to amplify signals close to implanted interfaces, pre-amplification can be included within the
interface. This is a common approach for implantable myoelectrodes, for examples the IMES [81, 90–
92]. Amplifier systems have been designed to connect to with cortical interfaces such as the Utah Array
[164] and to include wireless systems for data and power transfer [165–167].
A key consideration for implanting electronics is preventing short-circuits forming between other-
wise separate conductive tracks, and preventing corrosion of conductive track. A major issue therefore
is water ingress. To prevent water or moisture getting to electronics over long-term implantation a her-
metic, sealed, package should be used [165, 168, 169]. Implantable active electronics are not considered
in this thesis, however these concepts could be applied to the devices discussed in this thesis.
1.6.3.3 Spike Sorting and Information Decoding
Once recorded, neural signals must be sorted to identify spikes from different neurons and the inform-
ation contained must be decoded. This will enable the control signals for a prosthesis to be determined
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Figure 1.10: Electrode set-ups to obtain: 1. Single Differential, (Output = A − B); 2. Double-
Differential or True-Tripole, (Output = (A−B)− (B−C) = A− 2B + C); 3. Branched Electrode or
Quasi-Tripole, (Output = A+C2 − B = A−2B+C2 ). Adapted from [159, 160].
from the noisy neural signal. This is not a focus of this thesis but, the following references are suggested
for more information [54, 170, 171].
A key disadvantage with current processes is the selectivity of spike sorting algorithms, which
cannot differentiate between more than 8 to 10 spike types within the same spike train [172]. This further
reinforces the need to spatially isolate neurons within microchannels, therefore reducing the number of
spikes observed per electrode. However, improving electrode minaturisation and recording spike trains
with more than one electrode may allow increased differentiation as spatial and temporal components of
the signal could be considered.
1.7 The Host Response to Implanted Devices
1.7.1 Biocompatibility
This thesis aims to develop interfaces for nerve and muscle, which can be implanted chronically. There-
fore the interfaces must be biocompatible [79]. Biocompatibility is:
“the ability of [a] device to perform its intended function, with the desired degree of in-
corporation in the host, without eliciting any undesirable local or systemic effects in that
host.” [173]
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“The lack of understanding of the biological response to implanted constructs and the inability to
monitor the sites and match the mechanical properties of the probe to the neural tissue properties
continue to be an unsolved problem.”
Figure 1.11: A key issue in neurocompatibility identified by Durand et. al. following the International
Neuromodulation Society’s 11th World Congress and the 6th International Neural Engineering Confer-
ence [129].
Dependent upon function, a biocompatible device may be: inert, bioactive or bioresorbable. For
the chosen application, implantable recording devices for long-term use, the bulk of the device must be
protected, therefore an inert encapsulating layer is required. Improving the interface with soft tissue,
however, requires a bioactive or bioresorbable layer.
1.7.2 Myocompatibility
The biocompatibility of implantable muscle electrodes is rarely considered beyond the need for an inert
encapsulant. Myocompatibility, the extent to which a device is biocompatible with muscle, must be
considered for long-term implants.
Fibrosis around myoelectrodes is currently considered positive, preventing movement of the implant
away from the muscle [81, 97]. However, a persistent foreign body reaction may cause complications.
Tissue engineering presents possible solutions, where the encapsulant could be designed to form a scaf-
fold for muscle tissue growth, improving integration and reducing fibrosis [174, 175]. Myoelectrodes
must withstand the forces exerted by the muscle they are placed within or on. To date research has
primarily used designs with long working histories in clinical use. That these devices are approved for
long-term implantation and their function is good means there is less imperative to develop advanced
biocompatible approaches when compared with neural interfaces.
1.7.3 Neurocompatibility
Neurocompatibility is the extent to which a device is biocompatible with the nervous system. Neural tis-
sue is soft and easily damaged during implantation surgery or subsequently during the interface lifetime.
In peripheral nerves the fibrotic or glial scar responses can increase the distance between an interface and
the target axons. Over a few months in vivo the biological response to most neural interfaces causes sig-
nals to fade and disappear [98, 129]. Understanding and overcoming this limitation of neural interfaces
is a key issue, see fig. 1.11.
To improve the regeneration through MNIs the channel surfaces or bulk properties can be modified.
Current implant materials, silicone and polyimide, are suited for implantation as inert materials; how-
ever, channels can become blocked with fibrous tissue [51, 113]. Increasing the neurocompatibility of
MNIs will reduce fibrosis which currently limits minimum channel diameter, and may improve neural
regeneration, allowing smaller channels to be used, increasing selectivity.
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A range of strategies have been used to improve neurocompatibility and neural regeneration within
Nerve guidance conduits [71, 76, 78, 103, 176–180]. The main materials modifications explored in the
literature will be discussed below.
1.7.3.1 Bulk Neurocompatibility
It has been hypothesised, and demonstrated, that a mismatch between the mechanical properties of the in-
terface and the nerve can easily damage soft nerve tissues, and that better mechanical matching between
the soft neural tissue and the interface will reduce the foreign body response [4, 83, 98, 126, 181–183].
Mechanical properties also alter response on a cellular scale in vitro, encouraging neurite outgrowth at
optimal substrate stiffnesses [184–186]. Therefore the bulk properties of the materials chosen must be
considered. This study primarily considers silicone (polydimethylsiloxane, PDMS 4) interfaces. Sil-
icones can be made with a range of properties, but are typically compliant and elastic, but with poor
resistance to tear. Soft, medical grade silicones have been used since the 1940’s as medical materi-
als for cosmetic implants, the encapsulation of implantable electronics, and as a substrate for neural
interfaces [187–189]. Medical grade silicones are known for their biocompatibility and biodurability,
remaining stable for over 30 years implantation [189]. However, increasing flexibility of LIFE interfaces
has not statistically reduced glial scarring [83]. Therefore additional factors must be considered in order
to improve neurocompatibility. Chapter 5 of this thesis discusses the problem of mechanical mismatch
and the properties of materials used for neural interfaces.
1.7.3.2 Surface Topography
Cells respond to substrate shape, the topography of the surface. A typical example of this effect is
‘contact guidance’, where a cell elongates or grows in a preferential direction in response to surface
structure [190, 191]. Neuronal cell types exhibit impressive contact guidance on the right surface, with
axons, dendrites or neurites growing in alignment with a grooved structure [192–196]. Other surface
cues, such as roughness and porosity have shown promise for improving neurite outgrowth and cell
adhesion. Several studies have shown that neurite outgrowth can be increased on nanoscale structures
[197–199]. Chapter 4 in this thesis investigates the effect of surfaces topographies on neurite outgrowth
in vitro and the effect of surface topography on neurites will be discussed further in the introduction to
this chapter.
1.7.3.3 Chemical Modification
Improvements in neurocompatibility can also be achieved by modifying the interface surface chemistry.
This may require directly modifying the surface layer of the bulk material or by adsorbing a layer with
different chemical properties. Ion implantation, using hydroxyl-ions and metal ions, has been used
to improve neurocompatibility [200, 201]. Creating positively charged materials may improve neurite
4Not all silicones are polydimethylsiloxanes. The silicone used in this study, Sylgard 184, is a PDMS elastomer.
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outgrowth [180], and –COO− groups have been proposed (although not used successfully) [202].
1.7.3.4 Conductive Coatings
The conductive polymers poly(pyrrole) (PPy) and poly(3,4 ethylenedioxythiophene) (PEDOT) are com-
monly used in research as electrode coatings or [42, 98]. These polymers create a compliant surface
layer with improved mechanical matching compared with a bare metal electrode. Conductive polymers
also lower electrode impedance and increase the area for cell attachment, creating a roughened profile.
Conductive polymers can themselves be chemically modified. Peptide sequences have been bonded to
PEDOTs and demonstrated improved neurocompatibility in vitro [202–204]. Despite their promise, con-
ductive polymers are usually unstable, and rapid failure can occur in vivo [60, 205]. Carbon nanotubes
have also been proposed as surface coatings for neural implants. Currently these are approached with
caution due to their potential toxicity [42].
1.7.3.5 Proteins and Fillers
Peripheral nerve repair in vivo follows the path of the degenerated nerve, guided, in part, by the ex-
tracellular matrix (ECM) remaining following Wallarian degeneration [206]. Proteins, in particular the
basement membrane found basolaterally to peripheral nerve axons [207, 208], provide a “pavement or
handhold[s] for [axonal movement]” [22]. The primary components of ECM and basement membrane
are: collagens; laminins; nidogens; and proteoglycans. Other components include fibronectin and tenas-
cin [209–211]. These components polymerise either with themselves (e.g. laminin) or by bridging other
proteins (e.g. nidogens) [212].
Bellamkonda highlights laminin-1 (α1β1γ1, see [213]) and laminin-derived peptides (e.g. IKVAV)
as the most commonly used ECM proteins for peripheral nerve repair [177]. Laminin-1 is abundant in
many tissues, while alternative laminin types (e.g. α2β1γ1) may be more applicable to peripheral nerve
repair [179, 209, 214]. Proteins can be introduced into guidance conduits as surface coatings or within a
gel like scaffold. Where a scaffold is included within the nerve guide this provides and opportunity for
guidance in 3-dimensions [177,180]. Aligned fibres can create a structure with longitudinal cues similar
to the native nerve [215]. Directional cues can also be introduced using protein gradients, encouraging
neurite growth up a concentration gradient [177]. Chapter 3 in this thesis investigates the use of basement
membrane proteins for neural regeneration in an in vitro system.
1.7.3.6 Neurotrophic Factors
Neurotrophins are growth factors, which encourage neuron differentiation, regeneration or survival de-
pendent upon the cell and tissue type. In normal neural repair and autografts neurotrophic factors are
secreted by support cells and distal organs. The neurotrophic factors proposed to enhance neural re-
generation are: nerve growth factor (NGF); brain derived neurotrophic factor; glial cell line-derived
neurotrophic factor; neurotrophin-3; neurotrophin-4/5; and neurotrophin-6 [179, 206]. The molecules
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can be immobilised to the implant surface, or released in a controlled way to create a chemoattractive
gradient [76, 98, 176, 177, 179, 180]. To determine a suitable strategy with neurotrophic factors release
kinetics, concentration and co-delivery must be considered [76]. For controlled release within a MNI
a carrier must be introduced to the microchannels or to the distal lumen of the device, the use of vis-
cous ECM or synthetic materials would make filling microchannels a challenge. Neurotrophic factors
may be a suitable approach for encouraging neural regeneration within microchannels in future; how-
ever, current applications can cause undesired side-effects, such as transient neurite sprouting which then
degrades rapidly [76].
1.7.3.7 Cell Therapies
Autografts for neural repair contain support cells to encourage axon growth [78]. Schwann cells have
been used to align and guide axons in vivo [206, 215]. The cells can be seeded around the lumen of
a construct, or within a filler gel. These therapies are promising for very large defects [78], however
sourcing the cells is a challenge. Schwann cells are slow growing and harvesting autologous cells would
cause the donor site morbidity which guidance conduits aim to solve. This may be overcome with stem
cell therapies, however these are still in pre-clinical research and are likely to have a long lead-time to
clinical practice [76, 176]. The application of cellular therapy for MNIs would require the seeding, and
culture, of cells within microchannels in vitro prior to implant insertion, maintaining and confirming
culture viability within a long microchannel is a challenge. If the challenges with Schwann cell culture
and their use in MNIs are overcome this may lead to a new “gold standard” in nerve repair [76].
1.7.3.8 Testing Neurocompatibility
In order to determine whether a surface is neurocompatible prior to in vivo tests an in vitro assay or
assays must be carried out. Typically biocompatibility assays follow ISO10993-5, using fibroblast cell
lines and examining cytotoxicity. However, for known non-cytotoxic materials (e.g. implant grade
silicones), application specific tests should be used. Chapters 3 and 4 of this thesis describe such in vitro
neurocompatibility assays. Chapter 6 discusses in vivo tests of neurocompatibility.
The outgrowth of neuron processes, neurites, axons or dendrites can be observed in vitro [216].
Cell lines and primary cells have been used for this purpose 5. Primary cells are acquired directly
from the tissue of interest, while cell lines are the result of subculture of primary cells in vitro [217].
Typical primary cells used for neurocompatibility include: primary neurons from the cerebellum, the
hippocampus, and the striatum; dorsal root ganglion cells; [218, 219]. Typical cell lines include: rat
pheochromocytoma (PC-12) cells; mouse neuroblastoma N1E-115 cells; and human neuroblastoma SH-
SY5Y cells [216].
This thesis uses the PC-12 cell line. PC-12 cells are an immortalised rat adrenal gland pheochromo-
5Ex vivo slice cultures have also been used, but these are less common.
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cytoma cell line, developed in the 1970’s, which exhibit a neuronal phenotype on exposure to nerve
growth factor [220, 221]. The PC-12 cell neuronal phenotype has made the line popular for neural
biocompatibility assays [31, 198, 199, 222–225], and with results comparable to primary neural (spiral
ganglion) cells [226]. Cell lines have guaranteed purity and uniformity across the cell population; how-
ever, they are a less accurate model of the in vivo environment than primary cell cultures. Alternatively,
primary neural cultures are heterogeneous, for example DRG neuron cultures also contain glial cells,
and have a labour intensive preparation and limited lifespan. A cell line was chosen for this work to
minimise variation across and between experiments.
1.8 Surgical Approaches to Control
1.8.1 Targeted Reinnervation
For patients with amputation above the level of the shoulder standard myoelectric control techniques
cannot provide intuitive prosthetic control. Below the elbow, pattern recognition, using residual muscles,
can be accomplished, because muscles controlling the hand (e.g. extensor digitorm) reside in the limb.
In trans-humeral and, in particular, shoulder-disarticulation amputations the muscles controlling the
hand are not present; however, the nerves supplying them are. These can be rerouted to residual muscles
or muscle flaps in the amputation stump or torso, a procedure known as targeted muscle reinnervation
(TMR, see fig. 1.12) [227, 228]. This surgical technique has the advantage, compared with peripheral
nerve electrodes, that muscles act as biological signal amplifiers, and therefore signals can be recorded
using either surface electrodes or less invasive implantable myoelectrodes. Following nerve regeneration,
actions natural for hand control cause contraction of amputation stump and torso muscles. The signals
can then be recorded using standard EMG electrodes, and the muscle areas responsible for specific hand
actions can be “mapped-out”. Control of prostheses with up to 10 degrees of freedom has been demon-
strated, compared with the 1 to 3 DoF available with hybrid or body-powered shoulder-disarticulation
prostheses.
Typically TMR uses residual muscles or muscles available in the torso. To increase the number of
channels available free muscle flaps could be used [229]. The Regenerative Peripheral Nerve Interface
(RPNI) develops further on this principle, by implanting myoelectrodes within the muscle flaps during
reinnervation surgery [230, 231].
TMR has an additional advantage. Hand sensation has been observed in the skin overlying TMR
patient’s reinnervated muscles. Touch, temperature, pain, and vibration could be felt by the patients.
This finding has been exploited to directly use targeted sensory reinnervation of cutaneous nerves using
sensory fascicles of the median and ulnar nerves, in a single patient case study this has been shown to
create a sensory map of the hand at the innervated skin site [232].
Chapter 2 in this thesis presents preliminary investigation of a model to allow better understanding
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Figure 1.12: The targeted muscle reinnervation (TMR) procedure. Reproduced from [13] permission
received. REDACT IN ONLINE COPY.
of TMR and the biology and electrophysiology of reinnervation.
1.9 Implantable Interfaces and the Skin Barrier
Implantable interfaces are only a realistic clinical intervention if the data can be used outside the body,
to control an amputation prosthesis [233]. The challenge is to create a stable data connection across the
“skin barrier” without introducing a route for infection.
1.9.1 Telemetry
Wireless transmission has been accomplished using implanted systems [91, 93, 94, 165–167]. These
designs are highly complex, and have a limit on the amount of data which can be transferred. For example
the IMES system transmits a maximum of 32 channels approximately 470 samples/s, with a low-pass
corner of <235 Hz; sufficient only for gross muscle movements [81, 91]. Other designs, including one
developed by the author in collaboration with other UCL researchers (not reported in this thesis), have
enabled neural data transmission [166,167]. These designs limit the number of data channels which can
be transmitted, or require spike sorting and data reduction within the implant [234].
1.9.2 Hard-Wired Connections
An alternative, requiring simpler implanted devices, is the use of hard-wired connections. At their most
simple these are cables, which cross the skin through a cannula-like device. This approach provides a
route for infection and is a route of failure as wires break where they cross the skin [131,235]. Hochberg
et. al. successfully demonstrated the control of a prosthetic limb by tetraplegic patients using a cortical
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Figure 1.13: The intraosseous transcutaneous amputation prosthesis (ITAP) in position. Cutting flutes
prevent rotation. The flange is perforated with 0.7 mm diameter holes, to allow soft tissue in-growth and
create a stable skin interface. Healing cap (Stanmore Implants Worldwide) and Poron washer (Algeo
Ltd., Liverpool, UK) hold the skin against the flange to allow the soft tissue to adhere to the solid
implant. Reproduced from [237], with kind permission from Elsevier. ©2010 ASSH.
MEA; however, connection to the interface was carried out under aseptic conditions, and the design was
not suitable for regular use outside a clinical setting [133].
Stable connections across the skin barrier have been developed for prosthesis attachment. Typically
patients attach prostheses to their amputation stumps using suction cups, sleeves, sockets or harnesses.
This results in discomfort, sweating, chaffing, numbness, heterotopic ossification and potentially serious
skin infections (e.g. contact dermatitis). These common complaints by patients have led to research into
alternative solutions for attachment [11, 236, 237].
Osseointegration of a transcutaneous implant directly to the residual bone within the stump can
provide a solution to problems associated with prosthesis attachment. Work on implants for direct
skeletal attachment of external prostheses has been ongoing since the 1970’s [236, 238]. Early designs
failed quickly due to infection and this remains a challenge the many current designs aim to solve [238].
The intraosseous transcutaneous amputation prosthesis (ITAP) was developed at UCL and RNOHT,
Stanmore, in an attempt to overcome the problems with infection (see fig. 1.13). The device has been
used successfully in a transhumeral amputee [237] (see figs. 1.14a and 1.14b), in veterinary cases [239]
(see figs. 1.15a and 1.15b), and is undergoing clinical trials for use in transfemoral amputees. By in-
cluding a porous flange intended to mimic a natural transcutaneous structure (antlers) the ITAP creates
a stable interface with the soft tissues, intended to seal the skin and prevent infection [240]. The ITAP
device has shown promise for improving range of motion [237] and restoring weight bearing [239].
Combining an osseointegrated prostheses with a hard-wired connection will create a robust transcu-
taneous data connection without the channel limitations associated with signal telemetry. Combining
56
(a) Plain radiographs of the ITAP in position. A. Ventro-
lateral aspect. B. Dorsal aspect.
(b) Stable skin interface demonstrating skin attachment
to the flange (not visible).
Figure 1.14: The intraosseous transcutaneous amputation prosthesis (ITAP) in a transhumeral amputee
2 years following implantation. Reproduced from [237], with kind permission from Elsevier. ©2010
ASSH.
(a) Stable skin interfaces of two dogs, 28 weeks and 14
weeks postoperatively.
(b) Plain radiographs of the ITAP in the radius after A)
6 weeks ;B) 3 months;C) 5 months;and D) 7 months.
Figure 1.15: The intraosseous transcutaneous amputation prosthesis (ITAP) in veterinary cases (two
dogs). Reproduced from [239], with kind permission from John Wiley and Sons. ©2011 by The Amer-
ican College of Veterinary Surgeons.
electrophysiological recording and direct skeletal attachment was first reported by Pitkin et. al. [241] and
has since been demonstrated in human subjects by Ortiz-Catalan et. al. [233]. Chapter 2 in this thesis
presents work which is both clinically and temporally intermediate to the research described in [241]
and [233]. In these studies the wire was routed through a hole in the centre of the transcutaneous im-
plant, and exited the implant within the medullary canal of the bone, holes were drilled through the bone
cortex to allow the wire to pass through into the soft tissues of the limb. Pitkin et. al. [241] carried this
out during the surgery to implant the bone-anchor in a single stage procedure. Ortiz-Catalan et. al. [233]
used a two stage procedure, first the osseointegrated shaft was implanted into the bone and allowed to
heal. The second stage required connecting the transcutaneous part of the implant, passing the wire
through the osseointegrated shaft into the medulla and drilling a hole in the bone cortex to route the
wires into the soft tissue. The need to route the wire through the bone could be avoided if the connection
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exited the transcutaneous implant within the skin-crossing region.
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1.10 Summary
This introductory chapter has demonstrated that there is an unmet clinical need for intuitive upper-limb
prostheses with the same capabilities as the natural human hand. The current clinically available control
systems are unsuitable and users are left with a tradeoff between basic, reliable systems and complex
systems with lower reliability but more potential for intuitive control. A particular research focus is on
surgical interventions, with implantable muscle and neural interfaces, targeted muscle reinnervation, and
osseointegrated connections. These have yet to provide widespread clinical solutions and this thesis aims
to improve upon current designs and move these closer to patients.
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Chapter 2
In Vivo Electromyography
2.1 Introduction
Current powered upper limb prostheses are typically controlled by body power or surface elec-
tromyography (sEMG). Body power is easy to use and responds immediately to patients’ actions, how-
ever it requires a cumbersome harness and patients must re-learn how to control their limb. sEMG is
slower, but allows more degrees of freedom (DoF) to be controlled by implementing mode-switching
between the control signals and the motion.
EMG measures electrical events in muscles. These electrical events are the coordinated movement
of ions across the membrane of a muscle fibre during muscle movement, creating a current flux and
voltage change around the muscle. It is this voltage change which is measured by EMG [56].
Advanced sEMG controlled limbs in clinical use include the “i-Limb Ultra” which allows sequential
control of a series of pre-programmed, patient selected, grips and movements [242]. Mode switching
is obtained by one or more events, such as twitching, co-contraction of opposing muscles and button-
presses [19, 243].
As an electrical signal EMG is susceptible to interference. Firstly, general electrical noise can ob-
scure the signal, the extent to which this occurs is measured by the signal-to-noise ratio (SNR). Second,
the signal can be distorted by tissue filtering and other factors [244]. For EMG control, signal distortion
should be avoided and the SNR should be large, SNR ≥5 has been suggested for neural recordings [52].
Techniques to improve myoelectric control include multichannel proportional control, pattern re-
cognition and targeted muscle reinnervation (TMR) [244–248].
EMG is commonly recorded using skin surface electrodes. Skin surface electrodes are cheap and
easy to connect to prostheses, however they have many limitations. Signals from deep muscles are ob-
scured by tissue filtering and by stronger EMG from superficial muscles [15]. In addition, skin movement
and subcutaneous fat can make recording from single muscles difficult and increase crosstalk. Surface
signals can be unreliable due to other factors: skin impedance changes with humidity; electrode liftoff;
and difficulty placing electrodes in a repeatable position [81]. In addition, in a patient with an upper arm
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amputation it is very difficult to record many independent signals from the residual arm because there
are few remaining muscles.
2.1.1 Implantable EMG Electrodes
Implantable electrodes are typically of two types: intramuscular electrodes, and epimysial electrodes.
Epimysial electrodes are placed on the muscle surface, secured with sutures, while intramuscular elec-
trodes are inserted into the muscle belly and hold in place with barbs [86].
Electrodes implanted on muscles have been in use for functional electrical stimulation (FES) for
over 20 years, with some implanted systems working for over 15 years [86]. Per-electrode survival
rates of 90% at 4 years for lower limb FES electrodes [249] and 98.7% at 16 years for upper limb FES
electrodes have been reported [86]. The majority of failures are found within 2 years of implantation,
with a plateau in survival after this point. In most cases failure is mechanical with electrode discs
becoming detached from the lead wire, or the lead wire fracturing proximal to the electrode [86, 249].
Mechanical failure was found to be more common in high load areas, for example the posterior muscles
of the lower limb and in hands following blunt trauma [86, 249]. In addition, there is an infection risk
with any implant, one patient (out of 27) experience peri-implant infection in one study, the infection
was associated with a suture rather than an electrode and cleared after revision surgery which removed
the electrode and lead proximal to the infection site [86].
In an in vivo study of 40 electrodes no functional electrode failures were observed. Tissue response
to epimysial electrodes typically resulted in a 179±299 µm fibrous capsule with few active fibroblasts
and very few or no macrophages present [85]. Intramuscular electrodes have been observed to migrate
outside their target muscle and tissue response is typically more severe forming 535±401 µm fibrous
capsules with many active fibroblasts and macrophages present [85].
Electrodes designed for FES are typically large and monopolar. Recording guidelines suggest the
use of biopolar electrodes with small interelectrode distances of around 20 mm or less [89]. New designs
of recording electrode allow multi-channel and multi-polar recording in a smaller area. For example, an
intramuscular polyimide wire electrode with 8, 40 µm diameter recording sites [95], and epimysial
polyimide paddle electrodes with 5, 800 µm diameter recording sites [96]. Larger numbers of smaller
electrodes allow detailed spacial information about the muscle activation to be obtained. This enables
more detailed control of prostheses; however, the thin flexible electrodes required may move within the
muscle belly altering the recorded signal [95].
The fibrous capsule surrounding implantable myoelectrodes can be of benefit to signal recording
[81]. The capsule prevents electrode movement relative to the muscle(s) of interest. In addition, the
capsule creates an environment of consistent impedance improving signal reliability [81, 250].
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2.1.1.1 Implantable Myoelectric Sensors
Implantable myoelectric sensors (IMES) are a wireless implantable EMG system. Developed from
BIONS (bionic neurons), an FES system, IMES are hermetically sealed cylinders 15 mm length, 2 mm
diameter, with electrodes at either end [81, 90–92].
The IMES system can operate with up to 32 implants over a wireless power-data link with a coil
fitted over the stump (a practical limitation due to coil size and limits on electrode placement) [81, 91].
However, at 32 implants sampling is limited to approximately 500 samples/second (S/s). To satisfy
Nyquist’s sampling theorem the sample rate should be no less than double the signal bandwidth, or no
less than double the highest frequency of interest [251]. Conventionally for EMG the highest frequency
components are 500 Hz, therefore sampling at 1 kHz or even 1.5 kHz is recommended [82, 252]. Un-
dersampled signals (such as those recorded by IMES at 500 S/s) will loose information about the EMG
signal; however, they may still be useful for prosthetic control as smoothing or averaging may be used in
control algorithms [252]. To record the full signal with IMES the number of implants would be reduced
to 16 (954 S/s) or 8 (1.8 kS/s) [81], fewer than the required DoF for the full control of a prosthetic hand.
As implantable electrodes IMES benefit from fibrosis holding it in place relative to the muscle.
Also, as implantable electrodes IMES avoid complications with subcutaneous fat reducing the radius of
the effective recording area from over 10 mm in patients with a thick subcutaneous fat layer [162] to less
than 5 mm if implanted [97]. Recording of independent muscle signals in the forearm has been reported
with IMES [253] and an acute first in human trial has occurred [92].
Alternative, similar, systems are also in development. For example the MyoPlant (Otto Bock),
which can connect to four paddle electrodes and transmit data at up to 4.8 kHz has been demonstrated
in vivo [93]. Another implantable system by Ripple LLC connects to four bipolar epimysial electrodes
and operates between 20 Hz and 300 Hz bandwidth [94].
2.1.2 Targeted Muscle Reinnervation
For patients with transradial (below elbow) amputations the muscles previously controlling the hand (e.g.
extensor digitorm) are often still present. These patients can benefit from pattern recognition techniques
to enable more intuitive prosthetic control.
For transhumeral (above elbow) amputees, in particular those with shoulder-disarticulation, the
muscles that previously controlled the hand are not present. Patients have to learn new control strategies
using surrogate antagonistic muscles for movements. However, nerves previously controlling these pa-
tients’ limbs are present. By re-routeing these nerves to residual, denervated muscles or muscle flaps in
the amputation stump or chest, a technique known as targeted muscle reinnervation (TMR), signals from
these nerves are amplified and can be picked up as EMG signals [227, 228]. When the patient attempts
an action with the amputated limb the newly reinnervated muscle is activated. Over 40 patients have
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undergone TMR to date with favourable clinical outcomes [254]. Further developments to TMR have
led to targeted sensory reinnervation (TSR), sensory mapping of the hand in the amputation stump [232],
in early patients this occurred through natural competitive skin reinnervation, however this has now been
surgically guided by coaption of sensory fascicles from the median and ulnar nerves to cutaneous nerves.
The availability of suitable muscle flaps in the upper arm or chest is limited. To further enhance
TMR free muscle flaps can be used to provide a greater number of independent channels where they
are not present in the stump [229]. An alternative to TMR is the RPNI (Regenerative Peripheral Nerve
Interface) where the addition of electrodes to the flaps during muscle transfer enables EMG record-
ings [230, 231]. In this case rat muscles are used m. extensor digitorum longus was freely transfered
to the right thigh and coapted to the peroneal nerve, the muscle is approximately 20 mm long and 5
mm wide, indicating that in a human forearm many RPNIs could be formed. However high levels of
cross-talk have been observed [personal correspondence], possibly due to the use of small muscles, and
strategies including wrapping muscle flaps in xenogenic matrix are being employed to better isolate
the recording sites [231]. Alternatively changes in electrode design, for example using smaller inter-
electrode distances, or double-differential (tripolar) electrodes, can increase selectivity and allow the use
of smaller muscle flaps for RPNI and TMR [162].
2.1.3 Transcutaneous Signal Transmission
Transcutaneous signal transmission is a significant challenge for implantable electrodes. Two main ap-
proaches are used: hard-wired connections, and wireless signal transmission. A study of a peripheral
nerve interface in a human volunteer found a >85% failure rate from 20 channels due to mechanical
fatigue of transcutaneous wires [131].
Hard-wired connections can carry a high risk of chronic infection. Head connectors are commonly
used hard-wired connections. These have been used successfully in human trials and are used in animal
studies [96, 133]. In this case wires are run subcutaneously to the site of interest, these long subcu-
taneous wires can increase noise levels and short shielded cables are better [56]. Aseptic conditions,
impractical outside a clinical or laboratory setting, are required for connecting to head connectors [133].
In laboratory conditions regular antibiotics and topical antiseptic are often required to reduce infection
risk [255, 256]. Head connectors, with bone screws or bone cement fixation are an example of bone-
anchoring, this provides stability to the connection site reducing fatigue and providing a secure platform
for head-stage amplifiers.
Wireless systems have been developed for both muscle and neural signal recording, the IMES dis-
cussed above is one example [81, 93, 167, 257]. Transmitting many channels of data at sufficient resolu-
tion and bandwidth to reconstruct the recorded signal is a challenge. For neural information data reduc-
tion methods must be used, otherwise the required data-rate limits the number of channels [167, 257].
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In addition the power requirements for data transmission over a day (8 to 12 hours) is expected to be a
major challenge. If the power link is inefficient, the battery would need to be significantly larger and
heavier, which is not a suitable solution to this design challenge [258].
2.1.3.1 Amputation Prostheses
Current prostheses attach to the amputation stump using suction cups, sleeves, sockets, harnesses or a
combination of these suspension devices. Complications include discomfort, sweating, chaffing, numb-
ness, heterotopic ossification and potentially serious skin infections (e.g. contact dermatitis). Patients
complain that “long use means sores the following day” [10]. When considered with unintuitive control
systems this leads to low patient satisfaction and high rates of prosthesis disuse [11].
Transcutaneous implants which osseointegrate directly to the residual bone within the stump can
avoid complications associated with prosthesis attachment. In addition osseointegrated prostheses can
withstand greater stresses than standard stump-socket interfaces, and provide a route for hard-wired data
transmission. These prostheses are in clinical use and are proving revolutionary [237].
Skeletal fixation of prostheses provides some unexpected benefits, for example osseoperception, a
restoration of tactile sensation, transmitted through the artificial limb and the osseointegrated implants,
for example to determine surface hardness [259, 260]. Range of motion also improves with osseointeg-
rated prostheses compared with stump-socket interfaces, making prostheses more intuitive for patients
before any control systems are added [261].
Infection is a risk for osseointegrated prostheses. In a study of 39 patients [262], after 2 years there
were 6 implant infections (15%) and 11 cases of soft tissue infection (28%). Of all patients surviving to
follow up only 2 had normal levels of bacterial growth at the implant site. 3 patients (8%) underwent
implant removal before or during the study. Of the 6 patients with implant related infections, 1 recovered
following a 6 month course of ciprofoxacin and 5 were undergoing treatment at the end of the study.
Failure rates of 20% and infection rates of 38% have been reported for transhumeral patients [263].
Combining bone-anchored prostheses with a hard-wired connection will reduce the fragility of
transcutaneous hard-wired connections and avoid most channel limitations associated with signal tele-
metry. This combination of bio-signal recording and direct skeletal attachment was reported by Pitkin
et. al. [241]. In a sedated rabbit amputation model it was shown that EMG signals from intramuscu-
lar electrodes could be transmitted through a bone-anchored pylon and then recorded. An intraosseous
transcutanous amputation prosthesis (ITAP) could be used to create a permanent transcutaneous conduit.
In addition to providing a stable anchor, ITAP integrates with soft tissue around the implant reducing the
risk of infection [237].
2.1.4 Aims and Hypotheses
The aims of this chapter are as follows:
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• To record epimysial EMG signals in cognisant, moving animals and transfer these signals using a
bone-anchored device.
• To investigate targeted muscle reinnervation in a sheep hind limb model using epimysial EMG
such that the resulting signals could be transmitted through ITAP.
The hypotheses of this chapter are as follows:
• EMG signal quality will be better from epimysial electrodes compared with skin surface elec-
trodes.
• Cross-talk from adjacent muscles will be minimal compared with the target muscle when using
epimysial electrodes.
• Neural regeneration and muscle activity will be observed following targeted muscle reinnervation
in a sheep hind limb model.
2.2 Methodology
All in vivo procedures described were carried out in accordance with The Animals (Scientific Procedures)
Act UK, 1986 (revised 2013) and local guidance.
2.2.1 Implantable Myoelectrodes 1
The following experiment is described in Al-Ajam et. al., 2013, IEEE Trans. Biomed. Eng. [2].
2.2.1.1 Construction of the Electrode / Bone-Anchored Device
A Ti-6Al-4V osseointegrated transcutaneous implanted device was constructed using laser sintering (see
fig. 2.1). A tapered stem allowed press fit of the device into bone. The device had a porous flange with
a strut size of 300 µm and a pore size of 700 µm, with struts arranged in an open-faced, cubic structure.
The device was shot-blasted and hydroxyapatite (HA) coated to improve soft tissue and bone adhesion.
During shot-blasting and coating, the external portion of the device was masked to maintain a smooth
finish.
A straight 2 mm hole was drilled from the uppermost surface of the device, exiting immediately
below the flange. This area was presumed to be within the soft tissues and above the region of the
implant associated with osseointegration, this eliminated the need for an additional hole in the tibial
cortex. A press fit sleeve was added to the external part of the device to house the electrical connections.
A bipolar epmysial electrode (Ardiem Medical) with Pt10Ir electrodes, interelectrode distance 10
mm, was passed through the implant. The leads were crimped to a 2-pin connector (LEMO UK Ltd,
Worthing, U.K) on the external portion of the implant. The lead was 316 stainless steel, 2-core coiled
cable with fluoropolymer insulation encapsulated in silicone. The socket was secured using epoxy resin.
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The cable was secured in the 2 mm hole using medical grade silicone elastomer (NuSil Med3-4013,
NuSil Technology LLC, CA, USA), in addition this was considered to reduce potential flexion of the
cable at the internal exit. The silicone was degassed, injected using a syringe, and cured for at least 24
hours at 50◦C. The HA coated flange and stem were masked to prevent contact with uncured silicone.
The implant was sterilized using ethylene oxide gas.
The implant design is shown in fig. 2.1 and the finished implant is shown in fig. 2.2.
Figure 2.1: 2D CAD design of the implant device showing: tapered stem; 15 mm diameter porous flange;
2 mm diameter hole for electrode cable; press fit sleeve. Image courtesy of Jay Meswania.
Figure 2.2: The finished bone-anchored device with epimysial electrode. Images from Al-Ajam et. al.,
IEEE TBME, ©2013 IEEE, with permission [2].
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2.2.1.2 Surgical Technique
One female sheep (Mule) was chosen for this study. All animal procedures were carried out in ac-
cordance with the United Kingdom Home Office Animals (Scientific Procedures) Act 1986. General
anesthesia was administered using isoflurane (Isoflo) in oxygen. A 5 cm incision was made over the left
tibia, 10cm inferior to the knee joint on the medial aspect. The tibia was exposed by dissection. Both
cortices of the tibia were drilled using a 4.6 mm diameter drill bit. The hole in the medial cortex was
enlarged using a 4.8 mm diameter drill bit. Both cortices were reamed, using a custom tapered reamer,
and the implant press fitted into the hole. 2 mm was allowed between the flange and the tibia to accom-
modate the electrode cable and soft tissue growth. This procedure is described as trans-tibial insertion,
to differentiate from the amputation model used by Pitkin et. al. [241].
A 10 cm incision was made over the lateral compartment muscles of the left leg. M. peronius ter-
tius was identified [264]. A subcutaneous tunnel was made between the 2 incisions through which the
epimysial electrode was passed. The electrode was secured to the epimysium at 6 points using 4-0 Pro-
lene (non-absorbable) suture. The incisions were washed with physiological saline solution and closed,
tension-free, in 2 subcutaneous and 1 cutaneous layers using Vicryl (absorbable) suture (Ethicon Inc.,
NJ, USA). Post-operative dressings were applied: Mepitel (Mo¨lnlycke Health Care Limited, Bedford-
shire, UK); sterile gauze; and a bandage. Correct positioning of the implant was confirmed by radio-
graphs (fig. 2.4). Antibiotics were given for 3 days post-operatively and fentanyl (analgesic) patches
for one week. The animal was individually housed and the first EMG signals were obtained 24 hours
post-operatively.
2.2.1.3 EMG Recording
Treadmill walking at 2 km/h was carried out weekly for 12 weeks. EMG signals were recorded us-
ing BIOPAC Equipment (MP150 and EMG100, AcqKnowledge software, BIOPAC Systems, Inc., CA,
USA). Recording parameters were: 1000 samples per second (sps); 100 Hz to 500 Hz band-pass; 500x
amplification. In addition to connecting the 2 pin LEMO connector for recording, a stainless steel needle
ground electrode was used, inserted subcutaneously over the left-leg hock joint.
At 2 weeks following surgery skin surface EMG signals were recorded for comparison. M. peroneus
tertius was identified by palpation. Following shaving and cleaning, self-adhesive surface electrodes
(Vermed Inc., VT, USA) were applied with an inter-electrode distance of 20 mm. The needle ground
electrode was placed over the hock joint as described above.
Signals were analysed using Acqknowledge software (V4.2, BIOPAC). The signals were rectified.
Mean power was calculated for 0.25 second epochs in a selected 4-second period (3 or 4 gait cycles).
Epochs with greater than mean average power were considered signal, all other epochs were considered
noise. SNR was calculated as the ratio between the mean average rectified signal EMG and the mean
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Figure 2.3: The bone-anchored device in situ. Intraoperative images demonstrating implantation of
the bone-anchored device and epimysial electrode in the ovine tibia. (Top left) Bone-anchored device
inserted transtibially. (Top right) Incision made over m. peroneus tertius. (Bottom left) Electrode sutured
epimysially. (Bottom right) Incision closed. Images from Al-Ajam et. al., IEEE TBME, ©2013 IEEE,
with permission [2].
Figure 2.4: Post-operative plain radiographs of the bone-anchored device showing trans-tibial insertion.
Left: lateral view; middle: anterior-posterior view; right: oblique view showing bipolar epimysial elec-
trode and electrode wire. Images from Al-Ajam et. al., IEEE TBME, ©2013 IEEE, with permission [2].
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average rectified noise EMG.
The process is described in eqs. (2.1) to (2.5).
SNR =
|Signal|
|Noise| (2.1)
if Pt > P¯ then EMGt = Signalt (2.2)
if Pt < P¯ then EMGt = Noiset (2.3)
P¯ =
∑
P
n
, ie. average of all P over samples (2.4)
Pt =
0.25s∑
t>0
V 2t
ft
n
, n = number of samples (0 < t ≤ 0.25s) (2.5)
Mean power is an averaged form of the nonlinear energy operator (NEO), which is large only when
the signal is high in power (proportional to V2) and high frequency [171]. An index which preferentially
detects high frequency signals will avoid reporting slow wave changes (e.g. movement artefact) as signal.
In addition averaging the NEO reduces the likelihood of false positives resulting from short-lived voltage
transients. Averaging is only suitable for the detection of muscle signals composed of many multiple
data points, for the detection of single motor unit action potentials averaging should not be used. The
use of the overall mean average as a detection threshold created an adaptive method and should reduce
experimenter bias and error.
2.2.1.4 Impedance Spectroscopy
In vitro impedance measurements were made using the EVAL-AD5934EBZ impedance monitor (Analog
Devices, MA, USA) by the potentiostatic method [265]. The frequency range for the impedance monitor
was 103 Hz to 105 Hz and the impedance range is 500 Ω <Z <1 MΩ, values measured outside this
range were considered unreliable. The impedance monitor was calibrated using a 100 kΩ (1%) resistor.
Pre-implanted and explanted epimysial electrode impedance was measured in 0.9% saline (physiological
saline) at 1 kHz to 77 kHz, 0.4 Vp-p, δ = 150 Hz. Following explantation the electrode impedance was
measured with 3 mm of surrounding tissue in 0.9% saline.
2.2.1.5 Post-explant Histology
After 12 weeks the animal was sacrificed by an intravenous injection of 20% pentobarbital solution. The
implant was removed: the electrode with a cuff of underlying muscle; and the bone-anchored device
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Solution Time Repeats Notes
Neutral Buffered Formal Saline 7 days Starts immediately following explantation
50% IMS 3 days 1
75% IMS 3 days 1
85% IMS 3 days 1
95% IMS 3 days 1
100% IMS 3 days 2
Chloroform 3 days 2 Fat removal
100% IMS 3 days 2
Table 2.1: Serial dehydration procedure for soft tissue samples: epimysial electrode.
with approximately 5 cm length of tibia and overlying tissue. The specimen was fixed in 10% formalin :
90% buffered saline solution.
The explanted electrode was dehydrated (Industrial Methylated Spirits, IMS) and defatted (Chloro-
form) for histology as shown in table 2.1.
The specimens were embedded in LR White Resin (London Resin Company Limited, London, UK).
Briefly: specimens were transferred to 50% resin / 50% IMS for 5 days, during which the specimens were
kept in a darkroom either under vacuum or on a tilted rotating plate. The 50% resin / 50% IMS step was
repeated. The specimens were transferred to 100% resin and kept in a darkroom either under vacuum
or on a tilted rotating plate for 5 days. The 100% resin step was repeated. Specimens were transferred
to plastic containers and cast by immersion in resin:accelerator (10ml:1 drop, London Resin Company
Limited, London, UK). The specimens were placed at -20◦C to cure for at least 24 hours.
The specimens were sectioned, placed on a clear perspex backing, ground and polished until 100
µm thick. Sections taken through the implant and surrounding tissue was stained with toluidine blue for
20 minutes followed by Paragon stain for 20 minutes. The electrode samples were stained with toluidine
blue. Tissue integration of the transcutaneous portion was assessed using an Olympus BH2 microscope
(Olympus Optical Company Ltd, Tokyo, Japan) with Zeiss KS300 3.0 image-analysis software (Imaging
Associates, Thame, UK). Sections were ground, polished, sputter coated with Au/Pd and osseointegra-
tion of the stem portion was assessed using backscatter scanning electron microscopy (JSM-5000, JEOL,
Tokyo, Japan).
2.2.2 Implantable Myoelectrodes 2
Bone-anchored devices were created and implanted as described in section 2.2.1. N = 6 skeletally mature
sheep (Mules) were used. To protect the external socket connectors silicone masking caps (Greentree
Shercon, Tewkesbury, UK) were used. EMG recording was carried out and analysed as described in
section 2.2.1. Recordings were made at the following time points: 1, 2, 3, 4, 6, 8, 14 and 19 weeks
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following implantation. At 19 weeks surface EMG recording were made for comparison. The animals
were sacrificed after 19 weeks. Impedance readings were made as described in section 2.2.1. In addi-
tion, in vivo impedance readings were made using the same parameters immediately following terminal
anaesthesia. Histology was carried out as described in section 2.2.1.
2.2.2.1 Pre-terminal stimulation of adjacent muscles
Pre-terminal muscle stimulation was used to assess crosstalk from adjacent muscles. General anaes-
thesia was administered as described in section 2.2.1. The leg was shaved and the following muscles
were exposed by dissection: peroneus tertius; tibialis anterior; peroneus longus; gastrocnemius. The
motor nerve branch to each muscle was identified and exposed. Motor nerves were stimulated using a
Medtronic Vari-Stim III Surgical Nerve Stimulator (Medtronic Inc., MN, USA) set to a 1 mA pulse. 6
readings per muscle were elicited over a 60 second period and were recorded using the BIOPAC acquisi-
tion system as described above (section 2.2.1). Stimulus peak (V) and muscle signal peak (V) were from
adjacent muscles were compared with the targeted muscle, peroneus tertius.
2.2.3 Targeted Muscle Reinnervation 1
A bone-anchored device was created and implanted into one sheep (Mule) as described in section 2.2.1.
2.2.3.1 Surgical Technique
Following implantation of the bone-anchored device as described in section 2.2.1 targeted muscle rein-
nervation (TMR) was carried out. M. peroneus tertius was exposed by a 15 cm incision and the muscle
was retracted laterally to expose the peroneal nerve. The nerve branches to m. tibialis anterior and the
lateral comparment were identified. Three insertion points in m. tibialis anterior were identified and
one branch was transected close to the muscle. The nerve was freed from surrounding tissue distally to
proximally until the branch joined the peroneal nerve. The motor nerve branch to m. peroneus tertius
was identified and sectioned approximately 1 cm proximal to the insertion point. The distal portion
of n. peroneus tertius was coapted to the freed proximal portion of n. tibialis anterior using 3, 8-0
nylon monofilament sutures (non-absorbable, S&T, Switzerland). Sutures were placed at 120◦ intervals
around the circumference of the epineurium. The epimysial electrode was sutured onto the epimysium
of m. peroneus tertius as previously described. The incision was closed in layers
2.2.3.2 EMG Recording
EMG recording was carried out and analysed as described in section 2.2.1. Recordings were made
weekly.
2.2.3.3 Force Plate Analysis
At weekly intervals before or after EMG recording force plate measurements were carried out. Force
plate measurements were first made 4 days before surgery. The force plate (left and right) was calibrated
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using a 50kg weight. The sheep was weighed before measurements were taken. The sheep walked across
the force plate and at least 6 recordings for each hind limb (left and right) were taken each week. The
force measurements were normalised for weight and reported as Fmax/weight.
2.2.4 Data Analysis
Unless otherwise stated data were analysed using SPSS version 21.0 (Windows and Linux versions).
The data were not assumed to be normally distributed, and the conditions for parametric testing were not
met, therefore non-parametric tests were used.
2.3 Results
2.3.1 Implantable Myoelectrodes 1
2.3.1.1 Gross morphology
Visual inspection of the skin-implant interface at 12 weeks indicated a stable interface. Slight reddening
of the skin was observed (see fig. 2.5), but the wound was dry and no exudate was present. A fibrous cap-
sule had formed around the electrode and cable, however the surrounding muscle appeared healthy. The
external socket connector accumulated debris during use. This appeared to be external environmental
debris.
Figure 2.5: The bone-anchored device implant skin interface after 12 weeks demonstrating slight red-
dening. Image from Al-Ajam et. al., IEEE TBME, ©2013 IEEE, with permission [2].
2.3.1.2 EMG Signals
SNR followed an increasing trend for the first 11 weeks of testing, from 4.4 in week 1 to a maximum of
6.5 in week 8. A representative EMG recording is presented in fig. 2.6. From week 5 to week 10 SNR
was greater than 5. The SNR at week 2 was greater for epimysial compared with surface electrodes (5.1
and 1.6 respectively). Signal quality deteriorated rapidly after 11 weeks due to the debris accumulation
discussed above.
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Figure 2.6: A representative epimysial EMG recording taken during treadmill walking. 3 distinct muscle
activations can be seen, indicating 3 gait cycles. Adapted from Al-Ajam et. al., IEEE TBME, ©2013
IEEE, with permission [2].
2.3.1.3 Impedance Spectroscopy
The electrode impedance at 1 kHz increased from 1.6 kΩ pre-implantation to 2.3 kΩ post-explantation.
A log-log plot of absolute impedance pre-implantation and post-explantation is given in fig. 2.7.
Figure 2.7: Log-log plot of electrode impedance pre-implantation and post-explantation, measured in
0.9% saline.
2.3.1.4 Histology
A fibrous capsule of between 70 µm and 250 µm formed around the electrode, see fig. 2.9b. The capsule
consisted of parallel collagen fibres interspersed with similarly aligned fibroblast nuclei. A layer of
fibroblasts was present at the electrode–tissue interface. During histological processing the electrode
was lost due to failure of the silicone to integrate with the resin, in subsequent histological processing
the electrode was removed from the capsule before processing to avoid tissue loss and resin fracture.
73
Osseointegration of the HA coated stem was observed with bone growth up to the edge of the stem,
see fig. 2.8. The dermis anchored to the porous flange and a healthy epidermis was observed above the
electrode and early stage bony bridging was observed, see fig. 2.9a. The gap between the flange and the
bone was approximately 6 mm, larger than the intended size of 2 mm to 3 mm.
Figure 2.8: A - Backscatter scanning electron micrograph of the bone-anchored device. B - Arrows show
‘osseointegration’ with the HA coating (H) plasma sprayed onto the stem (S). C - Section through the
skin-implant interface showing the keratinized epithelium (E) integrating with the stem (S) and adjacent
HA coating (H). Image from Al-Ajam et. al., IEEE TBME, ©2013 IEEE, with permission [2].
(a) Skin-implant interfaces of bone-anchored device
porous flange. The dermis is integrated with the
porous section and a healthy epidermis has formed.
Some epithelial downgrowth was observed.
(b) Electrode-tissue interface of the epimysial elec-
trode. A thin fibrous capsule has formed. Muscle
fasciculi are present below the fibrous tissue.
Figure 2.9: Soft tissues responses to the bone-anchored device and the epimysial electrode.
2.3.2 Implantable Myoelectrodes 2
A single animal (6036) was diagnosed with osteomylitis following chronic infection of a surgical site
involved in a concurrent study, betadine and intramuscular antibiotics were administered, following no
recovery at week 5 the animal was sacrificed and a single further animal added to the study. A single an-
imal (6027) exhibited Johne’s disease (paratuberculosis), a para-natally acquired infection of ruminants
not associated with this study [266], this animal was sacrificed at 12 weeks. A total of 5 animals were
sacrificed after 19 weeks.
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2.3.2.1 Gross Morphology
In implants placed proximally with large amounts of skin movement sieving was observed. Sieving is
the exposure of the flange as the skin moves downward, forming an epidermal layer within or below the
flange, rather than above the flange. This complication was first observed at week 4 with thinning and
nerosis of the skin overlying the flange. In a single animal this progressed and the flange became visible
at 8 weeks with dry necrosis of the skin. Abnormal skin reddening around the flange was not observed
in this case and no exudate or other evidence of infection was observed. Fibrous capsules had formed
around the electrodes and cable in every animal overlying healthy muscle.
2.3.2.2 EMG Signals
The socket connection was broken on a single animal (6027) and recordings could not be made at week
19.
Non-parametric correlation between signal-to-noise ratio and implantation time was calculated us-
ing Spearman’s rho. The correlation was significant and positive, with a coefficient of 0.389 (p = 0.006).
Using single mean values for each subject at each time point a linear best fit gives R2 = 0.151 (see
fig. 2.10). Of the 6 animals sacrificed after 19 weeks, 5 showed an increasing linear trend in SNR and
1 showed a decreasing linear trend (see fig. 2.11). SNR for implanted electrodes (6.82±3.59) was sig-
nificantly greater than for skin surface electrodes (1.46±0.37) at 19 weeks (p = 0.016). A comparison
of signal to noise ratios is shown in fig. 2.12. Representative EMG recordings for implanted and skin
surface electrodes are shown in figs. 2.13a and 2.13b. In the skin surface recording, in addition to the
muscle activations observed using the epimysial electrode, activity is observed at the level of the muscle
of interest where only small or no activations are observed in the epimysial recordings. This indicates
contamination with other muscle signals, where the signal is mostly removed in the epimysial recording,
but causes crosstalk in the skin surface recording.
2.3.2.3 Pre-terminal stimulation of adjacent muscles
There was a significant reduction in peak stimulus voltage with motor nerve distance from the electrode.
Peak stimulus voltage is the magnitude of the stimulus artefact from the nerve stimulator, peak EMG
is the magnitude of the muscle response to stimulus. All adjacent muscles exhibited significantly lower
peak EMG and stimulus voltages compared with the targeted peroneus tertius (p<0.004, pcut >0.0083˙).
Peak EMG fell significantly with muscle distance from the recording site, peak stimulus artefact fell
significantly with increasing change in nerve supply between the stimulation site and the recording site.
The muscles with greatest EMG signal are the peroneal nerve muscles: peroneus tertius
(0.0259±0.0040 V), peroneus longus (0.0188±0.0026 V), and tibialis anterior (0.0084±0.0025 V).
The most distant muscle, the gastrocnemius, has the lowest peak EMG voltage (0.0048±0.0012 V).
Peak EMG signals are plotted in fig. 2.14.
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Figure 2.10: Change in mean EMG SNR with time following surgery, n = 6. One animal, 6034, was
sacrificed after 30 days. Linear line of best fit with 95% confidence intervals of the mean. The trend is
significant R2 = 0.151, ρ = 0.389, p = 0.006.
Figure 2.11: Change in individual mean EMG SNRs with time following surgery, n = 6. One animal,
6034, was sacrificed after 30 days. Linear lines of best fit with 95% confidence intervals of the mean.
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Figure 2.12: Difference in mean EMG SNR between implanted and skin surface electrodes 19 weeks
after surgery, n = 5. Due to the broken socket connector animal 6027 was left out of the comparison.
The difference is significant p = 0.016.
The greatest stimulus artefact voltage was observed on the deep peroneal nerve muscles: peroneus
tertius (0.246±0.031 V) and tibialis anterior (0.134±0.041 V). The muscle on the superficial peroneal
nerve, peroneus longus (0.060±0.011 V), when stimulated exhibited the next largest artefact. The gast-
rocnemius (0.025±0.015 V) is on a different motor branch, the tibial nerve, and had the smallest stimulus
artefact. Peak stimulation artefacts are plotted in fig. 2.15.
2.3.2.4 Impedance Spectroscopy
Impedance values are shown in fig. 2.16. Pre-implantation mean impedance was 1.3 kΩ (1338 ± 18 Ω),
this increased to 2.2 kΩ (2153 ± 244 Ω) after 19 weeks in vivo, and 3.1 kΩ (3093 ± 1296 Ω) following
explant. There was a significant difference in impedance between: pre-implant and in vivo impedance
(p ≤ 0.003); and pre-implant and explanted impedance (p ≤ 0.008). There was no significant difference
between in vivo and explanted impedances (p ≥ 0.245).
2.3.3 Targeted Muscle Reinnervation 1
2.3.3.1 Gross Morphology
To reduce skin movement the implant was placed in a more distal position than in the n = 6 study.
The interface appeared stable. A fibrous capsule formed around the electrode and cable with some
muscle atrophy observed on the m. tibialis anterior and m. peroneus tertius. The coapted nerve was in
continuity, however fibrosis had formed along the surgical approach obstructing the view of the coaption
site.
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(a) Epimysial EMG.
(b) Surface EMG.
Figure 2.13: Representative implanted epimysial and skin surface EMG recordings taken at the same
time from the same muscle during treadmill walking. 3 distinct muscle activations can be seen in the
epimysial signal, indicating 3 gait cycles.
2.3.3.2 EMG Signals
Muscle activations were first noticed after approximately 1 month with an increase in SNR from 1.86, 22
days post-operatively to 3.20, 29 days post-operatively. Muscle signals were observed in every recording
after 29 days post-operatively (see fig. 2.17). At 58 days post operatively SNR peaked at 6.64 , at 12
weeks post operatively SNR was 4.27.
2.3.3.3 Force Plate Analysis
Pre-operatively no significant difference in Fmax/weight was observed between the left and right legs (p
= 0.478). For the first month following TMR the force was significantly different between limbs and the
difference showed an increasing trend with time (p<0.006, pcut >0.007). From 45 days post-operatively
the force was not significantly different between the legs (p>0.039, pcut <0.024). The normalised force
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Figure 2.14: Peak EMG signal during selective muscle stimulation, n = 1. Recordings taken epimysially
overlying the peroneus tertius, muscles stimulated individually at nerve supply using a 1 mA pulse.
Significant differences are indicated by paired letters: a, p = 0.004; b,c,d, p = 0.002; e, p = 0.001; f, p =
0.003.
Figure 2.15: Peak stimulus artefact during selective muscle stimulation, n = 1. Recordings taken from
the epimysial electrode overlying the peroneus tertius, muscles stimulated individually at nerve supply
using a 1 mA pulse. Significant differences are indicated by paired letters: a,b,c,d,f, p = 0.002; e, p =
0.004.
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Figure 2.16: Mean 1kHz impedance change of epimysial electrodes following 19 weeks implantation,
n = 6. A single mean value for each subject is reported. Significant differences are indicated by paired
letters: a, p = 0.003; b, p = 0.008.
Figure 2.17: Representative EMG recordings following TMR, showing recovery of activations at 29 days
post operatively and activations at recording sessions up to 12 weeks (85 days) post-operatively.
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is reported in fig. 2.18.
Figure 2.18: Force per sheep weight following targeted muscle reinnervation, n = 1. The left leg has
undergone TMR between n. tibialis anterior and m. peroneus tertius. Significantly different pairs are
indicated with an asterisk (*).
2.4 Discussion
2.4.1 Implantable Myoelectrodes 1
The 12 week experiment is the first to describe EMG signal recording with a transcutaneous bone-
anchored device conduit from a cognisant subject. Over the study period signals could be considered
good quality for most recording sessions after 5 weeks [52]. After this the device failed, due to contam-
ination of the external connector caused by the housing environment.
Once the device had been cleared of debris post-explantation impedance could be measured. The
impedance values were in the range found in the subsequent (n = 6) study, indicating that the loss of
signal quality was due to debris and not internal device failure. Impedance can be expected to be stable
following fibrous capsule formation [267]; however, it may be possible to reduce the impedance by
selecting more appropriate electrode materials that are more biocompatible and reduce the thickness of
the fibrous capsule. Alternative designs may also influence impedance, but it was not the objective of
this study to investigate design of epimysial electrodes.
Signals from epimysial electrodes were found to be of better quality than from surface electrodes,
however there were a number of potential confounding factors. The comparison surface EMG recordings
were only in a single animal at a single time point shortly (2 weeks) following surgery. In addition the
sheep model is not optimal for surface recordings, it is difficult to sufficiently shave the leg for electrode
attachment and the extent of skin movement around the ankle joint may create artefact or move the
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electrodes from optimal placement over the muscle.
The chosen design is an improvement on previous designs, which required a hole to be made
through the bone cortex through which to pass the recording wire [241]. In an amputation model, the
only required hole would be that already present at the distal bone (eg. humeral or femoral) end. In this
study early stage bony bridging was observed, however this did not impinge upon the electrode cable. In
longer term studies bone growth up to the electrode wire may cause device failure, this is also a criticism
of Pitkin et al, where natural healing of the hole in the bone cortex may lead to cable damage. A possible
solution to this issue in longer-term studies is a silicone bend protection grommet surrounding the cable
until at least the edge of the porous flange.
2.4.2 Implantable Myoelectrodes 2
The 19 week experiment provides a longer implantation time to examine whether: a) signal deterioration
occurs over the long term; b) whether the bone-anchor is a robust design.
The bone-anchor was found to be robust, with no failures due to loosening within the bone. In one
animal the external socket connection was damaged and recordings could not be made at week 19. This
damage was confined to the commercial LEMO socket, the titanium bone-anchored device and sleeve
were undamaged, this indicates that a redesign of the sleeve could be made to: better protect the LEMO
connector; or provide a fail-safe mechanism that avoids permanent damage to the bone-anchored device
if the applied force exceeds a threshold [268]. This may not be an issue with these electrodes in humans
where patients would look after the connectors.
After 19 weeks early stage bony bridging was also observed. This did not impinge upon the elec-
trode cable in any of the animals, however, as discussed above cable protection may be needed for
longer-term applications.
The skin sieving observed was primarily attributed to skin movement overlying the flange. This may
have been compounded by additional factors: following surgery the site was bandaged and compressed,
movement caused the bandage to bunch over the proximal area, causing more pressure to be applied;
the flanges had a rectangular cross-section with 90◦ angles between the radial and vertical directions
creating a sharp edge underneath the skin; only a thin skin layer was sutured over the flange to allow
dermal attachment, because the flange sits removed from the bone this may stretch the skin and result
in inadequate soft tissue cover (see. fig. 2.4). A domed type implant as used in animal [239] and
human [237] patients may prevent these problems by having soft edges facing the skin interface. In
addition, cable protection may allow the implant to be placed closer to the bone reducing skin stretching.
Finally, future implants should be placed less proximal to reduce skin movement and consideration
should be made to design an implant for use with a healing cap similar to the Poron washer use by
human patients [237].
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An increase in signal-to-noise ratio with time was observed, with a single exception, over 19 weeks.
Signal quality in the first 7 to 8 weeks was lower than observed in the n = 1 study, however signal
quality then increased and remained high for 50 days. Signals from epimysial electrodes were found
to be significantly better than from skin surface electrodes, although a large variability in epimysial
electrode SNR was observed. Targeting electrodes to m. peroneus tertius may have reduced crosstalk
from adjacent muscles and the level of skin movement in the model, combined with other confounding
factors, may have contributed to lower quality surface EMG.
Crosstalk was also investigated directly, by neural stimulation of the local adjacent muscles. Peak
EMG (recorded from the epimysial electrode targeted to m. peroneus tertius) was found to decrease with
increasing distance from the electrode. This is to be expected, firstly because the body can be considered
a volume conductor some fraction of the current flow within any given muscle will be present throughout
the body, and can therefore be recorded [56]. Second because recorded potential decreases with increased
distance from any given muscle fibre [269]. In addition, the tibia can be expected to block current flow
from muscles on the opposing side of the leg, attenuating the signal from the gastrocnemius [269].
Crosstalk can be reduced by reducing the pick-up volume of the electrodes. The double-differential
(true-tripole) electrode and its electrical equivalent the pseudo-tripole can reduce pick-up volume in the
presence of resistive tissue layers [160,270]. In addition reducing interelectrode distance (10 mm in this
study) could further reduce pick-up volume [162].
Crosstalk should also be investigated using multiple electrode sites. In this study only the m. per-
oneus tertius was used with a single targeted bipolar electrode. A greater number of electrodes (≥6)
should be used targeted over different muscles. In the sheep model the following distinct muscles are
available locally within the hind limb (identified by dissection by Y. Al Ajam): tibialis anterior, peroneus
tertius, peroneus longus, flexor digitorum longus, gastrocnemius, and soleus. Additional muscles are
present, however due to interdigitation or inaccessibility these were discounted as surgically unavail-
able.
The trend in peak stimulus voltage recorded epimysially over the m. peroneus tertius was different
to that of peak EMG and can therefore not be fully explained by distance from stimulus site to recording
site, although artefact decreases linearly with distance when only one single muscle is considered [271].
The greatest voltages are observed when stimulating n. peroneus tertius and n. tibialis anterior, which
are both branches of the deep peroneal nerve supplying the anterior compartment. N. peroneus longus is
a superficial peroneal nerve branch supplying the lateral compartment and has the next greatest voltage.
Finally the gastrocnemius is supplied by a branch of the n. tibialis. This leads to a tentative hypothesis
that the stimulus artefact is following a conductive pathway along the nerves and that therefore, a greater
stimulus artefact voltage is observed when stimulating muscles, which have more similar nerve supplies.
As with EMG amplitude, stimulus artefact can be reduced by using a smaller inter-electrode distance
83
[271].
The change in impedance with implantation for the experiment with 6 sheep was in the range ob-
tained from the initial study where there was one individual, validating the results from that experiment.
Again the change in impedance can be attributed to fibrous capsule formation following implantation.
Because the impedance value following 12 weeks implantation (2.3 kΩ) is in the range of the values fol-
lowing 19 weeks implantation (2.2 kΩ± 0.2 kΩ) a stable fibrous capsule and therefore stable impedance
readings may have been reached [267]. The non-significant increase in impedance following explant-
ation may be due to crosslinking of the capsule by the fixative and ionic availability in the different
solutions used (interstitial fluid compared with isotonic saline).
2.4.3 Targeted Muscle Reinnervation
Recovery in gait and muscle activity was observed following reinnervation. This supports the use of
sheep hind limb as a model for TMR. Muscle recovery was observed after approximately 1 month, this
correlates with the peak difference in force distribution between legs. This indicates that m. peroneus
tertius reinnervation leads to gait recovery, and that reinnervation is required for a return to normal gait.
A learning effect may also be key to gait recovery, this could be tested in a 3 group study: one group
as per this study; one group m. peroneus tertius deinnervated without reinnervation; one group section
taken from n. peroneus tertius and reversed before coaption back into n. peroneus tertius.
The change in gait measured by force plate assessment was not apparent by visual inspection.
Following initial surgical recovery no signs of lameness were observed supporting the use of the chosen
nerve transfer for TMR studies in the sheep model.
By the end of the study there was no difference in weight bearing between the operated and non
operated hind limbs, however muscle activation patterns (fig. 2.17) were qualitatively different from
normal muscle (fig. 2.6). This was expected [56], because not all the motor axons present can be expected
to reinnervate the nerve, therefore larger groups of muscle fibres will be reinnervated by a single motor
axon and act as one unit compared with the more even axon distribution and therefore fibre activations
in normal muscle. This leads to the change in signal morphology with fewer larger spikes within the
compound trace.
TMR patients may benefit from implantable electrodes, removing the need to wear a waistcoat
with skin surface electrodes [227]. This has been investigated using needle electrodes, with offline
classification accuracy equivalent to that from surface electrodes [272]. Needle electrodes are not optimal
for TMR patients, as reinnervated muscles are sensitive to needle insertion at the reinnervation site.
Epimysial electrodes may overcome this issue: the surgeon performing TMR can implant the electrodes
during the same procedure as in this study and as others have for RPNI [231], eliminating the need
for further surgery. Furthermore, where bipolar needle electrodes have been used [272], the reduced
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interelectrode distance and reduced pick up area results in highly variable recordings (of few motor
units) from large muscles. Epimysial electrodes can be expected to overcome this problem.
Alternatively to electrode implantation during TMR, the electrode could be implanted once the
re-innervated muscles stabilise and demonstrate firing following patient’s thought of given limb move-
ments [229], this may be around 6 months after surgery provided the patient is given adequate train-
ing [273]. Training includes maximising EMG power from individual re-innervated muscles and prac-
tising movements and grasps by mirroring a computer interface. This will allow targeting the implanted
electrodes to the relevant muscles and the sites of greatest or most specific EMG signal. In addition,
implanting the electrodes during TMR may reduce the rate of reinnervation and cause greater muscle
atrophy, while this two step procedure can be expected to limit these potential complications.
Delay prior to reinnervation may adversely effect the rate and success of reinnervation. Following
a brief review of the literature, patients were found to undergo TMR between 6 and 17 months following
the initial amputation (with a mean of 11 months) [227, 229, 274]. This delay is to allow healing of
the skin around the amputation, ensure no complications are present, and to assess patients for TMR.
However, the delay may adversely affect reinnervation, following denervation both muscle and nerve
can change irreversibly. Muscle undergoes denervation atrophy following long term denervation where
myofibrils are reabsorbed or misalign and muscle cells undergo apoptosis-like cell death, although this
process and timeline following denervation is not clear in humans [275]. In addition, muscle fibre type
changes, collagen fills space left by muscle atrophy and the muscles blood supply reduces: a delay of
only 1 month can lead to over 50% loss of reinnervated muscle force. It should be noted that in TMR
the chosen muscles are typically denervated immediately prior to reinnervation, however the nerves
chosen had been left without a target organ following amputation. Over time the number of axons
available for reinnervation may reduce contributing to the loss of muscle force [276]. However, there
is evidence that, even following 12 months following nerve transection, individual axons will innervate
more muscle fibres than normal and therefore, in healthy muscle such as that used in TMR, lead to
a normal number of innervated muscle fibres and normal muscle force [277]. Denervation atrophy
may be avoided or reduced in TMR patients by using the recording electrodes for FES while awaiting
reinnervation, evidence from spinal cord injury patients has demonstrated that beginning FES usage
shortly following injury significantly reduces muscle loss [278].
In addition, reinnervation is expected to be less successful in older patients, to date it has been used
successfully in patients over the age of 50 [227], however the nerve is expected to repair more slowly and
less effectively [279]. A key finding for improving neural repair in older amputees is that neural debris
slows reinnervation, by clearing this debris axon growth and neuromuscular junction formation may be
facilitated [280].
In this study, due to cost, time and ethical constraints, there was no delay between nerve transec-
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tion and coaption, therefore this can be considered a poor model of TMR as practised in amputees. A
prolonged axotomy study similar to that used by Fu and Gordon [277] may be applicable, in the sheep
model this would involve transection of n. peroneus tertius with targeted reinnervation to m. peroneus
tertius following a delay of approximately 12 months (to appropriately mirror the case in human TMR
patients).
2.4.4 Conclusions
It is concluded that the sheep model chosen is suitable for the transfer of EMG signals using a bone-
anchored device in cognisant, moving animals. The model should be refined and extended as discuss
above to improve: implant robustness; the skin interface; and the number of recording sites. Once
this is carried out the model will lend itself to pre-clinical testing of epimysial electrode designs with
hard-wired interfaces.
The findings of this study indicate that a bone-anchored device would be suitable for transcutaneous
signal transmission in human patients. The implanted device described above may require significant
alteration for human use [237]. A domed flange shape has been discussed above. In addition the bone-
anchor and flange will need to be sized to fit the patient.
The implant design presented requires a hole through the centre of the bone-anchored device, break-
ing the skin barrier created by the porous flange and introducing a route for infection. In this study a
medical grade silicone was used to seal the hole; however this may not be suitable for human use. Sil-
icones are often viscous and, even when degassed, form bubbles when injected into samples. Bubbles
may weaken the seal or result in no seal forming. For human applications a hermetic seal is sugges-
ted, this will prevent water and infection ingress through the lumen of the bone-anchored device. A
metal-in-glass or metal-in-ceramic feedthrough is suggested which can be soldered to the body of the
bone-anchor. This feed-through should then be sealed with a medical grade silicone on the patient side
to provide a second barrier to infection.
Alternative bone-anchored device designs may already be suitable for signal transmission: for pa-
tients with a two-part prosthesis [236, 281] the skin penetrating abutment could be removed from the
osseointegrated portion and a modified abutment used as a hard-wired transcutaneous pathway, this has
been demonstrated recently in human patients (January 2013), following the research described in this
chapter (the first experiment began in October 2011, the second experiment began in July 2012) [233]. It
should be noted that the abutments described do not have a porous flange design to encourage skin and
soft tissue integration, therefore the skin seal, although assumed to be of lower quality, can be broken
and reformed around a new implant without requiring significant tissue removal.
This study demonstrates that epimysial electrodes can be placed on a muscle in the same surgical
session as TMR and that reinnervation will occur. It is unknown whether the extent and quality of
86
reinnervation is reduced due to the epimysial experiments. This should be examined in an animal model
to determine whether simultaneous TMR and implantation can be suggested for clinical practice.
This chapter presents a technique for accurate 1-to-1 mapping of electrodes and muscles without
relative movement. However, untargeted mono-polar electrodes may also perform well [282], some con-
trol algorithms show robustness to electrode movement and reduced electrode number [283]. Implanting
electrodes may even reduce classification accuracy, however targeting muscle directly during implanta-
tion may overcome these issues [284]. Untargeted systems would reduce surgery time and invasiveness,
but further work is required to confirm whether the extra time spent targeting electrodes to muscles is
beneficial for patients.
This study used passive electrodes with recording equipment sited outside the body. Further work
is ongoing to develop active electrodes with signal amplification at the recording site and multiplexing
using an active implant. This will enable multiple electrodes to be implanted using a single hard-wired
connection. In addition, amplified and digitised signals will be less susceptible to cable artefact and
external noise. To account for differing surgical approaches and patient anatomy active implants can be
produced with different cable lengths, which are then chosen, connected and sealed during surgery using
Craggs connectors [285]. In addition to a mutiplexed recoding system, additional channels could be
introduced for sensory feedback by stimulation of nerves within the amputation stump, where stimulation
signals are carried using the same hard-wired connection. This has the potential to provide patients with
prosthesis attachment, control and sensation.
This study presents a series of in vivo experiments with limitations due to the model, including:
some anatomical differences; a trans-tibial rather than amputation insertion; the single channel design;
and a lack of patient feedback. Some of these issues will be overcome in further work with a more ad-
vanced device design; however, it is not ethically feasible to carry out an amputation model and training
and control issues can only be considered with a non-human primate or human study.
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Chapter 3
In Vitro Neuron Adhesion Studies: Basement
Membrane Proteins
3.1 Introduction
Improving neurocompatibility of microchannel surfaces may improve their function. Reducing the ad-
verse foreign body response will prevent channel occlusion and enable the in vivo use of smaller diameter
microchannels [51, 113, 146].
Microchannel neural interfaces are regenerative electrodes, and must therefore be sutured within
a transected peripheral nerve. In order for microchannel electrodes to function axons must regenerate
along the circa 5 mm gap created between the proximal and the distal nerve endings [59, 113].
The gold standard for neural repair and regeneration following complete nerve transection is the
autograft, but taking the graft can lead to donor site morbidity. Synthetic nerve guidance channels
(NGCs) have been introduced to overcome donor site morbidity associated with autografts and provide
a reproducible off-the-shelf alternative [75, 77, 78, 178, 286]. MNIs can be considered a special case of
NGCs, therefore the same strategies to improve neurocompatibility and neural regeneration apply. Fur-
thermore, the challenges in interfacing with chronically amputated nerves make improving regeneration
imperative for the clinical use of MNIs. Previous animal models have shown increased inflammatory
response to neural interfaces and the formation of benign but often painful neural tumours (neuromas)
in the absence of a target organ [287, 288].
Strategies to improve neurocompatibility and neural regeneration within nerve guides include:
tailored materials; coatings; scaffolds; topography; release of trophic factors or other signalling mo-
lecules; electrical cues; the inclusion of support cells or stem cells; and the development of anisotropic-
ally distributed cues [71, 76, 176–180].
For neural electrodes some strategies are unsuitable. MNIs must be made from a flexible insulator,
which interfaces with electronic components; suitable materials are medical grade silicones, polyimides
and to a lesser extent fluorocarbon polymers [289], therefore materials choice is restricted. This study
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will use silicone (Polydimethylsiloxane, PDMS).
Strategies, which lend themselves readily to application within microchannels are the use of coat-
ings, trophic factors, electrical cues and cells. These factors could be isotropically or anisotropically
distributed along the axis of regeneration (proximally to distally).
In healthy nerve there is intimate contact between nerve axons, Schwann cells and the endoneurial
basement membrane (or Schwann cell basement membrane). Following nerve injury and Wallerian de-
generation axons can regrow, guided by the remaining extracellular matrix (ECM) architecture, trophic
factors and support cells [71]. It is this natural regeneration pathway that is restored by autografts [178].
Autografts do not contain active neurons or axons, but have active support cells and ECM arranged in the
correct micro-environment for axonal regrowth. By making the micro-environment within microchan-
nels similar to that of autografts neural regeneration may be improved.
This chapter will focus on a coating strategy for improving neural regeneration: mimicking the
extracellular matrix of the peripheral nervous system.
3.1.1 Endoneurial Basement Membrane
Components of the endoneurial basement membrane (BM) have been shown to improve neurite out-
growth in vitro. In addition, ECM gel1, a mixture of basement membrane proteins and proteoglycans,
has been shown to promote neurite outgrowth [290–293]; however, ECM gel is poorly characterised and
unlikely to be approved for human implantation [294–296]. This implies that a well-characterised, ECM
gel-like, endoneurial basement membrane coating may improve neurite outgrowth in vitro and in vivo.
Basement membranes are primarily comprised of Collagen-IV (C-IV), Laminins (Ln), Perlecan,
Heparan sulphate and Nidogens (Nid) [24, 297]. There are minor components that include fibulin and
tenascins [297, 298]. Typical proportions in Engelbreth-Holm-Swarm tumor have been determined as
60% Ln, 30% C-IV, 6% Nid with other proteins present in smaller amounts [299,300]. Ln expression in
the endoneurial basement membrane is primarily the merosin form of Ln, Ln-2 (α2β1γ1) [297,301,302].
Other forms of Ln are expressed in the peripheral nervous system: for example, in the perineurium, Ln-9
(α4β2γ1) and Ln-11 (α5β2γ1); and at neuromuscular junctions Ln-4 (α2β2γ1), Ln-9, and Ln-11 [303].
The α2 chain Ln-2 and Ln-4 are readily extracted from placenta and may be more applicable to neural
regeneration than the more commonly used Ln-1 (α1β1γ1) [179].
Recently Ln-2 derived peptides have shown promise in vivo and in vitro [203,304]. However, Ln-2
dosing of nerve-derived scaffolds has not been shown to improve neurite outgrowth [305]. Other derived
proteins are in regular use, for example RGD (arginyl glycyl aspartic acid), which provides adhesion
sites for many integrins, has shown promise for neural regeneration [306, 307].
BM proteins self-assemble in vitro (see fig. 3.1) [211, 308–311]. C-IV and Ln form independent
1ECM gel is sourced from from Engelbreth-Holm-Swarm sarcoma in mice. It is sold commercially under the following names:
Matrigel™ (BD Biosciences), Cultrex® (Trevigen), ECM gel (Sigma-Aldrich), and others.
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sheet-like structures. In turn C-IV and Ln are connected by Nid [209] and perlecan [207]. This self-
assembled structure may act to present binding domains to cells and therefore should be investigated for
use as a coating for neural outgrowth.
Figure 3.1: Structure of a typical basement membrane (BM). Laminin polymerises at the basolateral
cell surface, anchored to cell receptors. Nidogens and perlecans form bridges between the laminin and a
network of collagen type-IV. Reprinted by permission from Macmillan Publishers Ltd (Nature Publishing
Group): Nature Reviews Cancer [207], ©2003.
3.1.2 Aims and Hypotheses
This chapter presents an in vitro study investigating the effect of adsorbed protein surface coatings on
neurite outgrowth. The proteins that will be considered are: poly-D-lysine; C-IV; Ln-2,-4; Ln-1; Nid-1;
fibronectin and poly-L-orthinine. Because basement membrane preparations are poorly characterised,
application specific protein concentrations will be determined for each protein.
The aim of this study is to develop and test a coating that could be applied within a microchannel
to improve neural regeneration. Therefore the coating method must be suitable for application within a
small diameter (<200 µm) tube. In addition the coating should require as few steps to apply as possible.
The hypotheses for this chapter are as follows:
1. Endoneurial basement membrane protein coatings increase neurite outgrowth on silicone surfaces
compared with poly-D-lysine (PDL) coated or uncoated controls.
2. Collagen-IV + Laminin + Nidogen multi-protein coatings increase neurite outgrowth on silicone
surfaces compared with single protein coatings.
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3. Multi-protein coating order does not significantly change neurite outgrowth on silicone surfaces.
4. Multi-protein coatings do not significantly change neurite outgrowth on silicone surfaces com-
pared with ECM gel coatings.
3.2 Methodology
3.2.1 Preparation of Silicone Surfaces for In Vitro Assays
Silicone (Sylgard 184, Dow Corning, Midland, MI) was spin coated onto 25 mm × 75 mm glass slides
using a WS-400BZ-6NPP-Lite spin coater (Laurell Technologies). Approximately 2 mL of uncured, 1:1
mixed, silicone was extruded onto the slide using a syringe. The slide was spun at the following speeds:
100 rpm for 20 s; 500 rpm for 30 s; 1000 rpm for 15 s. The coated slide was cured at between 50◦C and
75◦C for 12 hours.
Spin coated silicone surfaces were prepared for seeding. The samples were UV sterilised for 12
hours. Samples were divided into 1 cm2 sections, supported on 19 mm diameter glass cover slips (VWR)
and placed into 6-well plates. The samples were coated with protein as follows (see also table 3.1).
3.2.1.1 Poly-D-Lysine
Poly-D-lysine (PDL) was supplied as a lyophilized powder (30 kDa to 70 kDa molecular weight). This
was allowed to come to room temperature. The PDL was reconstituted in sterile filtered sterile distilled
water (SDW) to give a 0.1 mg/ml solution. The solution was separated into 1 ml aliquots and stored at
-20◦C.
For cell culture flasks 1ml of 0.1 mg/ml PDL solution is sufficient to coat 25 cm2 (a coating density
of 4 µg/cm2). To coat a surface sufficient dilute PDL was allowed to come to room temperature (eg.
3 ml for 1 T-75 culture flask). The PDL solution was pipetted onto the surface and full coverage was
ensured. The surface was incubated for 20 minutes at 36◦C. The PDL solution was removed and the
surface washed thoroughly with PBS three times. The surface was placed in an incubator for at least 2
hours to dry.
For silicone surfaces the dilution factor was altered to coat 1 cm2 with a 150 µl droplet. The PDL
solution was micropipetted onto the surface. The surface was incubated for 20 minutes at 36◦C. The
surface was washed thoroughly with PBS three times. The surface was placed in an incubator at 36◦C
for at least 2 hours to dry.
3.2.1.2 Collagen-IV
Collagen-IV was supplied as a lyophilized powder. C-IV was reconstituted in sterile PBS to give a 1
mg/ml solution. The solution was separated into 1 ml aliquots and stored at -20◦C.
To coat a silicone surface sufficient dilute C-IV was allowed to come to room temperature to coat 1
cm2 with a 150 µl droplet of the desired concentration. The C-IV solution was micropipetted onto the
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surface. The surface was incubated for 1 hour at 36◦C. The surface was washed thoroughly with PBS
three times. The surface was placed in an incubator at 36◦C for at least 2 hours to dry.
3.2.1.3 Laminin-2,-4
Ln-2,(-4) was supplied at a concentration of 0.5 mg/ml in 50 mM Tris-HCL with 150 mM NaCl. This
was thawed slowly at 4◦C to prevent gelling. Ln was reconstituted in cold (∼4◦C) sterile PBS to give a
0.1 mg/ml solution. The solution was separated into 0.5 ml aliquots and stored at -20◦C.
To coat a silicone surface sufficient dilute Ln was allowed to come to room temperature to coat 1
cm2 with a 150 µl droplet of the desired concentration. The Ln solution was micropipetted onto the
surface. The surface was incubated for 2 hours at 36◦C. The surface was washed thoroughly with PBS
three times. The surface was placed in an incubator at 36◦C for at least 2 hours to dry.
3.2.1.4 Laminin-1
Ln-1 was supplied was supplied at a concentration of 1 mg/ml in 50 mM Tris-HCL with 150 mM NaCl.
This was thawed slowly at 4◦C to prevent gelling. The Ln-1 was reconstituted in cold (∼4◦C) sterile
PBS to give a 0.1 mg/ml solution. The solution was aliquoted into 0.5 ml aliquots and stored at -20◦C.
To coat a silicone surface sufficient dilute Ln-1 was allowed to come to room temperature to coat 1
cm2 with a 150 µl droplet of the desired concentration. The Ln-1 solution was micropipetted onto the
surface. The surface was incubated for 2 hours at 36◦C. The surface was washed thoroughly with PBS
three times. The surface was placed in an incubator at 36◦C for at least 2 hours to dry.
3.2.1.5 Nidogen-1
Nid-1 was supplied as a lyophilized powder. Nid-1 was reconstituted in sterile PBS to give a 0.1 mg/ml
solution. The solution was separated into 0.1 ml aliquots and stored at -20◦C.
To coat a silicone surface sufficient dilute Nid-1 was allowed to come to room temperature to coat
1 cm2 with a 150 µl droplet of the desired concentration. The Nid-1 solution was micropipetted onto the
surface. The surface was incubated for 1 hour at 36◦C. The surface was washed thoroughly with PBS
three times. The surface was placed in an incubator at 36◦C for at least 2 hours to dry.
3.2.1.6 Fibronectin
Fibronectin (Fn) was supplied as a lyophilized powder. This was thawed slowly at 4◦C. Fn was recon-
stituted in sterile PBS to give a 0.1 mg/ml solution. The solution was separated into 0.5 ml aliquots and
stored at -20◦C.
To coat a silicone surface sufficient dilute Fn was allowed to come to room temperature to coat 1
cm2 with a 150 µl droplet of the desired concentration. The Fn solution was micropipetted onto the
surface. The surface was incubated for 2 hours at 36◦C. The surface was washed thoroughly with PBS
three times. The surface was placed in an incubator at 36◦C for at least 2 hours to dry.
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3.2.1.7 ECM Gel
Growth-factor reduced ECM gel (E6909, Sigma-Aldrich) was supplied as a liquid at a concentration of 7
mg/mL to 9 mg/mL, a concentration of 8 mg/mL was assumed. The ECM gel was diluted in in sufficient
phosphate buffered saline to coat 1 cm2 with a 150 µl droplet of the desired concentration. The ECM
gel solution was micropipetted onto the surface. The surface was incubated for 2 hours at 36◦C. The
surface was washed thoroughly with PBS three times. The surface was placed in an incubator at 36◦C
for at least 2 hours to dry.
3.2.1.8 Poly-L-Orthinine
Poly-L-Orthinine (PLO) was supplied as a lyophilized powder (30 kDa to 70 kDa molecular weight).
This was allowed to come to room temperature. The PLO was reconstituted in sterile filtered SDW to
give a 1 mg/ml solution. The solution was separated into 1ml aliquots and stored at -20◦C.
To coat a silicone surface sufficient dilute PLO was allowed to come to room temperature to coat
1 cm2 with a 150 µl droplet of the desired concentration. The PLO solution was micropipetted onto the
surface and full coverage was ensured. The surface was incubated for 20 minutes at 36◦C. The PLO
solution was removed and the surface washed thoroughly with PBS three times. The surface was placed
in an incubator at 36◦C for at least 2 hours to dry.
Protein Source Reconstituted in Incubation time
(minutes)
Poly-D-Lysine P7280,
Sigma-Aldrich
Sterile Distilled
Water
20
Poly-L-Orthinine P3655,
Sigma-Aldrich
Sterile Distilled
Water
20
Collagen-IV C5533,
Sigma-Aldrich
Phosphate Buffered
Saline Solution
60
Laminin-2,-4 L6274,
Sigma-Aldrich
Phosphate Buffered
Saline Solution
120
Laminin-1 L2020,
Sigma-Aldrich
Phosphate Buffered
Saline Solution
120
Nidogen-1 2570-ND, R&D
Systems
Phosphate Buffered
Saline Solution
60
Fibronectin F2006,
Sigma-Aldrich
Phosphate Buffered
Saline Solution
120
ECM Gel E6909,
Sigma-Aldrich
Phosphate Buffered
Saline Solution
120
Table 3.1: Protein sources, solvents and incubation conditions.
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3.2.2 Protein Coating of Silicone Surfaces
3.2.2.1 Protein concentration optimisation
Firstly the optimal concentration of the chosen proteins was determined. Silicone surfaces were prepared
and coated using the above procedures at the concentrations shown in table 3.2. The optimal concen-
trations determined are shown in table 3.2. Where an doubling (or greater) in protein concentration did
not result in a significant increase in neurite outgrowth measures the lower concentration was considered
optimal.
3.2.2.2 Laminin-2,(-4) and Laminin-1
Laminin-2,-4 was compared with Laminin-1 at the same concentration. The optimal concentration de-
termined was used (1 µg/cm2, see table 3.2).
3.2.2.3 Comparison of Optimal Concentrations
The optimal coating concentrations of PDL, Ln-2,-4, and C-IV were compared with a basement mem-
brane mimicking surface coating.
To mimic basement membrane in vitro multi-protein surface coatings were used. Optimal concen-
trations determined with single-protein coatings were used (see table 3.2). Nid-1 coating concentration
was determined using a 1:1 molar ratio of Ln-2,-4 to Nid-1 [210]. The molecular masses of Ln-1, Ln-
2 and Ln-4 are highly similar (850 kDa) and the molecular mass of Nid-1 is known (150 kDa) [209].
Therefore a 1:1 molar ratio of Ln-2,-4 to Nid-1 will have a mass ratio of 1:0.176 (1:0.175 was used in
this study).
To form a C-IV + Nid-1 + Ln-2,-4 layer-by-layer coating (CNL) surfaces were coated with the
optimal C-IV coating concentration, washed and dried as described above. Surfaces were coated with
Nid-1, washed and dried as described above. Finally, surfaces were coated with Ln-2,-4, washed and
dried as described above.
3.2.2.4 Comparison of Multi-Protein Coatings: Experiment 1
Different methods for forming multi-protein coatings were evaluated and compared with CNL coatings
and commercial standard ECM gel coatings as described above.
To form an alternative Ln-2,-4 + Nid-1 + C-IV layer-by-layer coating (LNC) surfaces were first
coated with the optimal Ln-2,-4 coating concentration, washed and dried as described above, followed
by Nid-1 and finally C-IV.
An all-in-one procedure was developed. C-IV, Nid-1 and Ln-2,-4 were diluted and mixed to give an
optimal coating concentration of each protein in a single 150 µl droplet. The surface was incubated for
2 hours at 36◦C. The surface was washed thoroughly with PBS three times. The surface was placed in
an incubator at 36◦C for at least 2 hours to dry.
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Surface Coating Concentration(s)
(µg/cm2)
Abbreviation
Optimisation
Poly-D-Lysine 2, 4, 10, 20 PDL
Poly-L-Orthinine 1, 5, 10, 20, 40 PLO
Collagen-IV 1, 5, 10, 20, 40 C-IV
Laminin-2,-4 0.1, 0.5, 1, 2, 5 Ln-2,-4
Fibronectin 1, 2, 5 Fn
Nidogen-1 0.5, 1, 2 Nid-1
Laminin-2,(-4)
and Laminin-1
Laminin-2,-4 1 Ln-2,-4
Laminin-1 1 Ln-1
Comparison of
Optima
Poly-D-Lysine 10 PDL
Collagen-IV 10 C-IV
Laminin-2,-4 1 Ln-2,-4
Nidogen-1 N/A Nid-1
Layer-by-Layer (Collagen-IV +
Nidogen-1 + Laminin-2,-4)
10 + 0.175 + 1 CNL
Uncoated N/A Uncoated
Comparison of
Multi-Protein
Coatings:
Experiment 1
Layer-by-Layer (Collagen-IV +
Nidogen-1 + Laminin-2,-4)
10 + 0.175 + 1 CNL
Layer-by-Layer (Laminin-2,-4 +
Nidogen-1 + Collagen-IV)
1 + 0.175 + 10 LNC
All-in-One (Collagen-IV +
Nidogen-1 + Laminin-2,-4)
10 + 0.175 + 1 All-in-One
ECM Gel 11.175 ECM Gel
Comparison of
Multi-Protein
Coatings:
Experiment 2
Layer-by-Layer (Collagen-IV +
Laminin-2,-4)
10 + 1 CL
Layer-by-Layer (Laminin-2,-4 +
Collagen-IV)
1 + 10 LC
All-in-One (Collagen-IV +
Laminin-2,-4)
10 + 1 CL All-in-One
All-in-One (Collagen-IV +
Nidogen-1 + Laminin-2,-4)
10 + 0.175 + 1 All-in-One
ECM Gel 11.175 ECM Gel
Collagen-IV 10 C-IV
Table 3.2: Protein coating concentrations used for each experiment or group of experiments.
3.2.2.5 Comparison of Multi-Protein Coatings: Experiment 2
The effect of different constituents in the multi-protein coatings were evaluated. The all-in-one, ECM gel
and 10 µg/cm2 C-IV coatings were formed as described above. Coatings without Nid-1 were developed.
To form Ln-2,-4 + C-IV layer-by-layer coatings (LC) surfaces were first coated with the optimal
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Ln-2,-4 coating concentration, washed and dried as described above, followed by C-IV.
To form C-IV + Ln-2,-4 layer-by-layer coatings (CL) surfaces were first coated with the optimal
C-IV coating concentration, washed and dried as described above, followed by Ln-2,-4.
To form C-IV + Ln-2,-4 all-in-one coatings (CL all-in-one) C-IV and Ln-2,-4 were diluted and
mixed to give an optimal coating concentration of each protein in a single 150 µl droplet. The surface
was incubated for 2 hours at 36◦C. The surface was washed thoroughly with PBS three times. The
surface was placed in an incubator at 36◦C for at least 2 hours to dry.
3.2.3 Analysis of Coating by Raman Microscopy
In addition to cell seeding surfaces, n=2 samples were prepared for additional analysis by freeze drying.
Once dry, the samples were transferred to a Raman microscope for analysis. Spectrographs of surfaces
with and without protein coatings were taken and analysed. Raman Microscopic images were taken
using a Labram 300 (Horiba Jobin Yvon, at the UCL Eastman Dental Institute) with a HeNe (633 nm)
laser. 100 spectra were captured for 2 seconds each and averaged.
3.2.4 Analysis of Coating by BCA Assay
Separate surfaces were prepared by dropping 50 µl PDMS into each well of a 98 well plate, giving a
PDMS surface area of 0.31 cm2. PDMS was prepared under particle free conditions and well plates were
coated under aseptic conditions. Well plates were placed on a plate shaker for at least 12 hours at 37◦C
to ensure complete coating of the well surface. Wells were checked under an optical microscope, in all
cases the well surface was completely covered with PDMS.
Surfaces were coated with proteins (n = 3) as above (table 3.2) using 100 µl droplets. Surfaces were
washed 3 times with PBS. Washed PDMS surfaces were allowed to dry in an incubator at 36◦C.
3.2.4.1 BCA Assay
Protein concentrations on surfaces were analysed using a micro BCA assay (bicinchoninic acid assay,
Pierce Micro BCA Protein Assay Kit, Thermo Fisher Scientific Inc.) [312]. The BCA assay is a variation
on the Lowry assay, and detects cuprous ions generated from a reaction of cupric ions with protein.
Because the assay detects ions in solution, rather than the formation of a chromophore following reagent–
protein binding, it is valid for the measurement of adsorbed or bound proteins [313].
A bovine serum albumin standard (BSA) curve was used. BSA was diluted in PBS to form con-
centrations from 0.001 mg/ml to 0.04 mg/ml. 100 µl droplets of protein were placed into PDMS coated
well plates, the surfaces were not washed, surfaces were allowed to dry in an incubator.
150 µl BCA working reagent was added to each well including standards and blank reference. The
well plate was sealed and placed on a plate shaker for 2 hours at 37◦C.
The plate was allowed to cool and absorbance was measured at 562 nm using a NanoDrop1000
spectrophotometer (Thermo Scientific). Protein concentrations were calculated using the interpolation
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lines given by the standard curve. Amount of protein per well plate, and therefore per cm2 was calculated
for each sample.
3.2.5 Cell Line
All in vitro assays were carried out using the PC-12 cell line (European Collection of Cell Cultures,
Porton Down, UK (catalogue number: 88022401).
Within any single experiment cells from a single population (passage) were used to reduce exper-
imental error. Previous studies have suggested that the line should be used before passages 6 to 10 to
avoid senescence [198, 199, 314]. However, this was not feasible because the PC-12 cells were received
at passage 7. Therefore the cells were used within 6 passages (passage ≤ 12).
Cells were culture expanded in 25 cm2 cell culture flasks (Corning) coated with 4 µg/cm2 Poly-D-
Lysine (PDL). PDL was chosen as the cell adhesion coating for culture expansion because it interacts
electrostatically with cell membranes, and therefore is unlikely to upregulate the expression of specific
cell adhesion molecules [315].
The following cell culture media was used: RPMI 1640 (R8758, Sigma) + 10 mM HEPES Buffer +
1 mM Sodium Pyruvate + 1% penicillin-streptomycin + 10% Horse Serum + 5% Foetal Bovine Serum
(FBS). Standard subculture technique was used: cells were detached using trypsin-EDTA (Gibco) and
agitation, centrifuged to form a cell pellet, resuspended as a single-cell suspension using a small diameter
needle and seeded onto 2 new PDL coated flasks.
Prior to seeding onto test surfaces cells were primed by culturing with NGF 7S (50 ng/mL) in
complete media for at least 7 days. Priming with NGF enhances the rate of neurite outgrowth following
seeding [316].
3.2.6 Cell Seeding
Cells were seeded at a rate of 5,000 cells per cm2. Cells were detached from culture flasks using trypsin-
EDTA and agitation, centrifuged to form a cell pellet and resuspended in media + 50 ng/mL NGF to give
single-cell suspension at 50,000 cells/mL. Cells were dropped onto the silicone sample surface in a 100
µL droplet using a gilson pipette. Samples were place in an incubator at 37◦C, 5% CO2, for 1 hour to
adhere to the sample surface. The samples were then flooded with 2 mL media + 50 ng/mL NGF and
incubated for 96 hours with a single media change after 48 hours.
3.2.7 Neurite Outgrowth Assay
3.2.7.1 Scanning Electron Microscopy
After 96 hours incubation cells (n=6 samples) were prepared for scanning electron microscopy (SEM).
Media was removed from each sample. 2 ml 2.5% gluteraldehyde fixative in 0.1M sodium cacodylate
buffer (pH 7.4) was added to each sample. After 30 minutes the fixative was removed and the samples
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Alcohol Concentration (vol.%
Alcohol in dH2O)
Time (minutes) Number of repeats
IMS 20 5 2
IMS 30 5 2
IMS 40 5 2
IMS 50 5 2
IMS 60 5 2
EtOH 90 5 2
EtOH 96 10 2
EtOH 100 15 2
Table 3.3: Alcohol series used for dehydration of cell monolayers on silicone sample. IMS = industrial
methylated spirits. EtOH = Ethanol. Alcohol diluted in distilled water.
were washed in 0.1M sodium cacodylate buffer (pH 7.4). The samples were dehydrated in ascending
alcohol series (see table 3.3). The samples were covered with a loose lid and air dried for at least
12 hours. The transition solvent hexamethyldisilazane caused the silicone samples to swell and curl,
damaging or detaching the cell layer, therefore no transition solvent was used.
Dry samples were mounted onto aluminium stubs using double sided carbon tape. Samples were
sputter coated with Au/Pd for 2.5 minutes at 20 mA using an Emitech K550 sputter coater. Conductive
paint was used to create a conductive bridge between the sample and the aluminium stub. Prepared
samples were image under a scanning electron microscope at 15 keV and 20 keV (JEOL JSM 5500 LV,
JEOL, Welwyn Garden City, UK). 6 images were taken of each sample at 400× magnification. Images
were taken approximately equidistantly across the sample surface. In addition representative images
were taken at 40×, 100× and 200×.
3.2.7.2 Immunoflourescence Microscopy
To visualise the actin cytoskeleton immunflourescent staining was used. This allowed confirmation that
the processes observed under SEM are cellular and not image artefact.
After 96 hours incubation cells (n=1 samples) were prepared for fluorescence microscopy. Media
was removed from each sample. 2 ml 4% formalin in phosphate buffered saline was added to each
sample. After 30 minutes the fixative was removed and the samples were washed in PBS. Cells were
permeabilised using 0.1% Triton-X (Sigma-Aldrich) in PBS for 15 minutes. Samples were washed 3
times with PBS and 1% phalloidin-FITC was added to each sample. Samples were incubated at room
temperature for 1 hour. Samples were washed 3 times with PBS and stained with 0.1% Hoechst 33258
(Sigma-Aldrich) in PBS for 15 minutes. Samples were washed and stored under PBS prior to imaging.
Samples were imaged using an Axioskop 2 Plus light microscope (Zeiss) with FITC and DAPI
filters and images were recorded using Axiovision software (Zeiss).
98
3.2.7.3 Neurite Length and Number
Neurite length and Neurite number were determined from 400x electron micrographs using ImageJ soft-
ware (version 1.46r to version 1.49m, NIH, USA) [317, 318]. Linear extensions from the cell were
measured for all cells exhibiting extensions fully within the field of view. Extensions were considered
neurites when they extended at least 1 cell diameter from the cell edge. The number of neurites per cell
exhibiting neurites was recorded.
3.2.8 Data Analysis
Analysis of neurite number and neurite length was carried out using SPSS 21.0, Mac and Linux versions
(SPSS Inc., IBM, Chicago, IL). Data were tested for normality using the Kolmogorov-Smirnov test. Data
were not found to be normally distributed, therefore non-parametric statistical analyses were performed.
For each experiment neurite number and neurite length for all groups were compared using the
Kruskal-Wallis one-way analysis of variance test. If a significant difference was observed pair-wise
Mann-Whitney U tests were performed to identify differences between groups. If no significant differ-
ence was found using the Kruskal-Wallis test the p-value was reported and no further statistical tests
were carried out. Differences were considered significant at the α ≤ 0.05 level.
Pair-wise tests were corrected for multiple comparisons using Holm-Bonferroni correction [319].
This is intended to reduce the likelihood of type I errors.
3.3 Results
Data are reported as mean ± standard deviation to 3 significant figures unless otherwise stated. Neurite
outgrowth data are plotted as median, interquartile range and inner fences (1.5 times interquartile range).
Where data are highly skewed a log scale is used. p-values are tabulated in the appendix.
3.3.1 Raman Microscopy
All results for the Raman microscopy showed the PDMS spectrum predominating (example fig. 3.2). No
protein signatures were visible due to the relative thickness of the PDMS and protein layers. Even with
the normalisation for the PDMS spectrum protein signatures were not observed.
3.3.2 BCA Assay
Comparisons between protein types may not be valid due to the differing reaction characteristics for each
protein. In addition statistical comparisons were not made due to the low number of measurements for
each group (n = 3).
The results demonstrate that for increasing protein concentration applied, concentration on the
PDMS surface increases for C-IV, Fn and Ln-2,-4. For PDL and PLO this trend was not observed.
Nid-1 was tested at one concentration due to cost constraints and showed the least consistent readings
across n = 3 samples. The trend fitted well to a linear model for C-IV (R2 = 0.917) and Fn (R2 = 0.948).
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Figure 3.2: Raman Microscope Spectra of protein coated and uncoated PDMS surfaces. Averages of 100
x 2 second spectra. Observable spectra are for coated and uncoated PDMS.
For Ln-2,-4 a logarithmic model fitted the data more closely (R2(linear) = 0.885, R2(log) = 0.933). For
Ln-2,-4 with an applied concentration≤ 2 µg/cm2 a linear model fitted the data more closely (R2(linear)
= 0.975, R2(log) = 0.908).
There was no consistent trend with coating order for multi-protein coatings. LNC layer-by-layer
coatings had a lower concentration than CNL layer-by-layer coatings, however LC layer-by-layer coat-
ings had a higher concentration than CL layer-by-layer coatings.
3.3.3 Protein Concentration Optimisation
3.3.3.1 Poly-D-Lysine Concentration
PC-12 cells adhered to PDL coated surfaces. The cells also extended neurites. Results are plotted in
figs. 3.4a and 3.4b. The optimum concentration of PDL observed was 10 µg/cm2.
The number of neurites per cell was greatest on surfaces coated with 10 µg/cm2 PDL (1.79 ±
1.36 neurites). Fewer neurites per cell were observed on surfaces coated with 20 µg/cm2 (1.71 ± 1.12
neurites), 4 µg/cm2 (1.34 ± 0.55 neurites) and 2 µg/cm2 (1.28 ± 0.60 neurites) of PDL. None of the
differences observed were statistically significant (Kruskal-Wallis p value = 0.078).
Cells extended the longest neurites on surfaces coated with 10 µg/cm2 PDL (59.1 ± 42.2 µm).
Significantly shorter neurites were observed on surfaces coated with 20 µg/cm2 (22.8 ± 9.43 µm, p ≤
0.001) and 2 µg/cm2 (32.2 ± 23.6 µm, p = 0.002). PC-12 cells on surfaces coated with 4 µg/cm2 exten-
ded shorter neurites (36.2 ± 23.6 µm), however this was not significantly different to the neurite length
on surfaces coated with 10 µg/cm2 PDL (p = 0.093). No other significant differences were observed (p
≥ 0.019, pcut = 0.016).
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Figure 3.3: Concentration of proteins on PDMS following 3 PBS washes. Determined using a micro
BCA assay (n=3).
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(a) PC-12 cell neurite number on Poly-D-
Lysine coated samples. Data displayed on a
logarithmic scale. Differences not significant,
p = 0.078.
(b) PC-12 cell neurite length on Poly-D-
Lysine coated samples. Data displayed on a
logarithmic scale. Significant differences are
indicated by paired letters: a, p = 0.002; b, p =
0.001; c, p <0.001.
Figure 3.4: PC-12 cell neurite outgrowth data for silicone samples coated with Poly-D-Lysine at the
following concentrations: 20 µg/cm2; 10 µg/cm2; 4 µg/cm2; 2 µg/cm2.
3.3.3.2 Poly-L-Orthinine Concentration
PC-12 cells adhered well to PLO coated surfaces, however the coating was non-uniform, with large
areas of the surface showing low cell attachment, while cells attached in small areas, typically forming a
striped pattern. Cells did extend neurites that could be measured, however the coating was inconsistent
therefore PLO was discounted and no measurements were made.
3.3.3.3 Collagen IV Concentration
PC-12 cells adhered to C-IV coated surfaces and extended measurable neurites at every concentration
tested. Two experiments were carried out to determine the optimal C-IV concentration: the first experi-
ment used 10, 5 and 1 µg/cm2 C-IV, the results did not appear to plateau within this range therefore the
concentrations were extended. The second experiment used 40, 20 and 10 µg/cm2 C-IV, a plateau was
found within this range therefore no further experiments were needed. The optimum concentration of
C-IV observed was 10 µg/cm2.
Collagen IV Concentration: Experiment 1 Results are plotted in figs. 3.5a and 3.5b. No significant
difference in neurite number was observed between the samples tested (Kruskal-Wallis p value = 0.217).
A maximum number of neurites was observed on surfaces coated with 5 µg/cm2 C-IV (2.48 ± 1.39
neurites). Fewer neurites were observed on surfaces coated with 10 µg/cm2 C-IV (2.31 ± 1.16 neurites)
and 1 µg/cm2 C-IV (2.20 ± 1.17 neurites).
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Significantly longer neurites were observed on surfaces coated with 10 µg/cm2 C-IV compared
with all other samples (41.7 ± 30.4 µm, p <0.002). Neurites were significantly longer on surfaces
coated with 5 µg/cm2 C-IV (35.5 ± 26.6 µm) than on surfaces coated with 1 µg/cm2 C-IV (19.8 ± 13.5
µm, p <0.001).
(a) PC-12 cell neurite number on Collagen-IV
coated samples. Data displayed on a logar-
ithmic scale. Differences not significant, p =
0.217.
(b) PC-12 cell neurite length on Collagen-IV
coated samples. Data displayed on a logar-
ithmic scale. Significant differences are in-
dicated by paired letters: a, p <0.001; b, p =
0.001; c, p <0.001.
Figure 3.5: PC-12 cell neurite outgrowth data for silicone samples coated with Collagen-IV at the fol-
lowing concentrations: 10 µg/cm2; 5 µg/cm2; 1 µg/cm2.
Collagen IV Concentration: Experiment 2 No significant differences in neurite number (Kruskal-
Wallis p value = 0.942) or neurite length (Kruskal-Wallis p value = 0.063) were observed. The results
are plotted in figs. 3.6a and 3.6b. Cells expressed the most neurites on surfaces coated with 10 µg/cm2
C-IV (3.48 ± 1.74 neurites). Fewer neurites per cell were observed on surfaces with 20 µg/cm2 C-IV
(3.38 ± 1.88 neurites) and 40 µg/cm2 C-IV (3.01 ± 1.81 neurites).
The longest neurites were on surfaces coated with 10 µg/cm2 C-IV (48.5 ± 33.7 µm). Neurites
were shorter on surfaces with 20 µg/cm2 C-IV (45.2 ± 31.9 neurites) and 40 µg/cm2 C-IV (43.0 ± 31.8
neurites).
3.3.3.4 Laminin-2 (-4) Concentration
PC-12 cells adhered to Ln-2,-4 coated surfaces and extended measurable neurites on some of the tested
coating concentrations. Two experiments were carried out to determine the optimal Ln-2,-4 concen-
tration: the first experiment used 0.1, 0.5 and 1 µg/cm2 Ln-2,-4, the results did not appear to plateau
within this range therefore the concentrations were extended. The second experiment used 1, 2 and 5
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(a) PC-12 cell neurite number on Collagen-IV
coated samples. Data displayed on a logar-
ithmic scale. Differences not significant, p =
0.942.
(b) PC-12 cell neurite length on Collagen-IV
coated samples. Data displayed on a logar-
ithmic scale. Differences not significant, p =
0.063.
Figure 3.6: PC-12 cell neurite outgrowth data for silicone samples coated with Collagen-IV at the fol-
lowing concentrations: 40 µg/cm2; 20 µg/cm2; 10 µg/cm2.
µg/cm2 Ln-2,-4, a plateau was found within this range therefore no further experiments were needed.
The optimum concentration of Ln-2,-4 observed was 1 µg/cm2.
Laminin-2 (-4) Concentration: Experiment 1 No cells with neurites were observed on surfaces coated
with 0.1 µg/cm2 Ln-2,-4, therefore these surfaces were not included in the statistical comparisons. The
observed data are plotted in figs. 3.7a and 3.7b.
Significantly more neurites per cell were observed on surfaces coated with 1 µg/cm2 Ln-2,-4 (2.73
± 1.73 neurites) compared with surfaces coated with 0.5 µg/cm2 Ln-2,-4 (1.90 ± 1.27 neurites, p =
0.0264). Neurites were also longer on surfaces coated with 1 µg/cm2 Ln-2,-4 (36.4± 28.5 µm) compared
with surfaces coated with 0.5 µg/cm2 Ln-2,-4 (21.6 ± 10.8 µm, p = 0.0037).
Laminin-2 (-4) Concentration: Experiment 2 The results are plotted in figs. 3.8a and 3.8b. No signific-
ant difference in number of neurites per cell was observed between the concentrations tested (Kruskal-
Wallis p value = 0.388). The most neurites per PC-12 cell were observed on surfaces coated with 2
µg/cm2 Ln-2,-4 (3.27 ± 1.82 neurites). Fewer neurites per cell were observed on surfaces coated with 1
µg/cm2 Ln-2,-4 (3.17 ± 1.80 neurites) and 5 µg/cm2 Ln-2,-4 (3.10 ± 1.89 neurites).
Neurites were significantly longer on surfaces coated with 1 µg/cm2 Ln-2,-4 (26.3 ± 21.8 µm)
compared with all other samples (p <0.007). Neurite length was not significantly different between
surfaces coated with 2 µg/cm2 Ln-2,-4 (24.3 ± 21.2 µm) and 5 µg/cm2 Ln-2,-4 (22.1 ± 17.4 µm, p =
0.166).
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(a) PC-12 cell neurite number on Laminin-2,-
4 coated samples. Data displayed on a logar-
ithmic scale. The difference is significant, p =
0.0264.
(b) PC-12 cell neurite length on Laminin-2,-
4 coated samples. Data displayed on a logar-
ithmic scale. The difference is significant, p =
0.0037.
Figure 3.7: PC-12 cell neurite outgrowth data for silicone samples coated with Laminin-2,-4 at the
following concentrations: 0.5 µg/cm2; 1 µg/cm2.
(a) PC-12 cell neurite number on Laminin-2,-
4 coated samples. Data displayed on a logar-
ithmic scale. Differences not significant, p =
0.388.
(b) PC-12 cell neurite length on Laminin-2,-
4 coated samples. Data displayed on a log-
arithmic scale. Significant differences are in-
dicated by paired letters: a, p = 0.006; b, p
<0.001.
Figure 3.8: PC-12 cell neurite outgrowth data for silicone samples coated with Laminin-2,-4 at the
following concentrations: 1 µg/cm2; 2 µg/cm2; 5 µg/cm2.
3.3.3.5 Fibronectin Concentration
PC-12 cells adhered to surfaces coated with Fn in the range tested, however neurite outgrowth was not
observed therefore an optimum concentration could not be determined. Fn was not used in subsequent
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experiments.
3.3.3.6 Nidogen-1 Concentration
Few PC-12 cells adhered to Nid-1 coated surfaces at the concentrations tested, the numbers were not
sufficient to quantify neurite outgrowth. Therefore, Nid-1 single protein coatings were not used in
subsequent experiments. An optimal coating concentration was calculated using a 1:1 molar ratio of
Nid-1:Ln-2,-4.
3.3.4 Laminin-2,(-4) and Laminin-1
Laminin-2,(-4) was compared with Laminin-1 at 1 µg/cm2. No differences in neurite number (p =
0.0554) or neurite length (p = 0.4396) were observed between the samples. The results are plotted in
figs. 3.9a and 3.9b. More neurites per cell were observed on Ln-1 coated surfaces (2.95 ± 1.81 neurites)
compared with Ln-2,-4 coated surfaces (2.42 ± 1.41 neurites). However, the neurites were longer on
Ln-2,-4 coated surfaces (58.7 ± 36.6 µm) than on Ln-1 coated surfaces (53.5 ± 29.4 µm).
(a) PC-12 cell neurite number on Laminin-2,-
4 and Laminin-1 coated samples. Data dis-
played on a logarithmic scale. The difference
is not significant, p = 0.0554.
(b) PC-12 cell neurite length on Laminin-2,-
4 and Laminin-1 coated samples. Data dis-
played on a logarithmic scale. The difference
is not significant, p = 0.4396.
Figure 3.9: PC-12 cell neurite outgrowth data for silicone samples coated with 1 µg/cm2 Laminin-2,-4
compared with 1 µg/cm2 Laminin-1.
3.3.5 Comparison of Optimal Concentrations
PC-12 cells adhered to surfaces and extended measurable neurites with every coating tested. The results
are plotted in figs. 3.10a and 3.10b.
The greatest number of neurites per cell was on layered CNL coating (5.77 ± 3.30 neurites), this
was significantly greater than all other samples (p <0.003). No significant difference in neurites per cell
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was observed between C-IV (4.34 ± 2.96 neurites) and Ln-2,-4 (3.65 ± 1.73 neurites) coated surfaces
(p = 0.225). PC-12 cells on PDL coated surfaces exhibited a significantly lower number of neurites per
cell (2.14 ± 0.889 neurites) compared with all other sample (p <0.001).
Neurite length was significantly increased on C-IV coated surfaces (49.3 ± 35.3 µm) compared
with all other sample (p <0.004). PC-12 cells on layered CNL coatings exhibited significantly longer
neurites (45.5 ± 36.6 µm) than cells on Ln-2,-4 (35.8 ± 26.3 µm, p <0.002) and PDL (25.6 ± 15.6
µm, p <0.001) coated surfaces. Ln-2,-4 coated surfaces increased neurite length compared with PDL
controls (p <0.005).
(a) PC-12 cell neurite number per cell. Data
are displayed on a log scale. Significant differ-
ences are indicated by paired letters: a,b,c,e, p
<0.001; d, p = 0.002.
(b) PC-12 cell neurite length. Data are dis-
played on a log scale. Significant differ-
ences are indicated by paired letters: a,c,d, p
<0.001; b, p = 0.004; e, p = 0.003; f, p =
0.001.
Figure 3.10: PC-12 cell neurite length and neurite number per cell on protein coated silicone surfaces.
CNL Layer-by-Layer is a layered coating of 10 µg/cm2 collagen-IV + 0.175 µg/cm2 nidogen-1 + 1
µg/cm2 laminin-2,-4.
3.3.6 Comparison of Multi-Protein Coatings: Experiment 1
PC-12 cells adhered to surfaces and extended measurable neurites with every coating tested. Results are
plotted in figs. 3.11a and 3.11b
Number of neurites per cell was not significantly different between CNL (3.55 ± 2.67 neurites),
ECM gel (3.49 ± 2.40 neurites), and all-in-one (3.36 ± 2.07 neurites) coated samples (p ≥ 0.843).
Significantly fewer neurites per PC-12 cell were observed on LNC coated samples (2.89± 1.80 neurites,
p <0.018).
The longest neurites were observed on CNL (28.7 ± 23.5 µm) coated samples, and neurite lengths
on ECM gel (28.6 ± 26.6 µm) and all-in-one (27.7 ± 24.2 µm) coated samples were not significantly
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lower (p ≥ 0.090). Significantly shorter neurites were observed on LNC coated samples (23.0 ± 19.6
µm, p <0.001) compared with all other samples.
(a) PC-12 cell neurite number per cell. Data
are displayed on a log scale. Significant dif-
ferences are indicated by paired letters: a, p =
0.010; b, p = 0.016; c, p = 0.018.
(b) PC-12 cell neurite length. Data are dis-
played on a log scale. Significant differ-
ences are indicated by paired letters: a,b,c, p
<0.001.
Figure 3.11: PC-12 cell neurite length and neurite number per cell on protein coated silicone surfaces.
ECM Gel is a coating of 11.175 µg/cm2 ECM Gel (Sigma Aldrich). All-in-One is a mixed coating of
10 µg/cm2 collagen-IV + 0.175 µg/cm2 nidogen-1 + 1 µg/cm2 laminin-2,-4. CNL Layer-by-Layer is a
layered coating of 10 µg/cm2 collagen-IV + 0.175 µg/cm2 nidogen-1 + 1 µg/cm2 laminin-2,-4. LNC
Layer-by-Layer is a layered coating of 1 µg/cm2 laminin-2,-4 + 0.175 µg/cm2 nidogen-1 + 10 µg/cm2
collagen-IV.
3.3.7 Comparison of Multi-Protein Coatings: Experiment 2
PC-12 cells adhered to surfaces and extended measurable neurites with every coating tested. Results are
plotted in figs. 3.12a and 3.12b
Significantly fewer neurites per PC-12 cell were observed on LC layer-by-layer coated surfaces
(2.79 ± 2.23 neurites) compared with ECM gel (3.51 ± 2.07 neurites, p = 0.0001) and all-in-one (3.49
± 2.29 neurites, p = 0.0009) coated surfaces. No other significant differences were observed (p≥ 0.011,
pcut = 0.004). Neurite number per cell was intermediate on CL layer-by-layer (3.33 ± 2.35 neurites),
CL all-in-one (3.09 ± 2.40 neurites) and C-IV (3.20 ± 2.25 neurites) coated surfaces.
The longest neurites were observed on all-in-one coated surfaces (49.3 ± 30.5 µm), this was sig-
nificantly longer than on LC layer-by-layer (40.0 ± 27.1 µm, p <0.001) and CL layer-by layer (43.4 ±
29.0 µm, p <0.001) coated surfaces. No other significant differences were observed (p ≥ 0.019, pcut
= 0.004). The averages of neurite length on different coatings were: ECM gel (47.3 ± 34.9 µm), C-IV
(45.5 ± 33.1 µm), and CL all-in-one (44.2 ± 31.9 µm).
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(a) PC-12 cell neurite number per cell. Data are dis-
played on a log scale. Significant differences are
indicated by paired letters: a,b, p <0.001.
(b) PC-12 cell neurite length. Data are displayed on
a log scale. Significant differences are indicated by
paired letters: a,b, p <0.001.
Figure 3.12: PC-12 cell neurite length and neurite number per cell on protein coated silicone surfaces.
ECM Gel is a coating of 11.175 µg/cm2 ECM Gel (Sigma Aldrich). All-in-One is a mixed coating of
10 µg/cm2 collagen-IV + 0.175 µg/cm2 nidogen-1 + 1 µg/cm2 laminin-2,-4. CL Layer-by-Layer is a
layered coating of 10 µg/cm2 collagen-IV + 1 µg/cm2 laminin-2,-4. LC Layer-by-Layer is a layered
coating of 1 µg/cm2 laminin-2,-4 + 10 µg/cm2 collagen-IV. CL All-in-One is a mixed coating of 10
µg/cm2 collagen-IV + 1 µg/cm2 laminin-2,-4.
3.3.8 Cell Morphology
Cell morphology varied between surfaces and between cells, representative images are presented in
figs. 3.13 and 3.14. Cells did not adhere to uncoated surfaces and very few cells adhered to Nid-1 coated
surfaces (figs. 3.13a and 3.13b), and while cells adhered to Fn coated surfaces, cell seeding was uneven
and there was no evidence of cell soma spreading (fig. 3.13g). Soma spreading, neurite extension, net-
work formation, uniform cell distribution, and a high proportion of cells exhibiting neuronal phenotype
were considered indicators of surface neurocompatibility.
PC-12 cells on PDL adhered and a low proportion of cells exhibited neuronal phenotype (fig. 3.13e),
there was little evidence of network formation between neurites. In contrast on Ln-2,-4, C-IV, and
PLO coated surfaces the majority of the cells exhibited neurites and highly branched networks formed
(figs. 3.13c, 3.13d and 3.13f). In addition, some PC-12 cells on Ln-2,-4 and C-IV coated surfaces
exhibited spreading of the cell soma and increased contact with the surface. On PLO coated surfaces
cells formed striped or string like patterns in small areas of the substrate, while there was low cell
adhesion in most areas, this limited network formation and caused elongated soma and cell polarisation
(fig. 3.13f).
PC-12 cell morphology is similar between ECM gel, all-in-one, CL, CL all-in-one and CNL coated
samples (figs. 3.14a to 3.14c, 3.14e and 3.14g). Branched neurite networks form and cell soma exhibited
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spreading. However, a lower proportion of cells exhibited a neuronal phenotype on LNC samples, and
less branching, network forming and soma spreading was observed (fig. 3.14d). On LC coated samples
soma spreading, neurite branching and network formation was observed, however neurites appeared
shorter (fig. 3.14f).
Immunoflourescence microscopy demonstrated a similar cell morphology, with neurites forming
branched networks on C-IV and all-in-one coated surfaces (example images are given in the following
chapter, see figs. 4.24a and 4.24b). This confirmed that the observed processes are part of the cells and
contain actin cytoskeletons. In all other respects the immunoflourescence microscopy confirmed the
results from the SEM images, however the depth of focus was less and image quality was lower. SEM
images were used for analysis and are reported.
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(a) 2 µg/cm2 Nidogen-1. (b) Uncoated Silicone.
(c) 10 µg/cm2 Collagen-IV. (d) 1 µg/cm2 Laminin-2,-4.
(e) 10 µg/cm2 Poly-D-Lysine. (f) 10 µg/cm2 Poly-L-Orthinine.
(g) 1 µg/cm2 Fibronectin.
Figure 3.13: Scanning Electron Micrographs of PC-12 cells on protein coated surfaces following 96
hours incubation: 3.13a) 2 µg/cm2 Nidogen-1; 3.13b) Uncoated Silicone; 3.13c) 10 µg/cm2 Collagen-
IV; 3.13d) 10 µg/cm2 Laminin-2,-4; 3.13e) 10 µg/cm2 Poly-D-Lysine; 3.13f 10 µg/cm2 Poly-L-
Orthinine; 3.13g 1 µg/cm2 Fibronectin.
111
(a) ECM gel coating. (b) All-in-One coating.
(c) CNL coating. (d) LNC coating.
(e) CL coating. (f) LC coating.
(g) CL all-in-one coating.
Figure 3.14: Scanning Electron Micrographs of PC-12 cells on protein coated surfaces following 96
hours incubation: 3.14a 11.175 µg/cm2 ECM gel; 3.14b Collagen-IV + nidogen-1 + laminin-2,-4 all-
in-one coating using optimal concentrations; 3.14c Collagen-IV + nidogen-1 + laminin-2,-4 layer-by-
layer coating using optimal concentrations; 3.14d Laminin-2,-4 + nidogen-1 + collagen-IV layer-by-
layer coating using optimal concentrations; 3.14e Collagen-IV + laminin-2,-4 layer-by-layer coating
using optimal concentrations; 3.14f Laminin-2,-4 + collagen-IV layer-by-layer coating using optimal
concentrations; 3.14g Collagen-IV + laminin-2,-4 all-in-one coating using optimal concentrations.
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3.4 Discussion
3.4.1 Analysis of Coatings by Raman Microscopy and BCA Assay
Previous studies have found 0.13 µg/cm2 bovine serum albumin adsorbed to steel with large grains (22
µm), while 0.71 µg/cm2 adsorbed to smaller grained steels (320 nm) [320]. The values observed in
this study fall within this range, however the difference in surfaces, proteins and solution concentrations
can be expected to alter the results. In contrast protein adsorption on polyurethane hydrogel films has
been shown to be in the range 1 µg/cm2 to 4 µg/cm2 for bovine serum fibrinogen and 8 µg/cm2 to 16
µg/cm2 for bovine serum albumin, depending upon sample hydrophilicity and swelling [321]. In this
study surfaces were not modified to improve hydrophilicity, which may improve protein adsorption.
To reduce desorption, and increase initial protein concentration proteins could be attached by silan-
isation. This has been used for fibronectin, with concentrations of 1.5 µg/cm2 achieved [322]. For PDL,
silanisation has achieved a surface concentration of 2.1 µg/cm2 [323]. To silanise proteins steps which
alter the surface topography may be required, therefore direct comparisons between proteins may not
be applicable [324]. The adsorption method does not alter underlying surface topography, avoiding this
potential confound.
The BCA assay response is dependent upon the protein composition, with the amino acids cysteine,
cystine, tryptophan and tyrosine key to the formation of the coloured product [312]. Two proteins tested
in this study did not include these residues (poly-D-lysine, poly-L-orthinine), therefore these could not
be measured reliably using the BCA assay. Alternative assays such as the Lowry assay and the Brad-
ford assay are also dependent upon protein composition [325]. For this reason comparisons are only
valid within the concentration gradient for a given protein, not between proteins. A standard curve for
each protein used would allow this problem to be overcome, however other confounds such including
variations in incubation time are likely to make the comparisons invalid between protein types.
Alternative methods for the measurement of protein adsorption include ATR/FTIR (investigated
previously) [326], Raman microscopy (investigated in this study), surface plasmon resonance (SPR)
[327] and radio-labelling [328]. ATR/FTIR (attenuated total internal reflection/Fourier transform in-
frared spectroscopy) was discounted in previous work for the same reason Raman microscopy was un-
successful in this study: the PDMS spectrum predominates the spectrum. Spin coating ultra-thin PDMS
surfaces on glass or crystal may overcome this problem and should be investigated in future. SPR would
also require spin coating ultra-thin PDMS layers, however the equipment is cost prohibitive, especially
since surface regeneration of the SPR chips could not be guaranteed. Radio-labelling was discounted
due to the cost for modifying each protein used, potential effects of iodination on protein structure, and
the complexity of waste disposal.
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3.4.2 Protein Concentration Optimisation
The optimal concentrations found were: 10 µg/cm2 PDL; 10 µg/cm2 C-IV; and 1 µg/cm2 Ln-2,(-4).
Optimal concentration was not determined for PLO, Fn or Nid-1. Using the 1:1 molar ratio of Ln to
Nid-1 an theoretical optimal concentration of Nid-1 was calculated as 0.175 µg/cm2 [209, 210].
PC-12 cells did not adhere in sufficient number to PDMS surfaces coated with Nid-1, higher con-
centrations may have resulted in increased cell adhesion but this was not investigated. Nidogen-1 has
been shown to induce process formation and migration of Schwann cells [329]. Therefore, while effects
were not observed in this study, they may be present with other cell types or in vivo.
The observations for Fn coated PDMS agree with results by Tomaselli et. al., who observed poor
attachment and low neurite outgrowth on Fn coated surfaces [330]. In contrast the RGD binding epitope
(present in Fn) does improve neurite outgrowth and is effective for improving neural regeneration in
vivo, although to a lesser extent than the IKVAV domain of laminin [331, 332].
The concentration ranges chosen were either suggest by the supplier or from work by other re-
searchers. Often researchers describe the concentration of protein in a solution used, but not the surface
area treated or the volume of protein solution used. For example Soussou et. al. used 50 µg/cm2 PDL,
50 µg/cm2 PLO, and 125 µg/cm2 reconstituted basement membrane on glass cover slips, however they
do not measure the actual amount remaining following washing [300]. The supplier, Sigma Aldrich,
suggest using between 0.5 ml and 1.0 ml of a 0.1 mg/ml solution to coat 25 cm2, giving a surface con-
centration of between 2 µg/cm2 and 4 µg/cm2. Therefore, for this work concentrations in this range
were chosen. The detail supplied in this thesis will make replication and comparison of results easier for
future research.
The peaks or plateaus in neurite outgrowth response observed for PDL, C-IV and Ln-2,(-4) indicate
a number of possible explanations.
First, the response may reach an optimum because the concentration at the surface reaches a max-
imum, and no more protein adsorbs with increased concentration. This is not supported by the BCA
assay data which show that C-IV and Ln-2,(-4) surface concentration increases with increasing protein
applied. Second, the surface may become saturated, and any additional protein will rest on top of the
protein already adsorbed. This explanation presents a further theory, that protein adsorbed as a second
protein layer is less tightly bound than protein adsorbed to the PDMS surface, this supports the obser-
vation of peak responses rather than plateau responses, and a logarithmic relationship between applied
protein and final concentration (observed with Ln-2,-4). Finally, the cell response may be limited to a
given number of binding sites per area, therefore increasing the binding site concentration has no ef-
fect, or a negative effect on cell response. This is supported by research showing a sigmoidal response
between RGD concentration and cell attachment, with a critical maximum density beyond which re-
sponse is asymptotic to a theoretical maximum number of cells [333].
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3.4.3 Laminin-2,(-4) and Laminin-1
Laminin-2,(-4) has been suggested as more suitable for peripheral nerve applications than Laminin-
1 [179]. This study found no significant difference in neurite outgrowth between coatings at the same
initial concentration. However, neurites were longer and fewer on Ln-2,(-4), this may indicate a time
dependent maturation of the cells, with PC-12 cells on Ln-2,(-4) undergoing “whisker trimming” prior
to the 96 hour time point in this study, where small non-networked neurite branches are removed in
favour of branches in a network with other cells. No conclusions on the relative merits of Ln-1 and
Ln-2,(-4) can be drawn at this stage.
Additional factors may affect the results of this experiment. The choice of a neuronal-like cell line
may not be representative of peripheral nervous system cells. In addition, there may be differences,
which were not observed due to the n = 6 repeats used in this study, although these are likely to be of
small effect size and therefore may not be biologically relevant (i.e. translate to the complex in vivo
environment). A power analysis prior to any future experiments could use this data to indicate a suitable
n, however a post hoc power analysis of the observed data would not be valid because of the inverse
relationship between the p-value and power [334, 335]. Also, the relative cost of Ln-2,(-4) and Ln-1
must be considered (681 and 139 £/mg respectively).
This experimental series focused on Ln-2 due to its role in the endoneurial BM [179]. Other Ln
isoforms such as Ln-8, -9, and -11, which are present in the PNS, should be examined in vitro.
3.4.4 Comparison of Optimal Concentrations
In this experiment coatings were layered in the order C-IV, Nid-1, LN-2,-4: suggesting that LN-2,-4 will
be most prevalent at the coatings surface. Improvements to neurite outgrowth on sBM compared with
LN-2,-4 suggest that C-IV and Nid-1: encourage LN-2,-4 recognition site presentation; directly enhance
neurite outgrowth; and/or stabilise the coatings.
This work has shown that endoneurial BM protein coatings increase neurite outgrowth on silic-
one surfaces compared with PDL coated controls. Multi-protein coatings significantly increase num-
ber of neurites compared with optimised single layer coatings, and significantly increase neurite length
compared with PDL and Ln-2,-4 coated samples. We therefore suggest that a multi-protein coating is
promising for the promotion of neural regeneration within microchannels.
3.4.5 Comparison of Multi-Protein Coatings
The well-defined multi-protein coatings developed in this study are as conducive to neurite outgrowth
as the tested concentration of ECM gel. Furthermore, a simple, all-in-one mix of basement membrane
proteins is one of the most effective coatings, and lends itself better to use in large-scale applications
than the time intensive layer-by-layer coatings.
The relative concentration of proteins in the defined multi-protein coatings differed from ECM
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gel. In ECM gel major components are present in the following amounts 60% Ln, 30% C-IV, 6%
Nid (10:5:1 mass ratio), while in this work the multi-protein coatings used 89.5% C-IV, 8.9% Ln and
1.6% Nid. It should be noted that the relative concentrations of Ln and Nid found by Kleinman et. al.
agree approximately with a 1:1 molar ratio, however the difference may be due to some Nid remaining
bound to the Ln therefore slightly increasing the Ln concentration [299]. This study used growth factor
reduced ECM gel. This aims to reduce the abundance of growth factors including nerve growth factor
and epidermal growth factor [294]. As a result growth factor reduction increases the relative abundance
of structural proteins, such as laminin, nidogen and fibronectin [296].
In this study, the ECM gel concentration used was not optimised, an equal concentration to the
multi-protein coatings was chosen, C-IV and Ln are major components of ECM gel; however, their
concentration is likely to have been reduced due to the presence of other ECM molecules. The ECM gel
concentration could be further optimised. The three-protein coating developed in this work lends itself
well to a factorial analysis of the effect of changing single protein concentrations within a multi-protein
coating. Optimising multi-protein coatings may further improve neurocompatibility, and would allow a
test of a 10:5:1 mass ratio of Ln:C-IV:Nid, more similar to that found in reconsitituted BM.
The LNC layer-by-layer and LC layer-by-layer coatings are less effective at promoting neurite out-
growth than other multi-protein coatings. This may be because to C-IV sheet formation in vitro creates
a suitable scaffold for smaller basement membrane proteins [308]. Alternatively, correctly presented Ln
binding sites may best promote neurite outgrowth. Competitive protein adsorption on surfaces from mix-
tures follows a process called the Vroman effect: proteins adsorb to and desorb from surfaces at random,
over time proteins with higher affinity for the surface replace lower-affinity proteins. Smaller proteins
typically diffuse through solution more quickly, so adsorb more rapidly, however larger proteins have
more sites for bonding with surfaces, and therefore larger proteins typically have a higher affinity for
surfaces [336]. It is possible that, the Vroman effect may lead to partial Ln displacement by larger C-IV
proteins, creating a disordered transient structure [336,337]; therefore, a longer final incubation time may
lead to complete coating remodelling, forming a structure similar to an all-in-one mixed coating. It is
possible that the long macromolecular fibril structure of C-IV is responsible for increased neurite length
on C-IV coated surfaces compared to multi-protein coated surfaces, and that competitive displacement
during multi-protein coating partially disorders in vitro C-IV sheets leading to reduced neurite length.
Coatings without Nid-1 (CL layer-by-layer and CL all-in-one) were shown to induce less neurite
outgrowth than the best coatings with Nid-1 (All-in-one, ECM gel). These differences were not signific-
ant in all cases. However, this may indicate a trend, supporting the use of Nid-1 as a binding protein to
ensure the correct presentation of binding sites on Ln.
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3.4.6 General Discussion
The data show that endoneurial BM proteins enhance neurite outgrowth compared with controls. How-
ever, Nid-1 did not support PC-12 cell attachment at the coating concentrations tested, and is cost pro-
hibitive at higher concentrations. C-IV and All-in-one are the coatings indicated to most improve neural
regeneration within microchannels in this study. The all-in-one coating will be used within microchan-
nels in a following chapter, and the results of in vivo testing are presented in this thesis.
This work may be applicable to other nerve guidance conduits, especially where scaffolds mimick-
ing the fascicular or endoneurial structure are used, for example multichannel collagen conduits [338].
As part of a hierarchical design endoneurial proteins may improve axonal guidance and reduce the dis-
organisation associated with neural repair.
These findings support evidence by Tonge et. al. [292] who found that ECM gel, C-IV and Ln
support neurite outgrowth in vitro. The results of this study suggest that C-IV is more conducive to
neural regeneration than Ln and that C-IV contributes most to the induction of neural outgrowth by ECM
gel. In line with previous research a summation of the effects of Ln and C-IV was not observed [292].
In contrast, additive combinatorial effects of Ln and C-IV have been described [339], suggesting that,
in this case, protein-protein interactions in the basement membrane reduce, rather than increase, the
availability of binding sites to cells.
At time points longer than those tested in this study (15 days) neurite outgrowth on Ln (unspecified
form) is greater than on C-IV, and the addition of heparan-sulphate to a collagen-Ln co-coating has been
shown to increase neurite outgrowth [340]. This suggests an application for the investigated proteins as
part of a proteoglycan hydrogel filler for nerve guidance conduits.
To reduce upregulation of cell-adhesion molecules for a specific ECM protein PC-12 cells were
culture expanded in PDL coated flasks. However, supplier guidelines suggest culture-expansion on C-IV
coated surfaces or in suspension2. Therefore the cells may have been pre-selected for affinity to C-IV
coated surfaces by the supplier prior to delivery.
Although PC-12 cells are a well-established cell line for in vitro investigation of neurocompatibility,
a more complete in vitro model of neural outgrowth could be used to improve translation to the in vivo
environment. For example, dorsal root ganglion primary cells have been used for in vitro investigation
of neurite outgrowth [341]. During neural regeneration Schwann cell recruitment is crucial for directing
axonal growth [71, 76]; therefore these surfaces should additionally be tested for either Schwann cell
compatibility or using a neuron/Schwann cell co-culture.
ECM gel-like protein matrices can be derived from cells in vitro [311], and it has been shown that
tissue matched ECM gels improve cell adhesion, proliferation and function in vitro [342]. Decellularised
2Information from the supplier indicates that PC-12 cells are “routinely cultured on Collagen-IV coated flasks”; however,
cells supplied as growing cultures are “grown and dispatched in suspension”. In this study the PC-12 cells used were supplied
cryopreserved.
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ECM from Schwann cell culture may provide an alternative to recombinant or xenogenic protein mixes.
It should be noted that the lack of significant differences between multi-protein coated surfaces does
not imply the results are the same. Observed, insignificant, differences may have been below the effect
size allowed for in this study. However, the results do support the use of multi-protein coatings as any
effect is small in comparison to the difference when compared with single protein coatings.
This study determined optimal coating concentrations for single proteins and assumed that this
would translate to multi-protein coatings. However, interactions between the chosen ECM proteins are
likely to alter the effect of concentration upon neurite outgrowth, a hypothesis supported by the absence
of summation in effects seen in this study. A factorial study design testing multi-protein coatings should
be carried out to determine combinatorial effects
The results presented support the initial hypotheses with a few exceptions:
1. Endoneurial basement membrane protein coatings increase neurite outgrowth on silicone surfaces
compared with poly-D-lysine coated controls. However, PC-12 cells do not adhere to nidogen-1
coated or uncoated silicone surfaces.
2. Collagen-IV + Laminin + Nidogen multi-protein coatings increase neurite outgrowth on silicone
surfaces compared with most single protein coatings. However, neurite length is significantly
greater on collagen-IV coatings.
3. Multi-protein coating order significantly affects neurite outgrowth on silicone surfaces. Layer-by-
layer coatings starting with laminin significantly reduce neurite outgrowth compared with other
multi-protein coatings. However, layer-by-layer coatings starting with collagen-IV are as good as
all-in-one mixed coatings.
4. Collagen-IV + Laminin + Nidogen multi-protein coatings increase neurite outgrowth on silicone
surfaces compared with Collagen-IV + Laminin multi-protein coatings.
5. Optimal multi-protein coatings do not significantly change neurite outgrowth on silicone surfaces
compared with ECM gel coatings.
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Chapter 4
In Vitro Neuron Adhesion Studies:
Topography
4.1 Introduction and Hypotheses
The success of microchannel neural interfaces depends upon neural regeneration through the channels.
Enhanced regeneration can include increased number of axons per microchannel, reduced fibrotic cap-
sule width, or reduced channel diameter without causing fibrotic occlusion [113].
Topographical cues in a cell’s environment can alter cell response [196]. Regenerating axons
demonstrate substrate mediated responses following severe crush injuries, where Wallarian degeneration
of axons occurs but the myelin sheath remains in continuity (2◦ Sunderland Injury, [65]). In this case re-
generation is directed along the original endoneurial tube and the pattern of innervation is identical with
the original structure [64]. However, when a nerve is completely transected (for example in microchannel
neural interface implantation) these structural cues are lost, and the resulting nerve regeneration becomes
frustrated and disorganised. In nerve repair long gaps (over 5 mm) must be repaired using autograft or a
nerve guidance conduit (NGC) [71, 75–78].
NGCs aim to provide the structural, topographical, and in some cases molecular and cellular, cues
to enhance regeneration, and reduce incorrect patterns of reinnervation [26]. A MNI using successful
NGC strategies could enhance regeneration and encourage axonal growth towards the electrodes within
neural interfaces and therefore improve the implant function.
In this chapter two different topographies will be considered. Grooves, or ridges, have been shown
to cause ’contact guidance‘ of cells, a strategy, which may help provide directional cues to regenerating
axons and reduce disorganisation. Roughened surfaces have also been shown to alter cell response,
increasing cell adhesion and enhancing axon growth. Moreover, a combination of these topographical
cues may prove optimal for guiding and enhancing neural regeneration.
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4.1.1 Contact Guidance and Groove Dimensions
Grooved topographies can cause ‘contact guidance’ of cells [190, 191]. Contact guidance is the direc-
tional response by cells to a given surface, with preference to a given direction of movement, cell orient-
ation, or elongation. Contact guidance has been demonstrated with many cell types, in particular neural
cells where alignment with respect to a substrate is readily determined from neurite angle [192–196]. In
this chapter neurite orientation will be considered.
Dimensions of interest for contact guidance topographies are in the cell, axon and subcellular
ranges. Neuron cell bodies are typically 5 µm to 20 µm diameter and axons vary from <1 µm to 20
µm diameter and extend from µm to cm long [53]. PC-12 cells, used in this chapter, are typically at the
lower end of these dimensions, although it should be noted that cells will respond to cues outside these
ranges.
Neurites have been shown to align parallel to grooves between 1 µm and 100 µm wide [42, 343–
358]. There is high variability between cell types and the surfaces used; however, consensus is emerging
that features with an aspect ratio (depth / width) above a critical value of 0.1 induce more alignment,
and that increasing aspect ratio increases alignment [352, 359–362]. An overview of studies looking at
contact guidance of neuronal and other cell types is given in table 32 in the appendix.
Small groove sizes (<1 µm wide) are both less effective at aligning neurites, but can also cause
perpendicular alignment in some cell types [354–356]. Grooves can have other unexpected, but bene-
ficial, effects: inducing neuronal phenotype in cells [358, 363, 364]; reducing fibroblast adhesion while
maintaining Schwann cell adhesion [346]; and aligning neural support cells, enhancing neurite align-
ment [353].
Grooves are an artificial environment, alternative, more physiologically relevant, topographies have
been used to guide extending neurites. Schwann Cell-like topographies — imprints from aligned in
vitro Schwann cell culture and Schwann cell inspired artificial topographies — cause neurite alignment
and enhance neurite outgrowth from dorsal root ganglion cells [341, 365]. More complex groove to-
pographies also cause guidance, with neurons on zig-zag grooves extending longer, more aligned neur-
ites [366] and grooves with a gradient in width improving alignment compared with continual cross-
section grooves [226].
Recent in vivo studies have lent support to the use of alignment for nerve regeneration, with aligned
250 nm diameter polycaprolactone fibres and aligned peptide amphiphile nanofibres supporting suc-
cessful sciatic nerve regeneration [367, 368]. However, highly variable findings in vitro mean that any
intended topography and method must be tested both in vitro and also in vivo before conclusions can be
drawn.
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4.1.2 Roughened Surfaces and the Neural Extracellular Matrix
Surface topographies with similar roughness to extracellular matrix (ECM) may prove to be beneficial for
in vitro cell culture. Healthy nerve fascicles are compartmentalised by perineurial basement membrane,
which ensheaths individual fascicles [71, 178]. Basement membrane has a complex porous structure,
which cannot be mimicked due to the constraints on porosity imposed by the microchannel design,
however basement membrane feature size can be considered. Basement membrane features range in size
from 10 nm to 350 nm, with most features falling in the range 50 nm to 250 nm [369, 370]. Perineurial
basement membrane structure has not been studied; however, repeated protein configurations on the
order of 70 nm can be expected (due to laminin polymerisation) [371, 372].
In vitro these structures can be mimicked through surface roughness. Optimal values have been
found between 20 nm and 70 nm Ra, which enhance neural adhesion and neurite outgrowth [197, 198].
Importantly, coating surfaces with a protein layer may negate the effect of a roughened surface, possibly
because the features of interest are ’hidden‘ by the protein [198]. Basement membrane structures can
also be replicated accurately using polymer casting [373]. The complex porous structure may also be
key to cell response [374], however this study is limited to non-porous surfaces.
Roughened surfaces also affect cells involved in fibrotic capsule formation and microchannel occlu-
sion. Nanorough surfaces reduce fibroblast proliferation, and nano-porous surfaces can reduce astrocyte
adhesion, while maintaining neuronal cell activity [27, 199, 375].
Additional substrate factors alter cell response in vitro and in vivo, for example substrate stiffness
[184]. In neural cells substrate modulus affects alignment [185] and neurite branching [186]. In vivo it is
hypothesised that flexible electrodes will lower stress concentrations and micromotion at the electrode-
tissue interface, reducing tissue damage and the foreign body response [182, 183]. Stiffness of neural
interface materials is discussed in more details in chapter 5.
4.1.3 Multiscale Topographies
Implementing both micron scale grooves and nanoscale roughness will form a hierarchical structure,
with controlled features at both the µm and nm scales [376], mimicking the organisation of tissue over
different length scales [377]. The use of multiscale substrates has been shown to promote myogenesis
in human mesenchymal stem cells [376], alignment of mouse skeletal myoblasts [378] and alignment of
mouse embryonic fibroblasts [379]. For neurons this would allow the inclusion of outgrowth enhancing
sub-µm scale features or roughness and µm scale contact guidance patterns.
4.1.4 Aims and Hypotheses
This chapter presents an in vitro study looking at the effect of two different changes in surface topography
on neurite outgrowth. The two topographical changes considered are surface roughness and grooves.
The aim of this study is to develop and test a surface that could be applied within a microchannel
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to improve neural regeneration. Therefore limitations are placed upon the study: the structure must be
non-porous; any structures must fit within a microchannel without greatly altering its dimensions; and it
must be possible to create the structures using a simple manufacturing method.
To assess the extent to which neurites align with grooved surfaces the normalised cumulative peri-
odogram criterion is used [380, 381]. This provides an angle of alignment, the point at which the distri-
bution of angles is considered to diverge from that of a randomly distributed sample. For more aligned
samples the angle of alignment is expected to be nearer 0◦.
The hypotheses for this chapter are as follows:
• Increased roughness will improve in vitro neurite outgrowth on silicone substrates compared with
relatively smooth controls.
• PC-12 cells will exhibit increased alignment with cell scale surface grooves compared with smooth
controls.
• A combination of grooves and nanoscale roughening will: increase neurite outgrowth compared
with grooved samples; and increase neurite alignment compared with roughened samples.
• A combination of multiscale topography and nerve specific mixed-protein coatings will increase
neurite outgrowth compared with multiscale topography and single-protein coatings.
4.2 Methodology
4.2.1 Fabrication of Patterned Templates
Turned medical grade Ti-6Al-4V discs, 10 mm diameter, 5 mm thickness, were polished. An abrasive
paper series: P600; P1200; P2500; and P4000 was used, followed by buffing using an AP-A (agglomer-
ated alpha alumina) suspension (Struers Ltd, Rotherham, UK) and a polishing cloth. Surface roughness
was determined using surface profilometry, and surfaces with Ra <0.03 µm were accepted.
Discs were degreased in an ultrasound bath in 10% Decon90 (Decon Laboratories Ltd., Hove, UK)
for 10 minutes, rinsed in distilled water, and cleaned by an ultrasound bath in acetone for 10 minutes.
Cleaned, polished discs were patterned to create a negative topography that would act as a template
for silicone samples.
4.2.1.1 HF Etched Samples
Polished titanium discs were immersed in 2.5% hydrofluoric acid (HF). Surface roughness was found to
be linearly dependent upon time in HF up to 4 minutes, after 4 minutes no change in Ra was observed.
1 minute and 4 minute immersion in HF was chosen.
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Surface Groove Width (µm) Groove Spacing (µm) Groove Depth (µm) Aspect Ratio
30/30/10 30 30 10 0.33
30/30/5 30 30 5 0.17
15/30/10 15 30 10 0.67
Table 4.1: Groove geometries achieved in silicone using laser patterned Ti-6Al-4V templates. The values
refer to the positive, silicone samples. Aspect ratios are reported to 2 significant figures.
4.2.1.2 Grooved Samples
Parallel grooves were created by direct laser writing using a ClassIV Nd:YAG laser (Violino-2, Laservall,
Laser Lines Ltd, Oxon, UK). Polished titanium discs were cleaned by ultrasonification in acetone for one
minute immediately prior to laser etching. Discs were etched using a power of 50 % (40 kW peak, 10
W mean average), shot frequency of 10 kHz, write speed of 200 mm/s and a pulse width of 12 ns. Laser
spot size was 30 µm. To achieve greater groove depth a greater number of passes was used: two passes
for 5 µm deep grooves and five passes for 10 µm deep grooves. The groove geometries achieved are
listed in table 4.1. During the direct laser writing a HEPA filtered, rapid airflow was passed over the
surface of the discs to prevent sputtered particles from settling back on the disc surface.
4.2.1.3 Multiscale Samples
To form multiscale surface topographies polished Ti-6Al-4V discs were first grooved and and then HF
etched as described.
Multiscale surfaces were compared with smooth controls, etched samples and grooved samples.
4.2.2 Fabrication of Patterned Silicone Substrates
Silicone (Sylgard 184, Dow Corning, Midland, MI) was cast onto the Ti-6Al-4V templates as follows.
Silicone was speed mixed for two minutes at 2000 rpm with a speed mixer (DAC 150 FVZ-K, Synergy
Devices Ltd, High Wycombe, UK). Mixed silicone was degassed in a vacuum centrifuge for two minutes
at approximately 30 mbar and 500 rpm. Titanium samples and glass coverslips (borosilicate glass, 20
mm x 20 mm, VWR) were cleaned by ultrasonification in acetone for five minutes immediately prior
to casting. Discs were placed in a solution of HAEMO-SOL detergent (Cox Surgical, Surrey, UK) in
distilled water for 10 seconds and agitated to form a release layer. Discs were dried under vacuum.
Approximately 0.5 ml silicone was syringed onto the patterned surface each template, and a coverslip
placed on top of the silicone. Samples were placed in a dry oven at 150◦C for 1 hour. Templates were
soaked in ELGA distilled water for up to 30 minutes and gently removed to leave patterned silicone
adhered to glass coverslips.
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4.2.3 Vertical Scanning Interferometry
Surface roughness and groove dimensions were assessed using vertical scanning interferometry. Samples
were places in an interferometer (Contour GT, Bruker) and images were recorded using Vision64 soft-
ware (Release v5.30, Bruker). Vertical travel was adjusted depending upon sample profile from 20 µm
to 70 µm. An area 0.598 mm by 0.442 mm was imaged at 20x magnification.
4.2.4 Water Contact Angles
To determine surface hydrophilicity water contact angles were measured using sessile drop goniometry.
A 10 µL droplet of deionised water was placed onto the surface of each sample and the droplet im-
aged using a Nikon D90 digital camera and background lighting. 6 contact angle measurements were
taken per sample with the sample dried using a lint-free cloth between each measurement. For grooved
samples images were taken of angles parallel to and perpendicular to the groove direction to account for
directional spreading. Contact angles were measured using ImageJ software as shown diagrammatically
in fig. 4.1.
4.2.5 Surface Functionalisation
Prior to cell culture silicone substrates were washed three times for 5 minutes with 70% Industrial
Methylated Spirits, followed by rinsing three times for 5 minutes with phosphate buffered saline.
Samples were sterilised under UV for 12 hours.
Surfaces were coated with Collagen-IV to improve PC-12 cell adhesion. One 100 µl droplet of
Collagen-IV dissolved in phosphate buffered saline was pipetted onto each sample to give a coating
concentration of 10 µg/cm2. Samples were incubated for one hour at 37◦C, 5% CO2, and washed three
times with phosphate buffered saline and incubated again for at least a further two hours to dry.
In addition successful surfaces were coated with a mixed protein coating: 10 µg/cm2 Collagen-IV;
0.175 µg/cm2 Nidogen-1; 1 µg/cm2 Laminin-2,-4. Proteins were mixed in a 100 µl droplet of phosphate
buffered saline to give the required final surface concentration. Samples were incubated for 1 hour at
37◦C, 5% CO2, and washed three times with phosphate buffered saline and incubated again for at least
a further two hours to dry.
Figure 4.1: A diagram of water contact angle measurement, as seen in sessile liquid drop goniometry on
smooth solid surfaces. c©2013 Springer-Verlag, with permission [382]. REDACT IN ONLINE COPY.
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4.2.6 Analysis of Coating by Bicinchoninic Acid (BCA) Assay
Substrates (n = 3) were prepared for a protein assay. Polished control, 4 minute HF etched, 15/30/10
grooved and 15/30/10 grooved + 4 minute HF etched silicone surfaces were prepared as above.
Surfaces were coated with Collagen-IV as above using 100 µl droplets. Substrates were washed 3
times with PBS. Washed substrates were allowed to dry in an incubator.
4.2.6.1 BCA Assay
Protein concentrations on surfaces were analysed using a micro BCA assay (Pierce Micro BCA Protein
Assay Kit, Thermo Fisher Scientific Inc.) [312].
A bovine serum albumin solutions (BSA) were used to construct a standard curve. BSA was diluted
in PBS to form concentrations from 0.001 mg/ml to 0.04 mg/ml. 100 µl droplets of each BSA standard
were placed onto control substrates, the surfaces were not washed, surfaces were allowed to dry in an
incubator.
100 µl BCA working reagent was placed on each surface including standards and blank reference.
The well plate was sealed and incubated for 2 hours at 37◦C.
The plate was allowed to cool and adsorbance was measured at 562nm using a NanoDrop1000
spectrophotometer (Thermo Scientific). Protein concentrations were calculated using the interpolation
lines given by the standard curve. Amount of protein per substrate, and therefore per cm2 was calculated
for each sample.
4.2.7 Cell Line
All in vitro assays were carried out using the PC-12 cell line (ECACC, catalogue number: 88022401).
Within any single experiment cells from a single population (passage) were used to reduce exper-
imental error. Previous studies have suggested that the line should be used at passage 6 to 10 to avoid
senescence [198,199,314]. However, this was not feasible because the PC-12 cells were received at pas-
sage 7. Therefore the cells were used within 6 passages (passage≤ 12). Senescence of neurite outgrowth
was not observed with cells at ≤ passage 12.
Cells were culture expanded in 25 cm2 cell culture flasks (Corning) coated with 4 µg/cm2 Poly-D-
Lysine (PDL). PDL was chosen as the cell adhesion coating for culture expansion because it interacts
electrostatically with cell membranes [315], and therefore is unlikely to up-regulate the expression of
specific cell adhesion molecules.
The following cell culture media was used: RPMI 1640 (R8758, Sigma) + 10 mM HEPES Buffer +
1 mM Sodium Pyruvate + 1% penicillin-streptomycin + 10% Horse Serum + 5% Foetal Bovine Serum
(FBS). Standard subculture technique was used. Cells were detached using trypsin-EDTA (Gibco) and
agitation, centrifuged to form a cell pellet, resuspended as a single-cell suspension using a small diameter
needle and seeded onto 2 new PDL coated flasks.
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Alcohol Concentration (vol.% Alcohol in dH2O) Time (minutes) Number of repeats
IMS 20 5 2
IMS 30 5 2
IMS 40 5 2
IMS 50 5 2
IMS 60 5 2
EtOH 90 5 2
EtOH 96 10 2
EtOH 100 15 2
Table 4.2: Alcohol series used for dehydration of cell monolayers on silicone sample for scanning elec-
tron microscopy. IMS = industrial methylated spirits. EtOH = Ethanol. Alcohol diluted in distilled
water.
Prior to seeding onto test surfaces cells were primed by culturing with NGF 7S (50 ng/mL) in
complete media for at least 7 days. Priming with NGF enhances the rate of neurite outgrowth following
seeding [316].
4.2.8 Cell Seeding
Cells were seeded at 5,000 cells per sample (approximately 6350 cells/cm2). Cells were detached from
culture flasks using trypsin-EDTA and agitation, centrifuged to form a cell pellet and resuspended in
media + 50 ng/mL NGF to give single-cell suspension at 50,000 cells/mL. Cells were dropped onto the
silicone sample surface in a 100 µL droplet using a Gilson pipette. Samples were place in an incubator
at 37◦C, 5% CO2, for 1 hour to adhere to the sample surface. The samples were then flooded with 2 ml
media + 50 ng/ml NGF and incubated for 96 hours with a single media change after 48 hours.
4.2.9 Scanning Electron Microscopy
The media was completely removed from the samples prior to processing. 2 ml 2.5% gluteraldehyde
fixative in 0.1M sodium cacodylate buffer (pH 7.4) was added to each sample. After 30 minutes the
fixative was removed and the samples were washed twice in 0.1M sodium cacodylate buffer (pH 7.4).
The samples were dehydrated in ascending alcohol series (see table 4.2). The samples were covered with
a loose lid and air-dried for at least 12 hours.
Dry samples were mounted onto aluminium stubs using double-sided carbon tape. Samples were
sputter coated with Au/Pd for 2.5 minutes at 20 mA using an Emitech K550 sputter coater. Conductive
paint was used to create a conductive bridge between the sample and the aluminium stub.
Prepared samples were imaged using a JEOL JSM 5500 LV scanning electron microscope (JEOL,
Welwyn Garden City, UK). 6 images were taken of each sample at 400× magnification. Images were
taken approximately equidistantly across the sample surface. In addition representative images were
taken at 200×.
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4.2.10 Immunoflourescence Microscopy
4.2.10.1 Vinculin
After 96 hours incubation cells (n=1 samples) were prepared for fluorescence microscopy. Media was
removed from each sample. 2 ml of 4% formalin in phosphate buffered saline was added to each sample.
After 30 minutes the fixative was removed and the samples were washed in PBS. Primary antibody
(Primary anti-vinculin mouse monoclonal Antibody (V9131, Sigma-Aldrich, UK), dilution of 1:200
with PBS and 0.0025% Triton X) was added to each sample and incubated at room temperature for 1
hour. Samples were washed 3 times with PBS. The underside of each substrate was dried and placed in
a clean, dry welled-plate. The secondary antibody (Alexa Fluor 488 chicken anti-mouse IgG antibody
(A21200, Invitrogen, UK), dilution 1:1000 with PBS) was added to each sample and incubated for 2
hours at room temperature in the dark. Samples were washed 3 times with PBS and stored under PBS
prior to imaging.
Samples were imaged using an Axioskop 2 Plus light microscope (Zeiss) with a FITC filter and
images were recorded using Axiovision software (Zeiss).
4.2.10.2 Actin
After 96 hours incubation cells (n=1 samples) were prepared for fluorescence microscopy. Media was
removed from each sample. 2 ml 4% formalin in phosphate buffered saline was added to each sample.
After 30 minutes the fixative was removed and the samples were washed in PBS. Cells were permeab-
ilised using 0.1% Triton-X (Sigma-Aldrich) in PBS for 15 minutes. Samples were washed 3 times with
PBS and 1% phalloidin-FITC was added to each sample. Samples were incubated at room temperature
for 1 hour. Samples were washed 3 times with PBS and stained with 0.1% Hoechst 33258 (Sigma-
Aldrich) in PBS for 15 minutes. Samples were washed and stored under PBS prior to imaging.
Samples were imaged using an Axioskop 2 Plus light microscope (Zeiss) with FITC and DAPI
filters and images were recorded using Axiovision software (Zeiss).
4.2.11 Image Analysis
4.2.11.1 Cell Number
Cell number was determined from 200x images using ImageJ software (version 1.46r and version 1.46a,
NIH, USA) [317, 318] and the cell counter plugin.
4.2.11.2 Neurite Length and Number
Neurite length and neurite number were determined from 400x images using ImageJ software. Linear
extensions from the cell were measured for all cells exhibiting extensions fully within the field of view.
Extensions were considered neurites when they extended at least 1 cell diameter from the cell edge. The
number of neurites per cell exhibiting neurites was recorded.
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4.2.11.3 Neurite Angle
Neurite deviation (angle) from grooves was determined relative to the sample surface. 0◦ indicates
alignment parallel to grooves, 90◦ indicates alignment perpendicular to grooves. For un-grooved samples
deviation was calculated relative to the lower edge of the field of view.
4.2.12 Data Analysis
Prior to the following statistical analyses a randomly selected 10% of the micrographs were assessed by
a second investigator and the intra-class correlation coefficient was calculated. Correlation coefficient
minimum was set at 0.7 [383].
Analysis of cell number, neurite number, neurite length and neurite angle was carried out using
SPSS 21.0, Mac and Linux versions (SPSS Inc., IBM, Chicago, IL). Data were tested for normality using
the Kolmogorov-Smirnov test. Data were not found to be normally distributed, therefore non-parametric
statistical tests were used.
For each experiment cell number, neurite number, neurite length and neurite angle for all groups
were compared using the Kruskal-Wallis one-way analysis of variance test. If a significant difference
was observed pair-wise Mann-Whitney U tests were performed to identify differences between groups.
If no significant difference was found by Kruskal-Wallis test the p-value was reported and no further
statistical tests were used. Differences were considered significant at the alpha ≤ 0.05 level.
Pair-wise tests were corrected for multiple comparisons using Holm-Bonferroni correction [319].
This is intended to reduce the likelihood of type I errors.
4.2.12.1 Normalised Cumulative Periodogram
To compare alignment of cells on substrates the normalised cumulative periodogram (NCP) criterion was
used. The NCP criterion determines an angle of alignment for a given group of neurites. The NCP was
determined using MATLAB (MATLAB R2011b for Linux, Mathworks) as previously described [380].
Two versions of the NCP were used: firstly, as described in [380], where NCP divergence was tested
for every 5th angle ‘k’ (k=5); and second, a more sensitive version, where divergence was calculated
for every angle ‘k’ (k=1). For each method each sample was treated separated and data were reported
as median and range. In addition for k=1 a single NCP value for each surface was calculated using all
datapoints. The MATLAB script for the NCP written for this work is given in the appendix.
4.3 Results
Data are reported as mean ± standard deviation to 3 significant figures unless otherwise stated. Neurite
outgrowth data are plotted as median, interquartile range and inner fences (1.5 times interquartile range).
Where data are highly skewed a log scale is used. Neurite alignment data are plotted as histograms with
10◦ bins. All p-values are tabulated in the appendix.
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Figure 4.2: Change in Ra with HF etching time. Silicone samples patterned using etched Ti-6Al-4V
discs. All differences are significant, p ≤ 0.001.
4.3.1 Surface Roughness by Vertical Scanning Interferometry
The following surface roughnesses (Ra) were achieved (median, range): polished controls (147 nm, 112
nm to 169 nm); 1 minute HF etch (301 nm, 263 nm to 377 nm); 4 minute HF etch (409 nm, 406 nm to
418 nm). A significant difference in roughness was found by Kruskal Wallis test (p ≤ 0.001). Samples
etched for 1 minute were significantly rougher than polished controls (p ≤ 0.001). Samples etched for
4 minutes were significantly rougher than controls and samples etched for 1 minute (p ≤ 0.001). No
increase in roughness was detected if longer etching times were used beyond 4 minutes, in a single
sample test etching for 8 minutes gave a roughness 4% lower than that for a 4 minute etched sample. Ra
values are plotted in fig. 4.2.
The interferometry images show some non-uniformity on the polished surfaces, while the HF etched
surfaces are more uniform with evenly spread peaks and troughs.
4.3.2 Surface Topography by Vertical Scanning Interferometry
Due to high aspect ratio, steep side walls and possible overhangs created by the direct laser writing,
vertical scanning interferometry created a low resolution image of the surface indicating groove size and
the roughness profile of the base of grooves and top of ridges (figs. 4.3 to 4.10).
4.3.3 Water Contact Angles
Water contact angles are reported in fig. 4.11. Water contact angle increased on HF etched surfaces
compared with controls. The largest median water contact angles were observed on deep, narrow grooves
following etching. In contrast etching shallow, wide grooves reduced water contact angle. Droplet
spreading parallel to the grooves was observed on etched shallow, wide grooves, but was not observed
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Figure 4.3: Vertical Scanning Interferometry profile of an example polished control silicone control
surface. Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.4: Vertical Scanning Interferometry profile of an example 1 minute HF etched silicone surface.
Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.5: Vertical Scanning Interferometry profile of an example 4 minute HF etched silicone surface.
Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.6: Vertical Scanning Interferometry profile of an example 30/30/5 grooved silicone surface.
Area: 0.598 mm by 0.442 mm. Magnification: 20x.
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Figure 4.7: Vertical Scanning Interferometry profile of an example 30/30/10 grooved silicone surface.
Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.8: Vertical Scanning Interferometry profile of an example 15/30/10 grooved silicone surface.
Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.9: Vertical Scanning Interferometry profile of an example multiscale 30/30/5 grooved + 1
minute HF etched surface. Area: 0.598 mm by 0.442 mm. Magnification: 20x.
Figure 4.10: Vertical Scanning Interferometry profile of an example multiscale 15/30/10 grooved + 4
minute HF etched surface. Area: 0.598 mm by 0.442 mm. Magnification: 20x.
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Figure 4.11: Water contact angles for smooth, HF etched, grooved and multiscale silicone surfaces.
on other grooved surfaces.
4.3.4 BCA Assay
The lowest protein concentration was observed on control surfaces (0.479± 0.161 µg/cm2, see fig. 4.12).
The protein concentration was greater on 4 minute HF etched surfaces (0.586 ± 0.012 µg/cm2), and
greatest on 15/30/10 grooved surfaces (0.779 ± 0.061 µg/cm2). An intermediate protein concentration
was observed on multiscale surfaces (0.659 ± 0.042 µg/cm2).
4.3.5 Intraclass correlation
Intraclass correlation coefficients were greater than the minimum level set, ICC(3,1) = 0.702, ICC(3,k)
= 0.845. Therefore results were considered reliable between observers.
4.3.6 HF Etched Surfaces
Nano-scale roughening by HF treatment significantly increased number of cells per area compared with
control samples: 1 minute HF etch (p = 0.017); 4 minutes HF etch (p = 0.011). No significant difference
in number of cells per area was observed between the two etched sample groups.
Number of neurites per cell was significantly increased on surfaces that had been etched for 4
minutes (3.28 ± 1.66 neurites) compared with all other samples (p ≤ 0.001). Etching for 1 minute
did not significantly increase neurite number compared with control samples (p = 0.558): 2.82 ± 1.65
neurites; and 2.76 ± 1.63 neurites respectively, fig. 4.13a.
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Figure 4.12: Protein concentration on polished control, HF etched, grooved and multiscale silicone
surfaces. Determined using a micro-BCA assay.
Etching surfaces for 1 minute significantly increased neurite length compared with control samples
(p ≤ 0.001): 21.5 ± 16.4 µm; and 20.8 ± 19.1 µm respectively. Etching for 4 minutes significantly
reduced neurite length compared with all other samples (16.9 ± 13.1 µm, p ≤ 0.001), fig. 4.13b.
(a) PC-12 cell neurite number on HF etched
samples. Data displayed on a logarithmic
scale. Significant differences are indicated by
paired letters: a,b, p ≤ 0.001.
(b) PC-12 cell neurite length on HF etched
samples. Data displayed on a logarithmic
scale. Significant differences are indicated by
paired letters: a,b,c, p ≤ 0.001.
Figure 4.13: PC-12 cell neurite outgrowth data for silicone samples templated using Ti-6Al-4V samples
with the following surface treatments: polished controls; 1 minute HF etch; 4 minutes HF etch.
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Surface Median Angle of Alignment ◦ Median Angle of Alignment ◦ Angle of Alignment ◦
(range), n=6, k=1 (range), n=6, k=5 n=1, k=1
15/30/10 48.0565 (10.188,90) 90 (6.8,90) 0.59
30/30/10 87.433 (1.233,90) 43.195 (38.97,90) 2.574
Table 4.3: Angles of neurite alignment on grooved silicone surfaces calculated using the NCP criterion.
4.3.7 Grooved Surfaces
Significantly fewer PC-12 cells were observed on samples with deep grooves (10 µm) compared with
control samples (p ≤ 0.007). There was no significant difference in number of cells per area between
the different grooved samples (p ≥ 0.143). Samples with shallower grooves (5 µm) did not have a
significantly different number of cells per area compared with control samples (p = 0.045, pcut = 0.0125).
The number of neurites per cell was significantly reduced on the deep, narrow 15/30/10 grooved
samples (1.97 ± 1.05 neurites) compared with all other samples (p ≤ 0.001). The number of neurites
per cell did not change significantly between wider 30/30/10 samples (2.31 ± 1.42 neurites), shallower
30/30/5 samples (2.34 ± 1.43 neurites) and smooth controls (2.56 ± 1.70 neurites), fig. 4.14a.
The longest neurites were observed on shallow grooved 30/30/5 samples (23.5 ± 20.8 µm) these
were significantly longer than the neurites observed on 30/30/10 samples (21.5 ± 19.3 µm) and control
surfaces (21.5 ± 20.7 µm, p ≤ 0.001). Neurites expressed on 15/30/10 samples were of intermediate
length (22.2± 17.0 µm) and were not significantly different compared with all other sample groups (p≥
0.038, pcut = 0.025). The observed neurite lengths were not significantly different (p = 0.947) between
30/30/10 grooved samples and smooth control samples, where cells with the shortest neurites were found
fig. 4.14b.
Neurites on the deep, narrow 15/30/10 grooved samples were more aligned (31.6◦ ± 25.6◦) com-
pared with all other samples (p ≤ 0.001). Neurites were also more aligned on deep, wide 30/30/10
grooved surfaces (41.1◦ ± 26.0◦) compared with smooth controls (46.6◦ ± 26.7◦, p ≤ 0.001) and shal-
low 30/30/5 grooved surfaces (45.3◦ ± 25.5◦, p ≤ 0.001). PC-12 cells on shallow 30/30/5 grooved
samples did not align compared with smooth samples (p = 0.168). Neurite alignment is displayed as a
series of histograms with 10◦ bins, fig. 4.15. Angles of alignment are shown in table 4.3.
4.3.8 Multiscale Surfaces: Experiment 1
A first series of experiments was carried out using shallow 30/30/5 grooves and 1 minute HF etching.
These treatments were carried out in combination (multiscale) and separately and compared with pol-
ished controls.
No significant difference in cell number per area between samples was found by Kruskall Wallis
Test (p = 0.064), therefore Mann-Whitney U tests were not carried out.
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(a) PC-12 cell neurite number on grooved
samples. Data displayed on a logarithmic
scale. Significant differences are indicated by
paired letters: a,b,c, p ≤ 0.001.
(b) PC-12 cell neurite length on grooved
samples. Data displayed on a logarithmic
scale. Significant differences are indicated by
paired letters: a,b, p ≤ 0.001.
Figure 4.14: PC-12 cell neurite outgrowth data for silicone samples templated using Ti-6Al-4V samples
with the following laser patterned grooves: 30 µm wide, 30 µm spacing, 5 µm deep (30/30/5); 30 µm
wide, 30 µm spacing, 10 µm deep (30/30/10); 15 µm wide, 30 µm spacing, 10 µm deep (15/30/10).
Figure 4.15: Histograms of PC-12 cell neurite angles on grooved samples. Neurites are most aligned on
15/30/10 samples, and also aligned on 30/30/10 samples. 10◦ bins. N.B. total number of angles is not
equal between samples. Significant differences are indicated by paired letters: a,b,c,d,e, p ≤ 0.001.
Neurite number per cell was significantly reduced on 30/30/5 grooved (2.01± 1.30) compared with
controls (2.17 ± 1.29, p ≤ 0.001) and etched samples (2.31 ± 1.31, p ≤ 0.001). In addition, neurite
number was significantly reduced on grooved and etched samples (1.92 ± 1.12) compared with controls
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(p = 0.002) and etched samples (p ≤ 0.001). Neurite number was significantly increased on surfaces
templated with titanium alloy discs which were etched for 1 minute compared with smooth control
surfaces (p = 0.011). No significant difference in neurite number was observed between 30/30/5 grooved
and grooved and etched samples (p = 0.548), fig. 4.16a.
Neurite length was reduced significantly on 30/30/5 grooved (13.7 ± 9.02 µm) and multiscale
surfaces (15.0 ± 12.1 µm) compared with 1 minute HF etched surfaces (15.1 ± 10.1 µm) and polished
controls (14.8 ± 9.46 µm,p ≤ 0.003). PC-12 cells on multiscale surfaces exhibited significantly longer
neurites than on grooved surfaces (p = 0.014, pcut = 0.025). No significant difference in neurite length
was observed between 1 minute HF etched and polished control samples (p = 0.742), fig. 4.16b.
Neurites did not align on shallow 30/30/5 grooved multiscale surfaces (p = 0.774, fig. 4.17), there-
fore angles of alignment were not calculated.
(a) PC-12 cell neurite number on grooved and
etched samples. Data displayed on a logar-
ithmic scale. Significant differences are indic-
ated by paired letters: a,c,d, p ≤ 0.001; b, p =
0.002; e = 0.011.
(b) PC-12 cell neurite length on grooved and
etched samples. Data displayed on a logar-
ithmic scale. Significant differences are in-
dicated by paired letters: a, p = 0.014; b, p
= 0.003; c,d,e, p ≤ 0.001.
Figure 4.16: PC-12 cell neurite outgrowth data for silicone samples templated using Ti-6Al-4V samples
with the following surface treatments: polished controls; 1 minute HF etch; 30 µm wide, 30 µm spacing,
5 µm deep laser patterned grooves (30/30/5); multiscale 30/30/5 laser patterned grooves + 1 minute HF
etch.
4.3.9 Multiscale Surfaces: Experiment 2
A second series of experiments was carried out using deep, narrow 15/30/10 grooves and 4 minute HF
etching. These treatments were carried out in combination (multiscale), separately and compared with
smooth controls.
PC-12 cell number per area was significantly reduced on etched surfaces compared with 15/30/10
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Figure 4.17: Histograms of PC-12 cell neurite angles on grooved and etched samples. Neurites are
not significantly aligned on any samples. 10◦ bins. N.B. total number of angles is not equal between
samples. Differences are not significant, p = 0.774.
grooved and multiscale surfaces (p ≤ 0.008). There were significantly more cells per area on 15/30/10
grooved samples compared with controls (p = 0.006). No other significant differences were observed (p
≥ 0.055).
Significantly fewer neurites were observed on 15/30/10 grooved samples (1.60 ± 0.893) compared
with all other samples (p≤ 0.006, pcut ≥ 0.008). Neurite number was significantly reduced on multiscale
samples (1.77 ± 0.977) compared with etched (2.40 ± 1.50) and control samples (2.19 ± 1.23, p ≤
0.001). No significant difference in neurite number was observed between etched and control samples
(p = 0.192), fig. 4.18a.
Neurite length was significantly increased on all samples compared with control (16.5 ± 11.9 µm,
p ≤ 0.001). PC-12 cells expressed significantly longer neurites on multiscale surfaces (21.1 ± 14.1 µm)
compared with etched surfaces (20.1 ± 17.6 µm, p = 0.001). No significant differences in neurite length
were observed between: grooved (21.2 ± 15.8 µm) and multiscale surfaces (p = 0.231); and grooved
and etched surfaces (p = 0.044, pcut = 0.025), fig. 4.18b.
Neurites were more aligned on multiscale (39.9◦ ± 25.7◦) and grooved samples (37.3◦ ± 26.7◦)
compared with samples without grooves (p ≤ 0.01). There was no significant difference in alignment
between multiscale and grooved surfaces (p = 0.05, pcut = 0.025). Cells did not align on etched surfaces
(43.3◦ ± 25.8◦) compared with controls (43.4◦ ± 26.1◦, p = 0.917), fig. 4.19. Angles of alignment are
shown in table 4.4.
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Surface Median Angle of Alignment ◦ Median Angle of Alignment ◦ Angle of Alignment ◦
(range), n=6, k=1 (range), n=6, k=5 n=1, k=1
15/30/10 90 (3.59,90) 90 (1.57,90) 2.6
15/30/10 + 90 (8.53,90) 90 (14.71,90) 90
4 minute
HF etch
Table 4.4: Angles of neurite alignment on grooved and multiscale silicone surfaces calculated using the
NCP criterion.
(a) PC-12 cell neurite number on grooved and
etched samples. Data displayed on a logar-
ithmic scale. Significant differences are indic-
ated by paired letters: a, p = 0.006; b,c,d,e, p
≤ 0.001.
(b) PC-12 cell neurite length on grooved and
etched samples. Data displayed on a logar-
ithmic scale. Significant differences are indic-
ated by paired letters: a,b,c,d, p ≤ 0.001.
Figure 4.18: PC-12 cell neurite outgrowth data for silicone samples templated using Ti-6Al-4V samples
with the following surface treatments: polished controls; 4 minute HF etch; 15 µm wide, 30 µm spacing,
10 µm deep laser patterned grooves (15/30/10); multiscale 15/30/10 laser patterned grooves + 4 minute
HF etch.
4.3.10 Protein Mixes on Multiscale Surfaces
Experiments were carried out to compare multiscale surfaces with Collagen-IV (CIV) and Collagen-IV -
Laminin-2-4 - Nidogen-1 (All-in-one / All) coatings. These treatments were applied to control, 4 minute
HF etched, 15/30/10 grooved and multiscale silicone (PDMS) surfaces.
PC-12 cell number per area was significantly reduced on collagen-IV grooved samples compared
with collagen-IV coated control, etched and multiscale samples (p <0.001). Number of cells per area
reduced significantly on all-in-one coated grooved samples compared with all-in-one coated control
samples (p <0.001). No other significant differences were observed, although overall fewer cells were
observed on grooved samples, more on grooved and etched samples, and the greatest density of cells was
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Figure 4.19: Histograms of PC-12 cell neurite angles on grooved and etched samples. Neurites are most
aligned on 15/30/10 samples, and also aligned on 15/30/10 + 4 minute etch samples. 10◦ bins. N.B. total
number of angles is not equal between samples. Significant differences are indicated by paired letters:
a, p = 0.01; b, p = 0.005; c,d, p ≤ 0.001.
observed on control and HF etched surfaces.
Significantly fewer neurites were observed on collagen coated 15/30/10 grooved samples (1.86 ±
1.08) compared with etched (3.49 ± 1.78) or control (3.03 ± 1.64) collagen coated samples (p <0.001).
Neurite number was significantly reduced on all-in-one 15/30/10 samples (2.19 ± 1.25) compared with
control all-in-one samples (2.75 ± 1.53) (p <0.004), but not compared on all-in-one multiscale samples
(2.55 ± 1.32) compared with control samples (p = 0.481). Multiscale collagen coated samples (2.15 ±
1.01) had reduced neurite number compared with roughened collagen coated samples (3.49 ± 1.78) (p
<0.001). The addition of laminin and nidogen reduced neurite number only for all-in-one roughened
samples (2.67 ± 1.51) (p <0.002) and otherwise had no significant effect. More neurites were observed
on multiscale surfaces than grooved surfaces with both coatings, though this difference was not signific-
ant. Neurite number was increased (not significantly) by the addition of laminin and nidogen to coatings
on multiscale samples, fig. 4.20a.
Neurites were longer on collagen coated grooved (43.4 ± 29.2 µm) and multiscale (37.7 ± 16.4
µm) samples compared with collagen coated etched (28.72 ± 17.1 µm) and control (33.9 ± 23.2 µm)
samples (p <0.002). Neurites on multiscale samples coated with collagen, laminin and nidogen (54.0 ±
37.8 µm) were longer than control, roughened and grooved samples coated with the same proteins (36.1
± 23.2 µm, 24.3 ± 14.1 µm and 36.2 ± 23.5 µm respectively, p <0.001). No significant difference in
neurite length was observed between control and grooved samples with all-in-one coatings (p = 0.539),
although the all-in-one coated grooved sample neurites were significantly longer than on the respective
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HF etched samples (p <0.001). Neurites were significantly shorter on HF etched samples compared
with controls with both protein coatings (p <0.001). The mixed protein coatings altered neurite length
significantly compared with collagen coated samples in one case: with grooved samples (p = 0.001).
fig. 4.20b.
In all cases neurites were significantly more aligned on grooved and multiscale samples compared
with etched and control samples (p <0.001), fig. 4.21. All etched and control samples had mean average
angles in the range 42.2◦ to 48.8◦, while grooved and multiscale sample means fall in the range 21.0◦
to 33.6◦. No significant alignment was observed on surfaces with random roughness. Alignment was
significantly reduced on all-in-one multiscale surfaces compared with all-in-one grooved surfaces (p =
0.002), the same effect was not observed on collagen coated grooved and multiscale surfaces (p = 0.017,
pcut = 0.008).
(a) PC-12 cell neurite number on protein coated grooved
and etched samples. Data displayed on a logarithmic
scale. Significant differences are indicated by paired let-
ters: a,b,d,e,f, p ≤ 0.001; c, p = 0.004.
(b) PC-12 cell neurite length on protein coated grooved
and etched samples. Data displayed on a logarithmic
scale. Significant differences are indicated by paired let-
ters: a,c,d,e,f,g,h,i,k, p ≤ 0.001; b,j, p = 0.001.
Figure 4.20: PC-12 cell neurite outgrowth data for silicone samples templated using Ti-6Al-4V samples
with the following surface treatments: polished controls; 4 minute HF etch; 15 µm wide, 30 µm spacing,
10 µm deep laser patterned grooves (15/30/10); multiscale 15/30/10 laser patterned grooves + 4 minute
HF etch. Each substrate is coated with either collagen-IV or a mixed (all-in-one) collagen-IV - laminin-
2,-4 - nidogen coating.
4.3.11 Cell Morphology
Cell morphology was affected by the surfaces that they were attached to, see figs. 4.22a to 4.22h. Al-
though the images are representative the high variability between cell morphology means the images are
difficult to interpret without statistical analysis. However, cells on grooved samples, in particular those
with deeper grooves, appear to exhibit fewer, longer neurites, an observation supported by the statistical
analyses. Observations, not quantified, indicate that neurites grow preferentially along the top of ridges.
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Figure 4.21: Histograms of PC-12 cell neurite angles on protein coated grooved and etched samples. 10◦
bins. N.B. total number of angles is not equal between samples. Significant differences are indicated by
paired letters: a,b,c,d,e,f,g,h, p ≤ 0.001; i, p = 0.002.
Neurite-neurite interactions were observed on all surfaces. The exhibition of these interactions was
partly dependent upon the neurite length, with longer neurites more likely to encounter other neurites,
but also dependent upon the random local seeding density of PC-12 cells. Therefore the neurite-neurite
interations shown are not a strong indicator of surface suitability.
Immunoflourescence microscopy showed vinculin markers on some cells, indicating focal adhesion
formation (figs. 4.23a and 4.23b). In addition neurites could be observed using vinculin staining, this
indicated that non-specific binding was taking place. Furthermore, fluorescent antibodies adsorbed to the
modified substrates and the depth of focus was not sufficient for neurites to be imaged in high quality.
Therefore vinculin stains were not used for analysis and cell adhesion could not be quantified using
vinculin markers.
Immunoflourescence microscopy using actin staining was more successful, with low levels of non-
specific binding and adsorption to the substrate surface. Aligned neurites were observed on grooved
samples and cells on roughened samples appeared to express more, shorter neurites. Example images
are given in figs. 4.24a to 4.24h.
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(a) Smooth Control Surfaces. 400x. (b) 1 minute HF etched Surfaces. 400x.
(c) 4 minute HF etched Surfaces. 400x. (d) 30/30/5 Grooved Surfaces. 200x.
(e) 30/30/10 Grooved Surfaces. 200x. (f) 15/30/10 Grooved Surfaces. 200x.
(g) 30/30/5 Grooved Surfaces with 1 minute
HF etch. 200x.
(h) 15/30/10 Grooved Surfaces with 4 minute
HF etch. 200x.
Figure 4.22: Scanning Electron Micrographs of PC-12 cell neurite outgrowth on surfaces tested. Scale
bar length and magnification is specified for each image.
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(a) PC-12 cells on a 15/30/10 Grooved Surface. Vin-
culin markers are not readily distinguished and back-
ground fluorescence is visible. Groove angle is indicated
by dashed line. 40x magnification.
(b) PC-12 cells on a control surface. Vinculin markers
are visible, but not readily distinguished from cell back-
ground fluorescence. 100x magnification.
Figure 4.23: Vinculin stained PC-12 cells on modified topographies. Scale bar length and magnification
is specified for each image.
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(a) Smooth Control Surfaces coated with Col-
lagen.
(b) Smooth Control Surfaces coated with all-
in-one.
(c) 4 minute HF etched surfaces coated with
Collagen.
(d) 4 minute HF etched surfaces coated with
all-in-one.
(e) 15/30/10 Grooved Surfaces coated with
Collagen.
(f) 15/30/10 Grooved Surfaces coated with all-
in-one.
(g) 15/30/10 Grooved Surfaces with 4 minute
HF etch coated with Collagen.
(h) 15/30/10 Grooved Surfaces with 4 minute
HF etch coated with all-in-one.
Figure 4.24: Actin stained PC-12 cells on modified topographies with collagen-IV (10 µg/cm2) or all-
in-one coatings (10 µg/cm2 collagen-IV, 1 µg/cm2 laminin-2,-4, 0.175 µg/cm2 Nidogen). All images
were counter-stained with Hoechst 33258 and taken at 20x magnification. Where substrates are grooved,
groove angle is indicated by dashed line.
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4.4 Discussion
In all the conditions assessed in this study PC-12 cell growth was supported and neurites were observed.
4.4.1 Water Contact Angles
The observed surfaces fall within the hydrophobic region (>90◦). Due to the surface hydrophobicity,
increased geometric surface area and a rough profile, air may be present trapped between the water
droplet and the surface. This increase in hydrophobicity, and possible trapped air, may influence collagen
adhesion. This work uses FBS (and HS) supplemented media, it has been shown that cell adhesion
from FBS supplemented suspension is reduced on hydrophobic regions, whether or not trapped air is
removed [384]. This hydrophobicity presents a challenge for the use of PDMS as a neural biomaterial;
however, surface modifications may be able to overcome this problem and increase cell adhesion.
4.4.2 BCA Assay
Increasing surface roughness increased the concentration of collagen-IV adsorbed to the surface.
Grooves further increase the true surface area for adsorption without increasing the geometrical area,
explaining the high protein concentration observed on 15/30/10 grooved surfaces. HF etching of grooved
surfaces can be expected to smooth rough edges, reducing true surface area for adsorption and explaining
the reduction in adsorbed protein.
These findings are supported by the literature. Increasing surface roughness (Rq) from 2 nm to 32.9
nm (approximately 16x increase) increases surface fibrinogen saturation by about 70% and bovine serum
albumin saturation by about 30% [385]. Studies on poly-urethanes have shown that increasing roughness
from 7 nm to 117 nm (approximately 17x increase) increases bovine serum albumin saturation by about
35% [321]. However, no difference in bovine serum albumin adsorption was seen on surfaces with Ra
from 0.22 µm to 1.74 µm (approximately 7x increase), while a 50% increase in osteoblast number was
observed [386]. Changes in protein self assembly may also occur, with bovine serum albumin spreading
more evenly, and forming a dendritic rather than island structure on small (300 nm) compared with large
(>1 µm) stainless steel grain size. [387], it should be noted that surface roughness was constant with
change in grain size.
4.4.3 HF Etched Surfaces
Roughness’s in the range of basement membrane (10 nm to 350 nm) are achieved on polished controls
and following 1 minute HF etching. 4 minutes HF etching creates rougher surfaces; however, Raffa
et. al. show that even with differences in roughness collagen coating can eliminate difference in cell
adhesion [198]. Due to the topography of the polished surfaces the lowest roughnesses presented in the
literature (<100 nm Ra) could not be achieved, alternative materials such as silicon could be used to
145
create smoother surfaces.
In these experiments more cells were observed on HF etched surfaces compared with less rough
controls. This contrasts with results in the literature which showed that there is an optimal Ra value
between 20 nm and 70 nm, and that cell adhesion reduces on surfaces above 80 nm [197,198,388]. This
study contrasts with the literature, using collagen-IV coated silicone rather than silicon. The different
method of roughening, resulted in a rougher surface, mimicking nanoporous surfaces which have been
shown to improve PC-12 cell adhesion [199]. In this study rougher surfaces were found to adsorb more
collagen-IV, and an increase in collagen can be expected to support more cells as observed.
Neurite outgrowth was observed on all surfaces, with more, shorter neurites on the roughest surfaces
and the longest neurites observed on surfaces etched for 1 minute. Previous studies have shown increased
neurite outgrowth on lower roughness values (25 nm) [388]. Again, the results of this study are more
similar to those found by Moxon et. al., where 100 nm scale nanoporosity increased the number of
neurites expressed [199]. Cells exhibiting fewer, longer neurites can be considered to be more mature,
indicating that after 96 hours cells on smooth surfaces and the roughest surfaces were still in an immature
state, expressing large numbers of pathfinding neurites. PC-12 cells were mature and expressed few
longer neurites indicating a reduction in neurite architecture following path-finding.
It can be hypothesised that there is a synergistic effect of cell density, neurite number, and neurite
length. Increased cell density will increase the likelihood of neurite junctions forming, at which point
neurites typically stop extending and thicken. High levels of junction formation may result in greater
numbers of shorter neurites, as observed on the roughest surfaces. To reduce the effect of junction
formation cells must be seeded at a lower density.
4.4.4 Grooved Surfaces
On the deepest grooved samples cells resided mostly on the tops of ridges, this reduced the percentage
area available for cell adhesion, reducing cell number. On shallower grooved surfaces cells were ob-
served both in the valleys and on ridges. By confining PC-12 cells onto ridges the cells express fewer
neurites which align with the underlying architecture. This change agrees with previous research show-
ing reduced neurite architecture when cells are confined in channels [350]. PC-12 cells formed the fewest
neurites on the narrowest features, where the cells were expected to be most confined.
Neurite length results do not agree with previous studies. Cells confined on narrower grooved
samples were expected to form longer neurites [350, 358]; however, in this study the longest neurites
were observed on shallow, undulating grooves. Intermediate lengths were observed on deep, narrow
grooves, following the expected trend compared with the control surfaces. Cell morphology on the
shallow grooves (fig. 4.22d) showed long neurites expressed radially around cell soma, the traction forces
exerted by filopodia extending over the slightly convex ridge edges may encourage neurite extension
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[350]. So, while cells on grooves express long neurites, it can be hypothesised that a slight convex surface
would provide an alternative optimal surface for neurite outgrowth. Due to the nature of microchannels
(concave) this possibility cannot be exploited in this case.
Neurites aligned on deep grooves only with a groove aspect ratio >0.3, this is greater than the 0.05
or 0.1 values predicted in the literature [359]. In this research shallow grooves formed an undulating
surface, without sharp edges between grooves and ridges. Sharper grooves are expected to reduce the
aspect ratio required for alignment. To achieve sharper edges a smaller laser spot size could be used, the
30 µm spot size has a variation in intensity across its width, creating ‘U’ shaped negative groove profile,
leading to an ‘n’ shaped silicone ridge profile. Reich et. al. used femtosecond lasers to achieve direct
writing of 10 µm groove widths [226]. Alternatively photolithography can be used to pattern materials
with µm and nm scale precision [358, 360, 389].
The NCP criterion analysis was used to further characterise the extent of neurite alignment. In this
case the angles of alignment calculated for each sample using k = 5 and k = 1 disagree. In addition
the angles of alignment calculated using data from all samples, although giving the correct rank to the
samples provide unrealistically low values. Although reported for some later experiments, angles of
alignment will not be discussed hereafter.
4.4.5 Multiscale Surfaces: Experiment 1
To test for synergistic effects of µm scale grooving and nm scale roughening two groups were combined:
shallow 30/30/5 grooves and 1 minute HF etching.
Etching for 1 minute was not found to alter the number of cells on the surface, in contrast with
the results previously observed for HF etching. In addition fewer PC-12 cells were observed on shallow
grooved samples, in contrast with previous results.
Etching samples increased the number of neurites compared with controls, although not significant
in previous results the same trend was observed. The addition of grooves to samples reduced neurite
number in this experiment, again previous results did not see a significant reduction but the same trend
was observed. The reduction in neurite number observed on the multiscale surfaces is accounted for by
the effects of grooving, with the addition of etching causing no increase in neurite number.
In this experiment neurite length was reduced on shallow grooves, this contrasts with results previ-
ously observed. However, the addition of etching to grooved samples increased neurite length, indicating
that roughening is counteracting the negative effect grooving has on neurite outgrowth.
As shown previously neurites did not align on the shallow grooves with cells exhibiting extensions
radially around the soma.
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4.4.6 Multiscale Surfaces: Experiment 2
To test for synergistic effects of µm scale grooving and nm scale roughening two groups were combined
in a further experiment where alignment was expected: 15/30/10 grooves and 4 minute HF etching.
Data on cells per area contrasted with all previous results in this study, finding that increasing
roughness reduces cell number and that more cells are attached to samples with deep grooves.
Deep grooves reduced numbers of neurites, a phenomenon previously observed and discussed. Fur-
thermore, the addition of roughening to grooved surfaces caused an increase in neurite number, although
not to the control level. This indicates an additive effect where roughening is counteracting the negative
effect grooving has on neurite outgrowth.
Previously it was shown that etching for 4 minutes increased neurite number compared with con-
trols, this trend was observed in this experiment although it was not significant.
By roughening samples neurite length was increased, and this was true for grooved samples and
polished samples. Previously, roughening for 4 minutes was shown to reduce neurite length, a finding
disputed by the results of this experiment. As before longer neurites formed on grooved samples com-
pared with controls. The effect seen here implies a synergistic effect, where roughening and grooving
increase neurite length independently, and have an additive effect when combined.
Neurite alignment was observed on both grooved and multiscale surfaces. This agrees with previous
studies which have shown alignment on µm scale grooves in the presence of underlying isotropy [376,
378].
4.4.7 Protein mixes on Multiscale Surfaces
To examine the effects of differing protein coatings collagen-IV and mixed protein coatings were applied
to multiscale surfaces and relevant controls.
As with previous studies samples with deep grooves have a lower cell density. Roughening these
surfaces increases the number of cells per area indicating that this counteracts the negative effects of
grooving.
Cells expressed fewer neurites on grooved and multiscale surfaces compared with control or
roughened samples, as was previously observed. Again an additive effect, increasing neurite number
with roughening of grooved samples, was observed. In this case adding proteins to the coating tended to
reduce the neurite number on control or roughened surfaces, but increases it on grooved and multiscale
surfaces. The additional proteins may cause maturation and polarisation of cells on un-grooved surfaces,
but encourage neurite outgrowth in cases where cells are already polarised by the underlying topography.
This effect should be further examined, and protein expression at neurite ends could be characterised to
indicate growing and maturing neurites.
In this experiment, as shown previously, neurite length was reduced on roughened samples. Longer
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neurites were observed on grooved and multiscale samples, agreeing with previous results. For all-in-
one coated surfaces etching of grooved samples further increased neurite length, in agreement with the
previous results; however, this effect was not observed with collagen coated samples.
Alignment was observed on grooved and multiscale surfaces. The alignment effect is reduced on
multiscale samples with all-in-one coatings, possibly because cells with increased neurite number are
less polarised, so factors such as proteins, which increase neurite number will negatively impact neurite
alignment. This contrasts with studies that have shown greater neurite alignment and fewer neurites on
laminin peptide coatings compared with collagen-I coatings [351], however, in this study the complete
laminin protein was used, so the epitope concentration may be lower.
4.4.8 Conclusions
It is concluded that multiscale surfaces are optimal for the promotion of neurite outgrowth and alignment
in vitro. A synergistic effect of increasing neurite length and counteracting negative effects on neurite
number was observed.
The findings of this study support the generation of a further hypothesis: multiscale surfaces will
enhance neural regeneration within in vivo microchannels. Given the results presented in this chapter
then it may be possible that surfaces with roughnesses in the range of basement membrane may encour-
age increased cell attachment and an increase in the number and length of neural extensions. Meanwhile
grooves may guide extending axons and support cells along the length of a microchannel reducing the
extent of fascicular misalignment. Grooves may also enhance neural extension length in vivo reducing
the time in which regeneration takes place.
The addition of proteins to these surfaces to create an environment more representative of the neural
basement membrane has little effect on PC-12 cell neurite expression. Significant differences are more
regular and pronounced between topographies rather than with different proteins on the same topography.
A cell line or primary cell source from the peripheral nerve may alter this balance, demonstrating differ-
ences with protein coatings. This is unexpected, because previous research suggests that proteins obscure
small scale roughness changes (<300 nm feature size) [198]. In this study feature sizes on roughened
surfaces ranged from 100 nm to 2 µm peak-to-peak, therefore surface structures were not ’hidden‘ by a
protein coating with fibrils in the <100 nm range.
It is also proposed, based on the literature, that multiscale surfaces will alter the action of support
cells (Schwann cells) and cells associated with fibrosis in vivo. This may lead to reduced occlusion
within microchannels and a more stable nerve interface. In a best case scenario the roughened surface
would be accepted by the nerve as a perineural membrane, and a complete fascicle will regenerate within
a microchannel with minimal fibrotic tissue.
The surfaces developed fulfil the limitations set down for the study. None of the tested surfaces are
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porous. The largest structure tested has a periodicity of 60 µm, indicating that from 1 to 3 repeats could
fit on one wall of a microchannel. The structure indicated for further investigation has a periodicity of
45 µm, indicating that from 2 to 4 repeats could fit on one wall of a microchannel. Finally the structures
are manufactured by a simple negative printing process which could be readily be patterned on one or
two surfaces of a square cross-section microchannel by spin casting.
To create more defined structures, both roughnesses and grooves, silicon templates could be used.
This would allow nm to µm scale grooving by photolithography and reactive ion etching. Etching
processes on silicon can create controlled nm scale roughnesses from the 1 nm to 100 nm Ra scale.
This study has presented modifications aimed at the internal surfaces of microchannels, further work
could examine the effect of topographical changes on electrode surfaces. Patterning and roughening
electrodes is of interest to improve the impedance and charge injection properties [390]. Having differing
surface structures on the electrodes compared with the encapsulating silicone microchannel may cause
preferential attachment of cells to one or other of the surfaces [169, 391].
This study presents a series of in vitro experiments, using a neuron-like cell line. In the complex in
vivo environment additional factors will be present: other cell types; 3D structure; foreign body response;
etc.. Caution should be taken extrapolating the findings of this study to the in vivo environment without
further investigation using either more representative in vitro models or in vivo models.
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Chapter 5
The Manufacture of Microchannel Neural
Interfaces
5.1 Introduction and Hypotheses
Implantable neural interfaces must be small, both to communicate selectively with micron-scale neural
structures and to reduce harm to the host during electrode implantation [42]. This chapter describes four
methods for manufacturing microchannel neural interfaces.
The neural interfaces investigated in this chapter of this thesis can be divided generally into groups
by design and by manufacturing processes [392]. Neural interface designs have been discussed in chapter
1 of this thesis. Interfaces are grouped by their extent of invasiveness [55, 79]. Typically these designs
are: extraneural interfaces; interfascicular interfaces; and intrafascicular interfaces. Intrafascicular inter-
faces include microwires, microelectrode arrays and regenerative interfaces. Microchannel neural inter-
faces are regenerative interfaces with longitudinal insulating microchannels. This chapter will discuss
manufacturing processes used to create neural interfaces.
5.1.1 Microfabrication Techniques for Neural Interfaces
Processes will be considered in terms of their manufacturability and resulting materials properties. Man-
ufacturability is the ease with which the interface can be manufactured and the potential to scale up the
design, both physically to achieve more recording/stimulating channel and for mass or batch produc-
tion. Materials properties are a concern for any implantable device. One key consideration is reducing
damage to the implantation site by reducing mechanical property mismatch [102, 126, 181]. Tissues in
the peripheral or central nervous system are soft and flexible; Young’s modulus values for nerve under
tension range between 0.5 MPa and 30 MPa, for the central nervous system the magnitudes of these
properties are even lower, with cortical tissue having shear modulus between 0.5 kPa and 10 kPa [393].
To avoid relative micromotion between an interface and soft tissues, materials should be chosen with
elastic moduli as close to these tissues as possible.
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Examples of materials stiffnesses are given in table 5.1. Traditional electrode designs are hard and
stiff, intended for needle-like insertion into the tissue of interest [42]. The most basic electrode design,
a <100 µm microwire, can be made from a variety of metals: stainless steel, gold, platinum alloys,
tungsten and others [57]. Microwires can be formed into arrays [120] using intermediate PCBs and
stacked, in this manner arrays of up to 250 wires have been formed, with electrode pitch of 250 µm
within layers and approximately 500 µm between layers [121,122]. These designs are scalable, however
failure rates of the microwires are 40% over 18 months due to tissue reactions, impedance changes and
other unidentified causes [57, 121]. Thin film interfaces (discussed below) have also been stacked in a
similar manner [123].
Silicon based electrode designs allow for micron and sub-micron features to be manufactured using
repeatable and automated processes [102]. Typically planar photolithography and etching are used,
however techniques including laser cutting and micromachining are also in use. These stiff arrays have
an advantage when recording in 3-dimensions; the relative locations of electrode sites are known due to
the low deformation of the interface. In addition, application-specific integrated circuits (ASICs) can be
included within silicon interfaces using standard chip processing techniques.
The Utah Array and its derivatives are stiff spike arrays formed from >1 mm thick silicon wafers
[105,130,394], intended for cortical application they have been applied to the peripheral nervous system
[135]. The spike arrays are implanted at high speed using a pneumatic pulse [130]. The Michigan
array is formed as a planar design from thin silicon wafers, which can be assembled modularly to create
multi-site arrays [139, 395]. A single Michigan array can have many spike-like shanks along which
multiple electrode sites (4 is typical) are aligned. Other planar arrays have been developed using deep
reactive ion etching and direct laser writing to produce 64 channel systems on an array of <50 µm
diameter shanks allowing control over the final shank thickness [396,397]. Shanks can also be machined
to create thinner tips, requiring lower insertion forces [398]. Instead of machining down into a block
precursor, shank arrays have also been produced by electro-depositing a tapered, solid shank<1 µm over
thin plasma-enhanced chemical vapour deposited silicon nitride and electron beam sputtered platinum
layers [399]. Titanium substrates have also been used as a machinable support for chemical vapour
deposition of silicon devices, which resist buckling on implantation and can therefore be made smaller
than corresponding block silicon neural interfaces [400].
Ceramics and glasses are often used in active implants due to their hermetic properties, they
can resist moisture ingress to electronic components for months to years [392, 401]. New develop-
ments in ceramic feedthroughs have led to High-Temperature Cofired Ceramics (HTCC) which allow
the implementation of large numbers of electrode sites immediately situated on the feedthrough sur-
face [166, 169, 250]. Ceramic materials can also take the place of silicon as a stiff substrate for photo-
patterned electrodes [402].
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Polymeric materials present options for designing soft, flexible implants using cost effective and
varied polymer processing techniques. Electrically active parts of implants must be encapsulated in a
dielectric and this can be achieved simply using polymer moulding [167,403]. Encapsulation can also be
achieved by spin coating or dip coating to form thin layers, which conform to the device. Encapsulation
methods can be modified with sacrificial mould parts, or some encapsulant removal, to leave exposed
electrodes or complex structures [113, 404]. In this manner, using removable nylon filaments wrapped
with metal wires, microchannels of the filament dimension were produced with electrode sites created
by the wrapped wire [146].
5.1.2 Conductive Polymers
Instead of directly interfacing with the nervous system using a hard, stiff metal or alloy, compliant
conductors can be used as coatings or instead of metal tracks in neural interfaces [60, 425]. Elastic
moduli of typically conductive polymers are given in table 5.1. These conductors can be micro-patterned
and electrospun to form controlled topographies [426], the polymers can also be electrodeposited onto
electrode sites with controlled thickness, topography and electrical properties [205]. Metal-silicone
composites have been used to create compliant conductive tracks and electrodes [126].
In addition to reducing the potential harm through relative micromotion, conductive polymers can
reduce electrode impedance by 1 to 3 orders of magnitude [60]. Conductive polymers can also be doped
with bioactive molecules to modify cell reactions in vitro and in vivo, these materials show promise,
however research has yet to demonstrate that these are effective at improving in vivo electrode perform-
ance [426]. Currently conductive polymers are not sufficiently developed for use in long-term devices,
with poor mechanical and electrical stability (some coatings fail after 10 days in vivo) [60,205]. Compli-
ant conductors will not be considered further in this work, but are expect to become useful once current
challenges are overcome.
5.1.3 Thin film electrode arrays
Thin film electrode arrays are one way to increase neural interface compliance; the thin films are typically
flexible and can be designed in a variety of forms depending upon application [427]. The basic thin-film
design principle is presented in fig. 5.1.
Thin-film arrays include the TIME (transverse intrafascicular multichannel electrode) and tf-LIFE
(thin-film longitudinal intrafascicular electrode) [109, 428]. Fabrication of these devices is a wafer pro-
cess, meaning a silicon wafer is used as a substrate. A layer of polyimide is spin coated onto the wafer,
platinum is sputter coated on top of the polyimide, the platinum is coated with another polyimide layer
and the electrode sites are opened by reactive ion etching. This forms structures approximately 10 µm
thick with exposed microelectrodes and track buried within polyimide insulator. The poly-imide used
in this application is formed biphenyl dianhydride (BPDA) and p -phenilene diamine (PPD) precursors
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Table 5.1: Young’s Modulus (E, elastic modulus) values for example neural interface materials and
approximate modulus mismatch with neural tissue. Measurements were cross referenced against Ashby
and Jones, 2005 [405] where possible, to check for inaccuracies, no notable discrepancies were found.
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which are robust due to their low water uptake in vivo.
Thin polyimide layers can be bonded to a substrate to form a penetrating device, polyurethane
cylinders have been used to create a 16 electrode cortical interface [429]. Alternatively stiff substrates
can be included within the thin films to allow for penetration [430, 431]. However, polyimides may be
unsuitable for long-term applications because they adhere poorly to metal layers, causing rapid electrode
failure in a wet environment [427].
An alternative thin-film substrate is parylene-C, a poly(p-xylene chloride) which has been used to
form flexible neural probes [432]. Parylene is USP class-VI approved1, however cracking of coating
layers has been observed in vivo and delamination of parylene-metal bonds can occur in less than a week
in vitro [433, 434]. In addition, although flexible, both parylene-C and polyimide are non-stretchable
[427]. Stretchable, flexible implants would further reduce relative micromotion with tissue by better
mimicking tissue properties.
Thin-film interfaces have also been produced using Benzocyclobutene (BCB) a polymer with very
low water uptake. BCB is typically used as a spin coated dielectric on a silicon backing. Without silicon
BCB has have been used to provide flexibility aiming to reduce relative micromotion [408,435–437]. To
overcome handling issues with BCB, temporary stiffeners (e.g. crystalline glucose) have been used and
show promise [438], this may be applicable to other electrode types.
SU-8 negative photoresist may be advantageous for thin-film interfaces because it can be patterned
to form variable thickness films [439]. The biocompatibility of SU-8 has been demonstrated to a super-
ficial level, however it is not approved for medical devices [440]. Neural implants using SU-8 have been
designed and tested for up to 1 year in rats [142], indicating good neurocompatibility.
Silicones (or PDMS, polydimethylsiloxanes) have been used for a wide range of implants from
catheters and cosmetic prostheses to encapsulants for implanted electronics [187]. Many silicones with
a range of properties have USP class-VI approval and can be easily spin coated to a range of thicknesses.
Silicones are typically flexible and stretchable, this can present problems when coupled with a stiff
metallisation layer: the PDMS looses adhesion, and stretching the weak rubber can lead to tearing or
tracks breaking. Thin reinforcing layers of parylene have been suggested for silicone thin films to absorb
stretching forces [427].
5.1.3.1 The metal foil process
Early silicone based thin-film interfaces were formed by bonding separate sheets or by block moulding
silicone around metal electrodes and then exposing pads [441]. An automated manufacturing process
for smaller scale thin-films using silicone encapsulation was presented by Schuettler et. al. [442, 443],
based on work by Mortimer and by Naples et. al. [444, 445].
1United States Pharmacopoeia plastics designation VI is the most stringent test of biological reactivity in the USP classes. The
class includes in vivo implantation testing for toxicity.
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Figure 5.1: Schematic representation of a thin-film electrode array. Reproduced from [427], with kind
permission from Cambridge University Press.
The process uses thin metal foil instead of sputter coated metallisation, this creates thicker metal
tracks, reducing flexibility, but increasing the choice of metals available. Metal foils are typically 12.5
µm thick, however 5 µm to 25 µm foils can be used to increase flexibility or stability. Metal foils and
silicone rubber layers are laser structured to create metal tracks embedded within silicone encapsulant
and exposed at electrode sites. Any stiff substrate can be used instead of a silicon wafer, glass slides are
commonly used due to reduce costs. The technique has been expanded to form multi-layered devices
whereby more electrodes can be included per area (around 4.5 per mm2). This overcomes one limit-
ation to the number of electrodes by separating electrode tracks in 3-dimensions rather than the usual
2-dimensions of thin-film processes [446]. These arrays have been used in vivo for a variety of applica-
tions including cortical and retinal prostheses [427].
5.1.3.2 Flexible and Stretchable Track Designs
Thin-film designs with unstretchable substrates and designs using straight ribbons of metallisation typ-
ically cannot be elastically extended. Silicones are stretchable elastomers and it is desirable to design a
metallisation layer, which will stretch with the substrate.
Meander shaped tracks have been successfully used with 12.5 µm platinum foils to create structures
that can elongate over 20% before breaking [421]. With foils this comes at the expense of lower strength
and increased track area. This concept is similar to the design of Cooper cable, a coiled structure which
can survive millions of flexion cycles [285, 447].
Alternative methods have been developed for use with sputtered metal layers, previously metal films
fractured at as low as 1% strain and required non-stretchable substrates to prevent breakage [427, 448].
Compressive stresses can be designed into gold sputtered layers creating wrinkles, which allow up to
10% strain before failure [448–450].
Conducting materials designed to stretch have also been tested including metal nano-particle inks,
carbon nanotubes, conductive polymers and graphene layers [425, 451]. The reliability and long term in
vivo performance of these materials must be better characterised to determine whether they are suitable
for implanted neural interfaces. In addition the use of highly compliant designs complicates attachment
to soft tissues, especially in mechanically dynamic structures such as peripheral nerves and care should
be taken during handling and suturing to avoid stress concentrations or unwanted implant deformation
[452].
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5.1.3.3 From Thin Films to 3-Dimensions
To record from many neurons at any one time electrodes should be present at multiple sites within or
around the nerve. For 2-dimensional films (e.g. tf-LIFE) this means inserting one or more flat arrays
within the nerve [428,453]. More precise spatial offsets can be achieved by stacking flat arrays to create
multiple electrode sites in 3-dimensions [395].
Thin films are often rolled to create nerve cuffs. Multi-electrode polyimide cuffs have been designed
to be self curling, by curing on a cylindrical former, or by inducing variable stresses in the substrate
through stretching and spin coating [444, 454, 455]. Flexible films can be rolled to form ring structures
[456] and multilayered coils [149]. By introducing stress to one sheet of PDMS during plasma bonding
silicone cuff electrodes can be designed to self-coil [457].
Stacking flexible 2-dimensional films has been achieved in multiple ways. The metal foil process
has been modified to create small spatial offsets in 3-dimensions [446]. Musick et. al. used plasma
bonding to spatially offset rigid thin films using flexible silicone spacers [458]. This technique has since
been used to develop 3-dimensional flexible thin film stacks with offsets of around 100 µm [459].
5.1.4 Electrode surface roughening
To reduce impedance electrode surface area should be as large as possible, however neural electrodes
should be small to interface with intraneural structures and axons. To overcome this conflict electrodes
can be roughened, increasing the effective surface area while maintaining a small geometric surface area.
Controlled microstructures can be formed on electrode surfaces. Gold nanorods can be created on
flexible substrates using anodised porous alumina templates, these reduce 1kHz electrode impedance
by approximately 25 times, however this requires chip based photolithographic and sputter techniques
[460]. More complex 3-dimensional gold structures can also be created which show promise, however,
in vivo stability of these structures has not been demonstrated [461]. Sputtered platinum, iridium or
iridium oxide films can be used to alter electrode impedance, use of a thin titanium interlayer allows
the deposition of nano-crystalline or nano-granulated surfaces with good electrical properties for both
recording (impedance) and stimulation (charge injection capacity) [455].
Direct current (DC) etching is an effective, simple technique, which increases surface roughness,
this has been shown to almost halve impedance using a +2 V current source [462]. Randomised rough-
ness, achieved using low-current pulsated gold electroplating, can reduce electrode impedance by a factor
of 100 (3 M Ohms to 30 k Ohms) [463]. Laser patterning can also create random roughness on platinum
electrodes using low laser power to ablate only at points of interference, reducing impedance and improv-
ing charge injection properties [390]. Alternatively porous electrodes can be fabricated directly through
a variety of methods with surface areas more than 3.5 times the geometric surface area [391, 464].
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5.1.5 Microchannel Neural Interfaces
To date microchannel neural interfaces have been designed and manufactured using a range of tech-
niques. Work has been carried out on a range of devices at the University of Cambridge, University of
Birmingham and EPFL, Switzerland 2. Single microchannels for in vitro testing can be manufactured
cost and time effectively by hand. Briefly, wire conductors (e.g. gold) are wrapped around a nylon fil-
ament, the filament and wires are encapsulated in silicone and the filament is carefully removed once
the silicone is cured [146]. This technique has also been applied for passive in vivo interfaces, filaments
are spaced using copper grids and encapsulated, removal of the filaments leaves an array of longitudinal
microchannels [113,147]. By embedding microwires within the microchannels an active implant can be
formed [147, 148].
To form active interfaces metallisation is required. Ridged polyimide thin films with integrated
electrode tracks have been developed, these can be plasma treated and rolled to form microchannel
arrays [146, 149, 150]. A 15 µm thick polyimide film is spin coated onto a silicon wafer, followed
by deposition and patterning of a 175 nm thick gold layer. Photosensitive polyimide is spin coated to
form a 5 µm encapsulating layer and electrodes and pads are opened using photolithography. A thick
photosensitive polyimide layer (15 µm to 100 µm) is spin coated and patterned to form microchannels.
These open thin film sheets are then plasma treated and rolled up, to form a coiled interface with an array
of longitudinal microchannels. Problems with sealing the microchannel caps have been encountered and
ongoing research at the University of Birmingham is investigating the use of 10 µm thick PDMS sheets
to fully close and therefore electrically isolate the microchannels [151].
Photo patternable PDMS (PP-PDMS) a photosensitive silicone has been used for the development
of microchannel interfaces [152]. In a thin-film process on a silicon wafer, a release layer is spin coated
followed by thin layer of PDMS. Gold electrodes are evaporated, patterned by a kapton shadow mask.
PP-PDMS was spin coated as a 30 µm thick encapsulant and exposed to UV light through a mask.
Masked areas did not cure and the uncured PP-PDMS could be removed in a solvent bath. Microchannels
were formed separately using an SU-8 mold, and plasma bonded to the thin film electrode sheet [153].
An alternative, thin film, design uses the same basic premise, however a lid is attached to the ridged
microchannels during surgery, avoiding the need to section or rhizotomize nerves [154].
The Georgia Tech Regenerative Electrode (GT-RE), developed at Georgia Tech College of Engin-
eering and Emory School of Medicine is a thin film based device [114, 115, 155]. The design concept
and development of passive electrodes has been presented. Briefly, a 70 µm silicone layer is spin coated
onto glass, silicone is plasma treated and a layer of SU-8 is spin coated. The SU-8 is patterned to form
100 µm by 100 µm microchannels. Finally a second 70 µm silicone layer is plasma bonded to the top of
2Additional work is currently ongoing at the University of Texas–Pan American, this group is not a collaborator of Cam-
bridge/Birmingham/EPFL to the knowledge of the author.
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the microchannels. In an active implant the 70 µm layers would contain patterned gold electrodes. This
forms patterned electrode designs and is promising for the construction of complex microchannel geo-
metries; however, SU-8 is unapproved for medical devices so should be avoided for designs aiming to be
first-in-human. In addition to plasma bonding surface silanisation can be used to significantly improve
bonding strength and better close microchannels [465].
Microchannel neural interface designs listed above are intended for use with tripolar electrode
designs, however different electrode setups can be used. The regenerative microchannel based elec-
trode interface (ReME) is a design developed at the University of North Carolina [157, 158]. Thin-film
techniques are used to spin coat a 10 µm layer of parylene, gold electrodes are patterned onto the polymer
with a titanium interlayer, and further polymer and electrode layers are patterned and pads are opened
using reactive ion etching. Microchannel walls are also patterned from parylene using reactive ion etch-
ing and the channels are sealed using a 10 µm silicone (PDMS) layer. This design includes longitudinal
and radial aligned electrodes, aimed at providing sense and control functions (recording and stimulating)
respectively. The authors suggest this can be created in 2-D or rolled to form a 3-D construct. No in vitro
or in vivo work has been presented with this electrode design, and only in silico numerical simulations
are presented in the most recent publication. In addition, the stresses applied when rolling parylene may
induce cracking, therefore care should be taken to ensure that the electrode design is robust.
5.1.6 Challenges
Current microchannel neural interface manufacturing processes have yet to overcome two limitations.
Firstly, where microchannels are insufficiently sealed the electrical isolation between neighbouring chan-
nels is reduced. This reduces microchannel selectivity and the signal amplitude [51]. Secondly, rolled
and other single layer microchannel neural interfaces have limited numbers of electrodes: the tracks
and interconnects take up lateral space, rolled polyimide interfaces have electrode present in just a few
microchannels (<10%) [51, 150].
5.1.7 Aims and Hypotheses
This chapter describes the manufacture of a microchannel neural interface, see fig. 5.2. The aims of this
chapter are as follows:
• To investigate manufacturing processes for microchannel neural interfaces.
• To improve channel sealing and electrode number in microchannel neural interfaces.
• To assess the resulting interface designs and reduce electrode impedances.
It was hypothesised that:
• Direct current etching will significantly reduce electrode impedance and this effect will be apparent
after in vitro and in vivo testing.
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Figure 5.2: A diagram describing the approximate manufacturing aim for a microchannel neural inter-
face.
5.2 Methodology
5.2.1 Microchannel Neural Interface Design
5.2.1.1 3D template method
The first prototype designs were developed using the methods developed by Lacour et. al. and FitzGerald
et. al. to develop silicone implants [51, 113].
Nylon monofilament (100 µm to 150 µm) was suspended between TEM grids (Agar Scientific, UK)
with grid sizes from between 100 and 50 lines-per-inch. This 3-dimensional template could be used to
create a passive microchannel device or metallisation could be introduced using wire wrapped around the
nylon filament. The templates were embedded in CF3-2186 silicone elastomer (NuSil) and Sylgard 184
(Dow Corning) and cured for 24 hours at 50◦C. The nylon monofilament was removed and the electrodes
were dissected into single–electrode blocks.
This method was found to be suitable for creating passive microchannel devices, however there are
a number of limitations when wire is introduced. If the wire is wrapped around the filament too tightly
it may be pulled into the channel when the filament is removed. Wires, which were not wrapped tightly
enough did not consistently contact the channel, resulting in variable exposed surface area and variable
impedance. To introduce an electrode to the centre of the array the wire must exit between the filaments
forming other channels, if the insulation is damaged and the wire touches an adjacent channel isolation
can be lost.
To avoid this limitation the inter-channel spacing was increased, however this reduced the transpar-
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ency of the electrode.
Prototype microchannel interfaces were prepared using 100 µm diameter copper wire (enamel
coated). The following method were used to remove the enamel coating: mechanical removal with
scalpel; flaming in a Bunsen flame for 30 seconds; 6M sulphuric acid for 48 hours at room temperature;
18M sulphuric acid for 5 minutes at 60◦C. The wires were examined using scanning electron microscopy.
Single microchannel interfaces were prepared with 2 wire electrodes, 5 mm inter-electrode distance,
wire coiled twice per electrode, on 150 µm nylon monofilament. The electrodes were embedded in CF3-
2186 silicone elastomer (NuSil) and cured for 24 hours at 50◦C. The nylon monofilament was removed
and the electrodes were disected into single–electrode blocks.
In order to test the inter-channel isolation (and intra-channel impedances) 4 channel electrodes were
produced using a 3D templating process. 150 µm nylon monofilament was arranged between 75 Grid
TEM Grids (Agar Scientific, UK). The grid holes were filled alternately. Electrodes were prepared with
2 wire electrodes, 5 mm inter-electrode distance, wire coiled four times per electrode, with 100 µm
diameter copper wire stripped using 18M sulphuric acid. The electrodes were embedded in CF3-2186
silicone elastomer and cured.
The microchannels were filled with 0.9% saline in distilled H2O and impedance values were meas-
ured using an EVAL–AD5934EBZ (Analog Devices) (see section 5.2.3). Impedance was measured
between two electrode sites within the same microchannel, or electrodes in separate microchannels.
5.2.1.2 Metal negative method
Due to limitations on miniaturisation an alternative electrode design was developed. This alternative
design aimed to achieve greater automation and reduce production times for implants. The design is
based on a coiled polyimide interface developed and tested previously [51, 149]. The manufacture of
the polyimide microchannel electrodes is cost prohibitive due to the manufacturing techniques used,
therefore an alternative method was developed which could be carried out with the available equipment
using silicone rather than polyimide encapsulants. This process is based upon the metal foil process
previously described [442, 443], the process is summarised in fig. 5.3.
A Laserval Violino-2 1064 nm laser was used with a spot size of 30 µm. Laservall Smartist 4.1
software on Windows XP was used to control the laser system. Laser power was 10 W average and 40
kW maximum peak power.
Briefly, grooves were laser written into an Aluminium substrate. To create a release layer Haemosol
detergent was used. The substrate was ultrasonicated in a saturated detergent in distilled water solution.
The substrate was dried by repeated heating (50◦C) and vacuum (50 mbar) cycles.
Silicone (Sylgard 184, Dow Corning) was spin coated over the substrate to a thickness of 30 µm
and cured until tacky for 1 hour at 80◦C. Pad windows were opened using direct laser writing. Platinum
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or stainless steel foil (Advent Research Materials, UK) was placed over the silicone, air was removed
under a 50 mbar vacuum for 30 seconds. The foil was patterned by laser cutting and excess was removed
manually using. A final layer of silicone encapsulant (30 µm) was spin coated and cured (1 hour at
150◦C).
To remove the interface from the substrate the substrate was placed in distilled water for at least
30 minutes. Gentle manipulation was used to remove the ridged microchannel interface. The interface
could then be plasma treated using an air plasma for 2 minutes at 2 Torr (forward power 50W, reflected
power 10W) and placed in an oven at 80◦C to bond once coiled.
Appropriate laser parameters for forming grooves on aluminium were determined from 77 vari-
ant settings (7 different power settings and 11 variations of number and spacing of lasered lines, see.
tables 5.2 and 5.3). The chosen method created a repeatable ridge of 130 µm height and 75 µm width
at the base. The chosen parameters are as follows: 2 parallel lines 10 µm apart; 80% power; 10,000 shot
frequency; 100 speed; 1 pass; and 100 repeats. Repeats were achieved by duplicating the line (in a .dxf
file) 100 times.
Laser Setting Power (%) Shot Freq. (Hz) Speed (mm/min) Passes n (lines) Passages
1 40 10000 50 1 100 1
2 40 10000 100 1 100 1
3 40 5000 50 1 100 1
4 40 10000 50 1 100 2
5 60 10000 50 1 100 1
6 40 10000 200 1 100 1
7 80 10000 100 1 100 1
Table 5.2: Laser parameters for metal negative method. Passes, n and passages all have the same effect
of laser etching the same line multiple times; however, the etching order varies, n was chosen to reduce
dust damage from etching adjacent lines.
5.2.1.3 Plasma bonding method
Due to the high failure rate of interfaces produced by the metal negative method an alternative design was
developed. This was based on a coiled polyimide interface developed and tested previously [51, 149].
Interfaces were formed in two parts and then joined by plasma bonding. The two parts will be
referred to as the electrode layer (Part A), and the microchannel layer (Part B). The process is summarised
in fig. 5.4.
First a layer of PSS (561223 Sigma, UK) was spin coated onto a 75 mm by 25 mm glass slide.
Slides were spun at 200 rpm for 15 seconds and 2000 rpm for 10 seconds. Slides were then placed
in an oven at 60◦C for 15 minutes to dry. Silicone (Sylgard 184) was mixed at the standard 10:1 (w:w)
ratio and 0.25 parts black pigment (Med-4800-2, Silicone-Polymers) was added to make the silicone less
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Figure 5.3: An overview of microchannel neural interface manufacture by the metal negative method.
1. Grooved aluminium negative created. 2. Silicone spin coated onto negative and pads opened. 3.
Stainless steel foil placed on spin coated silicone layer. 4. Pads and electrodes patterned using laser
cutter and excess foil removed. 5. Silicone spin coated onto foil. 6. Negative removed leaving open
electrode between ridges. Not to scale.
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Variation Lines per groove Line Spacing (µm) Groove Spacing (µm)
1 2 10 200
2 3 10 200
3 4 10 200
4 5 10 200
5 2 20 200
6 3 20 200
7 4 20 200
8 1 0 200
9 2 30 200
10 3 30 200
11 4 30 200
Table 5.3: Groove designs for metal negative method.
Figure 5.4: An overview of microchannel neural interface manufacture by plasma bonding. 1. Stainless
steel foil placed on a spin coated silicone layer. 2. Foil patterned using a laser cutter and excess removed.
3. Silicone spin coated onto patterned foil. 4. Pads and electrodes patterned using laser cutter and
silicone removed. This is part A. 5. Microchannels patterned using laser cutter and silicone removed.
This is part B. 6. Electrode layer (Part A) and microchannel layer (Part B) plasma bonded. Not to scale.
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transparent to laser light and therefore easier to laser pattern. Silicone was speed mixed for 2 minutes at
2500 rpm. Silicone was degassed at 30 mbar in a vacuum centrifuge for 1 minute or until bubbles were
no longer visible.
Part A was formed as follows: Silicone was spin coated onto PSS coated slides at 1000 rpm for 45
seconds. The slides were placed in an oven at 60◦C for 1 hour to part cure. Metal foil, 12.5 µm stainless
steel or platinum (Advent Research Materials, UK), was cut to size using an Nd:YAG laser cutter. Metal
foil was cleaned with isopropyl alcohol. Part cured silicone was removed from the oven and allowed
to cool for 5 minutes. Metal foil was placed onto the silicone avoiding air bubble formation. Any air
bubbles were removed under 50 mbar vacuum for 30 seconds. Electrode designs were cut into the foil
using an Nd:YAG laser cutter and excess metal foil was removed. A second layer of silicone was spin
coated onto the patterned foil at 1000 rpm for 45 seconds. Slides were cured in an over at 100◦C for
at least 1 hour. Electrode pads were patterned in the silicone using an Nd:YAG laser cutter. Silicone
covering the pads was removed. Slides were returned for the oven for at least 1 hour at 100◦C to fully
cure.
Part B was formed as follows: Silicone was spin coated onto PSS coated slides at 500 rpm for 45
seconds. The slides were placed in an oven at 100◦C for at least 1 hour to cure. Microchannels were
patterned in the silicone using an Nd:YAG laser cutter. Silicone strips remaining in the microchannels
were removed. Slides were returned for the oven for at least 1 hour at 100◦C to fully cure.
Part A and part B were bonded as follows: Both parts were cleaned with isopropyl alcohol and air
dried. Excess silicone surrounding the patterned metal or microchannel areas was removed to within 5
mm of the area of interest. The surfaces for bonding remained uppermost on the glass slide. Slides were
placed in a plasma oven. Silicone surfaces were plasma treated using air plasma for 2 minutes at 2 Torr,
forward power was 50W and reflected power was 10W. Samples were removed from the plasma oven
and immediately aligned and bonded. At least 1 kg force was applied to deform the surfaces and ensure
adhesion across the entire sample. Samples were placed in an oven at 80◦C for at least 1 hour to bond.
To lift samples off the substrate slides were placed in distilled water for 30 minutes to dissolve the PSS.
Gentle rocking typically removed the glass slide from part B, leaving parts A and B adhered to only one
glass slide. Samples could be removed full by longer immersion in distilled water.
Prior to coiling microchannel neural interfaces were cleaned with isopropyl alcohol and air dried.
Interfaces were placed with part B uppermost and were plasma treated using an air plasma for 2 minutes
at 2 Torr, forward power was 50W and reflected power was 10W. Samples were removed from the
plasma oven and immediately coiled and bonded. A clamp was used to hold the coil in place and coils
were placed in an oven at 80◦C for at least 1 hour to bond.
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5.2.1.4 Stacking method
Due to difficulties rolling interfaces with patterned platinum or stainless steel foil electrodes an alternat-
ive design was developed. This design is based on the plasma bonding method but sections are stacked
and bonded to form a 3D structure. The process is summarised in fig. 5.5.
Parts A and B were formed and bonded as above to create multiple small microchannel sections.
Two bonded sections were placed on PTFE slides, one with part A uppermost, the other with part
B uppermost. Slides were placed in a plasma oven. Silicone surfaces were plasma treated using an air
plasma for 2 minutes at 2 Torr, forward power was 50W and reflected power was 10W.
Samples were removed from the plasma oven and immediately aligned and bonded. At least 1 kg
force was applied to deform the surfaces and ensure adhesion across the entire sample. Samples were
placed in an oven at 80◦C for at least 1 hour to bond.
5.2.2 Connecting to Microchannel Neural Interfaces
To form an electrical connection between the interfaces’ contact pads and recording or stimulating equip-
ment, a spring loaded connector was used. Crosscut sprung pin probes (RS Components, UK) were
arrayed on a 2 mm pitch to match the connection pad design on the interface and attached to a Perspex
dowel. Before connection a stiff layer was placed underneath the interface, e.g. a ruler or a glass slide,
and the pin probes were pressed gently into contact with the interface.
5.2.3 Impedance Reduction by Electroetching
To reduce electrode impedance the surface area was increased, and oxidised layers were removed, by
electro-etching.
Impedance of stacked MNI electrodes was analysed in 0.9% saline using a Wayne Kerr 6500B
Precision Impedance Analyser (Wayne Kerr Electronics, UK). A 50 mV alternating source was used,
with a frequency sweep from 20 Hz to 1 MHz composed of 200 data points.
Additional in vitro impedance measurements for validation (not reported) were made using an
EVAL–AD5934EBZ (Analog Devices), 1kHz-77kHz, 0.4 Vp-p, 100kΩ calibration resistor. The board
was modified to include a switchable AD820ARZ operational amplifier (Analog Devices) with a signal
attenuation of 1/4, this allows small impedance values (ZUNKNOWN ) of <500Ω to be measured. This
increases the range of the impedance monitor to 100Ω <ZUNKNOWN <1MΩ. The standard frequency
range for the EVAL–AD5934EBZ is 103–105Hz.
Electrode impedance and phase was recorded before etching. Electrodes were placed in 0.9% saline
with a large (approximately 4 cm2) stainless steel ground electrode. The saline was degassed under
vacuum at 25 mbar for 5 minutes, followed by ultrasonication for 1 minute, and remaining bubbles on or
around the electrodes were removed using a fine tipped needle. A single electrode was connected to the
positive (+ 4 V DC) line of a voltage controlled power supply. The ground electrode was connected to the
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Figure 5.5: An overview of microchannel neural interface manufacture by stacking. Steps 1 to 6 are
replicated from the plasma bonding method. 1. Stainless steel foil placed on a spin coated silicone layer.
2. Foil patterned using a laser cutter and excess removed. 3. Silicone spin coated onto patterned foil. 4.
Pads and electrodes patterned using laser cutter and silicone removed. This is part A. 5. Microchannels
patterned using laser cutter and silicone removed. This is part B. 6. Electrode layer (Part A) and mi-
crochannel layer (Part B) plasma bonded. This is a microchannel section. 7. Two microchannel sections
are plasma bonded, part A to part B. This is repeated to form a stack. Not to scale.
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ground (0 V DC) and negative lines of a voltage controlled power supply. Current was passed through
the electrode setup for 5 minutes. The solution was refreshed (0.9% saline) and electrode impedance and
phase were recorded. Samples were placed in fresh 0.9% saline for 24 hours, after which the saline was
degassed under vacuum at 25 mbar for 5 minutes and electrode impedance and phase was recorded.
5.3 Results
5.3.1 3D template method
The 3D template method was used successfully to create microchannel structures without electrodes
(figs. 5.6a and 5.6b). However a range of challenges were encountered.
High density designs typically had non-uniform microchannel alignment, and occasionally nylon
filaments touched creating windows between microchannels (figs. 5.6c and 5.6d). In addition, high
density designs trapped air between the nylon, this was mostly removed using a vacuum centrifuge,
however degasing was limited by the fragility of the design (fig. 5.6d). The PDMS tended to adhere
to the nylon filaments and occasionally structures would tear when the filament was removed, this was
particularly common for high channel density designs.
Mechanical removal with a scalpel was chosen to remove the enamel coating from the wire for pro-
totype interfaces. Electrical isolation between channels was demonstrated for low microchannel density
designs. However, when microchannel density was increased wires tended to be exposed to multiple
microchannels and electrical isolation could not be guaranteed.
A key advantage of this design was the low setup cost, however the process could not be carried out
in batches and was very time intensive.
5.3.2 Metal negative method
The metal negative method was used to successfully create microchannel structures without electrodes.
Microchannel structures with electrodes were formed (figs. 5.7a and 5.7b), however a number of chal-
lenges were encountered.
The first challenge was removal of the microchannel structures from the template. Haemosol sur-
factant was used to provide a release layer, however electrode removal was not consistent and the silicone
often tore. Alternative substrates were considered, in particular a black medical grade PTFE would be
suitable, allowing laser cutting while ensuring silicone could be readily removed, due to time constraints
no alternative materials could be tested.
In addition, introducing electrode pads into the design was a challenge. The chosen method required
first spin coating the microchannel layer, then laser cutting pads, followed by applying and laser cutting
the metal foil layer. When applying the final silicone layer care was taken to prevent silicone passing
into the pads. Furthermore the pads were created while the silicone was still tacky (in order for the metal
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(a) Light micrograph of the 3D templating method.
TEM grids and nylon filaments are visible.
(b) Scanning electron micrograph of 3D templated
microchannels formed in PDMS.
(c) Scanning electron micrograph of 3D templated
microchannels formed in PDMS. Non-uniform
channel arrangement can be seen.
(d) Scanning electron micrograph of 3D templated
microchannels formed in PDMS. Pores formed by
trapped air can be seen in the centre of the channel
array. Channels to the lower right are occulded by
non-removed nylon filaments.
Figure 5.6: Light micrographs and scanning electron micrographs of processing steps and results in the
3D templating method.
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foil to stick), therefore some silicone did flow into the pads occluding them in some cases.
(a) Light micrograph of metal negative method mi-
crochannel interface: base view. Ridged microchan-
nels can be clearly seen below the electrode layer.
(b) Light micrograph of metal negative method mi-
crochannel interface: top view. Ridged microchan-
nels can be clearly seen and electrode holes are vis-
ible. A slight misalignment is present.
Figure 5.7: Light micrographs of a microchannel interface formed by the metal negative method.
5.3.2.1 The Effect of Laser Parameters on Groove Profile
Laser parameters (table 5.2) and groove designs (table 5.3) were varied to find a suitable groove profile
in the metal template. The resulting sizes are plotted in fig. 5.8. The chosen design used laser parameter
1 and groove design 7. This provided consistent groove profiles in the size range required. Groove height
was 130 µm and groove base width was 75 µm. Grooves formed a triangular cross section which could
be readily imaged by cutting across the ridges and laying against a glass slide end-on, see fig. 5.9a.
5.3.3 Plasma bonding method
Passive, non-electroded microchannel neural interfaces were successfully manufactured using the plasma
bonding method. However, a few challenges had to be overcome. Pressure and heat were required to
ensure strong bonding between plasma treated surfaces. 1 kg was found to be insufficient, therefore
mini-G-clamps were used to hold parts A and B together in an 80◦C dry oven.
Forming electrode containing microchannel neural interfaces was partly successful figs. 5.10a
and 5.10b. A challenge not overcome was the stiffness of the metal foil layer. The choice of 12.5
µm stainless steel foil created a flexible, but elastic electrode sheet, which could not be permanently
deformed. A malleable metal foil which deforms plastically under stress would be more suitable, for
example gold foils are available down to 1 µm thickness. At this thickness issues with handling would
be encountered.
The interfaces formed had a high electrode density, with electrodes present in 50% of microchannels
fig. 5.10a. This was achieved by using thin, <50µm, tracks and by connecting the ground electrodes in
an alternating pattern.
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Figure 5.8: Templated silicone ridges formed using laser cutting of 3 mm Aluminium sheet. The chosen
parameters are indicated using an arrow.
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(a) Silicone ridge examples templated from grooves
using laser parameter 1 and groove design 7.
(b) Profile of microchannels produced by cutting sil-
icone. 5X image by scanning interferometry. Mi-
crochannels are 150 µm depth, 200 µm width.
Figure 5.9: Microchannel neural interface profiles, in cross section or by white light vertical scanning
interferometry.
(a) Plasma bonded microchannel neural interface.
6 electroded channels (18 electrodes) are shown.
Electrodes to the right of the image have had excess
silicone removed.
(b) Plasma bonded microchannel neural interface.
End view of plasma bonded microchannels.
Figure 5.10: Light micrographs of a microchannel neural interface formed by the plasma bonding
method.
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5.3.4 Stacking Method
To overcome the problems with coiling electrodes the stacking method was developed. Microchannel
neural interfaces were successfully manufactured using the stacking method figs. 5.11g, 5.11h, 5.12a
and 5.12b. Additional processing steps are shown in figs. 5.11a to 5.11f.
The microchannel dimensions were determined by the equipment available and handling of the
finished neural interface. 200 µm diameter channels were chosen because at this width the PDMS could
be reliably cut using the laser without causing the separating ridges to fail. The addition of black pigment
to the PDMS was key to accurately cutting silicone to a depth of >50 µm. fig. 5.9b shows that channel
walls are uniform at 150 µm cutting depth. Once stacked the microchannels have a trapezoid cross
section, this is created partly by the laser (a wider heat affected zone is present at the silicone surface)
and partly by deformation due to the pressure applied during plasma bonding.
5.3.5 Impedance Reduction by Electroetching
DC etching significantly reduced electrode impedance from 88.9±66.9 kΩ to 27.2±19.8 kΩ (p<0.001).
Impedance did not significantly increase over the 24 hours after DC etching (p = 0.766), with final
impedance values of 29.5±21.0 kΩ.
Surface roughness measurement by vertical scanning interferometry showed a significant increase
in electrode pad roughness with DC etching (from 0.248 ± 0.0579 µm Ra to 0.575 ± 0.483 µm Ra, p =
0.009). After 24 hours there was no significant change in electrode roughness compared with immedi-
ately following DC etch (0.6117 ± 0.534 µm Ra, p = 1.00).
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(a) Laser cut foil showing three patterned electrodes
and through-holes. Excess foil not removed.
(b) Laser cut foil showing three patterned electrodes
and through-holes. Excess foil removed.
(c) Laser cut silicone electrode openings over stain-
less steel foil electrodes. A slight misalignment is
present. Excess silicone not removed.
(d) Laser cut silicone electrode openings over stain-
less steel foil electrodes. A slight misalignment is
present. Excess silicone removed. This is a com-
plete Part A.
(e) Laser cut silicone microchannels. Excess silic-
one not removed.
(f) Laser cut silicone microchannels. Excess silic-
one removed. This is a complete Part B.
(g) A stacked microchannel interface with the up-
permost microchannel layer exposed. A second set
of electrode tracks, in another microchannel layer,
can be seen to the right.
(h) A stacked microchannel interface in cross sec-
tion with two microchannel layers. The uppermost
layer is uncovered.
Figure 5.11: Light micrographs of processing steps in the stacking method.
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(a) A stacked microchannel neural interface. Over-
sized connection pads and silicone tubing for suture
can be seen. 20x magnification.
(b) A stacked microchannel neural interface in cross
section with 4 microchannel layers. 50x magnifica-
tion.
Figure 5.12: Light micrographs of a microchannel neural interface produced using the stacking method.
Images taken after in vivo study showing some adherent tissue (white/brown).
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5.4 Discussion
5.4.1 Microchannel Neural Interface Design
5.4.1.1 3D template method
The 3D template method has been used successfully in the past, and in this work, to create passive
microchannel neural interfaces. The addition of electrodes is simple in a single microchannel design,
and has been applied for in vitro testing [146]. However, including electrodes in a multi-microchannel
design is a challenge, which was not solved in this work.
This manufacturing technique has been applied to regular nerve guidance conduit designs. Longit-
udinal sacrificial fibres have been used to create large diameter microchannels (410 µm) within cross-
linked collagen gels [338,466]. These designs may be beneficial for nerve regeneration by guiding axon
structure in the absence of a normal neural tube or autograft.
5.4.1.2 Metal negative method
The metal negative method was used successfully in this work to create passive microchannel neural
interfaces. The first challenge in this method was the creation of a consistent microchannel profile,
which was accomplished in an aluminium substrate. Normal substrates for PDMS spin coating were not
suitable for laser cutting: medical-grade PTFE was typically white or clear and could not be cut with the
laser. Black PTFE may be a suitable alternative and should be tested.
Using black PTFE would help overcome the major challenge of this design, removing the finished
interfaces from the substrate. Because the PDMS is very flexible, and there is a large surface area contact
between the substrate and the interface, removal is difficult. A surfactant based removal layer helped,
however no consistent method was found. In addition, introducing metal tracks to the PDMS meant that
the manipulation required to remove the interface involved bending or damaging the tracks. This method
could be improved with alternative substrates.
5.4.1.3 Plasma bonding method
The plasma bonding method produced consistent microchannel designs in a batch process. However, the
chosen materials were unsuitable for rolling into a coiled design. Stainless steel foil is elastic (springy)
and will not consistently deform to allow the microchannel interface to be plasma bonded.
Despite this an alternative track-layer material may make the plasma bonding method most suitable
to microchannel manufacture. By creating a separate microchannel layer, the thin film electrode layer
can be manufactured using any method which need not be depth dependent. In addition, alternative
materials could be used, for example combining a polyimide electrode layer with a PDMS microchannel
layer will combine the advantages of photolithography and thin-film metal processing from polyimide
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with the stiffness advantages of PDMS.
This method demonstrated a high electrode density (electrodes in 50% of microchannels), using
thin tracks and an alternating pattern of connected ground electrodes. The alternating ground electrode
design may be useful for determining whether adjacent microchannels are electrically isolated; however,
this could not be tested in this case because the interfaces were not coiled and bonded.
5.4.1.4 Stacking method
The stacking method produced consistent microchannel interfaces in a batch process. The main limita-
tion was the minimum workable dimensions. Cutting thick PDMS using a laser created a large heat af-
fected zone, therefore to maintain the microchannel structure channels of 200 µm diameter were chosen.
This could be improved by using a laser with a smaller spot size or by further optimising the laser
parameters. For thinner silicone smaller size structures can be laser cut consistently, for example the
electrode width is typically 80 µm.
Plasma bonding the layers required the surfaces to be in intimate contact, this was achieved using
mini g-clamps to press surfaces together. These forces cannot be applied to coiled interface designs, and
therefore channel sealing can be poor [51]. In this work, once suitable plasma bonding parameters had
been chosen, poor microchannel sealing was not observed. In addition, where poor sealing is present
this can be seen under a light microscope following the bonding of one or more microchannel layers and
the layer can be rejected.
By stacking electrode layers, the number of electrode containing microchannels is less limited by
space compared with a long coil design. This will allow for more channels to include electrodes, up to
50% has been demonstrated in a single layer fig. 5.10a. In this work this advantage was not exploited and
layers with electrodes in 20% of microchannels (one of five) where used. To introduce more electrodes a
stackable or staggered interconnect is needed, this was not investigated in this work, however, techniques
presented in the literature could be adapted for use with a stacked design [150, 467–469].
The stacking method lends itself to the introduction of alternative, stiff materials, such as silicon
integrated circuits. Circuits could be used as the electrode layer in a microchannel design, allowing the
introduction of recording or stimulating circuitry at the electrode site, and to multiplex signals, over-
coming problems with large interconnects [personal correspondence]. Stacking also enables the use of
more complex microchannel designs, bifurcating microchannels have been used to direct regenerating
axons into channels of 20 µm diameter, with potential benefits in selectivity and action potential ampli-
fication [470].
5.4.2 Materials choice
The chosen materials, Sylgard 184 PDMS and 316 Stainless Steel foil are highly suited to prototyping
using the manufacturing processes described above. However, for clinical applications alternative ma-
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terials should be chosen. Previous work on microchannel interfaces has used Sylgard 184 [113], and it is
commonly used for microfluidics applications [471]. For nanometre scale features Sylgard 184 may not
be suitable [471], however this work concerned features >10 µm, therefore Sylgard 184 was sufficient.
A medical grade silicone (e.g. MED-1000, NuSil) should be used instead of the industrial PDMS for
clinical applications.
Stainless Steel was a suitable electrode metal in this case. To lower electrode impedance platinum
or platinum/iridium could be used [472], however the cost implications mean that stainless steel is still an
economical alternative. In this study interface designs were limited by equipment cost and availability.
For human applications, or long term in vivo applications alternative electrode materials should be con-
sidered. Platinum foil is available and has been used for electrode construction in the metal foil process
similar to that described in this work. In clinical applications implant cost is likely to be a small portion
of the total cost per patient, for example surgery and rehabilitation would incur high staffing costs.
5.4.3 Impedance Reduction by Electroetching
A reduction in electrode impedance was demonstrated using DC electrode etching. This can be ex-
plained by the increase in electrode surface roughness observed. The reduction in impedance (of more
than 3×) agrees with previous research demonstrating impedance reduction with electrode roughen-
ing [390, 391, 462–464]. Increased roughness can be considered similar to increased total surface area
(increased surface index), therefore a greater area is available for charge transfer at the electrode electro-
lyte interface.
5.4.4 Conclusions
This chapter presented manufacturing techniques for microchannel neural interfaces. Microchannel
neural interfaces were successfully designed and manufactured using a range of techniques. This chapter
presented 4 techniques in progression from least to most successful. It can be concluded that, of the tech-
niques tested in this chapter, the stacking method is most suited to microchannel electrode manufacture.
Alternative techniques, such as the plasma bonding method, could be improved by using alternative
materials or alternative manufacturing equipment.
It is proposed that microchannel neural interfaces produced by the stacking method will be suitable
for in vivo testing and that improvements on the designs presented will allow microchannel neural in-
terfaces to undergo clinical trials in patients for prosthesis control. In vivo tests of these interfaces will
be presented in chapter 6, where additional modifications are made using microchannel protein coatings
developed in chapter 3 of this thesis.
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Chapter 6
In Vivo testing of Microchannel Neural
Interfaces
6.1 Introduction and Hypotheses
The long term performance of neural interfaces depends upon integration with axons and the mainten-
ance of that connection. This is essentially associated with the biology at the interface and for that
reason assessment of a regenerative neural interface must be carried out in vivo to determine whether
the derived signals are appropriate for clinical applications. Work presented previously has shown that
in vitro neurocompatibility and neurite outgrowth can be enhanced using basement membrane protein
coatings (Chapter 3). The microchannel neural interface developed in chapter 5 of this thesis requires
neural regeneration for it to function as a neural interface, therefore the implant must be tested in an
animal model of neural regeneration. In addition, basement membrane protein coatings should be tested
in vivo to determine whether they improve regeneration within microchannels.
6.1.1 Neural Interfaces In Vivo
Many neural interfaces are primarily designed for cortical implantation (e.g. Utah arrays) and, therefore,
the cortical response to implanted devices has been studied extensively [57, 80, 98, 133, 134, 473–476].
This thesis focuses on applications in the peripheral nervous system, where implantation also causes
unavoidable injury [4, 55, 58, 103, 254]. In vivo tests have tried to assess the extent of this injury and
investigate strategies to minimise it.
6.1.1.1 Clinical In Vivo Studies
Implantable peripheral nerve interfaces have been in use clinically for functional electrical stimulation
since the 1970’s (with pioneering experiments in the 1960’s) [87, 88, 477], and have demonstrated im-
pressive selectivity over individual muscles over years of testing [478,479]. However, the use of invasive
interfaces only entered use for dexterous upper limb prosthesis control in the previous decade. The first
reported implantation of a microelectrode array (Utah array) in a human subject was on March 14th,
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2002 [131, 132, 480]. Over 96 days recording and stimulation of the median nerve of the left hand was
carried out. Control of a wheelchair and an articulated hand with sensory (grip force) feedback were
demonstrated. A percutaneous wire bundle was used to transmit signals to a control module, the per-
cutaneous site was closely monitored and no infection was observed. Over the course of the study the
connection wires failed due to fatigue and following explantation fibrosis of the array was observed. No
functional neural damage was observed over the course of the experiment. A human volunteer was used
for the study and the nerve could not be examined histologically for injury which may not have been
apparent on functional assessment, however no evidence of neural damage was reported after removal of
the array.
Subsequently short term human trials of selective neural interfaces have substantially increased.
Longitudinally implanted intra-fascicular electrodes (LIFEs) and transverse intra-fascicular mul-
tichannel electrodes (TIMEs) have been used in trials with upper limb amputees and have demonstrated
the survival of motor and sensory function many years after limb-loss [481, 482]. In short term experi-
ments graded motor and sensory signals have been demonstrated [100,481], allowing patients to control
grip force in order to hold soft or fragile objects [124]. These studies have been extended up to four
weeks [453, 483], with a decay in efficacy after only 10 days and potentially more serious damage or
performance reduction in the long term (not yet tested [484]). Ongoing research is investigating the use
of TIME interfaces to treat phantom limb pain [485].
Single channel intrafascicular wire interfaces have been implanted into all major nerves of an am-
putee patient’s upper limb (radial, ulnar and median) [486]. During a short-term (<1 day) trial 6 separate
interfaces were implanted into the three nerves and 32 nerve activation patterns, controlling 6 different
movements, were identified. However, a similar study showed low accuracy in predicting intended
movements (<2/3 movements predicted correctly) making the system unsuitable for use outside labor-
atory testing [487].
Longer-term trials are currently ongoing. Nerve cuffs are more common for long term use with
upper limb prostheses, where trials have investigated the use of cuffs for sensory feedback. Controlling
stimulation intensity and frequency allows the area and strength of the sensation to be varied [117]. Nerve
cuffs for sensory feedback have been combined with implanted muscle interfaces for prosthetic control
and a bone-anchored transcutaneous interface to allow long-term bi-directional communication with a
prosthesis [233]. This hybid design has also been proposed for use with LIFE interfaces alongside EMG
or body-powered control [482]. Permanent surgical interventions have also been investigated: targeted
sensory reinnervation overcomes issues with selectively stimulating small nerve fascicles by re-routing
them to cutaneous nerves, creating a hand map on the skin of a patient [232].
Following amputation, and the loss of afferent and efferent pathways to a limb, the central and peri-
pheral nervous systems reorganise, this reorganisation is a form of neuroplasticity. These neurological
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changes may provide benefits and challenges for neuro-prosthetic control [488]. Neuroplasticity can
lead to phantom limb pain and other harmful changes; however, it also allows the use of a prosthesis
as a rehabilitation tool. Providing motor control and sensory feedback can retrain the nervous system
towards embodiment and function use of prosthesis [489].
6.1.1.2 Experimental In Vivo Studies
Prior to clinical studies many neural interfaces have been tested in animal models1. These models allow
problems with peripheral nerve interfaces to be overcome before moving to large (or single case) clinical
trials.
Novel cuff designs with increased numbers of electrodes [490,491] or with alternative architectures
[116, 118] have been tested in feline and rat nerves. Promising results with fascicle selectivity from
multi-electrode cuffs have led to their use for sensory feedback for human patients. However, some
designs cause nerve damage in animal trials and have therefore not reached clinical tests.
Utah arrays have been tested in animal models in rats and cats over the short (<1 day) and long
term (weeks to months) [130,135,136]. The arrays cause axonal damage to rat sciatic nerve which led to
gait changes; however, recovery has been demonstrated over 8 weeks in vivo [135]. Macrophage activity
near the implants and loss in muscle signal strength have been observed [135, 136]. Importantly, studies
in cat sciatic nerve showed that surgical technique was critical for interface function, with damage at
implantation causing both acute and chronic changes: axons can regenerate following this damage, and
following implantation it is important that undamaged fascicles remain normal [106, 137]. The Utah
array requires fast pneumatic implantation into soft tissues to reduce elastic deformation, this can be
difficult to align correctly prior to insertion, although the use of stereotactic operating equipment can
improve accuracy [492]. Utah arrays have been shown to have fascicle selectivity, recruiting individual
muscles on sciatic nerve stimulation [493].
TIME and LIFE electrodes show promise in rat sciatic nerve studies, with only mild foreign body
reactions occurring [108, 125, 494]. This may be due to the small size and flexibility of these thin film
designs. Transverse implantation may damage more nerve fascicles; however, in a porcine model it
has been shown to provide more selective stimulation and recruitment, an example of the compromise
between invasiveness and selectivity [55, 79, 110].
Regenerative sieve interfaces have been tested in rat sciatic nerve [111, 112]. Axons regenerate;
however interfaces with small open areas restrict axon number and size. In some cases the implants can
fail over 6 to 12 months, due to micromotion and subsequent fibrotic restriction damaging axons as they
pass through the small diameter sieve holes [112]. More open regenerative scaffolds with linear aligned
fibres reduce the disruption to rat sciatic nerve regeneration; however these designs only capture signals
1This is almost always the case currently; however, early research or small changes to current clinical designs sometimes avoid
this step.
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from a small subset of axons [114].
6.1.1.3 The Microchannel Neural Interface In Vivo
Microchannel neural interfaces were first tested in vitro and in silico, demonstrating their usefulness for
action potential amplification [59, 144, 146, 149, 495]. Advances have since been made in vitro [145].
More importantly for clinical applications, in vivo testing has demonstrated that axons regenerate through
MNIs formed from a variety of materials [51, 113, 147, 148, 153, 154, 156, 470]; however there are chal-
lenges with developing highly selective microchannel devices.
The rat model has been used for all the published work to date2. Most studies use the sciatic nerve
model of neural regeneration [51, 113, 147, 148, 156]; however work has also used teased dorsal rootlets
from the vertebral column [153, 154]. Teasing rootlets is advantageous because the nerve remains in
continuity and can therefore record complex signals in acute recordings, for example spike trains related
to bladder pressure and voiding [153]. Most rootlets survive interface implantation and axons remain for
at least 3 months, although myelination reduces dramatically, in contrast where rootlets are cut where
they join the spinal cord, both number of axons and myelination reduce by over 90% [154]. If rootlet
teasing could be applied to peripheral nerves the requirement for nerves to regenerate within MNIs could
be avoided3.
Studies using the sciatic nerve model are more applicable to this aim which is to use MNIs for
control of upper-limb prostheses. In all studies of MNIs in peripheral nerves studies the nerve is severed
and allowed to regenerate through the device. The regenerated nerves form “mini-nerves” within the
microchannels [51, 113]. These “mini-nerves” have an extra-cellular structure similar to perineurium
and endoneurium within the microchannels, and are therefore also refered to as microfascicles [155].
Blood vessels may be present supplying the “mini-nerve”, maintaining a population of myelinated and
unmyelinated axons [51]. In vivo small diameter channels of 50 µm become blocked with fibrous,
connective tissue [51,113,156]. However, by slowly reducing the channel diameter this may be avoided
[470]. In addition, the trauma of implantation and resulting foreign body reaction cause fibrosis, which
can either completely occlude microchannels, or reduce the space for axonal regeneration [51, 113].
With the addition of a headstage to a microchannel system axon potentials can be monitored over
the course of regeneration [148]. In this case microchannels did not appear to interfere with muscle
reinnervation compared with control groups where the nerve was cut and no MNI was interposed. Us-
ing recordings during treadmill walking action potentials have been correlated with muscle motor unit
activity. In this study there was evidence that the fibrotic response within microchannels was partly due
to Schwann cell proliferation, with a layer of S-100 negative cells surrounding a second layer of S-100
2Found by standard literature search.
3The surgery required to rootlet teasing is complex and detailed; however this does not mean it could not be accomplished
for peripheral nerves. The use of a collagenase solution to divide the nerve into fascicles may assist with this surgery [personal
correspondence].
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positive cells, which in turn surrounded myelinated and unmyelinated axons4.
Microchannel neural interfaces should be designed such that neural regeneration is encouraged and
fibrosis is discouraged.
6.1.2 Assessing Neural Regeneration In Vivo
Evaluating peripheral nerve regeneration requires the use of an adequate model and methods [78]. Typ-
ically analysis consists of one or more of the following methods: morphology / histology; gait analysis;
and electrophysiology. This study will use all three methods to gain a global picture of neural regenera-
tion and function in microchannel neural interfaces.
6.1.2.1 The Animal Model
The choice of animal model is integral to the testing of neural interfaces and nerve guidance conduits
[177]. The rat is the most commonly used animal, with approximately 75% of studies using this model
[496]. Within this group the majority of studies (>85%) use the sciatic nerve [497]. The length of gap
used varies between studies, with up to 100 mm used in large animal models, for rat studies modal gap
length is 6 mm to 10 mm. In this work gap length is defined by the electrode design and is kept as long
as practical with the electrode design (allowing for suturing this resulted in gaps of 5 mm to 7 mm). It
should be noted that nerve regeneration is faster in rodents than in humans due to shorter distances: from
the cell bodies to the axon ends; and from any comparable site of injury to the end organ [498].
In addition there are differences in response to neurectomy between rat strains (e.g. Lewis,
Sprague–Dawley, Wistar, and others). Lewis rats have a much lower incidence of autotomy (self-
mutilation) following sciatic nerve transection than other rat strains, with Wistar rats also exhibiting
low autotomy incidence compared with other strains: this makes these strains more suited for studies
requiring long term loss of sciatic nerve function [499]. This is important for multiple reasons, primarily
ethically: autotomy is an indicator of discomfort and stress. Strain response is also important experi-
mentally: autotomy is an indicator of neuroma formation; and when assessing the sciatic function index
autotomy may confound results by shortening toes and therefore toe span. In addition group housing and
mixed sex housing has been shown to reduce autotomy rates [500].
6.1.2.2 Peripheral nerve histology
Histology is the most common outcome measure from in vivo neural regeneration studies [78, 497].
In 80% of studies regenerated tissue is examined qualitatively, and in 50% of studies the examination
includes some quantitative assessment of neuromorphometry [496]. Angius et. al. [496] found that,
although there are no standard measures, the most common reported measures of neuromorphometry
were: “number of myelinated fibers, total number of nerve fibers, axon diameter, myelin thickness and
4S-100 is a Schwann cell marker, therefore S-100 positive cells are Schwann cells and S-100 negative cells are not Schwann
cells.
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g-ratio [ratio of the inner axonal diameter to the total diameter including myelin]”. In addition, proteomic
analysis has been proposed, with GAP-43 mRNA levels indicating active neural regeneration [497].
Histological processing techniques for studies of neural regeneration vary widely, and are rarely
discussed by authors [496,501]. In basic terms the nerve can be sectioned along different axes: transverse
(perpendicular to the direction of regeneration); or longitudinally (along the direction of regeneration). In
addition the nerve can be sectioned at different levels: proximal to, within, or distal to the nerve conduit.
Stains for axons in the peripheral nervous system include silver impregnation and antibody staining (e.g.
anti-neurofilament) [502]. Staining for myelin requires different techniques, mordents (e.g. iron alum)
have been added to haemotoxylin staining to achieve myelin staining, toxic reagents including cyanide
and osmium tetroxide have also been used [502, 503]. A simple modification for paraffin embedded
nerve sections has been developed by Di Scipio et. al. [504], this uses osmium tetroxide to stain myelin,
while toluidine, haemotoxylin/eosin or Masson’s trichrome can be used for staining cells and connective
tissue. In this study we are concerned with regeneration within microchannels, therefore transverse
sections stained for myelin and/or haemotoxylin/eosin will allow visualisation of regenerated myelinated
and unmyelinated axons as well as quantification of microfascicle formation within microchannels.
Alternative morphometric measures can be taken, including total nerve diameter and target muscle
mass. These are typically assessed at the study end point following surgical removal; however magnetic
resonance neurography presents a solution for examining neural regeneration non-invasively. Magnetic
resonance images can be used to track neural regeneration, observe neuroma formation and evaluate
the extent of nerve damage following injury [78]. This presents advantages for clinical applications;
however it is cost prohibitive for animal research and does not provide the detail at the axon level given
by nerve histology.
6.1.2.3 Gait Analysis
Following sciatic nerve injury or transection in rats normal hind limb gait is lost. The extent of injury
and recovery can be measured using biomechanical measures. The sciatic function index (SFI) is a
reliable, convenient measure of rat hind limb function, which has been used extensively [78, 368, 503,
505–508]. The SFI was introduced in the 1980’s, as a quantitative method for assessing functional
recovery following sciatic nerve injury in rats by measuring the change in footprint shape during walking
[505]. This was updated by Bain et. al. in the late 1980’s to define complete sciatic nerve transection
with a score of -100 and control or sham operations with a score of 0 [506, 507]. Various methods for
recording footprints have been used: x-ray film and developer [506]; bromophenol blue paper [508]; and
carbon-black in oil [509].
SFI correlates weakly with other indicators of neural function, possibly indicating functional com-
pensation in addition to regeneration [510]. In addition for severe injuries, and in the first weeks of
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recovery, the SFI may not be reliable, but shows the same trends, between observers [508]. Recently
more global measures of hind limb function have been achieved using high speed optical tracking [511].
The SFI is considered the only standardised method of functional recovery in the rat model [496].
6.1.2.4 Electrophysiology
Electrophysiology can be used to determine neuromuscular function by monitoring nerve and muscle
action potentials. This is of particular interest to implants where the intended use is for recording and/or
stimulating nerves and muscles. Approximately 40% of neural regeneration studies examine electro-
physiology; however, the measures used vary widely between research groups, making direct compar-
isons often impossible [496]. Common measures include: compound muscle action potentials; sensory
and motor nerve action potentials; reflex tests; and nerve conduction velocities [503].
Typically following nerve injury, muscle action potentials are smaller and the latency (time from
stimulus to response) is greater. Nerve conduction velocity is lower where damage to myelin is present;
however measurement length and nerve temperature can have large confounding effects on conduction
velocities [78]. In addition anaesthesia can alter the results from electrophysiological studies; how-
ever, techniques to minimise neural transduction loss may not meet with local ethical approval [512].
Electrophysiology can be carried out serially over the course of an experiment, either under operating
conditions, or by using non-invasive or head stage methods: this is of particular interest for neural inter-
faces [78, 148].
6.1.3 Fibrin Glue
The use of an alternative implantation technique to attach the MNI (fibrin tissue glue) may improve
functional recovery through microchannels [513, 514]. Firstly, tissue glue fixation will require less ma-
nipulation of the nerve during surgery, reducing damage and allowing the nerve to be placed tension-free
in the conduit. In addition, fibrin matrix has been shown to improve neural regeneration within nerve
guidance conduits [515], can be used as a carrier for growth factors [516], and can be created from
autologous blood [517]. In this study a commercial fibrin will enclose the entire conduit and can be ex-
pected to permeate the microchannels by capillary action. Also, tissue glues are available commercially,
licensed for use for skin closure / dressing and for internal haemostasis / sealing.
6.1.4 Neural Extracellular Matrix
In chapter 3 of this thesis an experimental series was presented developing and testing a mixture of
neural basement membrane proteins for enhancing neural regeneration. The normal regenerative ar-
chitecture could be partly restored by coating microchannels with neural proteins: microchannels will
mimic the physical fascicular or endoneurial structure and the proteins will mimic the small-scale epitope
cues present in the endoneurium [71, 178, 338]. The neural basement membrane mixture of collagen-
IV, laminin-2,(-4) and nidogen-1 may improve nerural regeneration in vivo and should be tested as a
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microchannel neural interface coating [179].
6.1.5 Aims and Hypotheses
This chapter presents an in vivo study examining stacked microchannel neural interfaces, developed in
chapter 5 of this thesis, in a rat sciatic nerve model. The effect of an adsorbed basement membrane
protein coating as a modification for microchannel neural interfaces is tested. The coating consists of
10 µg/cm2 collagen-IV, 1 µg/cm2 laminin-2,-4, and 0.175 µg/cm2 nidogen-1 premixed to form an all-
in-one coating. The aim of this study is to determine whether the basement membrane protein coating
improves the function of a microchannel neural interface.
The hypotheses for this chapter are as follows:
1. Rat sciatic nerve axons regenerate through stacked microchannel neural interfaces in vivo.
2. Multi-protein coatings improve functional, histological and electrophysiological outcomes com-
pared with uncoated controls following microchannel neural interfaces implantation in a rat sciatic
nerve model.
3. Fibrin glue is a suitable method for in vivo fixation of microchannel neural interfaces compared
with standard microsurgical suture repair.
6.2 Methodology
All in vivo procedures described were carried out in accordance with The Animals (Scientific Procedures)
Act UK, 1986 (revised 2013) and local guidance.
6.2.1 Cadaveric implantation of a regenerative neural electrode
Prior to any in vivo experimentation a cadaveric test was carried out to determine the surgical approach
and the implantation method. One adult male Wistar rat was sacrificed by cervical fracture (procedure
carried out for the purposes of a study not discussed in this thesis).
The animal was placed in the right lateral position and the operative site was shaved. An incision
was made over the left thigh exposing the Gluteus muscle. Blunt dissection was performed between the
Gluteus superficialis and Biceps femoris muscles until the sciatic nerve was identified. The sciatic nerve
was freed from surrounding tissue and completely divided.
A dummy implant was interposed between the nerve endings using 9-0 polyamide monofilament
suture (Ethicon, W2829). It was decided that 3 epineurial sutures were required to fully secure the
implant within the nerve (see fig. 6.1). By observing retraction of the nerve following transection and
manipulation during suturing it was decided that the nerve should be divided more proximally, and
the junction between the proximal and middle third of the thigh was chosen. During the cadaveric
implantation the primary incision was widened to increase the view of the operative site, it was decided
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that the primary incision should run from the hip joint to the knee joint in order to fully expose the
operative site.
Following the dummy implantation the entire left hind-leg was shaved and exposed from the midline
to the ankle by blunt dissection beneath the skin. The muscles of the leg were exposed and alternative
surgical approaches were discussed. The animal was placed in a dorsal position and a ventral approach
was considered, however this would require dividing through a muscle to expose the sciatic nerve and risk
damaging a neurovascular bundle present on the muscle surface. The lateral approach was considered
less invasive.
Figure 6.1: Cadaveric assessment of neural interface implantation. Adult male Wistar rat in right lateral
position with left thigh and sciatic nerve exposed.
6.2.2 An In Vivo Comparison of Tissue Glue and Suture for Microchannel
Neural Interface Implantation
Adult male Wistar rats (12 weeks, N=4) were acclimatised in paired housing for 7 days prior to surgery.
Animals were randomly assigned to two groups. Both groups underwent the following procedures.
General Anesthesia was induced and maintained with 2% isoflurane (Isoflo, B506, Abbott) in oxygen (2
l/min). Animals were placed in the right lateral position. The operation site was shaved and prepared
with Hydrex Clear (0.5% w/v Chlorhexidine Gluconated in 70% v/v Denatured Ethanol B, Ecolab Ltd.)
and the operative field draped.
An incision was made over the left thigh between the knee and the hip joints approximately 5 mm
posterior to the femur. The subdermal fascia was incised and the underlying Gluteus superficialis and
Biceps femoris muscles were identified. Blunt dissection was performed between these 2 muscles to
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reveal the sciatic nerve. The sciatic nerve was exposed and freed from surrounding tissue and divided at
a the junction between the proximal and middle third of the thigh. Throughout the procedure care was
taken to keep the operative field moist with regular irrigation using isotonic saline (Vetivex 1).
The sterile implant was washed with isotonic saline (Vetivex 1) immediately prior to implantation.
Implantation was carried out as described in sections sections 6.2.2.1 and 6.2.2.2.
Incisions of both groups were washed with isotonic saline and closed with a continuous buried
subcuticular suture using 4-0 and 2-0 polyglactin 910 sutures (Vicryl, W9106). Final sutures were sub-
cutaneous and knots were run subcutaneously.
The wound was treated with moisture permeable spray dressing (Opsite, Smith and Nephew). An-
algesia was performed postoperatively using 2.5 mg/kg Flunixin (50 mg/mL in saline, Noorbrook) sub-
cutaneously. Animals were returned to darkened individual housing and monitored until recovery from
anasthesia was confirmed.
Animals were housed individually for 7 days after surgery and thereafter in pairs. The cage envir-
onment was enriched with extra bedding and other objects to reduce the likelihood of automutilation.
Water and food were provided ad libitum.
6.2.2.1 Suture
For group 1 the nerve ends were sutured into the implant. The proximal nerve end was placed in the
lumen of the implant abutted to the microchannels. The nerve was sutured to the implant using 9-0
polyamide monofilament suture (Ethicon, W2829). 3 epineurial sutures were used equidistant around
the nerve. Sutures were passed through the perineurium proximally to distally and through the wall of
the silastic tubing before being secured. The implant was manipulated to access the reverse side for
suturing.
The distal end was sutured in the same manner with sutures passing through the perineurium distally
to proximally and through the wall of the silastic tubing.
6.2.2.2 Tissue Glue
For group 2 the nerve ends were held in place using tissue glue. The proximal and distal ends of the
nerve were places in the lumen of the implant abutted to either end of the microchannels. Tisseel Tissue
Glue (Baxter, 2 mL, 1501764) was prepared according to manufacturer’s instructions and kept at 37°C
using Fibrinotherm equipment (Baxter). Tisseel was mounted into a mixer/applicator. The first 0.5 mL
was expelled onto a sterile gauze. Approximately 0.5 mL Tisseel was applied to the nerves and implant
encapsulating the entire area. The Tisseel was allowed to set for 3 minutes in situ.
6.2.3 An In Vivo Comparison of Internal Surface Coatings for Microchannel
Neural Interface Implantation
Adult male Lewis rats (12 weeks, N=24) were acclimatised in group housing for 7 days prior to surgery.
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Animals were randomly assigned to 4 groups. All groups underwent the following procedures.
General anaesthesia was induced and maintained with 2% isoflurane (Isoflo, B506, Abbott) in oxygen (1
to 2 l/min). Animals were placed in the right lateral position. The operation site was shaved and prepared
with Hydrex Clear (0.5% w/v Chlorhexidine Gluconated in 70% v/v Denatured Ethanol B, Ecolab Ltd.)
and the operative field draped.
An incision was made over the left thigh between the knee and the hip joints approximately 5 mm
posterior to the femur. The subdermal fascia was incised and the underlying Gluteus superficialis and
Biceps femoris muscles were identified. Blunt dissection was performed between these 2 muscles to
reveal the sciatic nerve. The sciatic nerve was exposed and freed from surrounding tissue and divided
at the junction between the proximal and middle third of the thigh. Throughout the procedure care was
taken to keep the operative field moist with regular irrigation using isotonic saline (Vetivex 1).
For all groups nerve ends were sutured to the implant. For two groups protein coated implants were
used, and for two groups uncoated control implants were used. Sterile interfaces were coated with and
all-in-one 10 µg/cm2 Collagen-IV + 1 µg/cm2 Laminin-2,-4 + 0.175 µg/cm2 Nidogen-1 multi-protein
coating previously described in Chapter 3. To coat the sample, sufficient mixed protein solution in the
ratio 10:1:0.175 (Collagen:Laminin:Nidogen) was placed within the lumen of the interface. The interface
was placed under vacuum for 5 minutes to remove and air and ensure the protein solution had sufficiently
penetrated the microchannels. The interfaces were placed in an incubator at 37◦C for 2 hours for protein
adsorption, interfaces were turned once after 1 hour. Coated interfaces were washed by immersion into
sterile phosphate buffered saline for 5 minutes 3 times. Coated and uncoated sterile implants were stored
in sterile isotonic saline prior to implantation.
The proximal nerve end was placed in the lumen of the implant abutted to the microchannels. The
nerve was sutured to the implant using 9-0 polyamide monofilament suture (S&T, 03180, Interfocus
Ltd, UK). 3 epineurial sutures were used equidistant around the nerve. Sutures were passed through the
perineurium proximally to distally and through the wall of the silastic tubing before being secured. The
implant was manipulated to access the reverse side for suturing.
The distal end was sutured in the same manner with sutures passing through the perineurium distally
to proximally and through the wall of the silastic tubing.
Incisions of both groups were washed with isotonic saline and closed with a continuous buried
subcuticular suture using 4-0 polyglactin 910 sutures (Vicryl, W9106, Johnson & Johnson International,
UK). Final sutures were subcutaneous and knots were run subcutaneously.
The wound was treated with moisture permeable spray dressing (Opsite, Smith and Nephew).
Analgesia was performed immediately postoperatively using 3 µg buprenorphine subcutaneously (as
buprenorphine hydrochloride, 3.24 µg in 1 ml, Vetergesic, Sogeval UK Ltd.). Animals were returned to
darkened group housing and monitored until recovery from anaesthesia was confirmed. One animal was
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lost during anaesthesia (Control, 4 week group), in all other cases recovery was uneventful.
Animals were housed in groups of 4. The cage environment was enriched with extra bedding and
other objects to reduce the likelihood of automutilation. Water and food were provided ad libitum.
6.2.4 Electroneurography using Microchannel Electrodes
For the N=24 tests electrophysiological assessment was carried out using the electrode containing mi-
crochannel neural interfaces. After 1 month (4 weeks) following surgery and 2 months (8 weeks) fol-
lowing surgery two groups each of 12 animals were anaesthetised and prepared using the techniques
described for implantation. The interface was exposed by dissection and the interface and nerve freed of
connective tissue.
First, stimulation was applied to the proximal nerve and signals were recorded from the microchan-
nel interface. A pair of stainless steel hook electrodes were used to lift the proximal nerve. The pads
of the microchannel interface were laid over a stiff metal bar, a spring loaded connector described in
Chapter 5 was used to form an electrical connection with the microchannel’s electrodes in a tripolar
configuration. Neural signals were recorded using a neural signal amplifier (Iso-DAMA8A, World Pre-
cision Instruments, Sarasota, USA) connected to BIOPAC recording equipment (MP150 and AcqKnow-
ledge software, BIOPAC Systems, Inc., CA, USA). Hook electrode stimulation was carried out using
the BIOPAC equipment: a balanced square 1ms ±0.1V pulse train of 10 Hz was used. Recordings were
made at 10 kiloSamples per second (kSps), amplified 1000x, with a high pass filter of 100 Hz and a low
pass filter of 10 kHz. In addition, the proximal nerve was stimulated using a Medtronic Vari-Stim III
Surgical Nerve Stimulator (Medtronic Inc., MN, USA) set to a 1 mA pulse.
Second, stimulation was applied to the nerve within the microchannel and signals were recorded
from the tibialis anterior muscle. Stainless steel epimysial electrodes were placed on the muscle belly of
the exposed muscle. The pads of the microchannel were connected as above. Muscle signals were re-
corded using BIOPAC amplifers and recording equipment (MP150, EMG100 and AcqKnowledge soft-
ware). Microchannel interface stimulation was carried out using the BIOPAC equipment: a balanced
square 1ms pulse train of 10 Hz between ±0.01V and ±0.1V was used. Recordings were made at 10
kSps, amplified 500x, with a high pass filter of 100 Hz and a low pass filter of 5 kHz. In addition, the
proximal nerve was stimulated using a Medtronic Vari-Stim III Surgical Nerve Stimulator (Medtronic
Inc., MN, USA) set to a 1 mA pulse.
The signal-to-noise ratio of outputs was calculated as the ratio of the peak-to-peak signal (µ) to the
noise standard deviation (σ), see eq. (6.1).
SNR =
µ
σ
(6.1)
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6.2.5 Histological Procedures
For the comparison of tissue glue and suture all animals were sacrificed 4 weeks following surgery.
For the comparison of internal surface coatings one uncoated group and one coated group were
sacrificed 4 weeks following surgery. The second control group and the second coated group were
sacrificed 8 weeks following surgery.
Animals were sacrificed by cervical fracture. For the N=4 tests the animal was laid in a left lateral
position and the implant was exposed by dissection. For the N=24 tests the implant site was already
exposed for electroneurography.
The neural interface and 1 cm of distal and proximal nerve were excised and immediately placed in
4% paraformaldehyde in phosphate buffered saline (PBS). After 2 to 6 hours in fixative the nerves were
washed and stored in 0.2 wt% glycine in PBS. Nerve samples were stored at 4◦C prior to histological
processing. Prior to histological processing the nerve was freed of any remaining connective tissue by
dissection and the sutures holding the nerve to the neural interface were cut. A single transverse cut
was made through the silicone tubing adjacent to the neural interface on the distal side. The distal and
proximal nerve sections were identified and removed carefully to preserve any microfascicles connected
to the distal end.
The tibialis anterior and biceps femoris muscles were excised from the right and left legs. The
muscles were stored in 4% paraformaldehyde at room temperature and weighed within 1 week.
The nerve fixation method described below is modified from Di Scipio et. al. [504]. Nerves for the
N=24 test were post-fixed to make myelin visible. Samples were post-fixed for 2 hours in 1% osmium
tetroxide (Agar Scientific) in 0.1M sodium cacodylate buffer. Samples were then washed 3 times in 0.1M
sodium cacodylate buffer. Samples from both tests were dehydrated in ascending alcohol series with 3
washes for 5 minutes at each concentration: 20% industrial methylated spirits (IMS); 30% IMS; 40%
IMS; 50% IMS; 60% IMS; 90% ethanol; 96% ethanol. Samples were washed twice in 100% ethanol for
30 minutes each and stored in ethanol prior to embedding. Samples were infiltrated by paraffin wax at
60◦C for at least 24 hours. Samples were then embedded in paraffin wax and a series of 5 µm transverse
sections were taken using a rotary microtome. Sections were stored for at least 24 hours at 60◦C to
partially deparaffinate.
All sections from the N=24 test and 50% of the sections from the N=4 test were then stained with
haemotoxylin and eosin by the following method. Samples were deparaffinated in a series of 3 xylene
baths for 4 minutes each. Samples were then taken to water in an ethanol series for 2 minutes each:
100% ethanol; 90% ethanol; 70% ethanol; tap water. Samples were immersed in Harris Haemotoxylin
(Sigma HHS32) for 8 minutes. Samples were washed by dipping in tap water and transferred to acid
alcohol for 20 seconds (70% industrial methylated spirits, 1% 18M HCl in distilled water). Samples
were immersed in eosin (eosin Y-solution, 0.5% aqueous, Merck KGaA, 1.09844.1000) for 8 minutes.
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Sections were washed under slowly running tap water and dehydrated in ascending ethanol series for 2
minutes each: 70% ethanol; 90% ethanol; 100% ethanol. Samples were cleared in 3 xylene baths for 4
minutes each.
50% of the sections from the N=4 test were stained using toluidine blue. Sections were de-
paraffinated and taken to water as described in the methods for haemotoxylin and eosin staining. Sections
were immersed in toluidine blue solution for 30 minutes at 37◦C (1 wt% toluidine blue, Agar Scientific,
in 50% propan-2-ol 50% distilled water). Sections were transferred to propan-2-ol for 1 minute. Sections
were dehydrated and cleared in xylene as described in the methods for haemotoxylin and eosin staining.
All samples were air dried for approximately 5 minutes following clearing then mounted using a
glass coverslip and DPX (VWR, 360294H). Slides were left flat for 1 hour to allow the mounting media
to set and then stored vertically.
6.2.5.1 Imaging and Analysis
Sections were imaged at 10x, 20x and 40x using an Olympus slide microscope. Images were assessed
using ImageJ, graticules were used to set image scales. Up to 50 axon cross sections per microchannel
were counted [156]. Axon density (axons per µm2) and axon diameter (µm) were determined [135].
Diameters were calculated using the axis parallel to the horizontal in the image and assuming a circular
axonal morphology. Axon densities (axons per area) were calculated for each section using the Cell
Counter ImageJ plugin. Statistical analysis was carried out using data from one proximal and one distal
section of each explanted interface.
6.2.6 Gait Analysis by the Sciatic Functional Index
Animals were monitored for autotomy during SFI walking assessments [518].
A walking track was created consisting of an 82 mm by 420 mm track section (lined with paper
for footpad recordings) with a large darkened box at one end. A similar design is shown by Brown et.
al. [507].
For the N=4 tests of tissue glue compared with suture carbon-black in oil was used [509]. Approx-
imately 1 g carbon black powder (Cornelissen and Son, UK) was mixed with approximately 5 ml clear
cooking oil to form a thick, non-toxic paint. Plain white paper was used for lining the track section.
Animals were identified prior to walking using tail tattoos. Animals’ hind feet were placed in a
petri dish containing the carbon-black in oil. Animals were placed at the end of the track section facing
towards the darkened box. Once animals had entered the darkened box the paper with footpads was
immediately removed and recorded photographically. Animals’ feet were cleaned with warm water
prior to returning to housing.
To reduce mess and potential toxicity a cleaner method was sought for the N=24 tests. Bromophenol
blue paper was chosen, this method uses water rather than carbon-black in oil [519], and has been used
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clinical with humans [520]. Bromophenol blue is prepared as a 0.5 wt% solution (Bromophenol Blue,
Sigma Aldrich, UK) in acetone. Paper is dipped into this solution, drip dried for 10 seconds and placed
in a dry oven at 37◦C for at least 1 hour to dry. This creates a yellow-blue paper which becomes brilliant
blue on contact with liquid water. The colour fades to blue upon contact with moist air therefore the
paper is sealed in a air tight bag until use. This paper is used for lining the track section.
Animals were identified prior to walking using tail tattoos. Animals’ hind feet were placed in a
petri dish containing warm tap water and excess water was removed using an absorbent tissue. Animals
were placed at the end of the track section facing towards the darkened box. Once animals had entered
the darkened box the bromophenol blue paper with footpads was immediately removed and recorded
photographically. Animals’ feet did not require cleaning and animals were returned to housing.
6.2.6.1 Calculating the Sciatic Function Index
Once a suitable set of prints from the normal and experimental hind paws have been recorded the SFI can
be calculated. All measurements were made using ImageJ. Because only relative measures were used
distances were recorded in pixels.
The formula derived by Bain et. al. was used [506]. The following measurement were taken (see
fig. 6.2): print length (PL); the distance between the first and fifth toes or toe spread (TS); the distance
between the second and fourth toes or intermediate toe spread (IT). These measurements were taken
for two sequential hind-limb prints, one from the operated or experimental side (E), and one from the
unoperated or normal side (N). This gave the following 6 measures: NPL, NTS, NIT, EPL, ETS, and
EIT.
A difference factor for each measurement is calculated using eqs. (6.2) to (6.4). The sciatic function
index (SFI) is calculated using eq. (6.5) from Bain et. al., 1989, [506].
Print Length Factor (PLF) =
EPL−NPL
NPL
(6.2)
Toe Spread Factor (TSF) =
ETS−NTS
NTS
(6.3)
Intermediate Toe Spread Factor (ITF) =
EIT−NIT
NIT
(6.4)
Sciatic Function Index (SFI) = −38.3× PLF + 109.5× TSF + 13.3× ITF− 8.8 (6.5)
193
Figure 6.2: Rat footpad traces with the following measurements marked: print length (PL); toe spread
(TS); intermediate toe spread (IT). These measurements are taken for the operated or experimental side
(E) and unoperated or normal side (N). Figure from Brown et. al. [507], permission received. Copyright
©1989 Wiley-Liss, Inc., A Wiley Company.
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6.2.7 Data Analysis
Unless otherwise stated data were analysed using SPSS version 21.0 (IBM, Windows and Linux ver-
sions). The data were not assumed to be normally distributed, and the conditions for parametric testing
were not met, therefore non-parametric tests were used. Where unpaired samples were present statistical
comparisons were made using the Mann Whitney U test. These cases are: muscle mass loss ratios; com-
parisons of histological morphometry between different treatment groups, and different time points; rates
of SFI increase per day; signal to noise ratios; comparisons of impedance between different treatment
groups. Where paired or related samples were present statistical comparisons were made using the Wil-
coxon signed-rank test. These cases are: comparisons of histological morphometry between proximal
and distal sections; comparisons of impedance between different time points. SFI was recorded as con-
tinual bivariate data (SFI and days since implantation) and correlations were evaluated using Spearman’s
rank correlation coefficient.
6.3 Results
6.3.1 Cadaveric Implantation of a Microchannel Neural Interface
The single animal cadaveric study demonstrated that a lateral approach to the sciatic nerve was suitable
and that the nerve could be exposed by blunt dissection following the skin incision. In addition it was
observed that the neural interface was of the correct diameter to suture within the nerve trunk.
6.3.2 An In Vivo Comparison of Tissue Glue and Suture for Microchannel
Neural Interface Implantation
6.3.2.1 Gross Anatomy
On explantation the nerve was in continuity with the neural interface in all animals (see figs. 6.3a
and 6.3b). A superficial infection associated with a skin suture was observed in one animal (fibrin
glue group), this had not penetrated the tissues to the nerve transection site. A gross difference was
observed between the groups. Where fibrin glue was used a thick transuclent capsule was present around
the nerve (see fig. 6.3b), in one animal this had partially bound the nerve to the soft tissues, making blunt
dissection for removal difficult.
6.3.2.2 Histology
When the implant was treated with tissue glue the nerve appeared to follow the glue rather than remain
within the lumen of the implant figs. 6.4a to 6.4f. In contrast when the implant was sutured in place the
nerve grew through the microchannels forming microfascicles or mini-nerves in a spiral formation (see
figs. 6.5a and 6.5b).
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(a) Interface implanted using microsutures. (b) Interface implanted using Tisseal (fibrin) tissue
glue.
Figure 6.3: Passive microchannel neural interfaces in situ 1 month following implantation, demonstrating
the sciatic nerve in continuity with the interface.
6.3.2.3 Sciatic Function Index
Three weeks and four weeks after surgery the sciatic function was greater in the tissue glue group com-
pared with the sutured group (see fig. 6.6). After 3 weeks regeneration SFI in the tissue glue group was
-66.6±21.3 (median± I.Q. range) and was -77.9±19.3 in the sutured group. One week later sciatic func-
tion had improved in both groups: -64.1±30.7 in the tissue glue group; and -74.6±36.0 in the sutured
group. Due to the nature of the study (pilot study with n = 2) no statistical comparison was made.
6.3.3 An In Vivo Comparison of Internal Surface Coatings for Microchannel
Neural Interface Implantation
6.3.3.1 Gross Anatomy
In one case after 30 days, a control sample, the neural interface was found not in continuity with the
nerve, following examination it was found that the sutures had pulled away from the epineurium at the
proximal end. The proximal nerve stump had remained within the lumen of the silicone guide, but no
regeneration into the microchannels was observed. In all other cases the MNI was in continuity with the
nerve and tissue had filled the silicone guides both proximally and distally (see figs. 6.7, 6.8a and 6.8b).
During removal of the nerve when the first nerve transection was made (proximal to the implant)
twitching of the hind-limb could be observed in some cases. After 4 weeks implantation, in the control
group twitching was observed in 1 of 6 cases, and in the sECM coated group twitching was observed
in 2 of 5 cases. After 8 weeks post implantation, in the control group twitching was observed in 4 of 6
cases, and in the sECM coated group twitching was observed in 4 of 6 cases. Twitching indicates that
the muscles of the distal limb have reinnervated, and that therefore the nerve has regenerated beyond the
MNI.
Following fixing with paraformaldehyde the interfaces were manually dissected. In some cases
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(a) Transverse distal sciatic nerve section 1. (b) Transverse distal sciatic nerve section 2.
(c) Transverse distal sciatic nerve section 3. (d) Transverse distal sciatic nerve section 4.
(e) Transverse distal sciatic nerve section 5. (f) Transverse distal sciatic nerve section 6.
Figure 6.4: Sequential transverse histology of sciatic nerve following tissue glue implanted interface. 5
µm sections from the proximal nerve portion, from proximal to distal, stained with haemotoxylin and
eosin. N.B. the sections are not immediately consecutive, there is approximately 50 µm of nerve between
each section not shown.
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(a) Interface implanted using microsutures, at 5x
magnification..
(b) Microfascicles, detail at 20x magnification.
Figure 6.5: Transverse histology of sciatic nerve following suture implanted interface. 5 µm sections
from the proximal nerve portion, stained with haemotoxylin and eosin. Microfasciles are present in a
spiral formation aligning with the spiral passive microchannel array design.
Figure 6.6: Sciatic Function Index following regeneration through Tisseal tissue glued and sutured mi-
crochannel conduits. n = 2 (N = 4) with 3 measurements per timepoint. A theoretical zero is included
for comparison.
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mini-nerves were observed growing into the microchannels and could be removed with careful dissection
(see fig. 6.8c). Tissue remained within some microchannels, this could be seen under scanning electron
microscopy (see figs. 6.9a and 6.9b).
Following MNI removal and dissection from the nerve some tissue was still present in the mi-
crochannels, when the plasma bonded layers were split using forceps mini-nerves could be seen within
the channels under light microscopy (see figs. 5.12b and 6.10).
Figure 6.7: Stacked microchannel neural interface in situ after 60 days (8 weeks) implantation. Nerve,
in continuity with the microchannel device, can be observed proximally (right) and distally (left).
(a) Microchannel neural interface
with nerves in continuity. Prox-
imal nerve on right.
(b) Microchannel neural interface
with distal nerve in continuity.
(c) Mini-nerves following removal
dissection from a microchannel
neural interface.
Figure 6.8: Light micrographs of microchannel neural interface dissection following 2 months in vivo.
6.3.3.2 Muscle Mass Changes
The relative changes in biceps femoris (BF) muscle mass and tibialis anterior (TA) muscle mass are
presented in figs. 6.11a and 6.11b. Relative loss is greater for the TA than for the BF at 8 weeks, with a
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(a) Microchannels with some adherent tissue. 180x
magnification.
(b) Microchannel with some adherent tissue. 400x
magnification.
Figure 6.9: Scanning electron Micrographs of microchannels following 2 months in vivo. Adherent
tissue and space where tissue has been removed by dissection can be seen.
Figure 6.10: Light micrograph of a microchannel neural interface split between two plasma bonded
layers. Images taken after in vivo study showing some adherent mini-nerve tissue (white/brown).
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0.660±0.142 TA loss in the sECM treated group and a 0.671±0.139 TA loss in the control group (median
± interquartile range), meaning that the deinnervated TA muscles were over 50% smaller relative to the
same muscle on the unimplanted (right) side. In contrast the BF muscles were approximately 20%
smaller after 4 weeks, and less than 10% smaller after 8 weeks. There was no significant difference in
muscle mass loss between the treatment groups for either the BF or TA at 4 and 8 weeks (p >0.794).
Within treatment groups a trend in decreasing muscle mass loss from 4 weeks to 8 weeks was
observed; however, this change was not significant. In the sECM treated group loss was greater at 4
weeks (0.195±0.260 median relative loss ± interquartile range) than at 8 weeks (0.028±0.145), this
difference was not significant (p = 0.434). There was no significant difference in BF mass loss from in
the control group between 4 weeks (0.127±0.549) and 8 weeks (0.032±0.146) (p = 0.395).
(a) Biceps Femoris muscle mass loss ratios. Differences
are not significant p ≥ 0.395.
(b) Tibialis Anterior muscle mass loss ratios. Differences
are not significant, p = 1.000.
Figure 6.11: Muscle mass loss ratios for biceps femoris and tibialis anterior. 0 is no change, >0 is
relative muscle atrophy on implanted side, <0 is relative muscle hypertrophy on implanted side.
6.3.3.3 Histology
Axons were visible in transverse histological sections in the majority of samples. Example images of
nerve proximal and distal to the implants are shown after 4 weeks implantation (figs. 6.12a to 6.12h) and
8 weeks implantation (figs. 6.13a to 6.13h).
At 4 weeks, little difference between the two treatment groups can be observed. The proximal
nerve has regularly spaced axons and blood vessels throughout a nerve, fascicles are not visible in these
sections indicating structural remodelling (figs. 6.12a to 6.12d). The distal nerves have axons and blood
vessels present in a disordered structure (figs. 6.12e to 6.12h).
After 8 weeks the proximal nerve is more disordered in both groups. Fascicles are visible in the con-
trol group sections, with axons and blood vessels bundled within concentric connective tissue (figs. 6.13a
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and 6.13b). The sECM treated group has formed a dense tissue with some axons present, the appearance
is in part due to an oblique section and the high level of osmium tetroxide fixation present (figs. 6.13c
and 6.13d). Distal to the implant at 8 weeks the control group has formed fasciles, with axons and blood
vessels surrounded by vascularised connective tissue (figs. 6.13e and 6.13f). The sECM treated groups
has formed a nerve without fascicles, but with regularly spaced axons and blood vessels (figs. 6.13g
and 6.13h).
Microfascicles were observed in a few cases. An oblique microfascile section is shown in fig. 6.14b
and transverse microfascicle sections are shown in fig. 6.14b. Staining quality appears poor; however,
a layer of connective tissue can be seen surrounding a stained linearly aligned tissue, indicating the
presence of myelinated axons.
Axon diameters and axon densities were calculated from transverse histological sections. Axon dia-
meter distributions are presented in figs. 6.15a and 6.15b and are summarised in box plot form fig. 6.16a.
Axon density is plotted in fig. 6.16b.
Axon diameters were analysed by comparing the different treatment groups (sECM coated or con-
trol) in the same location (proximal or distal) and time point (4 weeks or 8 weeks). 4 weeks after implant-
ation there is no significant difference between proximal axon diameters for the sECM coated (3.81±2.41
µm, median± interquartile range) and control interfaces (4.24±2.26 µm), p = 0.274. Distally the control
group axon diameters are significantly larger at 4 weeks (p = 0.0006): sECM coated group diameters are
3.29±2.22 µm; and control group diameters are 4.05±2.28 µm. After 8 weeks implantation proximal
axon diameters are not significantly different between treatment groups (p = 0.345): the sECM treated
group has slightly larger diameters (3.51±2.61 µm) compared with the treatment group (3.39±2.19 µm).
The distal axon diameters at 8 weeks are significantly larger in the sECM treated group (4.16±3.09 µm)
compared with the control group (3.12±2.00 µm, p <0.001).
Axon diameters were also analysed by comparing the different time points (4 weeks or 8 weeks)
in the same location (proximal or distal) and treatment group (sECM coated or control). There was
no significant difference in proximal diameter for sECM coated samples between 4 and 8 weeks post
implantation (p = 0.211). Distally sECM coated group axon diameters were significantly larger at 8
weeks compared with 4 weeks (p = 0.0012). In the control group axon diameters were significantly
smaller at 8 weeks compared with 4 weeks in both the proximal (p = 0.0023) and distal (p <0.001)
locations.
Finally, axon diameters were analysed by comparing the different locations (proximal or distal) at
the same time point (4 weeks or 8 weeks) and treatment group (sECM coated or control). For the control
group there was no significant difference between proximal and distal axon diameters at 4 weeks (p =
0.724) and 8 weeks (p = 0.363) post implantation. In the sECM coated group there was no significant
difference between proximal and distal axon diameters at 4 weeks post implantation (p = 0.0575); how-
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(a) 4 Weeks, Control, Proximal, 10x magnific-
ation.
(b) 4 Weeks, Control, Proximal, 40x magnific-
ation.
(c) 4 weeks, sECM treated, Proximal, 10x
magnification.
(d) 4 weeks, sECM treated, Proximal, 40x
magnification.
(e) 4 weeks, Control, Distal, 10x magnifica-
tion.
(f) 4 weeks, Control, Distal, 40x magnifica-
tion.
(g) 4 weeks, sECM treated, Distal, 10x mag-
nification.
(h) 4 weeks, sECM treated, Distal, 40x mag-
nification.
Figure 6.12: Transverse histology of regenerated nerves 4 weeks after microchannel neural interface
implantation. Proximal and distal sections are shown, at 10x and 40x magnification for sECM treated
and control interfaces.
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(a) 8 weeks, Control, Proximal, 10x magnific-
ation.
(b) 8 weeks, Control, Proximal, 40x magnific-
ation.
(c) 8 weeks, sECM treated, Proximal, 10x
magnification.
(d) 8 weeks, sECM treated, Proximal, 40x
magnification.
(e) 8 weeks, Control, Distal, 10x magnifica-
tion.
(f) 8 weeks, Control, Distal, 40x magnifica-
tion.
(g) 8 weeks, sECM treated, Distal, 10x mag-
nification.
(h) 8 weeks, sECM treated, Distal, 40x mag-
nification.
Figure 6.13: Transverse histology of regenerated nerves 8 weeks after microchannel neural interface
implantation. Proximal and distal sections are shown, at 10x and 40x magnification for sECM treated
and control interfaces.
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(a) Oblique microfascicle section. (b) Transverse microfascicle section.
Figure 6.14: Transverse and oblique histology of regenerated nerves 8 weeks after microchannel neural
interface implantation. Microfascicle sections are shown, at 40x magnification for an sECM interface.
ever distal axon diameters were significantly larger compared with proximal diameters at 8 weeks post
implantation ( p = 0.0113).
Axon densities were compared with respect to location (proximal or distal), time point (4 weeks or
8 weeks), and treatment group (sECM coated or control), while keeping the other dependent variables
constant. No significant differences in axon density were observed across all tests (p ≥ 0.188). Axon
density data is tabulated in table 6.1.
Group Weeks Location Median Axon Density
(axons/µm2)
Interquartile Range
Control 4 Proximal 0.0135 0.0201
Control 4 Distal 0.00783 0.00902
Control 8 Proximal 0.0155 0.0131
Control 8 Distal 0.00694 0.0143
sECM Treated 4 Proximal 0.00957 0.00950
sECM Treated 4 Distal 0.00999 0.00558
sECM Treated 8 Proximal 0.00734 0.00880
sECM Treated 8 Distal 0.00939 0.0126
Table 6.1: Axon densities following microchannel neural interface implantation after 4 weeks and 8
weeks. Sections taken proximal to and distal from the site of microchannel neural interface implantation.
Treated (sECM) and Untreated (Control) interfaces. All values to 3 significant figures.
6.3.3.4 Sciatic Function Index
An increasing trend in SFI was observed for both treatment groups (see fig. 6.17 and table 6.2). Linear
trends were calculated for each group in the form y = mx + b, the details are given in table 6.3. In both
groups the trend is weak but significant by Spearman’s rank correlation. The increase per day is larger
in the treated group (0.69 SFI units) than in the control group (0.48 SFI units). The rate of SFI increase
per day was calculated for each animal as the slope from a linear regression. There was no significant
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µ µ
(a) Histogram of axon diameters after 4 weeks implanta-
tion.
µ µ
(b) Histogram of axon diameters after 8 weeks implanta-
tion.
Figure 6.15: Histograms of axon diameter following implantation after 4 weeks and 8 weeks. Sections
taken proximal to and distal from the site of microchannel neural interface implantation. Treated (sECM)
and Untreated (Control) interfaces. 1 µm bins. This data is also presented in fig. 6.16a.
a b a c
d
c
e
b
d
f
e
f
(a) Boxplot of Axon Diameter. Significant differences
are indicated by paired letters: a, p = 0.002; b, p =
0.011; c,d,e,f, p = 0.001. This data is also presented in
figs. 6.15a and 6.15b.
(b) Boxplot of Axon Density. Differences are not signi-
ficant, p ≥ 0.188.
Figure 6.16: Boxplots of Axon Diameter and Axon Density following microchannel neural interface im-
plantation after 4 weeks and 8 weeks. Sections taken proximal to and distal from the site of microchannel
neural interface implantation. Treated (sECM) and Untreated (Control) interfaces.
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difference in SFI trend between the treatment groups (p = 0.9286, fig. 6.18). Median gradient of the
linear trend was 0.562±0.682 for the group with protein coated microchannels and 0.581±0.783 for the
untreated group (median ± I.Q. range, in SFI units per day).
Weeks following surgery Untreated Control SFI sECM Treated SFI
1 -85.2 ± 15.4 -83.7 ± 12.8
2 -77.4 ± 21.2 -78.4 ± 17.9
3 -83.8 ± 23.4 -76.6 ± 16.8
4 -74.5 ± 22.2 -72.0 ± 17.0
5 -81.9 ± 21.2 -69.5 ± 5.13
6 -74.4 ± 16.1 -61.8 ± 25.9
7 -68.4 ± 12.2 -55.5 ± 10.9
8 -49.4 ± 38.2 -51.7 ± 12.4
Table 6.2: Medians± interquartile range of sciatic function index (SFI)for 8 weeks following microchan-
nel neural interface implantation.
Group Slope (m) Intercept (b) R2 value Spearman’s ρ Significance
Control 0.48 -87.85 0.231 0.443243 <0.001
Treated 0.69 -91.31 0.394 0.665011 <0.001
Table 6.3: Correlation details for change in Sciatic Function Index by days following surgery. Signific-
ance for Spearman’s ρ calculated with respect to a null hypothesis of ρ = 0, not between groups. In both
cases the null hypothesis can be rejected.
6.3.3.5 Electrophysiology
Extracellular neural potentials were observed by recording from the microchannels following stimulation
of the proximal nerve (see fig. 6.19). Following stimulation using the microchannel neural interface
tibialis anterior compound motor action potentials were observed (see fig. 6.20).
Where spikes could be identified signal-to-noise ratios for the muscle and nerve signals were calcu-
lated. SNRs are shown in fig. 6.21. No significant differences in SNR either between treatment groups
or between time points were observed for either muscle recordings (p >0.201) or nerve recordings (p
>0.265).
Nerve recordings had consistently larger SNR in the treatment group compared with the control
group, at 4 weeks (sECM treatment SNR = 7.29±2.31, control group SNR = 5.96±1.53, median ±
I.Q. range) and at 8 weeks (sECM treatment SNR = 8.93±3.73, control group SNR = 5.51±0.480). In
addition an increasing trend in SNR was observed in the treatment group while a decreasing trend was
observed in the control group, neither difference was significant (p >0.533).
Muscle recording SNR was greater for the control group at 4 weeks (7.78±2.43) compared with
the sECM treated group at the same time point (6.05±1.60). While at 8 weeks the sECM treated group
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Figure 6.17: Sciatic Function Index following 2 months neural interface implantation. Linear trend lines
with 95% confidence intervals of the mean. Both trends are significant: sECM, R2 = 0.394, ρ = 0.665, p
<0.001; Control, R2 = 0.231, ρ = 0.443, p <0.001.
Figure 6.18: Rates of Sciatic Function Index increase per day following 2 months neural interface im-
plantation. Per animal linear trend slopes. The difference is not significant, p = 0.929.
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Figure 6.19: Evoked nerve signals recorded from microchannel neural interfaces.
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Figure 6.20: Evoked muscle signals recorded from tibialis anterior following stimulation through mi-
crochannel neural interface.
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SNR was greater (6.69±1.27) compared with the control group (5.76±2.45). Both difference were not
significant (p >0.201). The trends changes in SNR from 4 weeks to 8 weeks were also not significant:
increasing SNR in the treated group (p = 0.856); and decreasing SNR in the control group (p = 0.629).
Figure 6.21: Signal-to-noise ratios for stimulation and recording with microchannel neural interfaces
(MNI). 4 weeks and 8 weeks following interface implantation. Treated (sECM) and Untreated (Control)
interfaces. MNI recordings are made from within the microchannel following nerve stimulation with a
proximal hook electrode. Tibialis Anterior (Tib. Ant.) recordings are made using epimysial electrodes
following stimulation of the nerve through the MNI. The differences are not significant, p >0.201.
6.3.3.6 Impedance Spectroscopy
Impedance reduced over time in both groups. 1kHz impedance (see fig. 6.22a) was not significantly
different between electrodes randomly assigned to each group before surgery (p = 0.847). There was
no significant difference in 1 kHz impedance between the treated and untreated groups after 1 month
(p = 0.652), or after 2 months (p = 0.089). For the control group impedance was significantly lower
after 2 months implantation compared with before implantation (p = 0.01), no other significant differ-
ences between time points were observed (p ≥ 0.133). Complete impedance spectrographs are given in
fig. 6.22b.
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(a) 1kHz impedance plotted on a log scale. Significant
differences are indicated by paired letters: a, p = 0.01.
(b) Impedance plotted on a log-log scale.
Figure 6.22: Change in impedance following implantation.
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6.4 Discussion
Regeneration of rat sciatic nerve was observed through passive, coiled, microchannel neural interfaces
and electrode containing, stacked, microchannel neural interfaces. The regeneration was monitored
through histological, functional and electrophysiological assessment.
6.4.1 Cadaveric implantation of a regenerative neural electrode
The cadaveric study was important to determine: that the surgical approach was suitable; the appropriate
size of the neural interface; the suturing procedure was reliable; that the surgeon was sufficiently know-
ledgeable of the anatomy to keep surgical times to a minimum. Anatomical variations were slight, but
were present during the course of the studies, with the nerve occasionally branching within the surgical
window [497]. Variations were overcome by ensuring that the nerve was sutured proximal to any branch,
and that, where possible fascicles were placed in the same orientation at either end of the MNI lumen.
6.4.2 An In Vivo Comparison of Tissue Glue and Suture for Microchannel
Neural Interface Implantation
The results of this study do not support the hypothesis that fibrin glue is a suitable method for in vivo
fixation of MNIs compared with standard microsurgical suture repair. This is in part due to method
of fibrin application, on the outside of the MNI. In the fibrin glue group the nerve followed the glue
rather than remaining within the lumen of the implant, this indicated two hypotheses. 1) fibrin glue is
conducive to nerve growth, 2) To ensure regrowth down the microchannels the interface lumen must be
fully sealed. In this case there was a small slit in the lumen of the silicone tubing used as a nerve guide
proximal and distal to the interface, this was avoided in future applications by designing an alternative
nerve guide and by sealing the nerve guide using silicone.
Microfascicles were observed in the sutured nerves, indicating that axons had regenerated along the
microchannels. This supported the use of sutures for MNI implantation.
The benefits of both implantation methods could be exploited by filling the MNI lumen with fibrin
glue, either alone or as a carrier for biomolecules or cells, and then suturing the fibrin-MNI in place. A
number of challenges are expected in this design: fibrin is viscous and sets rapidly, a vacuum chamber
should be used to ensure the lumen is filled; fibrin will attach to the outside of the MNI, this should
be removed after it is set; Tisseal is expensive (∼ £50 per ml 5); fibin filling must be carried out under
sterile conditions either during or shortly before surgery. A further hypothesis is proposed: fibrin glue
filling will improve functional, histological and electrophysiological outcomes compared with untreated
controls following MNI implantation in a rat sciatic nerve model
Fibrin glue may benefit the electrophysiological function in addition to histological measures [513,
514]. This study only continued for 3 weeks, and observed no significant differences in SFI (due to a
52014 figure.
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low sample number). In a 12 week regeneration study no significant difference in sciatic function was
observed between fibrin glue and suture repair, however, SFI was more normal6, with mean values in the
range -35 to -55 (compared with -65 to -75 after 4 weeks in this study) [514].
6.4.3 An In Vivo Comparison of Internal Surface Coatings for Microchannel
Neural Interface Implantation
The results of this study support the hypothesis that rat sciatic nerve axons regenerate through stacked
microchannel neural interfaces in vivo. However, there is some inconclusive, evidence to support the hy-
pothesis that multi-protein coatings improve functional, histological and electrophysiological outcomes
compared with uncoated controls following MNI implantation in a rat sciatic nerve model.
In line with previous studies of MNIs tissue was seen within the microchannels and could be re-
moved, in part, during dissection [51, 113, 156]. However, these microfascicles (’mini-nerves’) could
not readily be observed following histological processing since they become brittle following osmium
treatment. In a few cases transverse sections could be observed, however staining quality was poor.
Myelinated and unmyelinated axon structures were observed proximal to and distal from the interfaces.
Difficulty with sectioning nerves following regeneration through an MNI has been noted by other re-
search groups, leading to quantitative analysis being abandoned in one case [148].
Distal axon diameters demonstrate significant differences between groups, the control group has
larger axons after 4 weeks and the treated group has larger axons after 8 weeks. This is further con-
firmed by the findings that axon diameters were significantly smaller in the control group after 8 weeks
compared with after 4 weeks, and that the opposite was found for distal axon diameters in the treatment
group (increase from 4 weeks to 8 weeks). The increase in, and significantly larger, distal axon diameters
supports the hypothesis that nerve regeneration is improved by sECM coatings. The differences are not
large compared with the data variability, after 8 weeks median distal axon diameters are approximately
30% larger in the treatment group compared with the control group.
Axon densities were not significantly different between the treatment groups. However, the greatest
axon densities were observed proximally in the control group, while the median densities were over
70% lower distally at both 4 weeks and 8 weeks. In contrast axon densities were more consistent in
the sECM treated group. This may be due to frustrated regeneration in the control group causing a
backup of sprouting axons proxmally, whereas the sECM coating encourages axon growth within the
microchannels. Where axons are encouraged to follow the microchannel they will be directed distally,
reducing axon number proximally and increasing the number of axons regenerating the correct direction
distally.
Axon diameter distributions are similar to previous studies [51] and axon densities reported here
6Less negative, i.e. closer to zero.
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fall close to the range of previous MNI results (0.000170 axons/µm2 to 0.0163 axons/µm2 in [51]).
Other studies of MNI regeneration have not reported detailed axon density and diameter data [148,156].
When compared with a study of an interface, which does not require complete nerve transection, the
MNI studies have a reduced axon diameter (mean diameters between 5.11 µm and 5.75 µm following
Utah array implantation [135]). MNI studies also show increased fibre density compared with a study of
Utah array implantation in rat sciatic nerve (example mean densities of 0.000723 axons/µm2 proximally
and 0.00136 axons/µm2 distally ), fibre densities for MNI implantation are more similar to the proximal
density values. Axon morphometry in healthy rat sciatic nerve shows some differences: diameter is
greater than observed in this study (5.52±0.37 µm, mean ± S.D.); axon densities are in the range of
the greatest densities observed in this study (0.011718±0.003287 axons/µm2, mean ± S.D.). Different
tissue processing methods used in this study compared with some previous work may have resulted in a
slight underestimate of fibre diameter; however this may only result in the mean axon diameters being
0.1 µm smaller than expected [501].
At much longer time points than those used in this study axon diameter distribution shifts right
(towards larger diameters); however, even after 200 days with immediate direct repair without a nerve
gap the normal bimodal axon diameter distribution does not return [521], and after 2 years axon diameters
are only 70% of the normal value [503]. In contrast, following nerve injury, axon counts are expected
to increase up to 3 or 6 months after injury due to axon sprouting and frustrated regeneration causing
retrograde (distal to proximal) axon growth [503]. Frustrated growth is expected in MNI implantation
because the interface creates a partial physical block to further axon growth.
The processing method, using osmium tetroxide, caused hardening of tissues with high lipid con-
centrations, and some samples did not section cleanly, causing smearing or breaking of the section. By
regularly changing the microtome blade this could be overcome, and high definition sections similar to
those reported by Di Scipio et. al. were obtained [504].
Muscle mass changes showed atrophy in both the tibialis anterior and the biceps femoris. This
occurred to a much greater extent in the more distal muscle, the tibialis anterior, due to the location
of the sciatic nerve transection. After 3 months a previous MNI study showed less extensive tibialis
anterior atrophy than observed here, this may be due to the one month difference in end-point, and to
interface and surgical variation [51]. The use of the contralateral muscles as a control may misrepresent
the changes in muscle mass: due to compensation by the non-operated limb hypertrophy may be present.
The sciatic function index and observation did not show a return to full function in either treatment
group, with median SFIs of approximately -50 observed after 8 weeks. There was no statistical dif-
ference observed in recovery rate between the two groups; however, the untreated control group values
consistently lagged the treated group in weeks 1 to 7. Assuming the linear trends observed continue full
function could be expected to return after 183 days for the control group and 132 days for the treatment
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group. However, this might not be true in practice because not all axons will regenerate and innerva-
tion patterns will be different. In addition, delayed reinnervation will cause loss of muscle mass and
function, leaving some more permanent loss of function. Functionally the implantation of MNIs causes
severe changes, in contrast implants which do not require nerve transection allow for rapid recovery of
function, within 4 weeks post operatively for Utah Array implantation. When compared with a previous
study of long nerve defects (12 mm gap, SFI <-80 after 12 weeks), the SFI values and rate of recovery
indicate good nerve function following regeneration through the MNI [368]. However, short defects
which do not disrupt nerve continuity (e.g. 5 mm nerve crush), recover much more quickly and more
completely than MNI implantation: recovery to approximately SFI = -10 have been observed within 4
to 8 weeks [503, 508].
Motor and neural spikes were observed in some cases following MNI implantation. Neural spike
amplitudes were within the range of previous recordings from in vivo MNIs [51, 148, 156]. Similarly
motor unit action potentials conformed with previous findings. Due to the limitations of the stimulation
equipment stimulus ramps could not be used to look for stimulation thresholds. All recorded SNRs were
greater than the commonly accepted standard, SNR ≥ 5 [52]. However, these SNRs were calculated
from identifiable spikes, setting an arbitrary minimum due to spikes which were either below the noise
level or not identified due to their similarity to noise. The use of automated spike sorting may overcome
this difficulty and provide a more objective measure of the noise and signal levels in MNI recordings
[54, 170, 171].
6.4.4 General Discussion
It is concluded that stacked microchannel neural interfaces are suitable for in vivo use, although modific-
ations and improvements are required. The interface coatings tested do not provide sufficient improve-
ments to support their use in future application; however, there is still a need for treatments to improve
neural regeneration within MNIs. One such treatment, fibrin, has shown unexpected promise, and should
be examined in future.
One case where MNIs may present an advantage is during targeted muscle reinnervation (TMR, see
chapter 2). For TMR nerves are transected and coapted to new, fresh muscle, close to the innervation
point. Because the nerve already undergoes a type 5 injury [64] a conduit or MNI can be interposed
during the reinnervation surgery. This may reduce the number of axons with reinnervate the target
muscle; however the MNI would allow direct sensory feedback, achieving targeted sensory reinnervation
[232] without the need for coaption to cutaneous nerves and providing a direct route to stimulate the
nerve rather than using the reinnervated skin.
Other alternative implantation methods have already been used with MNIs. Teased nerve rootlets
have been placed in microchannels, avoiding the need to transect the nerve, enabling recordings from
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day 1 following implantation and avoiding the injury and recovery time associated with transection
[153, 154]. This should be investigated in peripheral nerves in ex vivo, cadaveric, and if feasible in vivo
studies.
In comparison to previous studies the rate of survival (96%) in this experimental series was good.
In this study one superficial perioperative infection was observed at the normal study end point and one
loss during anaesthesia occurred during implantation in a total of 28 animals, no significant autotomy
was noted beyond toenail trimming in a few animals. Previous MNI studies have reported excellent,
100%, levels of recovery: 14/14 in [51]; 23/23 reported in [154]); 7/7 reported in [470]; 1/1 reported
in [147]. In contrast some studies state poor survival rates for rat sciatic nerve transection studies (35%,
30/86 in [514]): it is key that studies are carried out to minimise this loss, the choice of appropriate
strains (Lewis or Wistar), housing, anaesthesia and experimental protocol (e.g. minimising gap length)
will go some way to increasing survival rates [497].
Improvements to the study design should be considered in future. In particular the requirement to
carry out terminal anaesthesia for electrophysiology in this study. Chapter 2 of this thesis and previous
studies with MNIs have demonstrated the use of hard wired connections for muscle and nerve recordings
[148]. Recovery could be monitored both through function (SFI, nightly walking distance), and through
electrophysiology during normal behaviour, while reducing the number of animals. The combination of
MNI technology with ITAP bone anchored devices will make this possible in large animal models, and
modified bone anchored devices could be used to provide long-term head stages for small animal studies.
The in vivo experiments presented in this chapter are limited by the model chosen. Rats are known
to regenerate more quickly than humans [498], and other differences, such as nerve diameter and time
following amputation (nerve transection in this case) will alter the rate and ability of the nerve to re-
generate [143, 277]. Longer and larger nerves are present in larger animal models [496]; however, this
change to study design would be costly, and ethical concerns and reduced availability of suitable immun-
ological probes may make large models less suited. Further work is required to refine and improve upon
microchannel neural interfaces in order to ensure that, in future, they can provide the best possible upper
limb function for human amputees.
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Chapter 7
General Discussion, Contribution to Scientific
Research and Proposals for Future Work
This chapter summarises the key findings and conclusions of this thesis. The work is placed in the
context of current clinical and experimental solutions to amputee prosthetic control. Future work is pro-
posed including improvements required in engineering, experimental and clinical knowledge for the im-
plementation of epimysial electodes, hard-wired interfaces and microchannel neural interfaces (MNIs).
The main aim this thesis was to investigate and improve implantable devices for prosthetic control.
Chapter 1 presented an overview of upper limb amputation and currently available prostheses. The
limitations of current methods were identified, a central issue is the lack of intuitive, responsive sys-
tems. To achieve a more intuitive system it was proposed that an increased number of control signals are
required. Methods for recording these signals from muscle and nerve were described, along with the rel-
evant biology and electrophysiology. Interface designs follow a trade-off between invasivity and selectiv-
ity, this thesis considered two implantable interfaces from low invasivity (epimysial electrodes) to high
invasivity (MNIs). The challenge of biocompatibility for muscle and neural interfaces was considered,
in particular the challenge of encouraging nerve growth within small, long microchannels. Finally, sur-
gical interventions for upper limb amputees were considered, targeted muscle reinnervation (TMR) for
control, and intraosseous transcutaneous amputation prostheses (ITAP) for prosthetic attachment.
Chapter 2 presented the development and testing of a device to record epimysial EMG signals
in cognisant, moving animals and transfer these signals transcutaneously. The design was shown to
function for 19 weeks in vivo with recordable EMG signals in the majority of cases. The flange design
was found to cause skin failure at sharp edges, and a domed implant design was proposed. Further,
TMR was examined in a sheep model and recovery in gait and muscle activity was observed in tandem.
This model is proposed for further investigation including active electrode designs and RPNI-like free
muscle-flap implantations [230, 231].
This thesis has contributed to the literature surrounding the use of bone-anchored devices for bi-
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osignal transmission. This work improved upon research by Pitkin et al [241] and similar ideas have
led to the implementation of signal transmission in two-part osseointegrated prostheses [233, 281]. The
initial pilot study was published [1], leading to discussion of the use of our ovine lower limb model
for evaluating alternative muscle interface designs and signal transmission methods. Tripolar electrode
configurations are of particular interest, and the manufacturing methods described in Chapter 5 of this
thesis could be implemented to design a single interface with both tripolar and bipolar interfaces for a
direct comparison. The research group which undertook this study of implanted muscle electrodes are
undertaking further research to apply this design for human upper limb amputees, and funding for this
has been has been granted from a charitable organisation (RAFT).
Targeted muscle reinnervation is in clinical use at a small number of centres. However, there is
limited evidence surrounding the biological limits of TMR. Research into regenerative peripheral nerve
interfaces has led to the use of smaller and smaller free muscle flaps [230, 231, 522]; however it is not
known how multi-flap systems will survive or degrade over timescales required for clinical use (years).
The extent of crosstalk in TMR is not widely discussed and should be examined in a multi-muscle
system, the model presented in this work would be suitable for evaluating crosstalk by using up to the
6 muscles identified 1. Clinical observations have shown that during reinnervation and training motor
nerves coapted to a single muscle become coordinated [personal correspondence], the ability to monitor
biosignals during recovery provided by our model will allow this to be examined in detail. By recording
with a neural cuff interface on a coapted nerve and an epimysial interface on the reinnervated muscle,
correlation between the recorded ENG and EMG signals could be calculated to assess the extent of
coordination.
The implantable EMG based control system proposed overcomes some issues with current pros-
thesis control: electrode lift-off; repeatable placing of electrodes; etc.. However, standard muscle based
control will not provide intuitive control over hand movement in cases of transhumeral amputation or
shoulder disarticulation. TMR may provide more intuitive control by re-routing nerves previously re-
sponsible for hand and limb movement to surrogate muscles; however, there are limits on the number of
control signals due to muscle and nerve availability. Nerves cannot be dissected sufficiently to map the
nerve fibres responsible for a single muscle in the amputated limb to a single surrogate muscle. There-
fore, a more intuitive control system is needed, this may be achieved using neural control. Neural control
systems could increase the number of control signals, and provide sensory feedback by stimulating the
nerve. Recording neural signals is challenging: extracellular nerve voltages are small; and fibrosis at
the implant–nerve interface can hinder recordings. Following investigation into epimysial interfaces
the use of MNIs was considered because these interfaces confine regenerating axons within small dia-
meter, insulating, channels in theory increasing the signal voltage and avoid problems associated with
1All 6 muscles could not be used in a TMR model, however muscle proximity will allow crosstalk to be determined.
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Node of Ranvier position. However, MNIs require that the nerve is resected, and regenerates within the
interface. Although the greatest improvement in signal voltage should be achieved with long, narrow mi-
crochannels, nerves do not regenerate well through small structures and the channels become occluded
by fibrosis. To improve MNI function the neurocompatibility of the interfaces must be improved.
The neurocompatibility of a range of surface modifications and topographies was assessed in this
thesis. Chapter 3 investigated the effect of basement membrane proteins on neurocompatibility of silic-
one surfaces using a neural-like cell where neurite outgrowth was quantified. It was hypothesised that
basement membrane proteins would improve neurite outgrowth, and that combining BM proteins would
further improve neurocompatibility. This chapter demonstrated that BM proteins improve neurocom-
patibility in vitro with some noted exceptions. It was found that altering the order of application when
combining BM proteins significantly affects neurite outgrowth, with pre-mixed coatings performing as
well as the best layer-by-layer coatings. It was also found that coatings without Nidogen-1 performed
significantly worse than the best coatings in vitro. This was found to be as good as commercial standard
coatings and indicates coatings or gel fillers formed of BM proteins will improve neural regeneration in
vivo.
Previous research has suggested that the natural regeneration pathway should be mimicked to en-
courage axon regeneration, and that protein specificity may be important in the mechanisms of neural
growth [179]. In this study neural specific protein isoforms (laminin-2) were compared with generic,
commonly used isoforms (laminin-1), this test demonstrated no significant differences; however, the
concept that specific protein isoforms are more suited has not been disproven [179]. Therefore, this
study should be carried out again with a larger sample and a more suitable cell type (e.g. dorsal root gan-
glion neurons). It has been demonstrated that neural specific protein mixes can be formed, avoiding the
problems with Matrigel™-like ECM gels (poorly characterised, containing high levels of growth factors,
and with batch-to-batch variability) [294–296]. The protein concentrations achieved were measured, but
the change in concentration with time was not investigated, it can be expected that the protein coating
will partially desorb and be remodelled and replaced in vivo as the nerve regenerates over the few mm of
the MNI; however this needs to be investigated. A move to standardised protein mixes, with known pro-
tein concentrations at the material surface, could improve the understanding of how the protein interface
effects neurite extention and neurocompatibility.
Chapter 4 investigated the effect of multiscale grooved and roughened topographies on neural-like
cell neurite outgrowth. It was hypothesised that combining grooves and nanoscale roughening would
have a synergistic effect on neural-like cell number and neurite outgrowth in vitro. Roughening was
found to increase the number of neurites, while grooves increased the length of neurites, reduced neurite
number and caused neurites to align through contact guidance. A synergistic effect was observed where
roughening increased the number of neurites on grooved samples. Where protein mixtures investigated
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in Chapter 3 were used to coat multiscale surfaces the coatings altered the extent of cell polarisation
dependent upon on the underlying surface. These results indicate that grooved and roughened multiscale
topographies could be used within microchannel neural interfaces in vivo to improve nerve regeneration
within microchannels.
Multiscale or hierarchical topographies have been considered in vitro recently [376,378,379]; how-
ever, prior to this thesis this multiscale topographical biomimicry had not been applied to a neurocom-
patibility system. While similar to the artificial and natural Schwann-cell like topographies which have
shown promise in vitro [341, 365], introducing a roughening stage allows mimicry of sub-cell (ECM)
scale structures and could be used to tailor or enhance protein and cell adhesion.
The aim of both the in vitro studies of neurocompatibility was to develop a surface treatment which
could be applied to a microchannel lumen for in vivo implantation. Of these only the BM protein coating
was tested in vivo (chapter 6). Multiscale topographies could be applied to the MNIs developed in
chapter 5; however, this would require precise patterning within areas of the electrode layers, while
leaving unmodified flat surfaces for plasma bonding. Alternative methods include using removable or
dissolvable formers, or post-processing the silicone surface to leave a microstructure. These surface
topographies should be tested in vivo, and could be applied in a simpler in vivo test as the surface
of a nerve guidance conduit, where the topography could be applied to a flat silicone surface using the
negative template method described in this thesis, and where the flat surface is rolled to form the conduit.
To bring either of these surface modifications to clinical practice will require regulatory approval.
The regulatory approval for the inclusion of a modified topography within a MNI can expected to be not
substantially different from the requirements for approval of the MNI itself. However, the addition of a
protein or protein mixture within the MNI can be expected to increase the regulatory burden. Xenogenic
proteins have been given approval for use in nerve repair (e.g. NeuraGen® nerve guidance conduits,
formed from bovine type I collagen) [76], and allogenic and recombinant proteins have been approved
for use as drugs. In this work a combination of human (collagen-IV, laminin-2,-4, fibonectin), xenogenic
(laminin-1, ECM Gel), and recombinant human (nidogen-1) proteins have been used, it may be costly to
use all human or all recombinant human origin proteins; however this may be required for the coating to
be approved for clinical use.
Both studies of neurocompatibility presented in this thesis focussed upon PC-12 cells, an immortal-
ised cell line. This work should be expanded to consider the non-neuronal cells present in the peripheral
nerves, for example Schwann cells, and to assess the surfaces with a primary neural cell culture, for
example dorsal root ganglion (DRG) neurons. This would allow in vitro assessment of the glial and
neuronal response likely in vivo, but in a simplified system. The effects of basement membrane protein
combinations and multiscale topographies on gene expression in both Schwann cells and DRG neurons
could be examined using quantitative real-time PCR. In addition, an in vitro study of competitive adhe-
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sion could be used to determine the extent to which fibroblasts (in part responsible for fibrosis) adhere
to the surfaces compared with Schwann cells or neural cells.
Chapter 5 presented the manufacture and preliminary bench-testing of MNIs using 4 different
methods. Equipment and budget limitations determined the manufacturing processes chosen. It was
concluded that stacking of single microchannel layers was most suited to the manufacture of MNIs.
Working in thin film processes followed by plasma bonding enabled the formation of structures in 2-
and 3-dimensions. In addition, electroetching was used to increase electrode surface area and reduce
electrode impedance.
Improvements to MNI manufacture were achieved in this thesis. Stacking thin microchannel layers
allows an increased number of instrumented channels; however, this advantage was not exploited in vivo
in this thesis, due to the small size of the rat sciatic nerve, and thickness of the stacked layers. One
immediate improvement would be to reduce the silicone thickness in the electrode layer, allowing more
layers per stack. This could be accomplished using the laser patterning technology used in this thesis, or
alternatively photosensitive polyimide or silicone thin films and evaporated gold could be used allowing
further minaturisation of both the tracks and the microchannels [146, 149–152].
The mechanical properties of the interfaces manufactured in this project have not been assessed.
Experience while handling indicated that, although slightly flexible, the implants were robust and much
stiffer than the neural tissue. Accelerated tests should be used to determine whether plasma bonding is
suitable to hold layers for long-term implantation: the adhesion strength of plasma bonded samples could
be tested following a time course in heated saline with the Arrhenius equation used to determine bond
lifetime [523,524]. In addition, bending tests should be carried out on the electrode layers, to determine
the modulus of elasticity, and fatigue testing should be used to determine whether the interface will
survive movements associated with upper limb implantation. Cyclic 4-point bend testing could be used
to mimic forces experienced by the MNI during implantation and caused by muscle movement around
the interface in vivo.
In this thesis MNI manufacture was carried out in a batch process, with substrates mounted on small
glass slides. For larger scale production of a similar device the batch processing route may be suitable,
but a larger substrate carrier should be considered. For spiral MNI designs a 4′′ diameter silicon wafer is
used, allowing multiple interfaces to be manufactured on one carrier [151]. To plasma bond larger areas
in a controlled manner a flip-chip bonder could be used, to apply thermal-compression across the whole
interface surface. In addition, the use of a flip-chip bonder would allow more precise alignment of the
interface layers reducing the potential for wastage during manufacture.
Previous work on MNIs has proposed reducing the number of connections to and from the inter-
face while increasing the number of instrumented channels by coupling the MNI to an amplifier and
multiplexer at the implant site, creating an “active” array [151]. The ability to form MNIs by stacking
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layers lends itself well to the introduction of application specific integrated circuits (ASICs). A thinned
ASIC [525] could be used as a bus to connect multiple layers, amplify the signals and multiplex the
channels, reducing the number of cores required for cable transfer and reducing the likelihood of cable
artefact. Alternatively ASICs could be stacked in individual layers, either connected to the electrode
tracks, or with electrodes formed directly on the ASIC surface.
The use of “active” implants may also be useful for epimysial electrodes. Where many electrodes
are needed to record from multiple locations in an amputation stump a multiplexing system could be used
to reduce the number of cores passing through the bone-anchored device. In addition, amplification and
digitisation at the electrode site could be used to reduce susceptibility to cable artefact, cable impedance
noise, and external noise.
Chapter 6 investigated the performance of stacked MNIs in a rat sciatic nerve model. First, suture
and fibrin glue were compared as interface fixation methods, the nerve was seen to follow the fibrin
glue outside the interface lumen, therefore sutures were used to attach the interfaces for the second
experiment. In the second experiment the influence of all-in-one BM protein coatings on functional,
histological and electrophysiological outcomes was investigated. Some weak evidence for the use of
protein coatings was found, in particular improvements in distal axon diameters. Nerve regeneration
within stacked MNIs was within the ranges of previous studies, and alternative implantation methods or
improvements to the interface design may reduce frustrated axon sprouting and improve the regeneration
across MNIs.
This thesis has not demonstrated that MNIs are suitable for clinical investigation. First, MNIs can-
not be tested in short-term clinical studies, the implantation method tested in this thesis requires nerves
to regenerate before signals can be recorded. This may take over one month and will depend upon the
regenerative potential of nerves following long-term amputation. Second, this thesis has demonstrated
no dramatic improvement to MNI function or regeneration over previous studies. There is still a need to
test alternative solutions to improve the neurocompatibility of MNIs.
Alternative methods of MNI implantation have been used to avoid the long recovery times associ-
ated with nerve transection [153, 154]. The teased rootlet concept could be applied to peripheral nerves
to separate either fascicles, or small axon bundles. By laying these within instrumented microchannels,
then sealing the microchannels, recordings could be made immediately in vivo, and functional impair-
ment could be reduced.
For clinical use MNIs must remain functional over the lifetime of the patient. For active amputees,
the main target population for advanced prosthesis interfaces, lifetimes of more than 50 years may be
required. Studies of MNIs from acute implantation up to 5 months in vivo have been carried out to
date [51,148,153,154,156]. To better understand the chronic response to MNIs longer implantation times
should be considered. Head-stages or bone-anchored devices will allow recording from the interfaces
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throughout a study [148], by using regular or continual monitoring implantation times of one year or
above could be considered. For longer implantations the rat model may not be suitable due to the
expected mean lifetime2, in this case a larger animal model must be considered.
In clinical practice TMR and MNI interventions have major differences when compared with the
models used in this thesis. In particular, nerves of interest in upper limb amputees will have undergone
long delays, of months to years [227,229,274], prior to the surgical intervention. The effect of prolonged
axotomy on axon regeneration for TMR and MNI implantation should be examined [277]. For MNIs an
additional complication is present: the absence of an end organ. In this thesis nerve regeneration through
the MNI was presented with the natural reinnervation pathway (the sciatic nerve innervation), while in
amputees a surrogate end organ may be required. The role of end organ in regeneration through MNIs
should be assessed, and in addition, the potential to interpose MNIs during TMR could be investigated.
Implantable devices are promising interventions to provide improvements in hand control for upper-
limb prosthesis users. This thesis has investigated two such devices and demonstrated incremental im-
provements in device design. However, to achieve “intuitive, closed-loop, adaptive, and robust real-time
control” [14] further pre-clinical research and development is required.
7.1 Conclusions
Detailed conclusions to each study have been presented in the relevant experimental chapters of this
thesis. Key conclusions for each experimental chapter are summarised below.
Chapter 2 A bone-anchored device is suitable for transcutaneous signal transmission from epimysial elec-
trode(s) in cognisant moving animals and can be used to monitor recovery following targeted
muscle reinnervation.
Chapter 3 Endoneurial basement membrane protein coatings increase neurite outgrowth on silicone surfaces;
however, coating order and constituents can significantly affect neurite outgrowth.
Chapter 4 Multiscale surfaces with µm-scale grooves and nm-scale roughness can cause neurite alignment
and synergistically enhance neurite outgrowth.
Chapter 5 Stacking microchannel layers by plasma bonding is a suitable method for manufacturing mi-
crochannel neural interfaces which can overcome some problems with channel sealing and elec-
trode number.
Chapter 6 Peripheral nerve will regenerate through stacked microchannel neural interfaces; however, there is
inconclusive evidence that endoneurial basement membrane microchannel coatings improve nerve
regeneration.
2Mean laboratory rat lifetime is approximately 3 years [526]. Studies of more than 1 year can expect to run into problems
associated with natural lifespan.
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7.2 Future Work
In this thesis further hypotheses and extensions to the work have been proposed. Key proposed future
work is listed briefly below.
• Develop an active, hard-wired, multichannel epimysial electrode system for use with a bone-
anchored transcutaneous device.
• Develop a fail-safe mechanism and hermetic seal for the cable connection to the bone-anchored
transcutaneous device.
• Use a domed rather than rectangular cross-section flange for future bone-anchors to reduce epi-
dermal damage.
• Use the multichannel epimysial electrode system to investigate cross-talk from different electrode
configurations (e.g. tripolar) with and without targeted muscle reinnervation.
• Investigate the effect of learning following targeted muscle reinnervation.
• Investigate the response of primary neural and Schwann cell cultures to endoneurial basement
membrane proteins and multiscale topographies.
• Apply additional methods to the in vitro testing of neurite outgrowth including automated analysis
and qPCR.
• Investigate the lifetime, conformation and desorption of endoneurial basement membrane proteins
on silicone surfaces in a model in vitro environment.
• Investigate alternative laminin isoforms (e.g. laminins -8, -9 and -11).
• Carry out a multifactorial in vitro analysis of the effect of mixed endoneurial basement membrane
proteins on neurite outgrowth.
• Develop an in vitro microchannel model (transwell microfluidics) to investigate neurite outgrowth
through modified microchannels.
• Apply multiscale topographies to microchannels within a microchannel neural interface and in-
vestigate their effect in vivo.
• Increase the open cross sectional area of the microchannel neural interfaces by using thinner elec-
trode layers or by using alternative manufacturing techniques.
• Apply the stacking technique to form microchannel neural interfaces with medical grade silicones
(e.g. MED-1000) and metals more suited to long term implantation (e.g. Platinum).
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• Develop an active microchannel neural interface with either: an active bus ASIC; or with stacked
ASICs as electrode layers.
• Investigate the use of fibrin glue as a filler for the microchannel neural interface lumen.
• Investigate the effect of prolonged axotomy on neural regeneration for targeted muscle reinnerva-
tion and microchannel neural interfaces.
• Investigate the effect of an interposed microchannel neural interface on regeneration for targeted
muscle reinnervation.
• Develop a head-stage or other system for continual microchannel neural interface signal monitor-
ing from cognisant, behaving animals.
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Appendices
A Few Notes on Methodology
Mead’s Resource Equation was used to estimate sample sizes. A minimum size of n = 6 was set for all
non-exploratory experiments. For in vitro exploratory experiments both qualititive and quantitive data
were used, the β = 0.8 level of statistical power was not assumed, and a minimum sample size of n =
3 was set. For in vivo exploratory experiments both qualititive and quantitive data were used, statistical
power was not assumed, and a minimum sample size of n = 1 was set.
Statistical significance for all tests was set at α=0.05. To correct for multiple comparisons, keeping
the family-wise error rate less than α=0.05, the Holm-Bonferroni approximation was used, a refinement
of the Bonferroni correction [319, 527]. Briefly, all the relevant ‘m’ pairwise comparisons are made and
the p-values are ranked from lowest to highest (P 1 to Pm). The α for each for each ranked pairwise
comparison (αk) is modified such that αk = αm+1−k . An ordered series of αk (or pcut) are given:
0.05, 0.025, 0.016˙, 0.0125, 0.01, 0.0083˙, 0.00714..., 0.00625, 0.005˙, 0.005, 0.004˙5˙, 0.00416˙, 0.0038...,
0.0036..., 0.003˙, 0.003125.
For example 3 p-values are recorded from a family of tests, pa=0.57, pb=0.04 and pc=0.01. Without
correcting for multiple comparisons b and c would be considered significant. The ranked values are
as follows p1=0.01, p2=0.04 and p3=0.57. α1 = α3+1−1 therefore α1 =
0.05
3 = 0.16˙, p1=0.01<α1,
therefore the null hypothesis c can be rejected. α2 = α3+1−2 therefore α2 =
0.05
2 = 0.025, p2=0.04>α2,
therefore the null hypothesis b cannot be rejected. Once a null hypothesis is rejected all tests with larger
values of k are also not significant, therefore the null hypothesis a cannot be rejected.
For all tests Shapiro-Wilk tests of normality were carried out on each group. The presence of non-
parametric data (not normally distributed), and / or n<25 for all tests, required the use of non-parametric
statistical tests. These include:
Kruskal-Wallis Test A non-parametric one-way ANOVA test for k independent samples. p <α indic-
ates that at least one group is significantly different from all the others.
Mann-Whitney U Test A non-parametric test for 2 independent samples. p <α indicates that there is a
significant difference between the two groups.
Spearman’s Rank Correlation Coefficient A non-parametric measure of bivariate statistical depend-
ence. A +ve value indicates a positive correlation between x and y values. A value of 1 or -1
indicates that the data can be described using a monotonic function. Also known as Spearman’s ρ.
Wilcoxon signed-rank test A non-parametric test for 2 related samples. p <α indicates that there is a
significant difference between the two groups.
Statistical tests were carried out using SPSS versions 20, 21, and 22 for Linux and Windows (IBM).
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Tables of p-values
Poly-D-Lysine Concentration
Neurite Number Neurite Length Cell Number
p-Value 0.078 0.000 0.001
Table 1: Kruskal Wallis Test results for Poly-D-Lysine Concentration Series. 4, 10 and 20 µg/cm2 at 96
hours. pcut = 0.05, bold values are statistically significant.
PDL Concentration µg/cm2
20 10 4 2
PDL Concentration µg/cm2
20 - 0.956 (0.05) 0.21 (0.017) 0.043 (0.01)
10 - 0.174 (0.013) 0.023 (0.008)
4 - 0.412 (0.025)
2 -
Table 2: Mann-Whitney U test results for Neurite Number on Poly-D-Lysine Concentration Series. 4,
10 and 20 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
PDL Concentration µg/cm2
20 10 4 2
PDL Concentration µg/cm2
20 - 0.000 (0.008) 0.001 (0.01) 0.019 (0.017)
10 - 0.093 (0.025) 0.002 (0.0125)
4 - 0.259 (0.05)
2 -
Table 3: Mann-Whitney U test results for Neurite Length on Poly-D-Lysine Concentration Series. 4, 10
and 20 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
PDL Concentration µg/cm2
20 10 4 2
PDL Concentration µg/cm2
20 - 1.000 (0.05) 0.004 (0.008) 0.004 (0.01)
10 - 0.002 (0.017) 0.002 (0.0125)
4 - 0.485 (0.025)
2 -
Table 4: Mann-Whitney U test results for Cell Number on Poly-D-Lysine Concentration Series. 4, 10
and 20 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Collagen IV Concentration
Neurite Number Neurite Length
p-Value 0.217 0.000
Table 5: Kruskal Wallis Test results for Collagen IV Concentration Series. 1, 5 and 10 µg/cm2 at 96
hours. pcut = 0.05, bold values are statistically significant.
Collagen IV µg/cm2
10 5 1
Collagen IV µg/cm2
10 - 0.000 (0.017) 0.000 (0.025)
5 - 0.001 (0.05)
1 -
Table 6: Mann-Whitney U test results for Neurite Length on Collagen IV Concentration Series. 1, 5 and
10 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
Collagen IV µg/cm2
10 5 1
Collagen IV µg/cm2
10 - N/A N/A
5 - N/A
1 -
Table 7: Mann-Whitney U test results for Neurite Number on Collagen IV Concentration Series. 1, 5
and 10 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
Neurite Number Neurite Length
p-Value 0.942 0.063
Table 8: Kruskal Wallis Test results for Collagen IV Concentration Series. 10, 20 and 40 µg/cm2 at 96
hours. pcut = 0.05, bold values are statistically significant.
Collagen IV µg/cm2
40 20 10
Collagen IV µg/cm2
40 - 0.692 (0.05) 0.229 (0.017)
20 - 0.43 (0.025)
10 -
Table 9: Mann-Whitney U test results for Neurite Length on Collagen IV Concentration Series. 40, 20
and 10 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Collagen IV µg/cm2
40 20 10
Collagen IV µg/cm2
40 - 0.114 (0.025) 0.02 (0.017)
20 - 0.453 (0.05)
10 -
Table 10: Mann-Whitney U test results for Neurite Number on Collagen IV Concentration Series. 40,
20 and 10 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Laminin-2 (-4) Concentration
Neurite Number Neurite Length
p-Value 0.388 0.000
Table 11: Kruskal Wallis Test results for Laminin Concentration Series. 1, 2 and 5 µg/cm2 at 96 hours.
pcut = 0.05, bold values are statistically significant.
Laminin µg/cm2
5 2 1
Laminin µg/cm2
5 - 0.166 (0.05) 0.000 (0.017)
2 - 0.006 (0.025)
1 -
Table 12: Mann-Whitney U test results for Neurite Length on Laminin Concentration Series. 1, 2 and 5
µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
Laminin µg/cm2
5 2 1
Laminin µg/cm2
5 - 0.166 (0.017) 0.428 (0.025)
2 - 0.597 (0.05)
1 -
Table 13: Mann-Whitney U test results for Neurite Number on Laminin Concentration Series. 1, 2 and
5 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
Neurite Number Neurite Length
p-Value N/A N/A
Table 14: Kruskal Wallis Test results for the second Laminin Concentration Series. 0.1, 0.5 and 1 µg/cm2
at 96 hours. pcut = 0.05, bold values are statistically significant.
Laminin µg/cm2
0.1 0.5 1
Laminin µg/cm2
0.1 - N/A N/A
0.5 - 0.0264 (0.05)
1 -
Table 15: Mann-Whitney U test results for Neurite Length on the second Laminin Concentration Series.
0.1, 0.5 and 1 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Laminin µg/cm2
0.1 0.5 1
Laminin µg/cm2
0.1 - N/A N/A
0.5 - 0.0037 (0.05)
1 -
Table 16: Mann-Whitney U test results for Neurite Number on the second Laminin Concentration Series.
0.1, 0.5 and 1 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Fibronectin Concentration
Neurite Number Neurite Length Cell Number Alamar Blue Assay Hoescht DNA Assay
p-Value N/A N/A 0.001 0.001
Table 17: Kruskal Wallis Test results for Fibronectin Concentration Series. 1, 2 and 5 µg/cm2 at 96
hours. pcut = 0.05, bold values are statistically significant.
Fibronectin µg/cm2
5 2 1
Fibronectin µg/cm2
5 - 0.000 (0.017) 0.000 (0.025)
2 - 0.000 (0.05)
1 -
Table 18: Mann-Whitney U test results for Alamar Blue flourescence on Fibronectin Concentration
Series. 1, 2 and 5 µg/cm2. pcut in brackets, bold values are statistically significant.
Nidogen-1 Concentration
Neurite Number Neurite Length Cell Number Alamar Blue Assay Hoescht DNA Assay
p-Value N/A N/A 0.000 0.487
Table 19: Kruskal Wallis Test results for Nidogen-1 Concentration Series. 0.5, 1 and 2 µg/cm2 at 96
hours. pcut = 0.05, bold values are statistically significant.
Nidogen-1 µg/cm2
2 1 0.5
Nidogen-1 µg/cm2
2 - 0.000 (0.017) 0.000 (0.025)
1 - 0.000 (0.05)
0.5 -
Table 20: Mann-Whitney U test results for Alamar Blue flourescence on Nidogen-1 Concentration
Series. 0.5, 1 and 2 µg/cm2 at 96 hours. pcut in brackets, bold values are statistically significant.
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Poly-L-Orthinine Concentration
Neurite Number Neurite Length Cell Number Alamar Blue Assay Hoescht DNA Assay
p-Value N/A N/A 0.059
Table 21: Kruskal Wallis Test results for Poly-L-Orthinine Concentration Series. 5, 10, 20 and 40 µg/cm2
at 96 hours. pcut = 0.05, bold values are statistically significant.
Laminin-2,(-4) and Laminin-1
Neurite Number Neurite Length Cell Number
p-Value 0.0554 0.4396 0.635
Table 22: Mann-Whitney U test results for 1 µg/cm2 Laminin-1 and 1 µg/cm2 Laminin-2,-4 coatings at
96 hours. pcut = 0.05, bold values are statistically significant.
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Comparison of Optimal Concentrations
Neurite Number Neurite Length
p-Value 0.000 0.000
Table 23: Kruskal Wallis Test results for optimal coating concentrations. Untreated silicone, 10 µg/cm2
Collagen IV, 1 µg/cm2 Laminin-2,-4, 10 µg/cm2 Poly-D-Lysine, and CNL layer-by-layer at 96 hours.
pcut = 0.05, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
PDL C-IV Ln-2,-4 CNL
PDL - 0.000 (0.008) 0.004 (0.05) 0.000 (0.010)
C-IV - 0.000 (0.013) 0.003 (0.025)
Ln-2,-4 - 0.001 (0.017)
CNL -
Table 24: Mann-Whitney U test results for Neurite Length on the optimal coating concentrations. 10
µg/cm2 Collagen IV, 1 µg/cm2 Laminin-2,-4, 10 µg/cm2 Poly-D-Lysine, and CNL layer-by-layer at 96
hours. pcut in brackets, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
PDL C-IV Ln-2,-4 CNL
PDL - 0.000 (0.008) 0.000 (0.010) 0.000 (0.013)
C-IV - 0.225 (0.05) 0.002 (0.025)
Ln-2,-4 - 0.000 (0.017)
CNL -
Table 25: Mann-Whitney U test results for Neurite Number on the optimal coating concentrations. 10
µg/cm2 Collagen IV, 1 µg/cm2 Laminin-2,-4, 10 µg/cm2 Poly-D-Lysine, and CNL layer-by-layer at 96
hours. pcut in brackets, bold values are statistically significant.
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Comparison of Multi-Protein Coatings: Experiment 1
Neurite Number Neurite Length
p-Value 0.012 0.000
Table 26: Kruskal Wallis Test results for multi-protein coating concentrations. Experiment 1. ECM Gel,
CNL all-in-one, CNL layer-by-layer and LNC layer-by-layer at 96 hours. pcut = 0.05, bold values are
statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
ECM Gel All-in-one CNL CNL Layer-by-layer LNC Layer-by-Layer
ECM Gel - 0.996 (0.05) 0.902 (0.025) 0.010 (0.010)
All-in-one CNL - 0.843 (0.017) 0.006 (0.008)
CNL Layer-by-
layer
- 0.018 (0.013)
LNC Layer-by-
Layer
-
Table 27: Mann-Whitney U test results for Neurite Length on multi-protein coating concentrations.
Experiment 1. ECM Gel, CNL all-in-one, CNL layer-by-layer and LNC layer-by-layer at 96 hours. pcut
in brackets, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
ECM Gel All-in-one CNL CNL Layer-by-layer LNC Layer-by-Layer
ECM Gel - 0.424 (0.05) 0.313 (0.025) 0.000 (0.013)
All-in-one CNL - 0.090 (0.017) 0.000 (0.010)
CNL Layer-by-
layer
- 0.000 (0.008)
LNC Layer-by-
Layer
-
Table 28: Mann-Whitney U test results for Neurite Number on multi-protein coating concentrations.
Experiment 1. ECM Gel, CNL all-in-one, CNL layer-by-layer and LNC layer-by-layer at 96 hours. pcut
in brackets, bold values are statistically significant.
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Comparison of Multi-Protein Coatings: Experiment 2
Neurite Number Neurite Length
p-Value 0.001 0.003
Table 29: Kruskal Wallis Test results for multi-protein coating concentrations. Experiment 2. ECM Gel,
CNL all-in-one, LC layer-by-layer, CL layer-by-layer, CL all-in-one and 10 µg/cm2 C-IV at 96 hours.
pcut = 0.05, bold values are statistically significant.
p-value
(and
Bonferroni-
Holm
cut-off)
ECM Gel All-in-one
CNL
LC Layer-
by-layer
CL Layer-
by-Layer
CL all-in-
one
C-IV
ECM Gel - 0.206
(0.01)
0.019
(0.004)
0.026
(0.004)
0.366
(0.013)
0.431
(0.017)
All-in-one
CNL
- 0.0003
(0.003)
0.0006
(0.004)
0.032
(0.005)
0.042
(0.005)
LC Layer-
by-layer
- 0.9747
(0.05)
0.1449
(0.007)
0.1325
(0.006)
CL Layer-
by-Layer
- 0.1612
(0.008)
0.143
(0.006)
CL All-in-
one
- 0.9394
(0.025)
C-IV -
Table 30: Mann-Whitney U test results for Neurite Length on multi-protein coating concentrations.
Experiment 2. ECM Gel, CNL all-in-one, LC layer-by-layer, CL layer-by-layer, CL all-in-one and 10
µg/cm2 C-IV at 96 hours. pcut in brackets, bold values are statistically significant.
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p-value
(and
Bonferroni-
Holm
cut-off)
ECM Gel All-in-one
CNL
LC Layer-
by-layer
CL Layer-
by-Layer
CL all-in-
one
C-IV
ECM Gel - 0.632
(0.025)
0.0001
(0.003)
0.192
(0.007)
0.011
(0.004)
0.081
(0.006)
All-in-one
CNL
- 0.0009
(0.004)
0.381
(0.013)
0.032
(0.005)
0.181
(0.006)
LC Layer-
by-layer
- 0.0159
(0.004)
0.216
(0.008)
0.0492
(0.005)
CL Layer-
by-Layer
- 0.2169
(0.01)
0.653
(0.05)
CL All-in-
one
- 0.4169
(0.017)
C-IV -
Table 31: Mann-Whitney U test results for Neurite Number on multi-protein coating concentrations.
Experiment 2. ECM Gel, CNL all-in-one, LC layer-by-layer, CL layer-by-layer, CL all-in-one and 10
µg/cm2 C-IV at 96 hours. pcut in brackets, bold values are statistically significant.
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In Vitro Neuron Adhesion Studies: Topography
An Overview of Contact Guidance Studies
Varied Dimen-
sions
Constant
Dimensions
Substrate Cell Type Outcome Ref.
1 µm to 10 µm
pitch
200 nm deep Polystyrene PC-12
neuron-
like
Cells aligned with
smaller 1 µm and
1.5 µm pitch sub-
strates and became
polarised, express-
ing fewer, longer
neurites.
[343,
344]
5 µm to 95 µm
grooves
5 µm ridges,
3.4 µm deep
PMMA Rat radial
glia and
cortical
neurons
Glia adhered and
aligned on 5 µm
to 35 µm grooves,
neurons aligned on 5
µm to 8 µm grooves.
[345]
2 µm to 20 µm
grooves, with 2
µm to 20 µm
ridges
3 µm deep PCL NG108-
15 neuro-
blastoma
and
primary
Schwann
cells
Both cell types
aligned better on
smaller 5 µm to 10
µm features. 5 µm
to 10 µm features
reduced fibroblast
contamination in
primary culture.
[346]
100 nm to 400
nm deep
266 nm pitch Fused
quartz
Chick em-
bryonic
neur-
ons and
kidney
cells.
Kidney cells aligned
better to deeper
grooves, while neur-
ons did not align on
all topographies.
[347]
4 µm to 24 µm
pitch, 0.2 µm
to 2 µm deep
Perspex Chick em-
bryonic
neur-
ons and
kidney
cells.
Cells aligned best on
2 µm deep grooves,
with alignment in-
creasing with groove
depth.
[348]
100 nm to 400
nm width, 200
nm to 2 µm
pitch
300 nm deep PMMA Sympathetic
and sens-
ory
ganglion
neurons
Larger patterns are
more effective, espe-
cially with large (>1
µm) diameter axons.
[349]
20 µm to 60
µm grooves
11 µm deep, 10
µm ridges
Polyimide PC-12 Cells in 20 µm to
30 µm channels ex-
pressed fewer, more
aligned neurites.
[350]
5 µm and 10
µm pitch
2.5 µm deep PLGA PC-12 Alignment, longer
neurites and reduced
neurite number was
observed on 5 µm
and 10 µm pitch.
[351]
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Varied Dimen-
sions
Constant
Dimensions
Substrate Cell Type Outcome Ref.
2 µm to 69
µm deep, 50
µm to 350 µm
grooves
PDMS Rat em-
bryonic
neurons
Axons crossed small
edges (<10 µm
high), while axons
aligned at deeper
edges (>22 µm
high). An optimal
aspect ratio (>0.1)
is implied.
[352]
100 µm to 250
µm grooves
150 µm deep,
250 µm ridges
PLGA Transfected
HEK293T
cells
Neurites aligned and
extended more in
100 µm grooves.
[353]
1 µm to 4 µm
grooves, 14
nm to 1100 nm
deep
Fused
quartz
Xenopus
spinal
neurons
and rat
hippo-
campal
neurons
Xenopus neurons
aligned parallel
to smaller deeper
grooves, while rat
neurites aligned per-
pendicular to small
(<2 µm) grooves
and parallel to larger
(4 µm) and deeper
(>130 nm) grooves.
[354]
1 µm to 2 µm
grooves, 400
nm and 800 nm
deep
PDMS Rat hip-
pocampal
cells
Neurites extended
parallel to wider (2
µm), deeper (800
nm) grooves, and
perpendicular to
narrower (1 µm),
shallower (400
nm) grooves. The
grooves initiated
neurite extension,
and could be en-
hance with growth
factor addition.
[355]
1 µm to 8 µm
grooves, 50 nm
and 800 nm
deep
Quartz Various
CNS,
peripheral
and ol-
factory
neurons.
CNS neurons had
the ability to extend
perpendicularly
on 1 µm grooves,
while wider grooves
tended to suppress
perpendicular align-
ment. Peripheral
nerve cells were
not guided on small
grooves.
[356]
30 µm to 1000
µm grooves, 30
µm to 1000 µm
ridges
50 µm PDMS DRG,
hippo-
campal
neurons,
B104
neuro-
blastoma.
Cells bridged wide
grooves. Narrow
ridges reduced
bridging and in-
crease alignment.
[357]
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Varied Dimen-
sions
Constant
Dimensions
Substrate Cell Type Outcome Ref.
4 µm to 20 µm
pitch, 100 nm
to 1.2 µm deep
Polystyrene Human
fibro-
blasts
Alignment was best
on 10 µm pitch
substrates with deep
(800 nm) grooves.
Increasing aspect
ratio (depth / width)
increases alignment.
[359]
200 nm to 20
µm pitch, 200
nm to 900 nm
deep
Polystyrene Smooth
muscle
cells
Increased depth and
reduced width (ie.
increased aspect ra-
tio) improved align-
ment.
[362]
200 nm to 5 µm
deep
8 µm pitch PDMS Aortic en-
dothelial
cells
Cells aligned better
to deeper (>500 nm)
grooves,
[360]
400 nm to 4 µm
pitch, 75 to 880
nm deep
Silicon Stromal
fibro-
blasts
Alignment was bet-
ter with increasing
depth. Optimal pitch
was around 1 µm.
[361]
800 nm ridge,
100 nm groove,
1200 nm deep.
Silicon PC-12 Grooves enhanced
neuritogenesis and
cell differentiation.
[358]
750 nm to 20
µm pitch
350 nm deep PDMS Mesenchymal
stem cells
Cells aligned
and upregulated
neuronal mark-
ers, especially on
narrower structures.
[363]
10 µm pitch, 1
µm deep
PDMS Primary
em-
bryonic
fibro-
blasts
Grooves induced
neuronal phenotype
with greater effi-
ciency than other
substrates.
[364]
Table 32: An overview of groove/ridge dimensions used in contact guidance studies with neural and
other cell types. Typically pitch refers to total periodicity. Where not explicitly mentioned groove and
ridge widths are assumed to be equal (half the pitch value). Where stated the groove is the concave
section and ridges are the convex section of the periodical structure.
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NCP Periodogram MATLAB Code
1 % The basis for this script was originally written by Prof. Edith Seier ...
(http://faculty.etsu.edu/seier/) based upon work by P.C.Hansen et.al., It was ...
included as part of 'Introduction to Spectral Analysis' which is avalilable ...
online (https://webcache.googleusercontent.com/search?q= ...
cache:QVmA9zI6crkJ:read.pudn.com/downloads164/doc/comm/750295/day3.doc+&cd= ...
7&hl=en&ct=clnk). This Script has been modified to allow the user to print the ...
values of the Kolmogorov-Smirnov test, and to repeat the test for k neurites ...
(k=1:length(series)) in order to determine at which neurite the index can be ...
considered to deviate significantly from white noise. I would also like to ...
thank Marcello DiStasio for his KS test code, although this hasn't directly ...
been included here it inspired me to implement mine in this fashion ...
(http://chelly.us/lab/ks_test). This script is intended to replicate the ...
methods used by Nectow et. al. in their 2012 paper (PMID: 23008168). I would ...
like to thank Alex Nectow and Prof. Kaplan for their help with this and for ...
sending some raw data to get me started. This script correctly replicated the ...
above paper with some slight changes in the way graphs are produced. Users ...
should check the optional "for" statements around lines 265-315 for agreement ...
with the techniques in the above paper.
2 %
3 % Henry Lancashire, 2013
4
5 % Originally this script was designed to load an input file, this has been
6 % removed because it was a regular source of warnings.
7
8 % load a:datafile.dat;
9
10 YN = input('This process will now delete all the variables it needs to continue. ...
\nAre you happy to continue? [Y/N]\n\n','s');
11
12 if YN == 'Y';
13
14 clearvars Angles Diff_Vector LCDF Vector Vector_mean Vector_median Ytot ...
Ytotl ;
15 clearvars acut angles crit critl cuper cupera cuperal cuperl cut cv freq ...
freql ;
16 clearvars h indextot indextotl indfreq indfreql indtext indtextl iperiod ...
iperiodl ;
17 clearvars itime jtime k ksstat ktime largofre largofrel linea lineal maxav ;
18 clearvars maxmedian maxmean maxser maxpow maxpowl n n2 nobs nobsl ;
19 clearvars nyquist nyquistl p pfreq pfreql pmax pmaxl power powerl q ql ;
20 clearvars series seriesl sugarm sugarml sumtruth truth uniform ;
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21
22 elseif YN == 'N';
23
24 disp('Save any variables you need and try again.');
25
26 return
27
28 else
29
30 disp('Unknown answer, please use Y or N.');
31
32 return
33
34 end
35
36 % Data is included in a vector known as 'Angles'. This is the complete list of ...
angles to be sorted.
37
38 Angles = input('Choose vector of neurite angles to be used for NCP calculation.\n\n');
39
40 % Angles are forced to values between 0 and 90, this assumes a range of -180 to ...
180 degrees (extra terms have been added to expand this to -360, 360) , where ...
-180, 0, 180 are perfectly aligned and -90, 90 are perfectly perpendicular to ...
the surface.
41
42 angles = abs(Angles);
43
44 for k=1:(length(Angles))
45
46 if angles(k) <= 90
47 angles(k,1) = angles(k);
48
49 elseif 90 < angles(k) <= 180
50 angles(k,1) = 180 - angles(k);
51
52 elseif 180 < angles(k) <= 270
53 angles(k,1) = angles(k) - 180;
54
55 elseif 270 < angles(k) <= 360
56 angles(k,1) = 360 - angles(k);
57
58 else
59
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60 warning('Warn:Angles','Angle greater than 360 or less than -360 given. ...
\nCalculations will fail because this angle is unaccounted for in ...
for,if condition at approximately line 50. \nCheck your input vector.\n')
61
62 return
63
64 end
65
66 end
67
68
69 % Angles are sorted in ascending order.
70 Vector = sort(angles);
71
72 Diff_Vector = zeros((length(Vector)-1),1);
73
74 % The 'difference vector' is calculated, this calculated the period between a ...
given angle and the next angle.
75 for k=1:(length(Vector)-1),
76 Diff_Vector(k,1)=Vector(k+1)-Vector(k);
77 end;
78
79 % Diff_Vector = Diff_Vector';
80
81 series=Diff_Vector(:,1);
82
83
84 % IMPORTANT: NO MORE INPUT IS NEEDED - 'series' is sufficient
85
86 nobs=length(series); % identifies number of observations in series
87
88 % calculates the periodogram
89 sugarm=series-mean(series); % substracts the mean of the series
90 Ytot=fft(sugarm) ; % finds the Fast Fourier Transform
91 n=length(Ytot) ;
92 n2=floor(n/2)+1; % Floor added to prevent warnings when n2 is index
93 power=(abs(Ytot(1:n2)).ˆ2)/n; % calculates intensities
94 nyquist=1/2;
95 pfreq=(0:1:n/2);
96 largofre=length(pfreq)-1;
97 freq=pfreq/(largofre)*nyquist;
98 mpow=max(power); % finds the maximum intensity
99 pmax=1.1*mpow ;
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100 indextot=find(power==max(power)); % identifies the frequency with the maximum ...
intensity
101 indfreq=freq(indextot);
102 iperiod=1/indfreq;
103
104 indtext=indfreq+0.01 ;
105
106 % calculates cumulative periodogram
107 q=(nobs/2)+1;
108 % Critical values of the Komogorov-Smirnov Test
109 crit=1.36/(sqrt(q));
110 linea=freq*2; % to create the diagonal from 0,0 to 0.5,1
111 cuper=cumsum(power); % accumulates the intensities
112 cupera=cuper./max(cuper) ; % divides the intensities by total sum so that curve ...
goes up to 1
113
114 % cupera = cupera(2:q,1);
115 % linea = linea(2:q,1);
116 % freq = freq(2:q,1);
117
118 % It should be noted that this is a slightly incorrect implementation of the ...
calculation described by Nectow et. al. because it includes a point (0,0), or ...
(0,0+delta), as the DC portion of the signal. This is not required in the NCP ...
criterion and may propagate errors when using the Kolmogorov Smirnov test, ...
this point should therefore be removed by post processing.
119
120 % Calculated the linear cumulative distribution function for kstest
121 LCDF = cat(2,linea',freq');
122
123 % The Komogorov Smirnov test, this returns a p-value, however this isn't useful, ...
the critical-value, cv is (this should be ˜=crit).
124 [h,p,ksstat,cv] = kstest(cupera,LCDF,0.05);
125
126 disp(' ')
127 disp(' ')
128 disp('Results')
129 disp(' h p ksstat cv')
130 disp([h,p,ksstat,cv])
131
132 if any(or(cupera > linea' + crit' , cupera < linea' - crit'))
133
134 uniform = 'NCP diverges from uniform (95%CI).';
135 disp(uniform);
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136
137 else
138
139 uniform = 'NCP does not diverge from uniform (95%CI).';
140 disp(uniform);
141
142 end
143
144 % Calculating Mean-Median divergence.
145 for k=1:length(Vector),
146 Vector_mean(k)=mean(Vector(1:k));
147 end;
148
149 for k=1:length(Vector),
150 Vector_median(k)=median(Vector(1:k));
151 end;
152
153 % This test is intended to be a cycle from k=1:k=length(Diff_Vector) to determine ...
the point at which the index flips from within 95%CIs to outside 95%CIs. This ...
script requires that perio.m is run on all the data first. Alternatively, this ...
script can be copied into the end of perio.m (perio.m is obsolete in this ...
version) to run simultaneous, in this case cut and acut could be output ...
alongside h, p, kstat & cv.
154
155 sumtruth = zeros(size(Diff_Vector));
156
157 for k=1:(length(Diff_Vector))
158
159 % Diff_Vector = Diff_Vector';
160
161 seriesl=Diff_Vector(1:k,1);
162
163 % IMPORTANT: NO MORE INPUT IS NEEDED - 'series' is sufficient
164
165 nobsl=length(seriesl); % identifies number of observations in series
166
167 % calculates the periodogram
168 sugarml=seriesl-mean(seriesl); % substracts the mean of the series
169 Ytotl=fft(sugarml) ; % finds the Fast Fourier Transform
170 n=length(Ytotl) ;
171 n2=floor(n/2)+1; % Floor added to prevent warnings when n2 is index
172 powerl=(abs(Ytotl(1:n2)).ˆ2)/n; % calculates intensities
173 nyquistl=1/2;
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174 pfreql=(0:1:n/2);
175 largofrel=length(pfreql)-1;
176 freql=pfreql/(largofrel)*nyquistl;
177 mpowl=max(powerl); % finds the maximum intensity
178 pmaxl=1.1*mpowl ;
179 indextotl=find(powerl==max(powerl)); % identifies the frequency with the ...
maximum intensity
180 indfreql = freql(indextotl);
181 iperiodl = ones(size(indfreql))/indfreql;
182
183 indtextl=indfreql+0.01 ;
184
185 % calculates cumulative periodogram
186 ql=(nobsl/2)+1;
187 % Critical values of the Komogorov-Smirnov Test
188 critl=1.36/(sqrt(ql));
189 lineal=freql*2; % to create the diagonal from 0,0 to 0.5,1
190 cuperl=cumsum(powerl); % accumulates the intensities
191 cuperal=cuperl./max(cuperl) ; % divides the intensities by total sum so ...
that curve goes up to 1
192
193 % cupera = cupera(2:q,1);
194 % linea = linea(2:q,1);
195 % freq = freq(2:q,1);
196
197 % It should be noted that this is a slightly incorrect implementation ...
because it includes a point (0,0), or (0,0+delta), as the DC portion ...
of the signal. This is not required in the NCP criterion and may ...
propagate errors when using the Kolmogorov Smirnov test, this point is ...
therefore be ignored in post processing.
198
199 % Determine whether the NCP for (1:k) has fallen within the critical ...
values. A value of 1 (TRUE) means the NCP has fallen outside the ...
critical values at a given point along its length.
200 truth = any(or(cuperal > lineal' + critl' , cuperal < lineal' - critl'));
201
202 sumtruth(k) = truth;
203
204 end
205
206
207
208 % Optional for statement: Knock out all but the multiples of ...
247
(length(sumtruth))/100). This reduces the sensitivity of the test, but reduces ...
suprious errors according to Nectow when used with small numbers of angles and ...
a cut off of ˜5. This is similar to the next optional statment, but is a more ...
generic implementation.
209 %
210 % for k=1:(length(sumtruth))
211 %
212 % if mod(k,floor((length(sumtruth))/100)) == 0 ;
213 %
214 % sumtruth(k) = sumtruth(k) ;
215 %
216 % else
217 %
218 % sumtruth(k) = 0 ;
219 %
220 % end
221 %
222 % end
223 %
224
225 % Optional for statement: Knock out all but the multiples of 5. This reduces the ...
sensitivity of the test, but reduces suprious errors according to Nectow when ...
used with small numbers of angles and a cut off of ˜5.
226
227 % for k=1:(length(sumtruth))
228 %
229 % if mod(k,5) == 0 ;
230 %
231 % sumtruth(k) = sumtruth(k) ;
232 %
233 % else
234 %
235 % sumtruth(k) = 0 ;
236 %
237 % end
238 %
239 %end
240 %
241
242 % Determine the point (k) at which the NCP has fallen outside the critical values. ...
The -5 is to account for the 5 angle steps introduced above, omitting it and ...
the previous "for" statement will give a more sensitive, but less specific answer.
243
248
244 cut = (find(sumtruth > 0.5, 1, 'first')) - 5;
245
246 % Report the angle at which the NCP falls outside the critical values.
247 acut = Vector((cut),1);
248
249 disp(' ')
250 disp('Results')
251 disp(' cut angle')
252 disp([cut,acut])
253 % end
254
255 % Graphing the ranked angle data.
256 jtime = 1:1:(nobs+1);
257 subplot(2,2,1)
258 plot(jtime,Vector','b')
259 axis([0,nobs,0,90])
260 xlabel('Neuronal Index','Fontsize',8)
261 ylabel('Angle (degrees)','Fontsize',8)
262 title('A. Ranked Angles','Fontsize',10)
263
264 % Graphing the series - ie. the Difference Vector
265 maxser=max(series); % identifies maximum value to determine max value of y axis
266 itime=1:1:nobs ; % creates the sequence 1,2, .
267 figure(1)
268 subplot(2,2,2) % partitions the figure to have sub plots (4 plots arrayed in a ...
2x2 pattern)
269 plot(itime,series,'b') % plots the time series
270 axis([0,nobs,0,maxser])
271 % (labels for graph and axes are specified in next 3 lines)
272 xlabel('Neuronal Index','Fontsize',8)
273 ylabel('Angle Difference (degrees)','Fontsize',8)
274 title('\it{B. Time Series}','Fontsize',10)
275
276 % Graphing the mean-median divergence
277 maxmean = max(Vector_mean);
278 maxmedian = max(Vector_median);
279 maxav = max([maxmean,maxmedian]);
280 maxav = ceil(maxav);
281 subplot(2,2,3)
282 plot(jtime,Vector_mean,'--r')
283 axis([0,nobs,0,maxav+5])
284 xlabel('Neuronal Index','Fontsize',8)
285 ylabel('Mean or Median (degrees)','Fontsize',8)
249
286 hold on
287 plot(jtime,Vector_median,'g')
288 hold off
289 title('\it{C. Mean-Median Divergence}','Fontsize',10)
290
291 % Graphing the Cumulative Periodogram
292 ktime=1:1:q ;
293 subplot(2,2,4) ;
294 plot(ktime,cupera,'g')
295 axis([0 q 0 1])
296 xlabel('Neuronal Index','Fontsize',8)
297 hold on
298 plot(ktime,linea,'--r')
299 plot(ktime,linea+crit,':r') % plots the bands
300 plot(ktime,linea-crit,':r')
301 % text(0.01,0.9,['p-value=', num2str(p)],'Fontsize',8);
302 text(1,0.9,['Critical value= ', num2str(cv) ],'Fontsize',8);
303 text(1,0.8,[uniform],'Fontsize',8);
304 text(1,0.7,['Critical angle (degrees)= ', num2str(acut) ],'Fontsize',8);
305 text(1,0.6,['Critical neurite= ', num2str(cut) ],'Fontsize',8);
306 hold off
307 title('\it{D. Cumulative Periodogram}','Fontsize',10)
308
309 % The following graph is optional and adds nothing of use in this case, it
310 % is given below, unquote if needed.
311
312 % % Graphing the intensity / frequency curve.
313 % subplot(2,2,3)
314 % plot(freq,power,'g') % plots the intensities vs. the frequencies
315 % axis([0,0.5,0,pmax])
316 % xlabel('frequency','Fontsize',8)
317 % title('\it{C. Periodogram}')
318 % text(indtext,mpow,['maximum at freq=', num2str(indfreq)],'Fontsize',8);
319 % text(indtext+0.01,0.9*mpow,['period=', num2str(iperiod) ],'Fontsize',8);
320 %
321 % end;
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Tables of p-values
HF Etched Surfaces
p-value (and
Bonferroni-Holm
cut-off)
Control 1 minute
HF etched
4 minute
HF etched
Control - 0.017
(0.025)
0.011
(0.017)
1 minute HF
etched
- 0.977
(0.05)
4 minute HF
etched
-
Table 33: Mann-Whitney U test results for number of cells on roughened surfaces. Polished control
surfaces, 1 minute HF etched surfaces, and 4 minute HF etched surfaces at 96 hours. pcut in brackets,
bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 1 minute
HF etched
4 minute
HF etched
Control - 0.558
(0.05)
0.001
(0.017)
1 minute HF
etched
- 0.001
(0.025)
4 minute HF
etched
-
Table 34: Mann-Whitney U test results for Neurite Number on roughened surfaces. Polished control
surfaces, 1 minute HF etched surfaces, and 4 minute HF etched surfaces at 96 hours. pcut in brackets,
bold values are statistically significant.
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p-value (and
Bonferroni-Holm
cut-off)
Control 1 minute
HF etched
4 minute
HF etched
Control - 0.001
(0.017)
0.001
(0.025)
1 minute HF
etched
- 0.001
(0.05)
4 minute HF
etched
-
Table 35: Mann-Whitney U test results for Neurite Length on roughened surfaces. Polished control
surfaces, 1 minute HF etched surfaces, and 4 minute HF etched surfaces at 96 hours. pcut in brackets,
bold values are statistically significant.
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Grooved Surfaces
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/10 30/30/5 15/30/10
Control - 0.007 (0.01) 0.045 (0.0125) 0.001 (0.008)
30/30/10 - 0.671 (0.05) 0.143 (0.017)
30/30/5 - 0.198 (0.025)
15/30/10 -
Table 36: Mann-Whitney U test results for number of cells on grooved surfaces. Polished control sur-
faces, 30/30/10, 30/30/5, and 15/30/10 grooved surfaces at 96 hours. pcut in brackets, bold values are
statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/10 30/30/5 15/30/10
Control - 0.021 (0.0125) 0.107 (0.025) 0.001 (0.017)
30/30/10 - 0.619 (0.05) 0.001 (0.01)
30/30/5 - 0.001 (0.008)
15/30/10 -
Table 37: Mann-Whitney U test results for neurite number on grooved surfaces. Polished control sur-
faces, 30/30/10, 30/30/5, and 15/30/10 grooved surfaces at 96 hours. pcut in brackets, bold values are
statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/10 30/30/5 15/30/10
Control - 0.001 (0.0125) 0.168 (0.05) 0.001 (0.017)
30/30/10 - 0.001 (0.025) 0.001 (0.01)
30/30/5 - 0.001 (0.008)
15/30/10 -
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Table 38: Mann-Whitney U test results for neurite alignment on grooved surfaces. Polished control
surfaces, 30/30/10, 30/30/5, and 15/30/10 grooved surfaces at 96 hours. pcut in brackets, bold values are
statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/10 30/30/5 15/30/10
Control - 0.947 (0.05) 0.001 (0.008) 0.041 (0.017)
30/30/10 - 0.001 (0.01) 0.038 (0.0125)
30/30/5 - 0.296 (0.025)
15/30/10 -
Table 39: Mann-Whitney U test results for neurite length on grooved surfaces. Polished control sur-
faces, 30/30/10, 30/30/5, and 15/30/10 grooved surfaces at 96 hours. pcut in brackets, bold values are
statistically significant.
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Multiscale Surfaces: Experiment 1
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/5 + 1
minute etch
30/30/5 1 minute etch
Control - 0.002 (0.017) 0.001 (0.01) 0.011 (0.025)
30/30/5 + 1
minute etch
- 0.548 (0.05) 0.001 (0.0125)
30/30/5 - 0.001 (0.008)
1 minute etch -
Table 40: Mann-Whitney U test results for neurite number on grooved surfaces. Polished control sur-
faces, 30/30/5 grooved surfaces, 1 minute HF etched surfaces and multiscale 30/30/5 grooved + 1 minute
HF etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 30/30/5 + 1
minute etch
30/30/5 1 minute etch
Control - 0.001 (0.0125) 0.001 (0.01) 0.742 (0.05)
30/30/5 + 1
minute etch
- 0.014 (0.025) 0.003 (0.017)
30/30/5 - 0.001 (0.008)
1 minute etch -
Table 41: Mann-Whitney U test results for neurite length on grooved surfaces. Polished control surfaces,
30/30/5 grooved surfaces, 1 minute HF etched surfaces and multiscale 30/30/5 grooved + 1 minute HF
etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
255
Multiscale Surfaces: Experiment 2
p-value (and
Bonferroni-Holm
cut-off)
Control 15/30/10 + 4
minute etch
15/30/10 4 minute etch
Control - 0.061 (0.025) 0.006 (0.017) 0.055 (0.0125)
15/30/10 + 4
minute etch
- 0.729 (0.05) 0.008 (0.01)
15/30/10 - 0.005 (0.008)
4 minute etch -
Table 42: Mann-Whitney U test results for number of cells on grooved surfaces. Polished control sur-
faces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10 grooved + 4
minute HF etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 15/30/10 + 4
minute etch
15/30/10 4 minute etch
Control - 0.001 (0.0125) 0.001 (0.01) 0.192 (0.05)
15/30/10 + 4
minute etch
- 0.006 (0.025) 0.001 (0.017)
15/30/10 - 0.001 (0.008)
4 minute etch -
Table 43: Mann-Whitney U test results for neurite number on grooved surfaces. Polished control sur-
faces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10 grooved + 4
minute HF etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
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p-value (and
Bonferroni-Holm
cut-off)
Control 15/30/10 + 4
minute etch
15/30/10 4 minute etch
Control - 0.001 (0.0125) 0.001 (0.01) 0.001 (0.008)
15/30/10 + 4
minute etch
- 0.231 (0.05) 0.001 (0.017)
15/30/10 - 0.044 (0.025)
4 minute etch -
Table 44: Mann-Whitney U test results for neurite length on grooved surfaces. Polished control surfaces,
30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10 grooved + 4 minute
HF etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
p-value (and
Bonferroni-Holm
cut-off)
Control 15/30/10 + 4
minute etch
15/30/10 4 minute etch
Control - 0.005 (0.0125) 0.001 (0.01) 0.917 (0.05)
15/30/10 + 4
minute etch
- 0.05 (0.025) 0.01 (0.017)
15/30/10 - 0.001 (0.008)
4 minute etch -
Table 45: Mann-Whitney U test results for neurite alignment on grooved surfaces. Polished control
surfaces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10 grooved + 4
minute HF etched surfaces at 96 hours. pcut in brackets, bold values are statistically significant.
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Protein Mixes on Multiscale Surfaces
Neurite Number Neurite Length Cell Number Neurite Alignment
p-Value 0.000 0.000 0.000 0.000
Table 46: Kruskal Wallis Test results for protein coated multiscale surfaces. Polished control surfaces,
30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10 grooved + 4 minute HF
etched surfaces coated with either 10 µg/cm2 Collagen-IV or CNL all-in-one at 96 hours. pcut = 0.05,
bold values are statistically significant.
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Table 47: Mann-Whitney U test results for number of cells on protein coated multiscale surfaces. Pol-
ished control surfaces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10
grooved + 4 minute HF etched surfaces coated with either 10 µg/cm2 Collagen-IV or CNL all-in-one at
96 hours. pcut in brackets, bold values are statistically significant. Some comparisons are not applicable
due to a change in two variables, these are noted by grey italicised values.
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Table 48: Mann-Whitney U test results for neurite number on protein coated multiscale surfaces. Pol-
ished control surfaces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10
grooved + 4 minute HF etched surfaces coated with either 10 µg/cm2 Collagen-IV or CNL all-in-one at
96 hours. pcut in brackets, bold values are statistically significant. Some comparisons are not applicable
due to a change in two variables, these are noted by grey italicised values.
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Table 49: Mann-Whitney U test results for neurite length on protein coated multiscale surfaces. Pol-
ished control surfaces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10
grooved + 4 minute HF etched surfaces coated with either 10 µg/cm2 Collagen-IV or CNL all-in-one at
96 hours. pcut in brackets, bold values are statistically significant. Some comparisons are not applicable
due to a change in two variables, these are noted by grey italicised values.
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Table 50: Mann-Whitney U test results for neurite angle on protein coated multiscale surfaces. Pol-
ished control surfaces, 30/15/10 grooved surfaces, 4 minute HF etched surfaces and multiscale 30/15/10
grooved + 4 minute HF etched surfaces coated with either 10 µg/cm2 Collagen-IV or CNL all-in-one at
96 hours. pcut in brackets, bold values are statistically significant. Some comparisons are not applicable
due to a change in two variables, these are noted by grey italicised values.
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